From 7eb79058ab1e1fdda7d0d2bb476155e64d96c556 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Thu, 25 Jul 2024 11:12:25 +0200
Subject: [PATCH 01/22] Add voluntary forms to expected notice subtypes
 (TEDEFO-3556)

Also add the corresponding NTDs in the unit test data.
---
 .../analysis/fact/NoticeTypesIndexFact.java   |  3 +-
 .../tedefo-2578/invalid/notice-types/E1.json  | 48 +++++++++++++++++
 .../tedefo-2578/invalid/notice-types/E2.json  | 48 +++++++++++++++++
 .../tedefo-2578/invalid/notice-types/E3.json  | 48 +++++++++++++++++
 .../tedefo-2578/invalid/notice-types/E4.json  | 48 +++++++++++++++++
 .../tedefo-2578/invalid/notice-types/E5.json  | 48 +++++++++++++++++
 .../tedefo-2578/invalid/notice-types/E6.json  | 48 +++++++++++++++++
 .../invalid/notice-types/notice-types.json    | 54 +++++++++++++++++++
 .../tedefo-2578/valid/notice-types/E1.json    | 48 +++++++++++++++++
 .../tedefo-2578/valid/notice-types/E2.json    | 48 +++++++++++++++++
 .../tedefo-2578/valid/notice-types/E3.json    | 48 +++++++++++++++++
 .../tedefo-2578/valid/notice-types/E4.json    | 48 +++++++++++++++++
 .../tedefo-2578/valid/notice-types/E5.json    | 48 +++++++++++++++++
 .../tedefo-2578/valid/notice-types/E6.json    | 48 +++++++++++++++++
 .../valid/notice-types/notice-types.json      | 54 +++++++++++++++++++
 15 files changed, 686 insertions(+), 1 deletion(-)
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E1.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E2.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E3.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E4.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E5.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E6.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E1.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E2.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E3.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E4.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E5.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E6.json

diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/NoticeTypesIndexFact.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/NoticeTypesIndexFact.java
index 115adc3..079c53f 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/NoticeTypesIndexFact.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/NoticeTypesIndexFact.java
@@ -29,7 +29,8 @@ public Set<String> getExpectedNoticeSubtypes() {
           "20", "21", "22", "23", "24", "25", "26", "27", "28", "29",
           "30", "31", "32", "33", "34", "35", "36", "37", "38", "39",
           "40",
-          "CEI", "T01", "T02", "X01", "X02")
+          "CEI", "T01", "T02", "X01", "X02",
+          "E1", "E2", "E3", "E4", "E5", "E6")
         .collect(Collectors.toSet());
   }
 
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E1.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E1.json
new file mode 100644
index 0000000..b473848
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E1.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E1",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E2.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E2.json
new file mode 100644
index 0000000..b964082
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E2.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E2",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E3.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E3.json
new file mode 100644
index 0000000..dfb6e6b
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E3.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E3",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E4.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E4.json
new file mode 100644
index 0000000..c8ae741
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E4.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E4",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E5.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E5.json
new file mode 100644
index 0000000..c9ec70a
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E5.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E5",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E6.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E6.json
new file mode 100644
index 0000000..2656939
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/E6.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E6",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/notice-types.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/notice-types.json
index c5967ed..a176514 100644
--- a/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/notice-types.json
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/invalid/notice-types/notice-types.json
@@ -392,6 +392,60 @@
     "subTypeId" : "X02",
     "_label" : "notice|name|X02",
     "viewTemplateIds" : [ "summary", "X02" ]
+  }, {
+    "documentType" : "PIN",
+    "legalBasis" : "other",
+    "formType" : "planning",
+    "type" : "pin-only",
+    "description" : "Voluntary Pre-market Consultation Notice",
+    "subTypeId" : "E1",
+    "_label" : "notice|name|E1",
+    "viewTemplateIds" : [ "summary", "E1" ]
+  }, {
+    "documentType" : "PIN",
+    "legalBasis" : "other",
+    "formType" : "planning",
+    "type" : "pin-only",
+    "description" : "Voluntary Prior Information Notice",
+    "subTypeId" : "E2",
+    "_label" : "notice|name|E2",
+    "viewTemplateIds" : [ "summary", "E2" ]
+  }, {
+    "documentType" : "CN",
+    "legalBasis" : "other",
+    "formType" : "competition",
+    "type" : "cn-standard",
+    "description" : "Voluntary Contract Notice",
+    "subTypeId" : "E3",
+    "_label" : "notice|name|E3",
+    "viewTemplateIds" : [ "summary", "E3" ]
+  }, {
+    "documentType" : "CAN",
+    "legalBasis" : "other",
+    "formType" : "result",
+    "type" : "can-standard",
+    "description" : "Voluntary Award Notice",
+    "subTypeId" : "E4",
+    "_label" : "notice|name|E4",
+    "viewTemplateIds" : [ "summary", "E4" ]
+  }, {
+    "documentType" : "CAN",
+    "legalBasis" : "other",
+    "formType" : "completion",
+    "type" : "",
+    "description" : "Voluntary Completion Notice",
+    "subTypeId" : "E5",
+    "_label" : "notice|name|E5",
+    "viewTemplateIds" : [ "summary", "E5" ]
+  }, {
+    "documentType" : "CAN",
+    "legalBasis" : "other",
+    "formType" : "cont-modif",
+    "type" : "can-modif",
+    "description" : "Voluntary Contract Modification Notice",
+    "subTypeId" : "E6",
+    "_label" : "notice|name|E6",
+    "viewTemplateIds" : [ "summary", "E6" ]
   } ],
   "documentTypes" : [ {
     "id" : "BRIN",
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E1.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E1.json
new file mode 100644
index 0000000..b473848
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E1.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E1",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E2.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E2.json
new file mode 100644
index 0000000..b964082
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E2.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E2",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E3.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E3.json
new file mode 100644
index 0000000..dfb6e6b
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E3.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E3",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E4.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E4.json
new file mode 100644
index 0000000..c8ae741
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E4.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E4",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E5.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E5.json
new file mode 100644
index 0000000..c9ec70a
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E5.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E5",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E6.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E6.json
new file mode 100644
index 0000000..2656939
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/E6.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "E6",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/notice-types.json b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/notice-types.json
index 66ec2ec..c5b38d6 100644
--- a/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/notice-types.json
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2578/valid/notice-types/notice-types.json
@@ -410,6 +410,60 @@
     "subTypeId" : "X02",
     "_label" : "notice|name|X02",
     "viewTemplateIds" : [ "summary", "X02" ]
+  }, {
+    "documentType" : "PIN",
+    "legalBasis" : "other",
+    "formType" : "planning",
+    "type" : "pin-only",
+    "description" : "Voluntary Pre-market Consultation Notice",
+    "subTypeId" : "E1",
+    "_label" : "notice|name|E1",
+    "viewTemplateIds" : [ "summary", "E1" ]
+  }, {
+    "documentType" : "PIN",
+    "legalBasis" : "other",
+    "formType" : "planning",
+    "type" : "pin-only",
+    "description" : "Voluntary Prior Information Notice",
+    "subTypeId" : "E2",
+    "_label" : "notice|name|E2",
+    "viewTemplateIds" : [ "summary", "E2" ]
+  }, {
+    "documentType" : "CN",
+    "legalBasis" : "other",
+    "formType" : "competition",
+    "type" : "cn-standard",
+    "description" : "Voluntary Contract Notice",
+    "subTypeId" : "E3",
+    "_label" : "notice|name|E3",
+    "viewTemplateIds" : [ "summary", "E3" ]
+  }, {
+    "documentType" : "CAN",
+    "legalBasis" : "other",
+    "formType" : "result",
+    "type" : "can-standard",
+    "description" : "Voluntary Award Notice",
+    "subTypeId" : "E4",
+    "_label" : "notice|name|E4",
+    "viewTemplateIds" : [ "summary", "E4" ]
+  }, {
+    "documentType" : "CAN",
+    "legalBasis" : "other",
+    "formType" : "completion",
+    "type" : "",
+    "description" : "Voluntary Completion Notice",
+    "subTypeId" : "E5",
+    "_label" : "notice|name|E5",
+    "viewTemplateIds" : [ "summary", "E5" ]
+  }, {
+    "documentType" : "CAN",
+    "legalBasis" : "other",
+    "formType" : "cont-modif",
+    "type" : "can-modif",
+    "description" : "Voluntary Contract Modification Notice",
+    "subTypeId" : "E6",
+    "_label" : "notice|name|E6",
+    "viewTemplateIds" : [ "summary", "E6" ]
   } ],
   "documentTypes" : [ {
     "id" : "BRIN",

From 7776e5edf2495c7e418753ef7c7214983c277eae Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 9 Aug 2024 10:05:59 +0200
Subject: [PATCH 02/22] pom: Update to latest releases of eforms-core-java and
 efx-toolkit

---
 pom.xml | 4 ++--
 1 file changed, 2 insertions(+), 2 deletions(-)

diff --git a/pom.xml b/pom.xml
index 633c25c..81130aa 100644
--- a/pom.xml
+++ b/pom.xml
@@ -36,8 +36,8 @@
     <maven.compiler.source>${java.version}</maven.compiler.source>
     <maven.compiler.target>${java.version}</maven.compiler.target>
 
-    <version.eforms-core-java>1.4.0-SNAPSHOT</version.eforms-core-java>
-    <version.efx-toolkit>2.0.0-SNAPSHOT</version.efx-toolkit>
+    <version.eforms-core-java>1.4.0</version.eforms-core-java>
+    <version.efx-toolkit>2.0.0-alpha.4</version.efx-toolkit>
 
     <!-- Version - Third-party libraries -->
     <version.commons-collections4>4.4</version.commons-collections4>

From ee56149219afb277a4548bd07cc523a337bd33ba Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 9 Aug 2024 13:55:21 +0200
Subject: [PATCH 03/22] pom: Fix property names for maven plugin versions

Also update to the latest version.
---
 pom.xml | 8 ++++----
 1 file changed, 4 insertions(+), 4 deletions(-)

diff --git a/pom.xml b/pom.xml
index 81130aa..54a521c 100644
--- a/pom.xml
+++ b/pom.xml
@@ -58,8 +58,8 @@
     <version.xmlschema>2.3.0</version.xmlschema>
 
     <!-- Versions - Plugins -->
-    <version.compiler.version>3.10.1</version.compiler.version>
-    <version.compiler.plugin>3.3.0</version.compiler.plugin>
+    <version.compiler.plugin>3.13.0</version.compiler.plugin>
+    <version.shade.plugin>3.6.0</version.shade.plugin>
   </properties>
 
   <dependencyManagement>
@@ -384,12 +384,12 @@
         <plugin>
           <groupId>org.apache.maven.plugins</groupId>
           <artifactId>maven-compiler-plugin</artifactId>
-          <version>${version.compiler.version}</version>
+          <version>${version.compiler.plugin}</version>
         </plugin>
         <plugin>
           <groupId>org.apache.maven.plugins</groupId>
           <artifactId>maven-shade-plugin</artifactId>
-          <version>${version.compiler.plugin}</version>
+          <version>${version.shade.plugin}</version>
         </plugin>
         <plugin>
           <groupId>org.kie</groupId>

From e3ad5e163e8f65face0c84d8a2fea3f1ec335b82 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 9 Aug 2024 14:47:03 +0200
Subject: [PATCH 04/22] pom: Ensure kie-maven-plugin compiles using the
 expected Java version

This plugin seems to only use the maven.compiler.source property.
---
 pom.xml | 3 ++-
 1 file changed, 2 insertions(+), 1 deletion(-)

diff --git a/pom.xml b/pom.xml
index 54a521c..6e50bc6 100644
--- a/pom.xml
+++ b/pom.xml
@@ -33,6 +33,7 @@
 
     <java.version>11</java.version>
 
+    <maven.compiler.release>${java.version}</maven.compiler.release>
     <maven.compiler.source>${java.version}</maven.compiler.source>
     <maven.compiler.target>${java.version}</maven.compiler.target>
 
@@ -43,7 +44,7 @@
     <version.commons-collections4>4.4</version.commons-collections4>
     <version.commons-lang3>3.12.0</version.commons-lang3>
     <version.cucumber>7.11.1</version.cucumber>
-    <version.drools>8.44.0.Final</version.drools>
+    <version.drools>8.44.2.Final</version.drools>
     <version.istack>3.0.11</version.istack>
     <version.jackson>2.14.1</version.jackson>
     <version.jaxb-bind-api>4.0.0</version.jaxb-bind-api>

From 07e28cab967c8df301f04f1ce60982b5ed49b35b Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 9 Aug 2024 17:29:32 +0200
Subject: [PATCH 05/22] schematron: Load more data from the schematron files

---
 .../domain/schematron/SchematronAssert.java   |  9 ++
 .../schematron/SchematronDiagnostic.java      | 13 +++
 .../domain/schematron/SchematronFile.java     | 38 ++++++--
 .../domain/schematron/SchematronPattern.java  | 13 +++
 .../domain/schematron/SchematronPhase.java    | 25 +++++
 .../sdk/analysis/fact/SchematronFileFact.java | 15 +++
 .../sdk/analysis/util/SchematronParser.java   | 91 ++++++++++++++++---
 7 files changed, 185 insertions(+), 19 deletions(-)
 create mode 100644 src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronDiagnostic.java
 create mode 100644 src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronPattern.java
 create mode 100644 src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronPhase.java

diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronAssert.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronAssert.java
index 276d6da..f2b541d 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronAssert.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronAssert.java
@@ -2,6 +2,7 @@
 
 public class SchematronAssert {
   private final String id;
+  private String diagnostics;
 
   public SchematronAssert(String id) {
     this.id = id;
@@ -10,4 +11,12 @@ public SchematronAssert(String id) {
   public String getId() {
     return id;
   }
+
+  public String getDiagnostics() {
+    return diagnostics;
+  }
+
+  public void setDiagnostics(String diagnostics) {
+    this.diagnostics = diagnostics;
+  }
 }
diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronDiagnostic.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronDiagnostic.java
new file mode 100644
index 0000000..f9ac97d
--- /dev/null
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronDiagnostic.java
@@ -0,0 +1,13 @@
+package eu.europa.ted.eforms.sdk.analysis.domain.schematron;
+
+public class SchematronDiagnostic {
+  private final String id;
+
+  public SchematronDiagnostic(String id) {
+    this.id = id;
+  }
+
+  public String getId() {
+    return id;
+  }
+}
diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronFile.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronFile.java
index 799beb3..4d209cd 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronFile.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronFile.java
@@ -5,22 +5,48 @@
 
 public class SchematronFile {
   private final Path path;
-  private final List<SchematronAssert> asserts;
+  private List<SchematronPhase> phases;
+  private List<SchematronPattern> patterns;
+  private List<SchematronDiagnostic> diagnostics;
+  private List<SchematronAssert> asserts;
 
   public SchematronFile(Path path) {
-    this(path, null);
-  }
-
-  public SchematronFile(Path path, List<SchematronAssert> asserts) {
     this.path = path;
-    this.asserts = asserts;
   }
 
   public Path getPath() {
     return path;
   }
 
+  public List<SchematronPhase> getPhases() {
+    return phases;
+  }
+
+  public void setPhases(List<SchematronPhase> phases) {
+    this.phases = phases;
+  }
+
+  public List<SchematronPattern> getPatterns() {
+    return patterns;
+  }
+
+  public void setPatterns(List<SchematronPattern> patterns) {
+    this.patterns = patterns;
+  }
+
+  public List<SchematronDiagnostic> getDiagnostics() {
+    return diagnostics;
+  }
+
+  public void setDiagnostics(List<SchematronDiagnostic> diagnostics) {
+    this.diagnostics = diagnostics;
+  }
+
   public List<SchematronAssert> getAsserts() {
     return asserts;
   }
+
+  public void setAsserts(List<SchematronAssert> asserts) {
+    this.asserts = asserts;
+  }
 }
diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronPattern.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronPattern.java
new file mode 100644
index 0000000..58a921c
--- /dev/null
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronPattern.java
@@ -0,0 +1,13 @@
+package eu.europa.ted.eforms.sdk.analysis.domain.schematron;
+
+public class SchematronPattern {
+  private final String id;
+
+  public SchematronPattern(String id) {
+    this.id = id;
+  }
+
+  public String getId() {
+    return id;
+  }
+}
diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronPhase.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronPhase.java
new file mode 100644
index 0000000..ba9e6cc
--- /dev/null
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/domain/schematron/SchematronPhase.java
@@ -0,0 +1,25 @@
+package eu.europa.ted.eforms.sdk.analysis.domain.schematron;
+
+import java.util.ArrayList;
+import java.util.List;
+
+public class SchematronPhase {
+  private final String id;
+  private final List<String> activePatterns = new ArrayList<>();
+
+  public SchematronPhase(String id) {
+    this.id = id;
+  }
+
+  public String getId() {
+    return id;
+  }
+
+  public List<String> getActivePatterns() {
+    return activePatterns;
+  }
+
+  public void addActivePattern(String patternId) {
+    activePatterns.add(patternId);
+  }
+}
diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/SchematronFileFact.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/SchematronFileFact.java
index 7ac28ea..76be4ad 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/SchematronFileFact.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/SchematronFileFact.java
@@ -6,7 +6,10 @@
 import java.util.stream.Collectors;
 
 import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronAssert;
+import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronDiagnostic;
 import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronFile;
+import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronPattern;
+import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronPhase;
 
 /**
  * Represents a complete set of schematron rules.
@@ -25,6 +28,18 @@ public List<SchematronAssert> getAsserts() {
     return schematronFile.getAsserts();
   }
 
+  public List<SchematronDiagnostic> getDiagnostics() {
+    return schematronFile.getDiagnostics();
+  }
+
+  public List<SchematronPhase> getPhases() {
+    return schematronFile.getPhases();
+  }
+
+  public List<SchematronPattern> getPatterns() {
+    return schematronFile.getPatterns();
+  }
+
   public List<String> getDuplicateAssertIds() {
     Set<String> set = new HashSet<String>();
     return getAsserts().stream().map(SchematronAssert::getId).filter(id -> !set.add(id))
diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/util/SchematronParser.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/util/SchematronParser.java
index 8b88582..1a2cbf9 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/util/SchematronParser.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/util/SchematronParser.java
@@ -4,6 +4,7 @@
 import java.util.ArrayList;
 import java.util.List;
 import java.util.Locale;
+import java.util.stream.Collectors;
 
 import org.slf4j.Logger;
 import org.slf4j.LoggerFactory;
@@ -15,9 +16,13 @@
 import com.helger.xml.microdom.IMicroDocument;
 import com.helger.xml.microdom.IMicroElement;
 import com.helger.xml.microdom.IMicroNode;
+import com.helger.xml.microdom.serialize.MicroReader;
 
 import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronAssert;
+import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronDiagnostic;
 import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronFile;
+import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronPattern;
+import eu.europa.ted.eforms.sdk.analysis.domain.schematron.SchematronPhase;
 
 public class SchematronParser {
   private static final Logger logger = LoggerFactory.getLogger(SchematronParser.class);
@@ -27,32 +32,92 @@ private SchematronParser() {}
   public static SchematronFile loadSchematronFile(Path schematronFilePath) {
     logger.debug("Loading Schematron file " + schematronFilePath.toString());
 
+    SchematronFile schematronFile = new SchematronFile(schematronFilePath);
+
     IReadableResource schematron = new FileSystemResource(schematronFilePath);
+
+    final IMicroDocument doc = MicroReader.readMicroXML(schematron);
+    if (doc == null || doc.getAllChildren() == null) {
+      logger.error("Schematron file {} could not be loaded as XML", schematronFilePath);
+      return null;
+    }
+    List<IMicroNode> children = doc.getAllChildrenRecursive();
+    if (children == null) {
+      logger.error("Schematron file {} has unexpected structure", schematronFilePath);
+      return null;
+    }
+
+    // Parse phase definitions
+    List<SchematronPhase> phases = new ArrayList<>();
+    children.stream()
+        .filter(node -> node.isElement() && "phase".equals(node.getNodeName()))
+        .forEach(node -> {
+          IMicroElement element = (IMicroElement)node;
+          String id = element.getAttributeValue("id");
+          SchematronPhase phase = new SchematronPhase(id);
+          List<IMicroNode> phaseRefs = element.getAllChildren();
+          if (phaseRefs == null) {
+            logger.error("Incorrect definition for phase {}", id);
+            return;
+          }
+          phaseRefs.stream()
+              .filter(n -> n.isElement() && "active".equals(n.getNodeName()))
+              .map(n -> ((IMicroElement)n).getAttributeValue("pattern"))
+              .forEach(s -> phase.addActivePattern(s));
+
+          phases.add(phase);
+        });
+
+    schematronFile.setPhases(phases);
+
+    // Parse list diagnostic definitions
+    List<SchematronDiagnostic> diagnostics = children.stream()
+        .filter(node -> node.isElement() && "diagnostic".equals(node.getNodeName()))
+        .map(n -> ((IMicroElement)n).getAttributeValue("id"))
+        .map(s -> new SchematronDiagnostic(s))
+        .collect(Collectors.toList());
+
+    schematronFile.setDiagnostics(diagnostics);
+
     // Resolve all included files, so that they also get loaded.
-    final IMicroDocument doc = SchematronHelper.getWithResolvedSchematronIncludes(schematron,
+    final IMicroDocument docResolved = SchematronHelper.getWithResolvedSchematronIncludes(schematron,
         e -> handleError(e, schematronFilePath));
 
-    if (doc == null) {
-      logger.error("Schematron file {} could not be loaded as XML", schematronFilePath);
+    if (docResolved == null) {
+      logger.error("Schematron file {} with resolved includes could not be loaded as XML",
+          schematronFilePath);
       return null;
     }
 
-    List<SchematronAssert> asserts = new ArrayList<>();
-    List<IMicroNode> allChildren = doc.getAllChildrenRecursive();
+    List<IMicroNode> allChildren = docResolved.getAllChildrenRecursive();
     if (allChildren == null) {
       logger.error("Schematron file {} does not have the expected content", schematronFilePath);
       return null;
     }
+    
+    // Parse all patterns
+    List<SchematronPattern> patterns = allChildren.stream()
+        .filter(node -> node.isElement() && "pattern".equals(node.getNodeName()))
+        .map(n -> ((IMicroElement)n).getAttributeValue("id"))
+        .map(s -> new SchematronPattern(s))
+        .collect(Collectors.toList());
 
-    for (IMicroNode node : allChildren) {
-      if (node != null && node.isElement() && "assert".equals(node.getNodeName())) {
-        IMicroElement element = (IMicroElement)node;
-        SchematronAssert schAssert = new SchematronAssert(element.getAttributeValue("id"));
-        asserts.add(schAssert);
-      }
-    }
+    schematronFile.setPatterns(patterns);
+
+    // Parse all asserts
+    List<SchematronAssert> asserts = new ArrayList<>();
+    allChildren.stream()
+        .filter(node -> node.isElement() && "assert".equals(node.getNodeName()))
+        .forEach(n -> {
+          IMicroElement element = (IMicroElement)n;
+          String id = element.getAttributeValue("id");
+          SchematronAssert schematronAssert = new SchematronAssert(id);
+          String diag = element.getAttributeValue("diagnostics");
+          schematronAssert.setDiagnostics(diag);
+          asserts.add(schematronAssert);
+        });
 
-    SchematronFile schematronFile = new SchematronFile(schematronFilePath, asserts);
+    schematronFile.setAsserts(asserts);
 
     return schematronFile;
   }

From ec9288e3c0b0e30f75b80f30f858b40150b16b1c Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 9 Aug 2024 17:37:37 +0200
Subject: [PATCH 06/22] Add consistency checks for schematron files
 (TEDEFO-2768)

---
 .../sdk/analysis/drools/schematronRules.drl   |  25 ++
 .../tedefo-2768/invalid/notice-types/1.json   |  48 +++
 .../tedefo-2768/invalid/notice-types/16.json  |  48 +++
 .../invalid/notice-types/notice-types.json    | 148 ++++++++
 .../dynamic/complete-validation.sch           | 317 +++++++++++++++++
 .../invalid/schematrons/dynamic/config.sch    |   5 +
 .../dynamic/validation-stage-1a.sch           |  21 ++
 .../dynamic/validation-stage-1b-1.sch         |  40 +++
 .../dynamic/validation-stage-1b-16.sch        |  85 +++++
 .../static/complete-validation.sch            | 316 +++++++++++++++++
 .../static/validation-stage-1a.sch            |  21 ++
 .../static/validation-stage-1b-1.sch          |  40 +++
 .../static/validation-stage-1b-16.sch         |  85 +++++
 .../tedefo-2768/valid/notice-types/1.json     |  48 +++
 .../tedefo-2768/valid/notice-types/16.json    |  48 +++
 .../valid/notice-types/notice-types.json      | 148 ++++++++
 .../dynamic/complete-validation.sch           | 318 ++++++++++++++++++
 .../valid/schematrons/dynamic/config.sch      |   5 +
 .../dynamic/validation-stage-1a.sch           |  21 ++
 .../dynamic/validation-stage-1b-1.sch         |  40 +++
 .../dynamic/validation-stage-1b-16.sch        |  85 +++++
 .../static/complete-validation.sch            | 316 +++++++++++++++++
 .../static/validation-stage-1a.sch            |  21 ++
 .../static/validation-stage-1b-1.sch          |  40 +++
 .../static/validation-stage-1b-16.sch         |  85 +++++
 .../sdk/analysis/cucumber/tedefo-2768.feature |  31 ++
 26 files changed, 2405 insertions(+)
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/1.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/16.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/notice-types.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/complete-validation.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/config.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1a.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1b-1.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1b-16.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/complete-validation.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1a.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1b-1.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1b-16.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/1.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/16.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/notice-types.json
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/complete-validation.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/config.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1a.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1b-1.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1b-16.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/complete-validation.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1a.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1b-1.sch
 create mode 100644 src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1b-16.sch
 create mode 100644 src/test/resources/eu/europa/ted/eforms/sdk/analysis/cucumber/tedefo-2768.feature

diff --git a/src/main/resources/eu/europa/ted/eforms/sdk/analysis/drools/schematronRules.drl b/src/main/resources/eu/europa/ted/eforms/sdk/analysis/drools/schematronRules.drl
index f8a6af4..900e180 100644
--- a/src/main/resources/eu/europa/ted/eforms/sdk/analysis/drools/schematronRules.drl
+++ b/src/main/resources/eu/europa/ted/eforms/sdk/analysis/drools/schematronRules.drl
@@ -15,3 +15,28 @@ when
 then
   results.add(new ValidationResult($sch, "Schematron contains duplicate assert ids: " + $duplicates, ValidationStatusEnum.ERROR));
 end
+
+rule "All expected phases are present"
+when
+  /schematrons[ $sch: this, $schId: id ];
+  /noticeTypes[ $expected: id ]
+  not (exists /schematrons[ id == $schId ]/phases[ id == "eforms-" + $expected ])
+then
+  results.add(new ValidationResult($sch, "Schematron is missing phase for: " + $expected, ValidationStatusEnum.ERROR));
+end
+
+rule "Every pattern is part of at least one phase"
+when
+  /schematrons[ $sch: this, $schId: id ]/patterns[ $patternId: id ]
+  not (exists /schematrons[ id == $schId ]/phases[ activePatterns contains $patternId ])
+then
+  results.add(new ValidationResult($sch, "Schematron has pattern that is not part of any phase: " + $patternId, ValidationStatusEnum.ERROR));
+end
+
+rule "Every assert diagnostics is defined in the schematron file"
+when
+  /schematrons[ $sch: this, $schId: id ]/asserts[ $diagnosticId: diagnostics, diagnostics != null ]
+  not (exists /schematrons[ id == $schId ]/diagnostics[ id == $diagnosticId ])
+then
+  results.add(new ValidationResult($sch, "Schematron is missing diagnostic definitions for: " + $diagnosticId, ValidationStatusEnum.ERROR));
+end
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/1.json b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/1.json
new file mode 100644
index 0000000..f4a8a55
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/1.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "1",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/16.json b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/16.json
new file mode 100644
index 0000000..d5a465c
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/16.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "16",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/notice-types.json b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/notice-types.json
new file mode 100644
index 0000000..13d7343
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/notice-types/notice-types.json
@@ -0,0 +1,148 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeSubTypes" : [ {
+    "documentType" : "PIN",
+    "legalBasis" : "32014L0024",
+    "formType" : "planning",
+    "type" : "pin-buyer",
+    "description" : "Notice of the publication of a prior information notice on a buyer profile - general directive",
+    "subTypeId" : "1",
+    "_label" : "notice|name|1",
+    "viewTemplateIds" : [ "1", "summary" ]
+  }, {
+    "documentType" : "CN",
+    "legalBasis" : "32014L0024",
+    "formType" : "competition",
+    "type" : "cn-standard",
+    "description" : "Contract notice – general directive, standard regime",
+    "subTypeId" : "16",
+    "_label" : "notice|name|16",
+    "viewTemplateIds" : [ "16", "summary" ]
+  } ],
+  "documentTypes" : [ {
+    "id" : "BRIN",
+    "namespace" : "http://data.europa.eu/p27/eforms-business-registration-information-notice/1",
+    "rootElement" : "BusinessRegistrationInformationNotice",
+    "schemaLocation" : "schemas/maindoc/EFORMS-BusinessRegistrationInformationNotice.xsd",
+    "additionalNamespaces" : [ {
+      "prefix" : "cac",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "cbc",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonBasicComponents-2.3.xsd"
+    }, {
+      "prefix" : "ext",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonExtensionComponents-2.3.xsd"
+    }, {
+      "prefix" : "efext",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extensions/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionApex-2.3.xsd"
+    }, {
+      "prefix" : "efac",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "efbc",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionBasicComponents-2.3.xsd"
+    } ]
+  }, {
+    "id" : "CAN",
+    "namespace" : "urn:oasis:names:specification:ubl:schema:xsd:ContractAwardNotice-2",
+    "rootElement" : "ContractAwardNotice",
+    "schemaLocation" : "schemas/maindoc/UBL-ContractAwardNotice-2.3.xsd",
+    "additionalNamespaces" : [ {
+      "prefix" : "cac",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "cbc",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonBasicComponents-2.3.xsd"
+    }, {
+      "prefix" : "ext",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonExtensionComponents-2.3.xsd"
+    }, {
+      "prefix" : "efext",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extensions/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionApex-2.3.xsd"
+    }, {
+      "prefix" : "efac",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "efbc",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionBasicComponents-2.3.xsd"
+    } ]
+  }, {
+    "id" : "CN",
+    "namespace" : "urn:oasis:names:specification:ubl:schema:xsd:ContractNotice-2",
+    "rootElement" : "ContractNotice",
+    "schemaLocation" : "schemas/maindoc/UBL-ContractNotice-2.3.xsd",
+    "additionalNamespaces" : [ {
+      "prefix" : "cac",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "cbc",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonBasicComponents-2.3.xsd"
+    }, {
+      "prefix" : "ext",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonExtensionComponents-2.3.xsd"
+    }, {
+      "prefix" : "efext",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extensions/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionApex-2.3.xsd"
+    }, {
+      "prefix" : "efac",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "efbc",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionBasicComponents-2.3.xsd"
+    } ]
+  }, {
+    "id" : "PIN",
+    "namespace" : "urn:oasis:names:specification:ubl:schema:xsd:PriorInformationNotice-2",
+    "rootElement" : "PriorInformationNotice",
+    "schemaLocation" : "schemas/maindoc/UBL-PriorInformationNotice-2.3.xsd",
+    "additionalNamespaces" : [ {
+      "prefix" : "cac",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "cbc",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonBasicComponents-2.3.xsd"
+    }, {
+      "prefix" : "ext",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonExtensionComponents-2.3.xsd"
+    }, {
+      "prefix" : "efext",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extensions/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionApex-2.3.xsd"
+    }, {
+      "prefix" : "efac",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "efbc",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionBasicComponents-2.3.xsd"
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/complete-validation.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/complete-validation.sch
new file mode 100644
index 0000000..01ac52a
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/complete-validation.sch
@@ -0,0 +1,317 @@
+<?xml version="1.0" encoding="utf-8" ?>
+<!--File generated from metadata database-->
+<schema xmlns="http://purl.oclc.org/dsdl/schematron" queryBinding="xslt2">
+
+	<title>eForms schematron rules</title>
+	
+	<ns prefix="xs" uri="http://www.w3.org/2001/XMLSchema" />
+	<ns prefix="sch" uri="http://purl.oclc.org/dsdl/schematron" />
+	<ns prefix="cbc" uri='urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2' />
+	<ns prefix="cac" uri="urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2" />
+	<ns prefix="ext" uri="urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2" />
+	<ns prefix="efac" uri="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1" />
+	<ns prefix="efext" uri="http://data.europa.eu/p27/eforms-ubl-extensions/1" />
+	<ns prefix="efbc" uri="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1" />
+	<ns prefix="can" uri="urn:oasis:names:specification:ubl:schema:xsd:ContractAwardNotice-2" />
+	<ns prefix="cn" uri="urn:oasis:names:specification:ubl:schema:xsd:ContractNotice-2" />
+	<ns prefix="pin" uri="urn:oasis:names:specification:ubl:schema:xsd:PriorInformationNotice-2" />
+	<ns prefix="fn" uri="http://www.w3.org/2005/xpath-functions" />
+	
+	<let name="noticeSubType" value="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NoticeSubType/cbc:SubTypeCode/text()"/>
+
+	<!-- True if the current notice is a change notice. -->
+	<let name="isChangeNotice" value="boolean(/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Changes/efbc:ChangedNoticeIdentifier)"/>
+
+	<include href="config.sch"/>
+	
+	<phase id="eforms-1">
+		<active pattern="EFORMS-validation-stage-1a" />
+		<active pattern="EFORMS-validation-stage-1b-1" />
+	</phase>
+	<phase id="eforms-16BAD">
+		<active pattern="EFORMS-validation-stage-1a" />
+		<active pattern="EFORMS-validation-stage-1b-16" />
+	</phase>
+
+	<include href="validation-stage-1a.sch"/>
+	<include href="validation-stage-1b-1.sch"/>
+	<include href="validation-stage-1b-16.sch"/>
+
+	<diagnostics>
+		<diagnostic id="ND-AcceleratedProcedure" see="node:ND-AcceleratedProcedure">cac:ProcessJustification</diagnostic>
+		<diagnostic id="ND-AwardingTerms" see="node:ND-AwardingTerms">cac:AwardingTerms</diagnostic>
+		<diagnostic id="ND-AwardingTerms_BT-46-Lot" see="field:BT-46-Lot">cac:TechnicalCommitteePerson/cbc:FamilyName</diagnostic>
+		<diagnostic id="ND-BusinessAddress" see="node:ND-BusinessAddress">cac:PostalAddress</diagnostic>
+		<diagnostic id="ND-BusinessContact" see="node:ND-BusinessContact">cac:Contact</diagnostic>
+		<diagnostic id="ND-BusinessParty" see="node:ND-BusinessParty">cac:BusinessParty</diagnostic>
+		<diagnostic id="ND-BusinessParty_BT-501-Business-European" see="field:BT-501-Business-European">cac:PartyLegalEntity[cbc:CompanyID/@schemeName = 'EU']/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-BusinessParty_BT-501-Business-National" see="field:BT-501-Business-National">cac:PartyLegalEntity[cbc:CompanyID/@schemeName = 'national']/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-Buyer" see="node:ND-Buyer">cac:Party</diagnostic>
+		<diagnostic id="ND-Buyer_OPT-300-Procedure-SProvider" see="field:OPT-300-Procedure-SProvider">cac:ServiceProviderParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-Change" see="node:ND-Change">efac:Change</diagnostic>
+		<diagnostic id="ND-Company" see="node:ND-Company">efac:Company</diagnostic>
+		<diagnostic id="ND-Company_BT-16-Organization-Company" see="field:BT-16-Organization-Company">cac:PostalAddress/cbc:Department</diagnostic>
+		<diagnostic id="ND-Company_BT-501-Organization-Company" see="field:BT-501-Organization-Company">cac:PartyLegalEntity/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-Company_BT-502-Organization-Company" see="field:BT-502-Organization-Company">cac:Contact/cbc:Name</diagnostic>
+		<diagnostic id="ND-Company_BT-503-Organization-Company" see="field:BT-503-Organization-Company">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-Company_BT-506-Organization-Company" see="field:BT-506-Organization-Company">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-Company_BT-507-Organization-Company" see="field:BT-507-Organization-Company">cac:PostalAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-Company_BT-510_a_-Organization-Company" see="field:BT-510(a)-Organization-Company">cac:PostalAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-Company_BT-510_b_-Organization-Company" see="field:BT-510(b)-Organization-Company">cac:PostalAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-Company_BT-510_c_-Organization-Company" see="field:BT-510(c)-Organization-Company">cac:PostalAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-Company_BT-512-Organization-Company" see="field:BT-512-Organization-Company">cac:PostalAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-Company_BT-513-Organization-Company" see="field:BT-513-Organization-Company">cac:PostalAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-Company_BT-514-Organization-Company" see="field:BT-514-Organization-Company">cac:PostalAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-Company_BT-739-Organization-Company" see="field:BT-739-Organization-Company">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-ConcessionRevenue" see="node:ND-ConcessionRevenue">efac:ConcessionRevenue</diagnostic>
+		<diagnostic id="ND-ContractEUFunds" see="node:ND-ContractEUFunds">efac:Funding</diagnostic>
+		<diagnostic id="ND-ContractModification" see="node:ND-ContractModification">efac:ContractModification</diagnostic>
+		<diagnostic id="ND-ContractModification_BT-1501_s_-Contract" see="field:BT-1501(s)-Contract">efac:Change/efac:ChangedSection/efbc:ChangedSectionIdentifier</diagnostic>
+		<diagnostic id="ND-ContractingParty" see="node:ND-ContractingParty">cac:ContractingParty</diagnostic>
+		<diagnostic id="ND-CrossBorderLawUnpublish" see="node:ND-CrossBorderLawUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ExclusionGrounds" see="node:ND-ExclusionGrounds">cac:SpecificTendererRequirement</diagnostic>
+		<diagnostic id="ND-ExecutionRequirements" see="node:ND-ExecutionRequirements">cac:ContractExecutionRequirement</diagnostic>
+		<diagnostic id="ND-ExtendedDurationJustification" see="node:ND-ExtendedDurationJustification">efac:DurationJustification</diagnostic>
+		<diagnostic id="ND-FA" see="node:ND-FA">cac:FrameworkAgreement</diagnostic>
+		<diagnostic id="ND-Funding" see="node:ND-Funding">efac:Funding</diagnostic>
+		<diagnostic id="ND-GazetteReference" see="node:ND-GazetteReference">cac:AdditionalDocumentReference</diagnostic>
+		<diagnostic id="ND-GroupComposition" see="node:ND-GroupComposition">cac:LotsGroup</diagnostic>
+		<diagnostic id="ND-GroupComposition_BT-1375-Procedure" see="field:BT-1375-Procedure">cac:ProcurementProjectLotReference/cbc:ID[@schemeName='Lot']</diagnostic>
+		<diagnostic id="ND-InterestExpressionReceptionPeriod" see="node:ND-InterestExpressionReceptionPeriod">efac:InterestExpressionReceptionPeriod</diagnostic>
+		<diagnostic id="ND-LocalEntity" see="node:ND-LocalEntity">cac:PartyLegalEntity</diagnostic>
+		<diagnostic id="ND-LotAwardCriteria" see="node:ND-LotAwardCriteria">cac:AwardingCriterion</diagnostic>
+		<diagnostic id="ND-LotAwardCriteria_BT-539-Lot" see="field:BT-539-Lot">cac:SubordinateAwardingCriterion/cbc:AwardingCriterionTypeCode[@listName='award-criterion-type']</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionFixNumberUnpublish" see="node:ND-LotAwardCriterionFixNumberUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionNumberComplicatedUnpublish" see="node:ND-LotAwardCriterionNumberComplicatedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-FixedNumber" see="field:BT-541-Lot-FixedNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-fixed']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-ThresholdNumber" see="field:BT-541-Lot-ThresholdNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-WeightNumber" see="field:BT-541-Lot-WeightNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionTypeUnpublish" see="node:ND-LotAwardCriterionTypeUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotDistribution" see="node:ND-LotDistribution">cac:LotDistribution</diagnostic>
+		<diagnostic id="ND-LotDistribution_BT-330-Procedure" see="field:BT-330-Procedure">cac:LotsGroup/cbc:LotsGroupID</diagnostic>
+		<diagnostic id="ND-LotDuration" see="node:ND-LotDuration">cac:PlannedPeriod</diagnostic>
+		<diagnostic id="ND-LotEmploymentLegislation" see="node:ND-LotEmploymentLegislation">cac:EmploymentLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotEnvironmentalLegislation" see="node:ND-LotEnvironmentalLegislation">cac:EnvironmentalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotFiscalLegislation" see="node:ND-LotFiscalLegislation">cac:FiscalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5071-Lot" see="field:BT-5071-Lot">cac:Address/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_a_-Lot" see="field:BT-5101(a)-Lot">cac:Address/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_b_-Lot" see="field:BT-5101(b)-Lot">cac:Address/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_c_-Lot" see="field:BT-5101(c)-Lot">cac:Address/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5121-Lot" see="field:BT-5121-Lot">cac:Address/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5131-Lot" see="field:BT-5131-Lot">cac:Address/cbc:CityName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5141-Lot" see="field:BT-5141-Lot">cac:Address/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-727-Lot" see="field:BT-727-Lot">cac:Address/cbc:Region</diagnostic>
+		<diagnostic id="ND-LotPreviousPlanning" see="node:ND-LotPreviousPlanning">cac:NoticeDocumentReference</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument" see="node:ND-LotProcurementDocument">cac:CallForTendersDocumentReference</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument_BT-708-Lot" see="field:BT-708-Lot">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:OfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument_BT-737-Lot" see="field:BT-737-Lot">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NonOfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotProcurementScope" see="node:ND-LotProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-06-Lot" see="field:BT-06-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='strategic-procurement']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-262-Lot" see="field:BT-262-Lot">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-263-Lot" see="field:BT-263-Lot">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-271-Lot" see="field:BT-271-Lot">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-531-Lot" see="field:BT-531-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-754-Lot" see="field:BT-754-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='accessibility']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-774-Lot" see="field:BT-774-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='environmental-impact']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-775-Lot" see="field:BT-775-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='social-objective']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-776-Lot" see="field:BT-776-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='innovative-acquisition']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-805-Lot" see="field:BT-805-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='gpp-criteria']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotReservedParticipation" see="node:ND-LotReservedParticipation">cac:TendererQualificationRequest</diagnostic>
+		<diagnostic id="ND-LotReservedParticipation_BT-71-Lot" see="field:BT-71-Lot">cac:SpecificTendererRequirement[cbc:TendererRequirementTypeCode/@listName='reserved-procurement']/cbc:TendererRequirementTypeCode</diagnostic>
+		<diagnostic id="ND-LotResult" see="node:ND-LotResult">efac:LotResult</diagnostic>
+		<diagnostic id="ND-LotResultFAValues" see="node:ND-LotResultFAValues">efac:FrameworkAgreementValues</diagnostic>
+		<diagnostic id="ND-LotResult_BT-636-LotResult" see="field:BT-636-LotResult">efac:AppealRequestsStatistics[efbc:StatisticsCode/@listName='irregularity-type']/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_BT-712_a_-LotResult" see="field:BT-712(a)-LotResult">efac:AppealRequestsStatistics[efbc:StatisticsCode/@listName='review-type']/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_BT-759-LotResult" see="field:BT-759-LotResult">efac:ReceivedSubmissionsStatistics/efbc:StatisticsNumeric</diagnostic>
+		<diagnostic id="ND-LotResult_BT-760-LotResult" see="field:BT-760-LotResult">efac:ReceivedSubmissionsStatistics/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-301-LotResult-Financing" see="field:OPT-301-LotResult-Financing">cac:FinancingParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-301-LotResult-Paying" see="field:OPT-301-LotResult-Paying">cac:PayerParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-315-LotResult" see="field:OPT-315-LotResult">efac:SettledContract/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-320-LotResult" see="field:OPT-320-LotResult">efac:LotTender/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotReviewTerms" see="node:ND-LotReviewTerms">cac:AppealTerms</diagnostic>
+		<diagnostic id="ND-LotReviewTerms_BT-99-Lot" see="field:BT-99-Lot">cac:PresentationPeriod/cbc:Description</diagnostic>
+		<diagnostic id="ND-LotTender" see="node:ND-LotTender">efac:LotTender</diagnostic>
+		<diagnostic id="ND-LotTenderOriginCountry" see="node:ND-LotTenderOriginCountry">efac:Origin</diagnostic>
+		<diagnostic id="ND-LotTender_BT-191-Tender" see="field:BT-191-Tender">efac:Origin/efbc:AreaCode</diagnostic>
+		<diagnostic id="ND-LotTender_BT-779-Tender" see="field:BT-779-Tender">efac:AggregatedAmounts/cbc:PaidAmount</diagnostic>
+		<diagnostic id="ND-LotTender_BT-780-Tender" see="field:BT-780-Tender">efac:AggregatedAmounts/efbc:PaidAmountDescription</diagnostic>
+		<diagnostic id="ND-LotTender_BT-782-Tender" see="field:BT-782-Tender">efac:AggregatedAmounts/efbc:PenaltiesAmount</diagnostic>
+		<diagnostic id="ND-LotTender_OPP-030-Tender" see="field:OPP-030-Tender">efac:ContractTerm[not(efbc:TermCode/text()='all-rev-tic')][efbc:TermCode/@listName='contract-detail']/efbc:TermCode</diagnostic>
+		<diagnostic id="ND-LotTender_OPP-033-Tender" see="field:OPP-033-Tender">efac:ContractTerm[efbc:TermCode/@listName='rewards-penalties']/efbc:TermCode</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess" see="node:ND-LotTenderingProcess">cac:TenderingProcess</diagnostic>
+		<diagnostic id="ND-LotTenderingProcessExtension" see="node:ND-LotTenderingProcessExtension">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1251-Lot" see="field:BT-1251-Lot">cac:NoticeDocumentReference/cbc:ReferencedDocumentInternalAddress</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1311_d_-Lot" see="field:BT-1311(d)-Lot">cac:ParticipationRequestReceptionPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1311_t_-Lot" see="field:BT-1311(t)-Lot">cac:ParticipationRequestReceptionPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-131_d_-Lot" see="field:BT-131(d)-Lot">cac:TenderSubmissionDeadlinePeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-131_t_-Lot" see="field:BT-131(t)-Lot">cac:TenderSubmissionDeadlinePeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-132_d_-Lot" see="field:BT-132(d)-Lot">cac:OpenTenderEvent/cbc:OccurrenceDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-13_d_-Lot" see="field:BT-13(d)-Lot">cac:AdditionalInformationRequestPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-13_t_-Lot" see="field:BT-13(t)-Lot">cac:AdditionalInformationRequestPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-765-Lot" see="field:BT-765-Lot">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='framework-agreement']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-766-Lot" see="field:BT-766-Lot">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='dps-usage']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms" see="node:ND-LotTenderingTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-18-Lot" see="field:BT-18-Lot">cac:TenderRecipientParty/cbc:EndpointID</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-65-Lot" see="field:BT-65-Lot">cac:AllowedSubcontractTerms[cbc:SubcontractingConditionsCode/@listName='subcontracting-obligation']/cbc:SubcontractingConditionsCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-736-Lot" see="field:BT-736-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='reserved-execution']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-743-Lot" see="field:BT-743-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='einvoicing']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-744-Lot" see="field:BT-744-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='esignature-submission']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-75-Lot" see="field:BT-75-Lot">cac:RequiredFinancialGuarantee/cbc:Description</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-751-Lot" see="field:BT-751-Lot">cac:RequiredFinancialGuarantee/cbc:GuaranteeTypeCode[@listName='tender-guarantee-required']</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-76-Lot" see="field:BT-76-Lot">cac:TendererQualificationRequest[not(cac:SpecificTendererRequirement)]/cbc:CompanyLegalForm</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-761-Lot" see="field:BT-761-Lot">cac:TendererQualificationRequest[not(cac:SpecificTendererRequirement)]/cbc:CompanyLegalFormCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-764-Lot" see="field:BT-764-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='ecatalog-submission']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-801-Lot" see="field:BT-801-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='nda']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-97-Lot" see="field:BT-97-Lot">cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-060-Lot" see="field:OPT-060-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='conditions']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-071-Lot" see="field:OPT-071-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='customer-service']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-301-Lot-TenderReceipt" see="field:OPT-301-Lot-TenderReceipt">cac:TenderRecipientParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotValueEstimate" see="node:ND-LotValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriteria_BT-539-LotsGroup" see="field:BT-539-LotsGroup">cac:SubordinateAwardingCriterion/cbc:AwardingCriterionTypeCode[@listName='award-criterion-type']</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionFixNumberUnpublish" see="node:ND-LotsGroupAwardCriterionFixNumberUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish" see="node:ND-LotsGroupAwardCriterionNumberComplicatedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-FixedNumber" see="field:BT-541-LotsGroup-FixedNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-fixed']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-ThresholdNumber" see="field:BT-541-LotsGroup-ThresholdNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-WeightNumber" see="field:BT-541-LotsGroup-WeightNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionTypeUnpublish" see="node:ND-LotsGroupAwardCriterionTypeUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardingTerms" see="node:ND-LotsGroupAwardingTerms">cac:TenderingTerms/cac:AwardingTerms</diagnostic>
+		<diagnostic id="ND-LotsGroupFA" see="node:ND-LotsGroupFA">cac:TenderingProcess/cac:FrameworkAgreement</diagnostic>
+		<diagnostic id="ND-LotsGroupProcurementScope_BT-271-LotsGroup" see="field:BT-271-LotsGroup">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-LotsGroupValueEstimate" see="node:ND-LotsGroupValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-Modification" see="node:ND-Modification">efac:Change</diagnostic>
+		<diagnostic id="ND-ModificationReason" see="node:ND-ModificationReason">efac:ChangeReason</diagnostic>
+		<diagnostic id="ND-ModifiedSection" see="node:ND-ModifiedSection">efac:ChangedSection</diagnostic>
+		<diagnostic id="ND-NonEsubmission" see="node:ND-NonEsubmission">cac:ProcessJustification</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms" see="node:ND-NonUBLTenderingTerms">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-5010-Lot" see="field:BT-5010-Lot">efac:Funding/efbc:FinancingIdentifier</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-651-Lot" see="field:BT-651-Lot">efac:TenderSubcontractingRequirements/efbc:TenderSubcontractingRequirementsCode</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-7220-Lot" see="field:BT-7220-Lot">efac:Funding/cbc:FundingProgramCode</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-747-Lot" see="field:BT-747-Lot">efac:SelectionCriteria/cbc:CriterionTypeCode[@listName='selection-criterion']</diagnostic>
+		<diagnostic id="ND-NotAwardedReasonUnpublish" see="node:ND-NotAwardedReasonUnpublish">efac:DecisionReason/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-NoticeApproximateValueUnpublish" see="node:ND-NoticeApproximateValueUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-NoticeResult" see="node:ND-NoticeResult">efac:NoticeResult</diagnostic>
+		<diagnostic id="ND-NoticeResultGroupFA" see="node:ND-NoticeResultGroupFA">efac:GroupFramework</diagnostic>
+		<diagnostic id="ND-OperationType" see="node:ND-OperationType">efac:NoticePurpose</diagnostic>
+		<diagnostic id="ND-OptionsAndRenewals" see="node:ND-OptionsAndRenewals">cac:ContractExtension</diagnostic>
+		<diagnostic id="ND-OptionsAndRenewals_BT-57-Lot" see="field:BT-57-Lot">cac:Renewal/cac:Period/cbc:Description</diagnostic>
+		<diagnostic id="ND-Organization" see="node:ND-Organization">efac:Organization</diagnostic>
+		<diagnostic id="ND-Organization_OPT-201-Organization-TouchPoint" see="field:OPT-201-Organization-TouchPoint">efac:TouchPoint/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-Organization_OPT-302-Organization" see="field:OPT-302-Organization">efac:UltimateBeneficialOwner/cbc:ID</diagnostic>
+		<diagnostic id="ND-Organizations" see="node:ND-Organizations">efac:Organizations</diagnostic>
+		<diagnostic id="ND-Organizations_OPT-202-UBO" see="field:OPT-202-UBO">efac:UltimateBeneficialOwner/cbc:ID</diagnostic>
+		<diagnostic id="ND-OtherContractExecutionConditions" see="node:ND-OtherContractExecutionConditions">efac:ContractTerm</diagnostic>
+		<diagnostic id="ND-PMCAnswersDeadline" see="node:ND-PMCAnswersDeadline">efac:AnswerReceptionPeriod</diagnostic>
+		<diagnostic id="ND-Part" see="node:ND-Part">cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']</diagnostic>
+		<diagnostic id="ND-PartEmploymentLegislation" see="node:ND-PartEmploymentLegislation">cac:EmploymentLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartEnvironmentalLegislation" see="node:ND-PartEnvironmentalLegislation">cac:EnvironmentalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartFiscalLegislation" see="node:ND-PartFiscalLegislation">cac:FiscalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5071-Part" see="field:BT-5071-Part">cac:Address/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_a_-Part" see="field:BT-5101(a)-Part">cac:Address/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_b_-Part" see="field:BT-5101(b)-Part">cac:Address/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_c_-Part" see="field:BT-5101(c)-Part">cac:Address/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5121-Part" see="field:BT-5121-Part">cac:Address/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5131-Part" see="field:BT-5131-Part">cac:Address/cbc:CityName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5141-Part" see="field:BT-5141-Part">cac:Address/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-727-Part" see="field:BT-727-Part">cac:Address/cbc:Region</diagnostic>
+		<diagnostic id="ND-PartProcurementDocument_BT-708-Part" see="field:BT-708-Part">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:OfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-PartProcurementDocument_BT-737-Part" see="field:BT-737-Part">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NonOfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-PartProcurementScope" see="node:ND-PartProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-262-Part" see="field:BT-262-Part">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-263-Part" see="field:BT-263-Part">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-531-Part" see="field:BT-531-Part">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-PartReservedParticipation_BT-71-Part" see="field:BT-71-Part">cac:SpecificTendererRequirement[cbc:TendererRequirementTypeCode/@listName='reserved-procurement']/cbc:TendererRequirementTypeCode</diagnostic>
+		<diagnostic id="ND-PartReviewTerms" see="node:ND-PartReviewTerms">cac:AppealTerms</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-1251-Part" see="field:BT-1251-Part">cac:NoticeDocumentReference/cbc:ReferencedDocumentInternalAddress</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-13_d_-Part" see="field:BT-13(d)-Part">cac:AdditionalInformationRequestPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-13_t_-Part" see="field:BT-13(t)-Part">cac:AdditionalInformationRequestPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-765-Part" see="field:BT-765-Part">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='framework-agreement']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-766-Part" see="field:BT-766-Part">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='dps-usage']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-PartTenderingTerms" see="node:ND-PartTenderingTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-PartTenderingTerms_BT-736-Part" see="field:BT-736-Part">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='reserved-execution']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-Participants" see="node:ND-Participants">cac:EconomicOperatorShortList</diagnostic>
+		<diagnostic id="ND-Participants_BT-47-Lot" see="field:BT-47-Lot">cac:PreSelectedParty/cac:PartyName/cbc:Name</diagnostic>
+		<diagnostic id="ND-PaymentTerms" see="node:ND-PaymentTerms">cac:PaymentTerms</diagnostic>
+		<diagnostic id="ND-PostAwardProcess" see="node:ND-PostAwardProcess">cac:PostAwardProcess</diagnostic>
+		<diagnostic id="ND-Prize" see="node:ND-Prize">cac:Prize</diagnostic>
+		<diagnostic id="ND-ProcedureAcceleratedUnpublish" see="node:ND-ProcedureAcceleratedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ProcedurePlacePerformanceAdditionalInformation" see="node:ND-ProcedurePlacePerformanceAdditionalInformation">cac:RealizedLocation</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope" see="node:ND-ProcedureProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-262-Procedure" see="field:BT-262-Procedure">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-263-Procedure" see="field:BT-263-Procedure">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-271-Procedure" see="field:BT-271-Procedure">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-531-Procedure" see="field:BT-531-Procedure">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_OPP-040-Procedure" see="field:OPP-040-Procedure">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='transport-service']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-ProcedureTenderingProcess" see="node:ND-ProcedureTenderingProcess">cac:TenderingProcess</diagnostic>
+		<diagnostic id="ND-ProcedureTenderingProcess_OPP-090-Procedure" see="field:OPP-090-Procedure">cac:NoticeDocumentReference/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms" see="node:ND-ProcedureTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-01_c_-Procedure" see="field:BT-01(c)-Procedure">cac:ProcurementLegislationDocumentReference[not(cbc:ID/text()=('CrossBorderLaw','LocalLegalBasis'))]/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-01_e_-Procedure" see="field:BT-01(e)-Procedure">cac:ProcurementLegislationDocumentReference[cbc:ID/text()='LocalLegalBasis']/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-09_a_-Procedure" see="field:BT-09(a)-Procedure">cac:ProcurementLegislationDocumentReference[cbc:ID/text()='CrossBorderLaw']/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTypeUnpublish" see="node:ND-ProcedureTypeUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ProcedureValueEstimate" see="node:ND-ProcedureValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-PublicOpening" see="node:ND-PublicOpening">cac:OpenTenderEvent</diagnostic>
+		<diagnostic id="ND-PublicOpening_BT-133-Lot" see="field:BT-133-Lot">cac:OccurenceLocation/cbc:Description</diagnostic>
+		<diagnostic id="ND-ReceivedSubmissions" see="node:ND-ReceivedSubmissions">efac:ReceivedSubmissionsStatistics</diagnostic>
+		<diagnostic id="ND-ReviewRequests" see="node:ND-ReviewRequests">efac:AppealsInformation</diagnostic>
+		<diagnostic id="ND-ReviewRequestsStatistics" see="node:ND-ReviewRequestsStatistics">efac:AppealRequestsStatistics</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-786-Review" see="field:BT-786-Review">efac:AppealedItem/cbc:ID</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-790-Review" see="field:BT-790-Review">efac:AppealDecision/efbc:DecisionTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-791-Review" see="field:BT-791-Review">efac:AppealIrregularity/efbc:IrregularityTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-792-Review" see="field:BT-792-Review">efac:AppealRemedy/efbc:RemedyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-799-ReviewBody" see="field:BT-799-ReviewBody">efac:AppealProcessingParty/efbc:AppealProcessingPartyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-091-ReviewReq" see="field:OPT-091-ReviewReq">efac:AppealingParty/efbc:AppealingPartyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-092-ReviewBody" see="field:OPT-092-ReviewBody">efac:AppealProcessingParty/efbc:AppealProcessingPartyTypeDescription</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-301-ReviewBody" see="field:OPT-301-ReviewBody">efac:AppealProcessingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-301-ReviewReq" see="field:OPT-301-ReviewReq">efac:AppealingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-RootExtension" see="node:ND-RootExtension">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-010-notice" see="field:OPP-010-notice">efac:Publication/efbc:NoticePublicationID[@schemeName='ojs-notice-id']</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-011-notice" see="field:OPP-011-notice">efac:Publication/efbc:GazetteID[@schemeName='ojs-id']</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-012-notice" see="field:OPP-012-notice">efac:Publication/efbc:PublicationDate</diagnostic>
+		<diagnostic id="ND-Root_OPP-105-Business" see="field:OPP-105-Business">cac:BusinessCapability/cbc:CapabilityTypeCode</diagnostic>
+		<diagnostic id="ND-Root_OPT-300-Procedure-Buyer" see="field:OPT-300-Procedure-Buyer">cac:ContractingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-SecondStage" see="node:ND-SecondStage">cac:EconomicOperatorShortList</diagnostic>
+		<diagnostic id="ND-SecondStageWeightCriterionParameter" see="node:ND-SecondStageWeightCriterionParameter">efac:CriterionParameter</diagnostic>
+		<diagnostic id="ND-SecurityClearanceTerms" see="node:ND-SecurityClearanceTerms">cac:SecurityClearanceTerm</diagnostic>
+		<diagnostic id="ND-SelectionCriteria" see="node:ND-SelectionCriteria">efac:SelectionCriteria</diagnostic>
+		<diagnostic id="ND-SelectionCriteria_BT-752-Lot-ThresholdNumber" see="field:BT-752-Lot-ThresholdNumber">efac:CriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-SelectionCriteria_BT-752-Lot-WeightNumber" see="field:BT-752-Lot-WeightNumber">efac:CriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-SenderContact" see="node:ND-SenderContact">cac:SenderParty/cac:Contact</diagnostic>
+		<diagnostic id="ND-SettledContract" see="node:ND-SettledContract">efac:SettledContract</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-3202-Contract" see="field:BT-3202-Contract">efac:LotTender/cbc:ID</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-5011-Contract" see="field:BT-5011-Contract">efac:Funding/efbc:FinancingIdentifier</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-722-Contract" see="field:BT-722-Contract">efac:Funding/cbc:FundingProgramCode</diagnostic>
+		<diagnostic id="ND-SettledContract_OPT-300-Contract-Signatory" see="field:OPT-300-Contract-Signatory">cac:SignatoryParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-StrategicProcurementLot" see="node:ND-StrategicProcurementLot">efac:StrategicProcurement</diagnostic>
+		<diagnostic id="ND-StrategicProcurementLotResult" see="node:ND-StrategicProcurementLotResult">efac:StrategicProcurement</diagnostic>
+		<diagnostic id="ND-SubContractor_OPT-301-Tenderer-MainCont" see="field:OPT-301-Tenderer-MainCont">efac:MainContractor/cbc:ID</diagnostic>
+		<diagnostic id="ND-SubcontractedContract" see="node:ND-SubcontractedContract">efac:SubcontractingTerm</diagnostic>
+		<diagnostic id="ND-SubcontractingObligation" see="node:ND-SubcontractingObligation">cac:AllowedSubcontractTerms</diagnostic>
+		<diagnostic id="ND-TendererQualificationRequest" see="node:ND-TendererQualificationRequest">cac:TendererQualificationRequest</diagnostic>
+		<diagnostic id="ND-TenderingParty_OPT-300-Tenderer" see="field:OPT-300-Tenderer">efac:Tenderer/cbc:ID</diagnostic>
+		<diagnostic id="ND-TenderingParty_OPT-301-Tenderer-SubCont" see="field:OPT-301-Tenderer-SubCont">efac:SubContractor/cbc:ID</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-16-Organization-TouchPoint" see="field:BT-16-Organization-TouchPoint">cac:PostalAddress/cbc:Department</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-502-Organization-TouchPoint" see="field:BT-502-Organization-TouchPoint">cac:Contact/cbc:Name</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-503-Organization-TouchPoint" see="field:BT-503-Organization-TouchPoint">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-506-Organization-TouchPoint" see="field:BT-506-Organization-TouchPoint">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-507-Organization-TouchPoint" see="field:BT-507-Organization-TouchPoint">cac:PostalAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_a_-Organization-TouchPoint" see="field:BT-510(a)-Organization-TouchPoint">cac:PostalAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_b_-Organization-TouchPoint" see="field:BT-510(b)-Organization-TouchPoint">cac:PostalAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_c_-Organization-TouchPoint" see="field:BT-510(c)-Organization-TouchPoint">cac:PostalAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-512-Organization-TouchPoint" see="field:BT-512-Organization-TouchPoint">cac:PostalAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-513-Organization-TouchPoint" see="field:BT-513-Organization-TouchPoint">cac:PostalAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-514-Organization-TouchPoint" see="field:BT-514-Organization-TouchPoint">cac:PostalAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-739-Organization-TouchPoint" see="field:BT-739-Organization-TouchPoint">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-UBO_BT-503-UBO" see="field:BT-503-UBO">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-UBO_BT-506-UBO" see="field:BT-506-UBO">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-UBO_BT-507-UBO" see="field:BT-507-UBO">cac:ResidenceAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_a_-UBO" see="field:BT-510(a)-UBO">cac:ResidenceAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_b_-UBO" see="field:BT-510(b)-UBO">cac:ResidenceAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_c_-UBO" see="field:BT-510(c)-UBO">cac:ResidenceAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-UBO_BT-512-UBO" see="field:BT-512-UBO">cac:ResidenceAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-UBO_BT-513-UBO" see="field:BT-513-UBO">cac:ResidenceAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-UBO_BT-514-UBO" see="field:BT-514-UBO">cac:ResidenceAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-UBO_BT-706-UBO" see="field:BT-706-UBO">efac:Nationality/cbc:NationalityID</diagnostic>
+		<diagnostic id="ND-UBO_BT-739-UBO" see="field:BT-739-UBO">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-WinnerChosenUnpublish" see="node:ND-WinnerChosenUnpublish">efac:FieldsPrivacy</diagnostic>
+	</diagnostics>
+</schema>
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/config.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/config.sch
new file mode 100644
index 0000000..bb6e87b
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/config.sch
@@ -0,0 +1,5 @@
+<?xml version="1.0" encoding="UTF-8"?>
+<!-- URL prefix of the service to fetch a notice.
+	 The value must be between single quotes.
+	 The notice identifier will be appended, to build the URL used to fetch the corresponding notice XML. -->
+<let xmlns="http://purl.oclc.org/dsdl/schematron" name="urlPrefix" value="'http://localhost:8080/notices/'"/>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1a.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1a.sch
new file mode 100644
index 0000000..9ab9877
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1a.sch
@@ -0,0 +1,21 @@
+<?xml version="1.0" encoding="UTF-8"?>
+<pattern id="EFORMS-validation-stage-1a" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*">
+		<assert id="P-0001" role="ERROR" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NoticeSubType/cbc:SubTypeCode) &gt; 0">
+			rule|text|P-0001
+		</assert>
+		<assert id="P-0002" role="ERROR" test="($noticeSubType = ('1', '2', '3', 'X01', 'X02') and count(cac:ProcurementProjectLot) = 0) or (not(cbc:NoticeTypeCode/text() = ('1', '2', '3', 'X01', 'X02')) and count(cac:ProcurementProjectLot) > 0)">
+			rule|text|P-0002
+		</assert>
+	</rule>
+	<rule context="cac:ProcurementProjectLot/cbc:ID">
+		<assert id="P-0004" role="ERROR" test="@schemeName">
+			rule|text|P-0004
+		</assert>
+	</rule>
+	<rule context="cac:ProcurementProjectLot/cbc:ID/@schemeName">
+		<assert id="P-0005" role="ERROR" test="normalize-space(.) = ('Part', 'Lot', 'LotsGroup')">
+			rule|text|P-0005
+		</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1b-1.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1b-1.sch
new file mode 100644
index 0000000..2ea90d9
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1b-1.sch
@@ -0,0 +1,40 @@
+<?xml version="1.0" encoding="UTF-8" ?>
+<!--File generated from metadata database-->
+<pattern id="EFORMS-validation-stage-1b-1" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*[$noticeSubType = '1']">
+		<assert id="ND-BusinessParty-1" role="ERROR" diagnostics="ND-BusinessParty-BAD" test="count(cac:BusinessParty) = 0">rule|text|ND-BusinessParty-1</assert>
+		<assert id="ND-ContractingParty-1" role="ERROR" diagnostics="ND-ContractingParty" test="count(cac:ContractingParty) &gt; 0">rule|text|ND-ContractingParty-1</assert>
+		<assert id="ND-GazetteReference-1" role="ERROR" diagnostics="ND-GazetteReference" test="count(cac:AdditionalDocumentReference) = 0">rule|text|ND-GazetteReference-1</assert>
+		<assert id="ND-OperationType-1" role="ERROR" diagnostics="ND-OperationType" test="count(efac:NoticePurpose) = 0">rule|text|ND-OperationType-1</assert>
+		<assert id="ND-Part-1" role="ERROR" diagnostics="ND-Part" test="count(cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']) = 0">rule|text|ND-Part-1</assert>
+		<assert id="ND-ProcedureProcurementScope-1" role="ERROR" diagnostics="ND-ProcedureProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-ProcedureProcurementScope-1</assert>
+		<assert id="ND-ProcedureTenderingProcess-1" role="ERROR" diagnostics="ND-ProcedureTenderingProcess" test="count(cac:TenderingProcess) = 0">rule|text|ND-ProcedureTenderingProcess-1</assert>
+		<assert id="ND-RootExtension-1" role="ERROR" diagnostics="ND-RootExtension" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-RootExtension-1</assert>
+		<assert id="ND-SenderContact-1" role="ERROR" diagnostics="ND-SenderContact" test="count(cac:SenderParty/cac:Contact) = 0">rule|text|ND-SenderContact-1</assert>
+	</rule>
+	<rule context="/*/cac:ContractingParty[$noticeSubType = '1']">
+		<assert id="ND-Buyer-1" role="ERROR" diagnostics="ND-Buyer" test="count(cac:Party) &gt; 0">rule|text|ND-Buyer-1</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProject[$noticeSubType = '1']">
+		<assert id="ND-ProcedureValueEstimate-1" role="ERROR" diagnostics="ND-ProcedureValueEstimate" test="count(cac:RequestedTenderTotal) = 0">rule|text|ND-ProcedureValueEstimate-1</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms[$noticeSubType = '1']">
+		<assert id="ND-LotDistribution-1" role="ERROR" diagnostics="ND-LotDistribution" test="count(cac:LotDistribution) = 0">rule|text|ND-LotDistribution-1</assert>
+		<assert id="ND-TendererQualificationRequest-1" role="ERROR" diagnostics="ND-TendererQualificationRequest" test="count(cac:TendererQualificationRequest) = 0">rule|text|ND-TendererQualificationRequest-1</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:ProcurementLegislationDocumentReference[$noticeSubType = '1']">
+		<assert id="ND-CrossBorderLawUnpublish-1" role="ERROR" diagnostics="ND-CrossBorderLawUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-CrossBorderLawUnpublish-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '1']">
+		<assert id="ND-ContractModification-1" role="ERROR" diagnostics="ND-ContractModification" test="count(efac:ContractModification) = 0">rule|text|ND-ContractModification-1</assert>
+		<assert id="ND-NoticeResult-1" role="ERROR" diagnostics="ND-NoticeResult" test="count(efac:NoticeResult) = 0">rule|text|ND-NoticeResult-1</assert>
+		<assert id="ND-Organizations-1" role="ERROR" diagnostics="ND-Organizations" test="count(efac:Organizations) &gt; 0">rule|text|ND-Organizations-1</assert>
+		<assert id="ND-ReviewRequests-1" role="ERROR" diagnostics="ND-ReviewRequests" test="count(efac:AppealsInformation) = 0">rule|text|ND-ReviewRequests-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations[$noticeSubType = '1']">
+		<assert id="ND-Organization-1" role="ERROR" diagnostics="ND-Organization" test="count(efac:Organization) &gt; 0">rule|text|ND-Organization-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations/efac:Organization[$noticeSubType = '1']">
+		<assert id="ND-Company-1" role="ERROR" diagnostics="ND-Company" test="count(efac:Company) &gt; 0">rule|text|ND-Company-1</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1b-16.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1b-16.sch
new file mode 100644
index 0000000..67d8951
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/dynamic/validation-stage-1b-16.sch
@@ -0,0 +1,85 @@
+<?xml version="1.0" encoding="UTF-8" ?>
+<!--File generated from metadata database-->
+<pattern id="EFORMS-validation-stage-1b-16" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*[$noticeSubType = '16']">
+		<assert id="ND-BusinessParty-16" role="ERROR" diagnostics="ND-BusinessParty" test="count(cac:BusinessParty) = 0">rule|text|ND-BusinessParty-16</assert>
+		<assert id="ND-ContractingParty-16" role="ERROR" diagnostics="ND-ContractingParty" test="count(cac:ContractingParty) &gt; 0">rule|text|ND-ContractingParty-16</assert>
+		<assert id="ND-GazetteReference-16" role="ERROR" diagnostics="ND-GazetteReference" test="count(cac:AdditionalDocumentReference) = 0">rule|text|ND-GazetteReference-16</assert>
+		<assert id="ND-OperationType-16" role="ERROR" diagnostics="ND-OperationType" test="count(efac:NoticePurpose) = 0">rule|text|ND-OperationType-16</assert>
+		<assert id="ND-Part-16" role="ERROR" diagnostics="ND-Part" test="count(cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']) = 0">rule|text|ND-Part-16</assert>
+		<assert id="ND-ProcedureProcurementScope-16" role="ERROR" diagnostics="ND-ProcedureProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-ProcedureProcurementScope-16</assert>
+		<assert id="ND-ProcedureTenderingProcess-16" role="ERROR" diagnostics="ND-ProcedureTenderingProcess" test="count(cac:TenderingProcess) &gt; 0">rule|text|ND-ProcedureTenderingProcess-16</assert>
+		<assert id="ND-ProcedureTerms-16" role="ERROR" diagnostics="ND-ProcedureTerms" test="count(cac:TenderingTerms) &gt; 0">rule|text|ND-ProcedureTerms-16</assert>
+		<assert id="ND-RootExtension-16" role="ERROR" diagnostics="ND-RootExtension" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-RootExtension-16</assert>
+		<assert id="ND-SenderContact-16" role="ERROR" diagnostics="ND-SenderContact" test="count(cac:SenderParty/cac:Contact) = 0">rule|text|ND-SenderContact-16</assert>
+	</rule>
+	<rule context="/*/cac:ContractingParty[$noticeSubType = '16']">
+		<assert id="ND-Buyer-16" role="ERROR" diagnostics="ND-Buyer" test="count(cac:Party) &gt; 0">rule|text|ND-Buyer-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot'][$noticeSubType = '16']">
+		<assert id="ND-LotProcurementScope-16" role="ERROR" diagnostics="ND-LotProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-LotProcurementScope-16</assert>
+		<assert id="ND-LotTenderingProcess-16" role="ERROR" diagnostics="ND-LotTenderingProcess" test="count(cac:TenderingProcess) &gt; 0">rule|text|ND-LotTenderingProcess-16</assert>
+		<assert id="ND-LotTenderingTerms-16" role="ERROR" diagnostics="ND-LotTenderingTerms" test="count(cac:TenderingTerms) &gt; 0">rule|text|ND-LotTenderingTerms-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingProcess[$noticeSubType = '16']">
+		<assert id="ND-AuctionTerms-16" role="ERROR" diagnostics="ND-AuctionTerms" test="count(cac:AuctionTerms) &gt; 0">rule|text|ND-AuctionTerms-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingProcess/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-InterestExpressionReceptionPeriod-16" role="ERROR" diagnostics="ND-InterestExpressionReceptionPeriod" test="count(efac:InterestExpressionReceptionPeriod) = 0">rule|text|ND-InterestExpressionReceptionPeriod-16</assert>
+		<assert id="ND-PMCAnswersDeadline-16" role="ERROR" diagnostics="ND-PMCAnswersDeadline" test="count(efac:AnswerReceptionPeriod) = 0">rule|text|ND-PMCAnswersDeadline-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms[$noticeSubType = '16']">
+		<assert id="ND-LotProcurementDocument-16" role="ERROR" diagnostics="ND-LotProcurementDocument" test="count(cac:CallForTendersDocumentReference) &gt; 0">rule|text|ND-LotProcurementDocument-16</assert>
+		<assert id="ND-LotReservedParticipation-16" role="ERROR" diagnostics="ND-LotReservedParticipation" test="count(cac:TendererQualificationRequest) &gt; 0">rule|text|ND-LotReservedParticipation-16</assert>
+		<assert id="ND-LotReviewTerms-16" role="ERROR" diagnostics="ND-LotReviewTerms" test="count(cac:AppealTerms) &gt; 0">rule|text|ND-LotReviewTerms-16</assert>
+		<assert id="ND-NonUBLTenderingTerms-16" role="ERROR" diagnostics="ND-NonUBLTenderingTerms" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-NonUBLTenderingTerms-16</assert>
+		<assert id="ND-Participants-16" role="ERROR" diagnostics="ND-Participants" test="count(cac:EconomicOperatorShortList) = 0">rule|text|ND-Participants-16</assert>
+		<assert id="ND-PostAwardProcess-16" role="ERROR" diagnostics="ND-PostAwardProcess" test="count(cac:PostAwardProcess) &gt; 0">rule|text|ND-PostAwardProcess-16</assert>
+		<assert id="ND-SubcontractingObligation-16" role="ERROR" diagnostics="ND-SubcontractingObligation" test="count(cac:AllowedSubcontractTerms) = 0">rule|text|ND-SubcontractingObligation-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionNumberComplicatedUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionNumberComplicatedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionNumberComplicatedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionTypeUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionTypeUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:AwardCriterionParameter[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionFixNumberUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionFixNumberUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionFixNumberUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionNumberComplicatedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionTypeUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionTypeUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:AwardCriterionParameter[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionFixNumberUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionFixNumberUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionFixNumberUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingProcess[$noticeSubType = '16']">
+		<assert id="ND-ProcedureTypeUnpublish-16" role="ERROR" diagnostics="ND-ProcedureTypeUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-ProcedureTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingProcess/cac:ProcessJustification[$noticeSubType = '16']">
+		<assert id="ND-ProcedureAcceleratedUnpublish-16" role="ERROR" diagnostics="ND-ProcedureAcceleratedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-ProcedureAcceleratedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms[$noticeSubType = '16']">
+		<assert id="ND-TendererQualificationRequest-16" role="ERROR" diagnostics="ND-TendererQualificationRequest" test="count(cac:TendererQualificationRequest) &gt; 0">rule|text|ND-TendererQualificationRequest-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:ProcurementLegislationDocumentReference[$noticeSubType = '16']">
+		<assert id="ND-CrossBorderLawUnpublish-16" role="ERROR" diagnostics="ND-CrossBorderLawUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-CrossBorderLawUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:TendererQualificationRequest[$noticeSubType = '16']">
+		<assert id="ND-ExclusionGrounds-16" role="ERROR" diagnostics="ND-ExclusionGrounds" test="count(cac:SpecificTendererRequirement) &gt; 0">rule|text|ND-ExclusionGrounds-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-ContractModification-16" role="ERROR" diagnostics="ND-ContractModification" test="count(efac:ContractModification) = 0">rule|text|ND-ContractModification-16</assert>
+		<assert id="ND-NoticeResult-16" role="ERROR" diagnostics="ND-NoticeResult" test="count(efac:NoticeResult) = 0">rule|text|ND-NoticeResult-16</assert>
+		<assert id="ND-Organizations-16" role="ERROR" diagnostics="ND-Organizations" test="count(efac:Organizations) &gt; 0">rule|text|ND-Organizations-16</assert>
+		<assert id="ND-ReviewRequests-16" role="ERROR" diagnostics="ND-ReviewRequests" test="count(efac:AppealsInformation) = 0">rule|text|ND-ReviewRequests-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations[$noticeSubType = '16']">
+		<assert id="ND-Organization-16" role="ERROR" diagnostics="ND-Organization" test="count(efac:Organization) &gt; 0">rule|text|ND-Organization-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations/efac:Organization[$noticeSubType = '16']">
+		<assert id="ND-Company-16" role="ERROR" diagnostics="ND-Company" test="count(efac:Company) &gt; 0">rule|text|ND-Company-16</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/complete-validation.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/complete-validation.sch
new file mode 100644
index 0000000..c17da2c
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/complete-validation.sch
@@ -0,0 +1,316 @@
+<?xml version="1.0" encoding="utf-8" ?>
+<!--File generated from metadata database-->
+<schema xmlns="http://purl.oclc.org/dsdl/schematron" queryBinding="xslt2">
+	
+	<title>eForms schematron rules</title>
+
+	<ns prefix="xs" uri="http://www.w3.org/2001/XMLSchema" />
+	<ns prefix="sch" uri="http://purl.oclc.org/dsdl/schematron" />
+	<ns prefix="cbc" uri='urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2' />
+	<ns prefix="cac" uri="urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2" />
+	<ns prefix="ext" uri="urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2" />
+	<ns prefix="efac" uri="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1" />
+	<ns prefix="efext" uri="http://data.europa.eu/p27/eforms-ubl-extensions/1" />
+	<ns prefix="efbc" uri="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1" />
+	<ns prefix="can" uri="urn:oasis:names:specification:ubl:schema:xsd:ContractAwardNotice-2" />
+	<ns prefix="cn" uri="urn:oasis:names:specification:ubl:schema:xsd:ContractNotice-2" />
+	<ns prefix="pin" uri="urn:oasis:names:specification:ubl:schema:xsd:PriorInformationNotice-2" />
+	<ns prefix="fn" uri="http://www.w3.org/2005/xpath-functions" />
+	
+	<let name="noticeSubType" value="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NoticeSubType/cbc:SubTypeCode/text()"/>
+
+	<!-- True if the current notice is a change notice. -->
+	<let name="isChangeNotice" value="boolean(/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Changes/efbc:ChangedNoticeIdentifier)"/>
+
+	<phase id="eforms-1">
+		<active pattern="EFORMS-validation-stage-1a" />
+		<active pattern="EFORMS-validation-stage-1b-1" />
+	</phase>
+	<phase id="eforms-16">
+		<active pattern="EFORMS-validation-stage-1a" />
+		<active pattern="EFORMS-validation-stage-1b-16-BAD" />
+	</phase>
+
+	<include href="validation-stage-1a.sch"/>
+	<include href="validation-stage-1b-1.sch"/>
+	<include href="validation-stage-1b-16.sch"/>
+
+	<diagnostics>
+		<diagnostic id="ND-AcceleratedProcedure" see="node:ND-AcceleratedProcedure">cac:ProcessJustification</diagnostic>
+		<diagnostic id="ND-AuctionTerms" see="node:ND-AuctionTerms">cac:AuctionTerms</diagnostic>
+		<diagnostic id="ND-AwardingTerms" see="node:ND-AwardingTerms">cac:AwardingTerms</diagnostic>
+		<diagnostic id="ND-AwardingTerms_BT-46-Lot" see="field:BT-46-Lot">cac:TechnicalCommitteePerson/cbc:FamilyName</diagnostic>
+		<diagnostic id="ND-BusinessAddress" see="node:ND-BusinessAddress">cac:PostalAddress</diagnostic>
+		<diagnostic id="ND-BusinessContact" see="node:ND-BusinessContact">cac:Contact</diagnostic>
+		<diagnostic id="ND-BusinessParty" see="node:ND-BusinessParty">cac:BusinessParty</diagnostic>
+		<diagnostic id="ND-BusinessParty_BT-501-Business-European" see="field:BT-501-Business-European">cac:PartyLegalEntity[cbc:CompanyID/@schemeName = 'EU']/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-BusinessParty_BT-501-Business-National" see="field:BT-501-Business-National">cac:PartyLegalEntity[cbc:CompanyID/@schemeName = 'national']/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-Buyer" see="node:ND-Buyer">cac:Party</diagnostic>
+		<diagnostic id="ND-Buyer_OPT-300-Procedure-SProvider" see="field:OPT-300-Procedure-SProvider">cac:ServiceProviderParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-Change" see="node:ND-Change">efac:Change</diagnostic>
+		<diagnostic id="ND-Company" see="node:ND-Company">efac:Company</diagnostic>
+		<diagnostic id="ND-Company_BT-16-Organization-Company" see="field:BT-16-Organization-Company">cac:PostalAddress/cbc:Department</diagnostic>
+		<diagnostic id="ND-Company_BT-501-Organization-Company" see="field:BT-501-Organization-Company">cac:PartyLegalEntity/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-Company_BT-502-Organization-Company" see="field:BT-502-Organization-Company">cac:Contact/cbc:Name</diagnostic>
+		<diagnostic id="ND-Company_BT-503-Organization-Company" see="field:BT-503-Organization-Company">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-Company_BT-506-Organization-Company" see="field:BT-506-Organization-Company">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-Company_BT-507-Organization-Company" see="field:BT-507-Organization-Company">cac:PostalAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-Company_BT-510_a_-Organization-Company" see="field:BT-510(a)-Organization-Company">cac:PostalAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-Company_BT-510_b_-Organization-Company" see="field:BT-510(b)-Organization-Company">cac:PostalAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-Company_BT-510_c_-Organization-Company" see="field:BT-510(c)-Organization-Company">cac:PostalAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-Company_BT-512-Organization-Company" see="field:BT-512-Organization-Company">cac:PostalAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-Company_BT-513-Organization-Company" see="field:BT-513-Organization-Company">cac:PostalAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-Company_BT-514-Organization-Company" see="field:BT-514-Organization-Company">cac:PostalAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-Company_BT-739-Organization-Company" see="field:BT-739-Organization-Company">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-ConcessionRevenue" see="node:ND-ConcessionRevenue">efac:ConcessionRevenue</diagnostic>
+		<diagnostic id="ND-ContractEUFunds" see="node:ND-ContractEUFunds">efac:Funding</diagnostic>
+		<diagnostic id="ND-ContractModification" see="node:ND-ContractModification">efac:ContractModification</diagnostic>
+		<diagnostic id="ND-ContractModification_BT-1501_s_-Contract" see="field:BT-1501(s)-Contract">efac:Change/efac:ChangedSection/efbc:ChangedSectionIdentifier</diagnostic>
+		<diagnostic id="ND-ContractingParty" see="node:ND-ContractingParty">cac:ContractingParty</diagnostic>
+		<diagnostic id="ND-CrossBorderLawUnpublish" see="node:ND-CrossBorderLawUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ExclusionGrounds" see="node:ND-ExclusionGrounds">cac:SpecificTendererRequirement</diagnostic>
+		<diagnostic id="ND-ExecutionRequirements" see="node:ND-ExecutionRequirements">cac:ContractExecutionRequirement</diagnostic>
+		<diagnostic id="ND-ExtendedDurationJustification" see="node:ND-ExtendedDurationJustification">efac:DurationJustification</diagnostic>
+		<diagnostic id="ND-FA" see="node:ND-FA">cac:FrameworkAgreement</diagnostic>
+		<diagnostic id="ND-Funding" see="node:ND-Funding">efac:Funding</diagnostic>
+		<diagnostic id="ND-GazetteReference" see="node:ND-GazetteReference">cac:AdditionalDocumentReference</diagnostic>
+		<diagnostic id="ND-GroupComposition" see="node:ND-GroupComposition">cac:LotsGroup</diagnostic>
+		<diagnostic id="ND-GroupComposition_BT-1375-Procedure" see="field:BT-1375-Procedure">cac:ProcurementProjectLotReference/cbc:ID[@schemeName='Lot']</diagnostic>
+		<diagnostic id="ND-InterestExpressionReceptionPeriod" see="node:ND-InterestExpressionReceptionPeriod">efac:InterestExpressionReceptionPeriod</diagnostic>
+		<diagnostic id="ND-LocalEntity" see="node:ND-LocalEntity">cac:PartyLegalEntity</diagnostic>
+		<diagnostic id="ND-LotAwardCriteria" see="node:ND-LotAwardCriteria">cac:AwardingCriterion</diagnostic>
+		<diagnostic id="ND-LotAwardCriteria_BT-539-Lot" see="field:BT-539-Lot">cac:SubordinateAwardingCriterion/cbc:AwardingCriterionTypeCode[@listName='award-criterion-type']</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionFixNumberUnpublish" see="node:ND-LotAwardCriterionFixNumberUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionNumberComplicatedUnpublish" see="node:ND-LotAwardCriterionNumberComplicatedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-FixedNumber" see="field:BT-541-Lot-FixedNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-fixed']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-ThresholdNumber" see="field:BT-541-Lot-ThresholdNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-WeightNumber" see="field:BT-541-Lot-WeightNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionTypeUnpublish" see="node:ND-LotAwardCriterionTypeUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotDistribution" see="node:ND-LotDistribution">cac:LotDistribution</diagnostic>
+		<diagnostic id="ND-LotDistribution_BT-330-Procedure" see="field:BT-330-Procedure">cac:LotsGroup/cbc:LotsGroupID</diagnostic>
+		<diagnostic id="ND-LotDuration" see="node:ND-LotDuration">cac:PlannedPeriod</diagnostic>
+		<diagnostic id="ND-LotEmploymentLegislation" see="node:ND-LotEmploymentLegislation">cac:EmploymentLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotEnvironmentalLegislation" see="node:ND-LotEnvironmentalLegislation">cac:EnvironmentalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotFiscalLegislation" see="node:ND-LotFiscalLegislation">cac:FiscalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5071-Lot" see="field:BT-5071-Lot">cac:Address/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_a_-Lot" see="field:BT-5101(a)-Lot">cac:Address/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_b_-Lot" see="field:BT-5101(b)-Lot">cac:Address/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_c_-Lot" see="field:BT-5101(c)-Lot">cac:Address/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5121-Lot" see="field:BT-5121-Lot">cac:Address/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5131-Lot" see="field:BT-5131-Lot">cac:Address/cbc:CityName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5141-Lot" see="field:BT-5141-Lot">cac:Address/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-727-Lot" see="field:BT-727-Lot">cac:Address/cbc:Region</diagnostic>
+		<diagnostic id="ND-LotPreviousPlanning" see="node:ND-LotPreviousPlanning">cac:NoticeDocumentReference</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument" see="node:ND-LotProcurementDocument">cac:CallForTendersDocumentReference</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument_BT-708-Lot" see="field:BT-708-Lot">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:OfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument_BT-737-Lot" see="field:BT-737-Lot">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NonOfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotProcurementScope" see="node:ND-LotProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-06-Lot" see="field:BT-06-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='strategic-procurement']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-262-Lot" see="field:BT-262-Lot">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-263-Lot" see="field:BT-263-Lot">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-271-Lot" see="field:BT-271-Lot">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-531-Lot" see="field:BT-531-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-754-Lot" see="field:BT-754-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='accessibility']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-774-Lot" see="field:BT-774-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='environmental-impact']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-775-Lot" see="field:BT-775-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='social-objective']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-776-Lot" see="field:BT-776-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='innovative-acquisition']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-805-Lot" see="field:BT-805-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='gpp-criteria']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotReservedParticipation" see="node:ND-LotReservedParticipation">cac:TendererQualificationRequest</diagnostic>
+		<diagnostic id="ND-LotReservedParticipation_BT-71-Lot" see="field:BT-71-Lot">cac:SpecificTendererRequirement[cbc:TendererRequirementTypeCode/@listName='reserved-procurement']/cbc:TendererRequirementTypeCode</diagnostic>
+		<diagnostic id="ND-LotResult" see="node:ND-LotResult">efac:LotResult</diagnostic>
+		<diagnostic id="ND-LotResultFAValues" see="node:ND-LotResultFAValues">efac:FrameworkAgreementValues</diagnostic>
+		<diagnostic id="ND-LotResult_BT-636-LotResult" see="field:BT-636-LotResult">efac:AppealRequestsStatistics[efbc:StatisticsCode/@listName='irregularity-type']/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_BT-712_a_-LotResult" see="field:BT-712(a)-LotResult">efac:AppealRequestsStatistics[efbc:StatisticsCode/@listName='review-type']/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_BT-759-LotResult" see="field:BT-759-LotResult">efac:ReceivedSubmissionsStatistics/efbc:StatisticsNumeric</diagnostic>
+		<diagnostic id="ND-LotResult_BT-760-LotResult" see="field:BT-760-LotResult">efac:ReceivedSubmissionsStatistics/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-301-LotResult-Financing" see="field:OPT-301-LotResult-Financing">cac:FinancingParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-301-LotResult-Paying" see="field:OPT-301-LotResult-Paying">cac:PayerParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-315-LotResult" see="field:OPT-315-LotResult">efac:SettledContract/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-320-LotResult" see="field:OPT-320-LotResult">efac:LotTender/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotReviewTerms" see="node:ND-LotReviewTerms">cac:AppealTerms</diagnostic>
+		<diagnostic id="ND-LotReviewTerms_BT-99-Lot" see="field:BT-99-Lot">cac:PresentationPeriod/cbc:Description</diagnostic>
+		<diagnostic id="ND-LotTender" see="node:ND-LotTender">efac:LotTender</diagnostic>
+		<diagnostic id="ND-LotTenderOriginCountry" see="node:ND-LotTenderOriginCountry">efac:Origin</diagnostic>
+		<diagnostic id="ND-LotTender_BT-191-Tender" see="field:BT-191-Tender">efac:Origin/efbc:AreaCode</diagnostic>
+		<diagnostic id="ND-LotTender_BT-779-Tender" see="field:BT-779-Tender">efac:AggregatedAmounts/cbc:PaidAmount</diagnostic>
+		<diagnostic id="ND-LotTender_BT-780-Tender" see="field:BT-780-Tender">efac:AggregatedAmounts/efbc:PaidAmountDescription</diagnostic>
+		<diagnostic id="ND-LotTender_BT-782-Tender" see="field:BT-782-Tender">efac:AggregatedAmounts/efbc:PenaltiesAmount</diagnostic>
+		<diagnostic id="ND-LotTender_OPP-030-Tender" see="field:OPP-030-Tender">efac:ContractTerm[not(efbc:TermCode/text()='all-rev-tic')][efbc:TermCode/@listName='contract-detail']/efbc:TermCode</diagnostic>
+		<diagnostic id="ND-LotTender_OPP-033-Tender" see="field:OPP-033-Tender">efac:ContractTerm[efbc:TermCode/@listName='rewards-penalties']/efbc:TermCode</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess" see="node:ND-LotTenderingProcess">cac:TenderingProcess</diagnostic>
+		<diagnostic id="ND-LotTenderingProcessExtension" see="node:ND-LotTenderingProcessExtension">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1251-Lot" see="field:BT-1251-Lot">cac:NoticeDocumentReference/cbc:ReferencedDocumentInternalAddress</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1311_d_-Lot" see="field:BT-1311(d)-Lot">cac:ParticipationRequestReceptionPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1311_t_-Lot" see="field:BT-1311(t)-Lot">cac:ParticipationRequestReceptionPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-131_d_-Lot" see="field:BT-131(d)-Lot">cac:TenderSubmissionDeadlinePeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-131_t_-Lot" see="field:BT-131(t)-Lot">cac:TenderSubmissionDeadlinePeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-132_d_-Lot" see="field:BT-132(d)-Lot">cac:OpenTenderEvent/cbc:OccurrenceDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-13_d_-Lot" see="field:BT-13(d)-Lot">cac:AdditionalInformationRequestPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-13_t_-Lot" see="field:BT-13(t)-Lot">cac:AdditionalInformationRequestPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-765-Lot" see="field:BT-765-Lot">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='framework-agreement']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-766-Lot" see="field:BT-766-Lot">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='dps-usage']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms" see="node:ND-LotTenderingTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-18-Lot" see="field:BT-18-Lot">cac:TenderRecipientParty/cbc:EndpointID</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-65-Lot" see="field:BT-65-Lot">cac:AllowedSubcontractTerms[cbc:SubcontractingConditionsCode/@listName='subcontracting-obligation']/cbc:SubcontractingConditionsCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-736-Lot" see="field:BT-736-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='reserved-execution']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-743-Lot" see="field:BT-743-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='einvoicing']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-744-Lot" see="field:BT-744-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='esignature-submission']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-75-Lot" see="field:BT-75-Lot">cac:RequiredFinancialGuarantee/cbc:Description</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-751-Lot" see="field:BT-751-Lot">cac:RequiredFinancialGuarantee/cbc:GuaranteeTypeCode[@listName='tender-guarantee-required']</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-76-Lot" see="field:BT-76-Lot">cac:TendererQualificationRequest[not(cac:SpecificTendererRequirement)]/cbc:CompanyLegalForm</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-761-Lot" see="field:BT-761-Lot">cac:TendererQualificationRequest[not(cac:SpecificTendererRequirement)]/cbc:CompanyLegalFormCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-764-Lot" see="field:BT-764-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='ecatalog-submission']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-801-Lot" see="field:BT-801-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='nda']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-97-Lot" see="field:BT-97-Lot">cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-060-Lot" see="field:OPT-060-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='conditions']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-071-Lot" see="field:OPT-071-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='customer-service']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-301-Lot-TenderReceipt" see="field:OPT-301-Lot-TenderReceipt">cac:TenderRecipientParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotValueEstimate" see="node:ND-LotValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriteria_BT-539-LotsGroup" see="field:BT-539-LotsGroup">cac:SubordinateAwardingCriterion/cbc:AwardingCriterionTypeCode[@listName='award-criterion-type']</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionFixNumberUnpublish" see="node:ND-LotsGroupAwardCriterionFixNumberUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish" see="node:ND-LotsGroupAwardCriterionNumberComplicatedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-FixedNumber" see="field:BT-541-LotsGroup-FixedNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-fixed']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-ThresholdNumber" see="field:BT-541-LotsGroup-ThresholdNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-WeightNumber" see="field:BT-541-LotsGroup-WeightNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionTypeUnpublish" see="node:ND-LotsGroupAwardCriterionTypeUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardingTerms" see="node:ND-LotsGroupAwardingTerms">cac:TenderingTerms/cac:AwardingTerms</diagnostic>
+		<diagnostic id="ND-LotsGroupFA" see="node:ND-LotsGroupFA">cac:TenderingProcess/cac:FrameworkAgreement</diagnostic>
+		<diagnostic id="ND-LotsGroupProcurementScope_BT-271-LotsGroup" see="field:BT-271-LotsGroup">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-LotsGroupValueEstimate" see="node:ND-LotsGroupValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-Modification" see="node:ND-Modification">efac:Change</diagnostic>
+		<diagnostic id="ND-ModificationReason" see="node:ND-ModificationReason">efac:ChangeReason</diagnostic>
+		<diagnostic id="ND-ModifiedSection" see="node:ND-ModifiedSection">efac:ChangedSection</diagnostic>
+		<diagnostic id="ND-NonEsubmission" see="node:ND-NonEsubmission">cac:ProcessJustification</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms" see="node:ND-NonUBLTenderingTerms">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-5010-Lot" see="field:BT-5010-Lot">efac:Funding/efbc:FinancingIdentifier</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-651-Lot" see="field:BT-651-Lot">efac:TenderSubcontractingRequirements/efbc:TenderSubcontractingRequirementsCode</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-7220-Lot" see="field:BT-7220-Lot">efac:Funding/cbc:FundingProgramCode</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-747-Lot" see="field:BT-747-Lot">efac:SelectionCriteria/cbc:CriterionTypeCode[@listName='selection-criterion']</diagnostic>
+		<diagnostic id="ND-NotAwardedReasonUnpublish" see="node:ND-NotAwardedReasonUnpublish">efac:DecisionReason/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-NoticeApproximateValueUnpublish" see="node:ND-NoticeApproximateValueUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-NoticeResult" see="node:ND-NoticeResult">efac:NoticeResult</diagnostic>
+		<diagnostic id="ND-NoticeResultGroupFA" see="node:ND-NoticeResultGroupFA">efac:GroupFramework</diagnostic>
+		<diagnostic id="ND-OperationType" see="node:ND-OperationType">efac:NoticePurpose</diagnostic>
+		<diagnostic id="ND-OptionsAndRenewals" see="node:ND-OptionsAndRenewals">cac:ContractExtension</diagnostic>
+		<diagnostic id="ND-OptionsAndRenewals_BT-57-Lot" see="field:BT-57-Lot">cac:Renewal/cac:Period/cbc:Description</diagnostic>
+		<diagnostic id="ND-Organization" see="node:ND-Organization">efac:Organization</diagnostic>
+		<diagnostic id="ND-Organization_OPT-201-Organization-TouchPoint" see="field:OPT-201-Organization-TouchPoint">efac:TouchPoint/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-Organization_OPT-302-Organization" see="field:OPT-302-Organization">efac:UltimateBeneficialOwner/cbc:ID</diagnostic>
+		<diagnostic id="ND-Organizations" see="node:ND-Organizations">efac:Organizations</diagnostic>
+		<diagnostic id="ND-Organizations_OPT-202-UBO" see="field:OPT-202-UBO">efac:UltimateBeneficialOwner/cbc:ID</diagnostic>
+		<diagnostic id="ND-OtherContractExecutionConditions" see="node:ND-OtherContractExecutionConditions">efac:ContractTerm</diagnostic>
+		<diagnostic id="ND-PMCAnswersDeadline" see="node:ND-PMCAnswersDeadline">efac:AnswerReceptionPeriod</diagnostic>
+		<diagnostic id="ND-Part" see="node:ND-Part">cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']</diagnostic>
+		<diagnostic id="ND-PartEmploymentLegislation" see="node:ND-PartEmploymentLegislation">cac:EmploymentLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartEnvironmentalLegislation" see="node:ND-PartEnvironmentalLegislation">cac:EnvironmentalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartFiscalLegislation" see="node:ND-PartFiscalLegislation">cac:FiscalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5071-Part" see="field:BT-5071-Part">cac:Address/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_a_-Part" see="field:BT-5101(a)-Part">cac:Address/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_b_-Part" see="field:BT-5101(b)-Part">cac:Address/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_c_-Part" see="field:BT-5101(c)-Part">cac:Address/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5121-Part" see="field:BT-5121-Part">cac:Address/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5131-Part" see="field:BT-5131-Part">cac:Address/cbc:CityName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5141-Part" see="field:BT-5141-Part">cac:Address/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-727-Part" see="field:BT-727-Part">cac:Address/cbc:Region</diagnostic>
+		<diagnostic id="ND-PartProcurementDocument_BT-708-Part" see="field:BT-708-Part">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:OfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-PartProcurementDocument_BT-737-Part" see="field:BT-737-Part">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NonOfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-PartProcurementScope" see="node:ND-PartProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-262-Part" see="field:BT-262-Part">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-263-Part" see="field:BT-263-Part">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-531-Part" see="field:BT-531-Part">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-PartReservedParticipation_BT-71-Part" see="field:BT-71-Part">cac:SpecificTendererRequirement[cbc:TendererRequirementTypeCode/@listName='reserved-procurement']/cbc:TendererRequirementTypeCode</diagnostic>
+		<diagnostic id="ND-PartReviewTerms" see="node:ND-PartReviewTerms">cac:AppealTerms</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-1251-Part" see="field:BT-1251-Part">cac:NoticeDocumentReference/cbc:ReferencedDocumentInternalAddress</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-13_d_-Part" see="field:BT-13(d)-Part">cac:AdditionalInformationRequestPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-13_t_-Part" see="field:BT-13(t)-Part">cac:AdditionalInformationRequestPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-765-Part" see="field:BT-765-Part">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='framework-agreement']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-766-Part" see="field:BT-766-Part">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='dps-usage']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-PartTenderingTerms" see="node:ND-PartTenderingTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-PartTenderingTerms_BT-736-Part" see="field:BT-736-Part">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='reserved-execution']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-Participants" see="node:ND-Participants">cac:EconomicOperatorShortList</diagnostic>
+		<diagnostic id="ND-Participants_BT-47-Lot" see="field:BT-47-Lot">cac:PreSelectedParty/cac:PartyName/cbc:Name</diagnostic>
+		<diagnostic id="ND-PaymentTerms" see="node:ND-PaymentTerms">cac:PaymentTerms</diagnostic>
+		<diagnostic id="ND-PostAwardProcess" see="node:ND-PostAwardProcess">cac:PostAwardProcess</diagnostic>
+		<diagnostic id="ND-Prize" see="node:ND-Prize">cac:Prize</diagnostic>
+		<diagnostic id="ND-ProcedureAcceleratedUnpublish" see="node:ND-ProcedureAcceleratedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ProcedurePlacePerformanceAdditionalInformation" see="node:ND-ProcedurePlacePerformanceAdditionalInformation">cac:RealizedLocation</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope" see="node:ND-ProcedureProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-262-Procedure" see="field:BT-262-Procedure">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-263-Procedure" see="field:BT-263-Procedure">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-271-Procedure" see="field:BT-271-Procedure">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-531-Procedure" see="field:BT-531-Procedure">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_OPP-040-Procedure" see="field:OPP-040-Procedure">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='transport-service']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-ProcedureTenderingProcess" see="node:ND-ProcedureTenderingProcess">cac:TenderingProcess</diagnostic>
+		<diagnostic id="ND-ProcedureTenderingProcess_OPP-090-Procedure" see="field:OPP-090-Procedure">cac:NoticeDocumentReference/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms" see="node:ND-ProcedureTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-01_c_-Procedure" see="field:BT-01(c)-Procedure">cac:ProcurementLegislationDocumentReference[not(cbc:ID/text()=('CrossBorderLaw','LocalLegalBasis'))]/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-01_e_-Procedure" see="field:BT-01(e)-Procedure">cac:ProcurementLegislationDocumentReference[cbc:ID/text()='LocalLegalBasis']/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-09_a_-Procedure" see="field:BT-09(a)-Procedure">cac:ProcurementLegislationDocumentReference[cbc:ID/text()='CrossBorderLaw']/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTypeUnpublish" see="node:ND-ProcedureTypeUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ProcedureValueEstimate" see="node:ND-ProcedureValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-PublicOpening" see="node:ND-PublicOpening">cac:OpenTenderEvent</diagnostic>
+		<diagnostic id="ND-PublicOpening_BT-133-Lot" see="field:BT-133-Lot">cac:OccurenceLocation/cbc:Description</diagnostic>
+		<diagnostic id="ND-ReceivedSubmissions" see="node:ND-ReceivedSubmissions">efac:ReceivedSubmissionsStatistics</diagnostic>
+		<diagnostic id="ND-ReviewRequests" see="node:ND-ReviewRequests">efac:AppealsInformation</diagnostic>
+		<diagnostic id="ND-ReviewRequestsStatistics" see="node:ND-ReviewRequestsStatistics">efac:AppealRequestsStatistics</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-786-Review" see="field:BT-786-Review">efac:AppealedItem/cbc:ID</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-790-Review" see="field:BT-790-Review">efac:AppealDecision/efbc:DecisionTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-791-Review" see="field:BT-791-Review">efac:AppealIrregularity/efbc:IrregularityTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-792-Review" see="field:BT-792-Review">efac:AppealRemedy/efbc:RemedyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-799-ReviewBody" see="field:BT-799-ReviewBody">efac:AppealProcessingParty/efbc:AppealProcessingPartyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-091-ReviewReq" see="field:OPT-091-ReviewReq">efac:AppealingParty/efbc:AppealingPartyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-092-ReviewBody" see="field:OPT-092-ReviewBody">efac:AppealProcessingParty/efbc:AppealProcessingPartyTypeDescription</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-301-ReviewBody" see="field:OPT-301-ReviewBody">efac:AppealProcessingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-301-ReviewReq" see="field:OPT-301-ReviewReq">efac:AppealingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-RootExtension" see="node:ND-RootExtension">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-010-notice" see="field:OPP-010-notice">efac:Publication/efbc:NoticePublicationID[@schemeName='ojs-notice-id']</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-011-notice" see="field:OPP-011-notice">efac:Publication/efbc:GazetteID[@schemeName='ojs-id']</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-012-notice" see="field:OPP-012-notice">efac:Publication/efbc:PublicationDate</diagnostic>
+		<diagnostic id="ND-Root_OPP-105-Business" see="field:OPP-105-Business">cac:BusinessCapability/cbc:CapabilityTypeCode</diagnostic>
+		<diagnostic id="ND-Root_OPT-300-Procedure-Buyer" see="field:OPT-300-Procedure-Buyer">cac:ContractingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-SecondStage" see="node:ND-SecondStage">cac:EconomicOperatorShortList</diagnostic>
+		<diagnostic id="ND-SecondStageWeightCriterionParameter" see="node:ND-SecondStageWeightCriterionParameter">efac:CriterionParameter</diagnostic>
+		<diagnostic id="ND-SecurityClearanceTerms" see="node:ND-SecurityClearanceTerms">cac:SecurityClearanceTerm</diagnostic>
+		<diagnostic id="ND-SelectionCriteria" see="node:ND-SelectionCriteria">efac:SelectionCriteria</diagnostic>
+		<diagnostic id="ND-SelectionCriteria_BT-752-Lot-ThresholdNumber" see="field:BT-752-Lot-ThresholdNumber">efac:CriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-SelectionCriteria_BT-752-Lot-WeightNumber" see="field:BT-752-Lot-WeightNumber">efac:CriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-SenderContact" see="node:ND-SenderContact">cac:SenderParty/cac:Contact</diagnostic>
+		<diagnostic id="ND-SettledContract" see="node:ND-SettledContract">efac:SettledContract</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-3202-Contract" see="field:BT-3202-Contract">efac:LotTender/cbc:ID</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-5011-Contract" see="field:BT-5011-Contract">efac:Funding/efbc:FinancingIdentifier</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-722-Contract" see="field:BT-722-Contract">efac:Funding/cbc:FundingProgramCode</diagnostic>
+		<diagnostic id="ND-SettledContract_OPT-300-Contract-Signatory" see="field:OPT-300-Contract-Signatory">cac:SignatoryParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-StrategicProcurementLot" see="node:ND-StrategicProcurementLot">efac:StrategicProcurement</diagnostic>
+		<diagnostic id="ND-StrategicProcurementLotResult" see="node:ND-StrategicProcurementLotResult">efac:StrategicProcurement</diagnostic>
+		<diagnostic id="ND-SubContractor_OPT-301-Tenderer-MainCont" see="field:OPT-301-Tenderer-MainCont">efac:MainContractor/cbc:ID</diagnostic>
+		<diagnostic id="ND-SubcontractedContract" see="node:ND-SubcontractedContract">efac:SubcontractingTerm</diagnostic>
+		<diagnostic id="ND-SubcontractingObligation" see="node:ND-SubcontractingObligation">cac:AllowedSubcontractTerms</diagnostic>
+		<diagnostic id="ND-TendererQualificationRequest" see="node:ND-TendererQualificationRequest">cac:TendererQualificationRequest</diagnostic>
+		<diagnostic id="ND-TenderingParty_OPT-300-Tenderer" see="field:OPT-300-Tenderer">efac:Tenderer/cbc:ID</diagnostic>
+		<diagnostic id="ND-TenderingParty_OPT-301-Tenderer-SubCont" see="field:OPT-301-Tenderer-SubCont">efac:SubContractor/cbc:ID</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-16-Organization-TouchPoint" see="field:BT-16-Organization-TouchPoint">cac:PostalAddress/cbc:Department</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-502-Organization-TouchPoint" see="field:BT-502-Organization-TouchPoint">cac:Contact/cbc:Name</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-503-Organization-TouchPoint" see="field:BT-503-Organization-TouchPoint">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-506-Organization-TouchPoint" see="field:BT-506-Organization-TouchPoint">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-507-Organization-TouchPoint" see="field:BT-507-Organization-TouchPoint">cac:PostalAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_a_-Organization-TouchPoint" see="field:BT-510(a)-Organization-TouchPoint">cac:PostalAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_b_-Organization-TouchPoint" see="field:BT-510(b)-Organization-TouchPoint">cac:PostalAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_c_-Organization-TouchPoint" see="field:BT-510(c)-Organization-TouchPoint">cac:PostalAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-512-Organization-TouchPoint" see="field:BT-512-Organization-TouchPoint">cac:PostalAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-513-Organization-TouchPoint" see="field:BT-513-Organization-TouchPoint">cac:PostalAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-514-Organization-TouchPoint" see="field:BT-514-Organization-TouchPoint">cac:PostalAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-739-Organization-TouchPoint" see="field:BT-739-Organization-TouchPoint">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-UBO_BT-503-UBO" see="field:BT-503-UBO">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-UBO_BT-506-UBO" see="field:BT-506-UBO">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-UBO_BT-507-UBO" see="field:BT-507-UBO">cac:ResidenceAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_a_-UBO" see="field:BT-510(a)-UBO">cac:ResidenceAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_b_-UBO" see="field:BT-510(b)-UBO">cac:ResidenceAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_c_-UBO" see="field:BT-510(c)-UBO">cac:ResidenceAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-UBO_BT-512-UBO" see="field:BT-512-UBO">cac:ResidenceAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-UBO_BT-513-UBO" see="field:BT-513-UBO">cac:ResidenceAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-UBO_BT-514-UBO" see="field:BT-514-UBO">cac:ResidenceAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-UBO_BT-706-UBO" see="field:BT-706-UBO">efac:Nationality/cbc:NationalityID</diagnostic>
+		<diagnostic id="ND-UBO_BT-739-UBO" see="field:BT-739-UBO">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-WinnerChosenUnpublish" see="node:ND-WinnerChosenUnpublish">efac:FieldsPrivacy</diagnostic>
+	</diagnostics>
+</schema>
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1a.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1a.sch
new file mode 100644
index 0000000..9ab9877
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1a.sch
@@ -0,0 +1,21 @@
+<?xml version="1.0" encoding="UTF-8"?>
+<pattern id="EFORMS-validation-stage-1a" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*">
+		<assert id="P-0001" role="ERROR" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NoticeSubType/cbc:SubTypeCode) &gt; 0">
+			rule|text|P-0001
+		</assert>
+		<assert id="P-0002" role="ERROR" test="($noticeSubType = ('1', '2', '3', 'X01', 'X02') and count(cac:ProcurementProjectLot) = 0) or (not(cbc:NoticeTypeCode/text() = ('1', '2', '3', 'X01', 'X02')) and count(cac:ProcurementProjectLot) > 0)">
+			rule|text|P-0002
+		</assert>
+	</rule>
+	<rule context="cac:ProcurementProjectLot/cbc:ID">
+		<assert id="P-0004" role="ERROR" test="@schemeName">
+			rule|text|P-0004
+		</assert>
+	</rule>
+	<rule context="cac:ProcurementProjectLot/cbc:ID/@schemeName">
+		<assert id="P-0005" role="ERROR" test="normalize-space(.) = ('Part', 'Lot', 'LotsGroup')">
+			rule|text|P-0005
+		</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1b-1.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1b-1.sch
new file mode 100644
index 0000000..1bd476f
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1b-1.sch
@@ -0,0 +1,40 @@
+<?xml version="1.0" encoding="UTF-8" ?>
+<!--File generated from metadata database-->
+<pattern id="EFORMS-validation-stage-1b-1-BAD" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*[$noticeSubType = '1']">
+		<assert id="ND-BusinessParty-1" role="ERROR" diagnostics="ND-BusinessParty" test="count(cac:BusinessParty) = 0">rule|text|ND-BusinessParty-1</assert>
+		<assert id="ND-ContractingParty-1" role="ERROR" diagnostics="ND-ContractingParty" test="count(cac:ContractingParty) &gt; 0">rule|text|ND-ContractingParty-1</assert>
+		<assert id="ND-GazetteReference-1" role="ERROR" diagnostics="ND-GazetteReference" test="count(cac:AdditionalDocumentReference) = 0">rule|text|ND-GazetteReference-1</assert>
+		<assert id="ND-OperationType-1" role="ERROR" diagnostics="ND-OperationType" test="count(efac:NoticePurpose) = 0">rule|text|ND-OperationType-1</assert>
+		<assert id="ND-Part-1" role="ERROR" diagnostics="ND-Part" test="count(cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']) = 0">rule|text|ND-Part-1</assert>
+		<assert id="ND-ProcedureProcurementScope-1" role="ERROR" diagnostics="ND-ProcedureProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-ProcedureProcurementScope-1</assert>
+		<assert id="ND-ProcedureTenderingProcess-1" role="ERROR" diagnostics="ND-ProcedureTenderingProcess" test="count(cac:TenderingProcess) = 0">rule|text|ND-ProcedureTenderingProcess-1</assert>
+		<assert id="ND-RootExtension-1" role="ERROR" diagnostics="ND-RootExtension" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-RootExtension-1</assert>
+		<assert id="ND-SenderContact-1" role="ERROR" diagnostics="ND-SenderContact" test="count(cac:SenderParty/cac:Contact) = 0">rule|text|ND-SenderContact-1</assert>
+	</rule>
+	<rule context="/*/cac:ContractingParty[$noticeSubType = '1']">
+		<assert id="ND-Buyer-1" role="ERROR" diagnostics="ND-Buyer" test="count(cac:Party) &gt; 0">rule|text|ND-Buyer-1</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProject[$noticeSubType = '1']">
+		<assert id="ND-ProcedureValueEstimate-1" role="ERROR" diagnostics="ND-ProcedureValueEstimate" test="count(cac:RequestedTenderTotal) = 0">rule|text|ND-ProcedureValueEstimate-1</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms[$noticeSubType = '1']">
+		<assert id="ND-LotDistribution-1" role="ERROR" diagnostics="ND-LotDistribution" test="count(cac:LotDistribution) = 0">rule|text|ND-LotDistribution-1</assert>
+		<assert id="ND-TendererQualificationRequest-1" role="ERROR" diagnostics="ND-TendererQualificationRequest" test="count(cac:TendererQualificationRequest) = 0">rule|text|ND-TendererQualificationRequest-1</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:ProcurementLegislationDocumentReference[$noticeSubType = '1']">
+		<assert id="ND-CrossBorderLawUnpublish-1" role="ERROR" diagnostics="ND-CrossBorderLawUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-CrossBorderLawUnpublish-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '1']">
+		<assert id="ND-ContractModification-1" role="ERROR" diagnostics="ND-ContractModification" test="count(efac:ContractModification) = 0">rule|text|ND-ContractModification-1</assert>
+		<assert id="ND-NoticeResult-1" role="ERROR" diagnostics="ND-NoticeResult" test="count(efac:NoticeResult) = 0">rule|text|ND-NoticeResult-1</assert>
+		<assert id="ND-Organizations-1" role="ERROR" diagnostics="ND-Organizations" test="count(efac:Organizations) &gt; 0">rule|text|ND-Organizations-1</assert>
+		<assert id="ND-ReviewRequests-1" role="ERROR" diagnostics="ND-ReviewRequests" test="count(efac:AppealsInformation) = 0">rule|text|ND-ReviewRequests-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations[$noticeSubType = '1']">
+		<assert id="ND-Organization-1" role="ERROR" diagnostics="ND-Organization" test="count(efac:Organization) &gt; 0">rule|text|ND-Organization-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations/efac:Organization[$noticeSubType = '1']">
+		<assert id="ND-Company-1" role="ERROR" diagnostics="ND-Company" test="count(efac:Company) &gt; 0">rule|text|ND-Company-1</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1b-16.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1b-16.sch
new file mode 100644
index 0000000..67d8951
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/invalid/schematrons/static/validation-stage-1b-16.sch
@@ -0,0 +1,85 @@
+<?xml version="1.0" encoding="UTF-8" ?>
+<!--File generated from metadata database-->
+<pattern id="EFORMS-validation-stage-1b-16" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*[$noticeSubType = '16']">
+		<assert id="ND-BusinessParty-16" role="ERROR" diagnostics="ND-BusinessParty" test="count(cac:BusinessParty) = 0">rule|text|ND-BusinessParty-16</assert>
+		<assert id="ND-ContractingParty-16" role="ERROR" diagnostics="ND-ContractingParty" test="count(cac:ContractingParty) &gt; 0">rule|text|ND-ContractingParty-16</assert>
+		<assert id="ND-GazetteReference-16" role="ERROR" diagnostics="ND-GazetteReference" test="count(cac:AdditionalDocumentReference) = 0">rule|text|ND-GazetteReference-16</assert>
+		<assert id="ND-OperationType-16" role="ERROR" diagnostics="ND-OperationType" test="count(efac:NoticePurpose) = 0">rule|text|ND-OperationType-16</assert>
+		<assert id="ND-Part-16" role="ERROR" diagnostics="ND-Part" test="count(cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']) = 0">rule|text|ND-Part-16</assert>
+		<assert id="ND-ProcedureProcurementScope-16" role="ERROR" diagnostics="ND-ProcedureProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-ProcedureProcurementScope-16</assert>
+		<assert id="ND-ProcedureTenderingProcess-16" role="ERROR" diagnostics="ND-ProcedureTenderingProcess" test="count(cac:TenderingProcess) &gt; 0">rule|text|ND-ProcedureTenderingProcess-16</assert>
+		<assert id="ND-ProcedureTerms-16" role="ERROR" diagnostics="ND-ProcedureTerms" test="count(cac:TenderingTerms) &gt; 0">rule|text|ND-ProcedureTerms-16</assert>
+		<assert id="ND-RootExtension-16" role="ERROR" diagnostics="ND-RootExtension" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-RootExtension-16</assert>
+		<assert id="ND-SenderContact-16" role="ERROR" diagnostics="ND-SenderContact" test="count(cac:SenderParty/cac:Contact) = 0">rule|text|ND-SenderContact-16</assert>
+	</rule>
+	<rule context="/*/cac:ContractingParty[$noticeSubType = '16']">
+		<assert id="ND-Buyer-16" role="ERROR" diagnostics="ND-Buyer" test="count(cac:Party) &gt; 0">rule|text|ND-Buyer-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot'][$noticeSubType = '16']">
+		<assert id="ND-LotProcurementScope-16" role="ERROR" diagnostics="ND-LotProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-LotProcurementScope-16</assert>
+		<assert id="ND-LotTenderingProcess-16" role="ERROR" diagnostics="ND-LotTenderingProcess" test="count(cac:TenderingProcess) &gt; 0">rule|text|ND-LotTenderingProcess-16</assert>
+		<assert id="ND-LotTenderingTerms-16" role="ERROR" diagnostics="ND-LotTenderingTerms" test="count(cac:TenderingTerms) &gt; 0">rule|text|ND-LotTenderingTerms-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingProcess[$noticeSubType = '16']">
+		<assert id="ND-AuctionTerms-16" role="ERROR" diagnostics="ND-AuctionTerms" test="count(cac:AuctionTerms) &gt; 0">rule|text|ND-AuctionTerms-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingProcess/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-InterestExpressionReceptionPeriod-16" role="ERROR" diagnostics="ND-InterestExpressionReceptionPeriod" test="count(efac:InterestExpressionReceptionPeriod) = 0">rule|text|ND-InterestExpressionReceptionPeriod-16</assert>
+		<assert id="ND-PMCAnswersDeadline-16" role="ERROR" diagnostics="ND-PMCAnswersDeadline" test="count(efac:AnswerReceptionPeriod) = 0">rule|text|ND-PMCAnswersDeadline-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms[$noticeSubType = '16']">
+		<assert id="ND-LotProcurementDocument-16" role="ERROR" diagnostics="ND-LotProcurementDocument" test="count(cac:CallForTendersDocumentReference) &gt; 0">rule|text|ND-LotProcurementDocument-16</assert>
+		<assert id="ND-LotReservedParticipation-16" role="ERROR" diagnostics="ND-LotReservedParticipation" test="count(cac:TendererQualificationRequest) &gt; 0">rule|text|ND-LotReservedParticipation-16</assert>
+		<assert id="ND-LotReviewTerms-16" role="ERROR" diagnostics="ND-LotReviewTerms" test="count(cac:AppealTerms) &gt; 0">rule|text|ND-LotReviewTerms-16</assert>
+		<assert id="ND-NonUBLTenderingTerms-16" role="ERROR" diagnostics="ND-NonUBLTenderingTerms" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-NonUBLTenderingTerms-16</assert>
+		<assert id="ND-Participants-16" role="ERROR" diagnostics="ND-Participants" test="count(cac:EconomicOperatorShortList) = 0">rule|text|ND-Participants-16</assert>
+		<assert id="ND-PostAwardProcess-16" role="ERROR" diagnostics="ND-PostAwardProcess" test="count(cac:PostAwardProcess) &gt; 0">rule|text|ND-PostAwardProcess-16</assert>
+		<assert id="ND-SubcontractingObligation-16" role="ERROR" diagnostics="ND-SubcontractingObligation" test="count(cac:AllowedSubcontractTerms) = 0">rule|text|ND-SubcontractingObligation-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionNumberComplicatedUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionNumberComplicatedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionNumberComplicatedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionTypeUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionTypeUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:AwardCriterionParameter[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionFixNumberUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionFixNumberUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionFixNumberUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionNumberComplicatedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionTypeUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionTypeUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:AwardCriterionParameter[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionFixNumberUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionFixNumberUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionFixNumberUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingProcess[$noticeSubType = '16']">
+		<assert id="ND-ProcedureTypeUnpublish-16" role="ERROR" diagnostics="ND-ProcedureTypeUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-ProcedureTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingProcess/cac:ProcessJustification[$noticeSubType = '16']">
+		<assert id="ND-ProcedureAcceleratedUnpublish-16" role="ERROR" diagnostics="ND-ProcedureAcceleratedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-ProcedureAcceleratedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms[$noticeSubType = '16']">
+		<assert id="ND-TendererQualificationRequest-16" role="ERROR" diagnostics="ND-TendererQualificationRequest" test="count(cac:TendererQualificationRequest) &gt; 0">rule|text|ND-TendererQualificationRequest-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:ProcurementLegislationDocumentReference[$noticeSubType = '16']">
+		<assert id="ND-CrossBorderLawUnpublish-16" role="ERROR" diagnostics="ND-CrossBorderLawUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-CrossBorderLawUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:TendererQualificationRequest[$noticeSubType = '16']">
+		<assert id="ND-ExclusionGrounds-16" role="ERROR" diagnostics="ND-ExclusionGrounds" test="count(cac:SpecificTendererRequirement) &gt; 0">rule|text|ND-ExclusionGrounds-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-ContractModification-16" role="ERROR" diagnostics="ND-ContractModification" test="count(efac:ContractModification) = 0">rule|text|ND-ContractModification-16</assert>
+		<assert id="ND-NoticeResult-16" role="ERROR" diagnostics="ND-NoticeResult" test="count(efac:NoticeResult) = 0">rule|text|ND-NoticeResult-16</assert>
+		<assert id="ND-Organizations-16" role="ERROR" diagnostics="ND-Organizations" test="count(efac:Organizations) &gt; 0">rule|text|ND-Organizations-16</assert>
+		<assert id="ND-ReviewRequests-16" role="ERROR" diagnostics="ND-ReviewRequests" test="count(efac:AppealsInformation) = 0">rule|text|ND-ReviewRequests-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations[$noticeSubType = '16']">
+		<assert id="ND-Organization-16" role="ERROR" diagnostics="ND-Organization" test="count(efac:Organization) &gt; 0">rule|text|ND-Organization-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations/efac:Organization[$noticeSubType = '16']">
+		<assert id="ND-Company-16" role="ERROR" diagnostics="ND-Company" test="count(efac:Company) &gt; 0">rule|text|ND-Company-16</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/1.json b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/1.json
new file mode 100644
index 0000000..f4a8a55
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/1.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "1",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/16.json b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/16.json
new file mode 100644
index 0000000..d5a465c
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/16.json
@@ -0,0 +1,48 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeId" : "16",
+  "metadata" : [ {
+    "id" : "BT-02-notice",
+    "contentType" : "field",
+    "displayType" : "COMBOBOX",
+    "description" : "Notice Type",
+    "_label" : "field|name|BT-02-notice",
+    "readOnly" : true
+  } ],
+  "content" : [ {
+    "id" : "GR-Buyer",
+    "contentType" : "group",
+    "displayType" : "SECTION",
+    "description" : "Contracting Party and Provider related Information",
+    "_label" : "group|name|GR-Buyer",
+    "content" : [ {
+      "id" : "GR-ContractingAuthority",
+      "contentType" : "group",
+      "nodeId" : "ND-ContractingParty",
+      "displayType" : "GROUP",
+      "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+      "_label" : "group|name|ND-ContractingParty",
+      "_repeatable" : true,
+      "content" : [ {
+        "id" : "GR-ContractingAuthority-Buyer",
+        "contentType" : "group",
+        "displayType" : "GROUP",
+        "description" : "Contracting Party related Information (URL, Legal Type, Contracting Type, Activity, …)",
+        "_label" : "group|name|GR-ContractingAuthority-Buyer",
+        "content" : [ {
+          "id" : "OPT-300-Procedure-Buyer",
+          "contentType" : "field",
+          "displayType" : "COMBOBOX",
+          "description" : "Buyer Technical Identifier Reference",
+          "_label" : "field|name|OPT-300-Procedure-Buyer",
+          "_idSchemes" : [ "ORG" ]
+        } ]
+      } ]
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/notice-types.json b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/notice-types.json
new file mode 100644
index 0000000..13d7343
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/notice-types/notice-types.json
@@ -0,0 +1,148 @@
+{
+  "ublVersion" : "2.3",
+  "sdkVersion" : "1.10.0",
+  "metadataDatabase" : {
+    "version" : "1.10.0",
+    "createdOn" : "2023-11-15T14:00:00"
+  },
+  "noticeSubTypes" : [ {
+    "documentType" : "PIN",
+    "legalBasis" : "32014L0024",
+    "formType" : "planning",
+    "type" : "pin-buyer",
+    "description" : "Notice of the publication of a prior information notice on a buyer profile - general directive",
+    "subTypeId" : "1",
+    "_label" : "notice|name|1",
+    "viewTemplateIds" : [ "1", "summary" ]
+  }, {
+    "documentType" : "CN",
+    "legalBasis" : "32014L0024",
+    "formType" : "competition",
+    "type" : "cn-standard",
+    "description" : "Contract notice – general directive, standard regime",
+    "subTypeId" : "16",
+    "_label" : "notice|name|16",
+    "viewTemplateIds" : [ "16", "summary" ]
+  } ],
+  "documentTypes" : [ {
+    "id" : "BRIN",
+    "namespace" : "http://data.europa.eu/p27/eforms-business-registration-information-notice/1",
+    "rootElement" : "BusinessRegistrationInformationNotice",
+    "schemaLocation" : "schemas/maindoc/EFORMS-BusinessRegistrationInformationNotice.xsd",
+    "additionalNamespaces" : [ {
+      "prefix" : "cac",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "cbc",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonBasicComponents-2.3.xsd"
+    }, {
+      "prefix" : "ext",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonExtensionComponents-2.3.xsd"
+    }, {
+      "prefix" : "efext",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extensions/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionApex-2.3.xsd"
+    }, {
+      "prefix" : "efac",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "efbc",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionBasicComponents-2.3.xsd"
+    } ]
+  }, {
+    "id" : "CAN",
+    "namespace" : "urn:oasis:names:specification:ubl:schema:xsd:ContractAwardNotice-2",
+    "rootElement" : "ContractAwardNotice",
+    "schemaLocation" : "schemas/maindoc/UBL-ContractAwardNotice-2.3.xsd",
+    "additionalNamespaces" : [ {
+      "prefix" : "cac",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "cbc",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonBasicComponents-2.3.xsd"
+    }, {
+      "prefix" : "ext",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonExtensionComponents-2.3.xsd"
+    }, {
+      "prefix" : "efext",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extensions/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionApex-2.3.xsd"
+    }, {
+      "prefix" : "efac",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "efbc",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionBasicComponents-2.3.xsd"
+    } ]
+  }, {
+    "id" : "CN",
+    "namespace" : "urn:oasis:names:specification:ubl:schema:xsd:ContractNotice-2",
+    "rootElement" : "ContractNotice",
+    "schemaLocation" : "schemas/maindoc/UBL-ContractNotice-2.3.xsd",
+    "additionalNamespaces" : [ {
+      "prefix" : "cac",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "cbc",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonBasicComponents-2.3.xsd"
+    }, {
+      "prefix" : "ext",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonExtensionComponents-2.3.xsd"
+    }, {
+      "prefix" : "efext",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extensions/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionApex-2.3.xsd"
+    }, {
+      "prefix" : "efac",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "efbc",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionBasicComponents-2.3.xsd"
+    } ]
+  }, {
+    "id" : "PIN",
+    "namespace" : "urn:oasis:names:specification:ubl:schema:xsd:PriorInformationNotice-2",
+    "rootElement" : "PriorInformationNotice",
+    "schemaLocation" : "schemas/maindoc/UBL-PriorInformationNotice-2.3.xsd",
+    "additionalNamespaces" : [ {
+      "prefix" : "cac",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "cbc",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonBasicComponents-2.3.xsd"
+    }, {
+      "prefix" : "ext",
+      "uri" : "urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2",
+      "schemaLocation" : "schemas/common/UBL-CommonExtensionComponents-2.3.xsd"
+    }, {
+      "prefix" : "efext",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extensions/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionApex-2.3.xsd"
+    }, {
+      "prefix" : "efac",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionAggregateComponents-2.3.xsd"
+    }, {
+      "prefix" : "efbc",
+      "uri" : "http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1",
+      "schemaLocation" : "schemas/common/EFORMS-ExtensionBasicComponents-2.3.xsd"
+    } ]
+  } ]
+}
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/complete-validation.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/complete-validation.sch
new file mode 100644
index 0000000..c0a36f9
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/complete-validation.sch
@@ -0,0 +1,318 @@
+<?xml version="1.0" encoding="utf-8" ?>
+<!--File generated from metadata database-->
+<schema xmlns="http://purl.oclc.org/dsdl/schematron" queryBinding="xslt2">
+
+	<title>eForms schematron rules</title>
+	
+	<ns prefix="xs" uri="http://www.w3.org/2001/XMLSchema" />
+	<ns prefix="sch" uri="http://purl.oclc.org/dsdl/schematron" />
+	<ns prefix="cbc" uri='urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2' />
+	<ns prefix="cac" uri="urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2" />
+	<ns prefix="ext" uri="urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2" />
+	<ns prefix="efac" uri="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1" />
+	<ns prefix="efext" uri="http://data.europa.eu/p27/eforms-ubl-extensions/1" />
+	<ns prefix="efbc" uri="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1" />
+	<ns prefix="can" uri="urn:oasis:names:specification:ubl:schema:xsd:ContractAwardNotice-2" />
+	<ns prefix="cn" uri="urn:oasis:names:specification:ubl:schema:xsd:ContractNotice-2" />
+	<ns prefix="pin" uri="urn:oasis:names:specification:ubl:schema:xsd:PriorInformationNotice-2" />
+	<ns prefix="fn" uri="http://www.w3.org/2005/xpath-functions" />
+	
+	<let name="noticeSubType" value="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NoticeSubType/cbc:SubTypeCode/text()"/>
+
+	<!-- True if the current notice is a change notice. -->
+	<let name="isChangeNotice" value="boolean(/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Changes/efbc:ChangedNoticeIdentifier)"/>
+
+	<include href="config.sch"/>
+	
+	<phase id="eforms-1">
+		<active pattern="EFORMS-validation-stage-1a" />
+		<active pattern="EFORMS-validation-stage-1b-1" />
+	</phase>
+	<phase id="eforms-16">
+		<active pattern="EFORMS-validation-stage-1a" />
+		<active pattern="EFORMS-validation-stage-1b-16" />
+	</phase>
+
+	<include href="validation-stage-1a.sch"/>
+	<include href="validation-stage-1b-1.sch"/>
+	<include href="validation-stage-1b-16.sch"/>
+
+	<diagnostics>
+		<diagnostic id="ND-AcceleratedProcedure" see="node:ND-AcceleratedProcedure">cac:ProcessJustification</diagnostic>
+		<diagnostic id="ND-AuctionTerms" see="node:ND-AuctionTerms">cac:AuctionTerms</diagnostic>
+		<diagnostic id="ND-AwardingTerms" see="node:ND-AwardingTerms">cac:AwardingTerms</diagnostic>
+		<diagnostic id="ND-AwardingTerms_BT-46-Lot" see="field:BT-46-Lot">cac:TechnicalCommitteePerson/cbc:FamilyName</diagnostic>
+		<diagnostic id="ND-BusinessAddress" see="node:ND-BusinessAddress">cac:PostalAddress</diagnostic>
+		<diagnostic id="ND-BusinessContact" see="node:ND-BusinessContact">cac:Contact</diagnostic>
+		<diagnostic id="ND-BusinessParty" see="node:ND-BusinessParty">cac:BusinessParty</diagnostic>
+		<diagnostic id="ND-BusinessParty_BT-501-Business-European" see="field:BT-501-Business-European">cac:PartyLegalEntity[cbc:CompanyID/@schemeName = 'EU']/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-BusinessParty_BT-501-Business-National" see="field:BT-501-Business-National">cac:PartyLegalEntity[cbc:CompanyID/@schemeName = 'national']/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-Buyer" see="node:ND-Buyer">cac:Party</diagnostic>
+		<diagnostic id="ND-Buyer_OPT-300-Procedure-SProvider" see="field:OPT-300-Procedure-SProvider">cac:ServiceProviderParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-Change" see="node:ND-Change">efac:Change</diagnostic>
+		<diagnostic id="ND-Company" see="node:ND-Company">efac:Company</diagnostic>
+		<diagnostic id="ND-Company_BT-16-Organization-Company" see="field:BT-16-Organization-Company">cac:PostalAddress/cbc:Department</diagnostic>
+		<diagnostic id="ND-Company_BT-501-Organization-Company" see="field:BT-501-Organization-Company">cac:PartyLegalEntity/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-Company_BT-502-Organization-Company" see="field:BT-502-Organization-Company">cac:Contact/cbc:Name</diagnostic>
+		<diagnostic id="ND-Company_BT-503-Organization-Company" see="field:BT-503-Organization-Company">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-Company_BT-506-Organization-Company" see="field:BT-506-Organization-Company">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-Company_BT-507-Organization-Company" see="field:BT-507-Organization-Company">cac:PostalAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-Company_BT-510_a_-Organization-Company" see="field:BT-510(a)-Organization-Company">cac:PostalAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-Company_BT-510_b_-Organization-Company" see="field:BT-510(b)-Organization-Company">cac:PostalAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-Company_BT-510_c_-Organization-Company" see="field:BT-510(c)-Organization-Company">cac:PostalAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-Company_BT-512-Organization-Company" see="field:BT-512-Organization-Company">cac:PostalAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-Company_BT-513-Organization-Company" see="field:BT-513-Organization-Company">cac:PostalAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-Company_BT-514-Organization-Company" see="field:BT-514-Organization-Company">cac:PostalAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-Company_BT-739-Organization-Company" see="field:BT-739-Organization-Company">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-ConcessionRevenue" see="node:ND-ConcessionRevenue">efac:ConcessionRevenue</diagnostic>
+		<diagnostic id="ND-ContractEUFunds" see="node:ND-ContractEUFunds">efac:Funding</diagnostic>
+		<diagnostic id="ND-ContractModification" see="node:ND-ContractModification">efac:ContractModification</diagnostic>
+		<diagnostic id="ND-ContractModification_BT-1501_s_-Contract" see="field:BT-1501(s)-Contract">efac:Change/efac:ChangedSection/efbc:ChangedSectionIdentifier</diagnostic>
+		<diagnostic id="ND-ContractingParty" see="node:ND-ContractingParty">cac:ContractingParty</diagnostic>
+		<diagnostic id="ND-CrossBorderLawUnpublish" see="node:ND-CrossBorderLawUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ExclusionGrounds" see="node:ND-ExclusionGrounds">cac:SpecificTendererRequirement</diagnostic>
+		<diagnostic id="ND-ExecutionRequirements" see="node:ND-ExecutionRequirements">cac:ContractExecutionRequirement</diagnostic>
+		<diagnostic id="ND-ExtendedDurationJustification" see="node:ND-ExtendedDurationJustification">efac:DurationJustification</diagnostic>
+		<diagnostic id="ND-FA" see="node:ND-FA">cac:FrameworkAgreement</diagnostic>
+		<diagnostic id="ND-Funding" see="node:ND-Funding">efac:Funding</diagnostic>
+		<diagnostic id="ND-GazetteReference" see="node:ND-GazetteReference">cac:AdditionalDocumentReference</diagnostic>
+		<diagnostic id="ND-GroupComposition" see="node:ND-GroupComposition">cac:LotsGroup</diagnostic>
+		<diagnostic id="ND-GroupComposition_BT-1375-Procedure" see="field:BT-1375-Procedure">cac:ProcurementProjectLotReference/cbc:ID[@schemeName='Lot']</diagnostic>
+		<diagnostic id="ND-InterestExpressionReceptionPeriod" see="node:ND-InterestExpressionReceptionPeriod">efac:InterestExpressionReceptionPeriod</diagnostic>
+		<diagnostic id="ND-LocalEntity" see="node:ND-LocalEntity">cac:PartyLegalEntity</diagnostic>
+		<diagnostic id="ND-LotAwardCriteria" see="node:ND-LotAwardCriteria">cac:AwardingCriterion</diagnostic>
+		<diagnostic id="ND-LotAwardCriteria_BT-539-Lot" see="field:BT-539-Lot">cac:SubordinateAwardingCriterion/cbc:AwardingCriterionTypeCode[@listName='award-criterion-type']</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionFixNumberUnpublish" see="node:ND-LotAwardCriterionFixNumberUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionNumberComplicatedUnpublish" see="node:ND-LotAwardCriterionNumberComplicatedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-FixedNumber" see="field:BT-541-Lot-FixedNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-fixed']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-ThresholdNumber" see="field:BT-541-Lot-ThresholdNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-WeightNumber" see="field:BT-541-Lot-WeightNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionTypeUnpublish" see="node:ND-LotAwardCriterionTypeUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotDistribution" see="node:ND-LotDistribution">cac:LotDistribution</diagnostic>
+		<diagnostic id="ND-LotDistribution_BT-330-Procedure" see="field:BT-330-Procedure">cac:LotsGroup/cbc:LotsGroupID</diagnostic>
+		<diagnostic id="ND-LotDuration" see="node:ND-LotDuration">cac:PlannedPeriod</diagnostic>
+		<diagnostic id="ND-LotEmploymentLegislation" see="node:ND-LotEmploymentLegislation">cac:EmploymentLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotEnvironmentalLegislation" see="node:ND-LotEnvironmentalLegislation">cac:EnvironmentalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotFiscalLegislation" see="node:ND-LotFiscalLegislation">cac:FiscalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5071-Lot" see="field:BT-5071-Lot">cac:Address/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_a_-Lot" see="field:BT-5101(a)-Lot">cac:Address/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_b_-Lot" see="field:BT-5101(b)-Lot">cac:Address/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_c_-Lot" see="field:BT-5101(c)-Lot">cac:Address/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5121-Lot" see="field:BT-5121-Lot">cac:Address/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5131-Lot" see="field:BT-5131-Lot">cac:Address/cbc:CityName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5141-Lot" see="field:BT-5141-Lot">cac:Address/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-727-Lot" see="field:BT-727-Lot">cac:Address/cbc:Region</diagnostic>
+		<diagnostic id="ND-LotPreviousPlanning" see="node:ND-LotPreviousPlanning">cac:NoticeDocumentReference</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument" see="node:ND-LotProcurementDocument">cac:CallForTendersDocumentReference</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument_BT-708-Lot" see="field:BT-708-Lot">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:OfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument_BT-737-Lot" see="field:BT-737-Lot">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NonOfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotProcurementScope" see="node:ND-LotProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-06-Lot" see="field:BT-06-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='strategic-procurement']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-262-Lot" see="field:BT-262-Lot">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-263-Lot" see="field:BT-263-Lot">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-271-Lot" see="field:BT-271-Lot">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-531-Lot" see="field:BT-531-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-754-Lot" see="field:BT-754-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='accessibility']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-774-Lot" see="field:BT-774-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='environmental-impact']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-775-Lot" see="field:BT-775-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='social-objective']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-776-Lot" see="field:BT-776-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='innovative-acquisition']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-805-Lot" see="field:BT-805-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='gpp-criteria']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotReservedParticipation" see="node:ND-LotReservedParticipation">cac:TendererQualificationRequest</diagnostic>
+		<diagnostic id="ND-LotReservedParticipation_BT-71-Lot" see="field:BT-71-Lot">cac:SpecificTendererRequirement[cbc:TendererRequirementTypeCode/@listName='reserved-procurement']/cbc:TendererRequirementTypeCode</diagnostic>
+		<diagnostic id="ND-LotResult" see="node:ND-LotResult">efac:LotResult</diagnostic>
+		<diagnostic id="ND-LotResultFAValues" see="node:ND-LotResultFAValues">efac:FrameworkAgreementValues</diagnostic>
+		<diagnostic id="ND-LotResult_BT-636-LotResult" see="field:BT-636-LotResult">efac:AppealRequestsStatistics[efbc:StatisticsCode/@listName='irregularity-type']/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_BT-712_a_-LotResult" see="field:BT-712(a)-LotResult">efac:AppealRequestsStatistics[efbc:StatisticsCode/@listName='review-type']/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_BT-759-LotResult" see="field:BT-759-LotResult">efac:ReceivedSubmissionsStatistics/efbc:StatisticsNumeric</diagnostic>
+		<diagnostic id="ND-LotResult_BT-760-LotResult" see="field:BT-760-LotResult">efac:ReceivedSubmissionsStatistics/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-301-LotResult-Financing" see="field:OPT-301-LotResult-Financing">cac:FinancingParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-301-LotResult-Paying" see="field:OPT-301-LotResult-Paying">cac:PayerParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-315-LotResult" see="field:OPT-315-LotResult">efac:SettledContract/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-320-LotResult" see="field:OPT-320-LotResult">efac:LotTender/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotReviewTerms" see="node:ND-LotReviewTerms">cac:AppealTerms</diagnostic>
+		<diagnostic id="ND-LotReviewTerms_BT-99-Lot" see="field:BT-99-Lot">cac:PresentationPeriod/cbc:Description</diagnostic>
+		<diagnostic id="ND-LotTender" see="node:ND-LotTender">efac:LotTender</diagnostic>
+		<diagnostic id="ND-LotTenderOriginCountry" see="node:ND-LotTenderOriginCountry">efac:Origin</diagnostic>
+		<diagnostic id="ND-LotTender_BT-191-Tender" see="field:BT-191-Tender">efac:Origin/efbc:AreaCode</diagnostic>
+		<diagnostic id="ND-LotTender_BT-779-Tender" see="field:BT-779-Tender">efac:AggregatedAmounts/cbc:PaidAmount</diagnostic>
+		<diagnostic id="ND-LotTender_BT-780-Tender" see="field:BT-780-Tender">efac:AggregatedAmounts/efbc:PaidAmountDescription</diagnostic>
+		<diagnostic id="ND-LotTender_BT-782-Tender" see="field:BT-782-Tender">efac:AggregatedAmounts/efbc:PenaltiesAmount</diagnostic>
+		<diagnostic id="ND-LotTender_OPP-030-Tender" see="field:OPP-030-Tender">efac:ContractTerm[not(efbc:TermCode/text()='all-rev-tic')][efbc:TermCode/@listName='contract-detail']/efbc:TermCode</diagnostic>
+		<diagnostic id="ND-LotTender_OPP-033-Tender" see="field:OPP-033-Tender">efac:ContractTerm[efbc:TermCode/@listName='rewards-penalties']/efbc:TermCode</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess" see="node:ND-LotTenderingProcess">cac:TenderingProcess</diagnostic>
+		<diagnostic id="ND-LotTenderingProcessExtension" see="node:ND-LotTenderingProcessExtension">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1251-Lot" see="field:BT-1251-Lot">cac:NoticeDocumentReference/cbc:ReferencedDocumentInternalAddress</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1311_d_-Lot" see="field:BT-1311(d)-Lot">cac:ParticipationRequestReceptionPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1311_t_-Lot" see="field:BT-1311(t)-Lot">cac:ParticipationRequestReceptionPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-131_d_-Lot" see="field:BT-131(d)-Lot">cac:TenderSubmissionDeadlinePeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-131_t_-Lot" see="field:BT-131(t)-Lot">cac:TenderSubmissionDeadlinePeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-132_d_-Lot" see="field:BT-132(d)-Lot">cac:OpenTenderEvent/cbc:OccurrenceDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-13_d_-Lot" see="field:BT-13(d)-Lot">cac:AdditionalInformationRequestPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-13_t_-Lot" see="field:BT-13(t)-Lot">cac:AdditionalInformationRequestPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-765-Lot" see="field:BT-765-Lot">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='framework-agreement']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-766-Lot" see="field:BT-766-Lot">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='dps-usage']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms" see="node:ND-LotTenderingTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-18-Lot" see="field:BT-18-Lot">cac:TenderRecipientParty/cbc:EndpointID</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-65-Lot" see="field:BT-65-Lot">cac:AllowedSubcontractTerms[cbc:SubcontractingConditionsCode/@listName='subcontracting-obligation']/cbc:SubcontractingConditionsCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-736-Lot" see="field:BT-736-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='reserved-execution']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-743-Lot" see="field:BT-743-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='einvoicing']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-744-Lot" see="field:BT-744-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='esignature-submission']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-75-Lot" see="field:BT-75-Lot">cac:RequiredFinancialGuarantee/cbc:Description</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-751-Lot" see="field:BT-751-Lot">cac:RequiredFinancialGuarantee/cbc:GuaranteeTypeCode[@listName='tender-guarantee-required']</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-76-Lot" see="field:BT-76-Lot">cac:TendererQualificationRequest[not(cac:SpecificTendererRequirement)]/cbc:CompanyLegalForm</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-761-Lot" see="field:BT-761-Lot">cac:TendererQualificationRequest[not(cac:SpecificTendererRequirement)]/cbc:CompanyLegalFormCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-764-Lot" see="field:BT-764-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='ecatalog-submission']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-801-Lot" see="field:BT-801-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='nda']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-97-Lot" see="field:BT-97-Lot">cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-060-Lot" see="field:OPT-060-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='conditions']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-071-Lot" see="field:OPT-071-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='customer-service']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-301-Lot-TenderReceipt" see="field:OPT-301-Lot-TenderReceipt">cac:TenderRecipientParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotValueEstimate" see="node:ND-LotValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriteria_BT-539-LotsGroup" see="field:BT-539-LotsGroup">cac:SubordinateAwardingCriterion/cbc:AwardingCriterionTypeCode[@listName='award-criterion-type']</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionFixNumberUnpublish" see="node:ND-LotsGroupAwardCriterionFixNumberUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish" see="node:ND-LotsGroupAwardCriterionNumberComplicatedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-FixedNumber" see="field:BT-541-LotsGroup-FixedNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-fixed']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-ThresholdNumber" see="field:BT-541-LotsGroup-ThresholdNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-WeightNumber" see="field:BT-541-LotsGroup-WeightNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionTypeUnpublish" see="node:ND-LotsGroupAwardCriterionTypeUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardingTerms" see="node:ND-LotsGroupAwardingTerms">cac:TenderingTerms/cac:AwardingTerms</diagnostic>
+		<diagnostic id="ND-LotsGroupFA" see="node:ND-LotsGroupFA">cac:TenderingProcess/cac:FrameworkAgreement</diagnostic>
+		<diagnostic id="ND-LotsGroupProcurementScope_BT-271-LotsGroup" see="field:BT-271-LotsGroup">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-LotsGroupValueEstimate" see="node:ND-LotsGroupValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-Modification" see="node:ND-Modification">efac:Change</diagnostic>
+		<diagnostic id="ND-ModificationReason" see="node:ND-ModificationReason">efac:ChangeReason</diagnostic>
+		<diagnostic id="ND-ModifiedSection" see="node:ND-ModifiedSection">efac:ChangedSection</diagnostic>
+		<diagnostic id="ND-NonEsubmission" see="node:ND-NonEsubmission">cac:ProcessJustification</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms" see="node:ND-NonUBLTenderingTerms">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-5010-Lot" see="field:BT-5010-Lot">efac:Funding/efbc:FinancingIdentifier</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-651-Lot" see="field:BT-651-Lot">efac:TenderSubcontractingRequirements/efbc:TenderSubcontractingRequirementsCode</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-7220-Lot" see="field:BT-7220-Lot">efac:Funding/cbc:FundingProgramCode</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-747-Lot" see="field:BT-747-Lot">efac:SelectionCriteria/cbc:CriterionTypeCode[@listName='selection-criterion']</diagnostic>
+		<diagnostic id="ND-NotAwardedReasonUnpublish" see="node:ND-NotAwardedReasonUnpublish">efac:DecisionReason/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-NoticeApproximateValueUnpublish" see="node:ND-NoticeApproximateValueUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-NoticeResult" see="node:ND-NoticeResult">efac:NoticeResult</diagnostic>
+		<diagnostic id="ND-NoticeResultGroupFA" see="node:ND-NoticeResultGroupFA">efac:GroupFramework</diagnostic>
+		<diagnostic id="ND-OperationType" see="node:ND-OperationType">efac:NoticePurpose</diagnostic>
+		<diagnostic id="ND-OptionsAndRenewals" see="node:ND-OptionsAndRenewals">cac:ContractExtension</diagnostic>
+		<diagnostic id="ND-OptionsAndRenewals_BT-57-Lot" see="field:BT-57-Lot">cac:Renewal/cac:Period/cbc:Description</diagnostic>
+		<diagnostic id="ND-Organization" see="node:ND-Organization">efac:Organization</diagnostic>
+		<diagnostic id="ND-Organization_OPT-201-Organization-TouchPoint" see="field:OPT-201-Organization-TouchPoint">efac:TouchPoint/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-Organization_OPT-302-Organization" see="field:OPT-302-Organization">efac:UltimateBeneficialOwner/cbc:ID</diagnostic>
+		<diagnostic id="ND-Organizations" see="node:ND-Organizations">efac:Organizations</diagnostic>
+		<diagnostic id="ND-Organizations_OPT-202-UBO" see="field:OPT-202-UBO">efac:UltimateBeneficialOwner/cbc:ID</diagnostic>
+		<diagnostic id="ND-OtherContractExecutionConditions" see="node:ND-OtherContractExecutionConditions">efac:ContractTerm</diagnostic>
+		<diagnostic id="ND-PMCAnswersDeadline" see="node:ND-PMCAnswersDeadline">efac:AnswerReceptionPeriod</diagnostic>
+		<diagnostic id="ND-Part" see="node:ND-Part">cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']</diagnostic>
+		<diagnostic id="ND-PartEmploymentLegislation" see="node:ND-PartEmploymentLegislation">cac:EmploymentLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartEnvironmentalLegislation" see="node:ND-PartEnvironmentalLegislation">cac:EnvironmentalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartFiscalLegislation" see="node:ND-PartFiscalLegislation">cac:FiscalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5071-Part" see="field:BT-5071-Part">cac:Address/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_a_-Part" see="field:BT-5101(a)-Part">cac:Address/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_b_-Part" see="field:BT-5101(b)-Part">cac:Address/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_c_-Part" see="field:BT-5101(c)-Part">cac:Address/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5121-Part" see="field:BT-5121-Part">cac:Address/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5131-Part" see="field:BT-5131-Part">cac:Address/cbc:CityName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5141-Part" see="field:BT-5141-Part">cac:Address/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-727-Part" see="field:BT-727-Part">cac:Address/cbc:Region</diagnostic>
+		<diagnostic id="ND-PartProcurementDocument_BT-708-Part" see="field:BT-708-Part">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:OfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-PartProcurementDocument_BT-737-Part" see="field:BT-737-Part">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NonOfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-PartProcurementScope" see="node:ND-PartProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-262-Part" see="field:BT-262-Part">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-263-Part" see="field:BT-263-Part">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-531-Part" see="field:BT-531-Part">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-PartReservedParticipation_BT-71-Part" see="field:BT-71-Part">cac:SpecificTendererRequirement[cbc:TendererRequirementTypeCode/@listName='reserved-procurement']/cbc:TendererRequirementTypeCode</diagnostic>
+		<diagnostic id="ND-PartReviewTerms" see="node:ND-PartReviewTerms">cac:AppealTerms</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-1251-Part" see="field:BT-1251-Part">cac:NoticeDocumentReference/cbc:ReferencedDocumentInternalAddress</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-13_d_-Part" see="field:BT-13(d)-Part">cac:AdditionalInformationRequestPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-13_t_-Part" see="field:BT-13(t)-Part">cac:AdditionalInformationRequestPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-765-Part" see="field:BT-765-Part">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='framework-agreement']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-766-Part" see="field:BT-766-Part">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='dps-usage']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-PartTenderingTerms" see="node:ND-PartTenderingTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-PartTenderingTerms_BT-736-Part" see="field:BT-736-Part">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='reserved-execution']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-Participants" see="node:ND-Participants">cac:EconomicOperatorShortList</diagnostic>
+		<diagnostic id="ND-Participants_BT-47-Lot" see="field:BT-47-Lot">cac:PreSelectedParty/cac:PartyName/cbc:Name</diagnostic>
+		<diagnostic id="ND-PaymentTerms" see="node:ND-PaymentTerms">cac:PaymentTerms</diagnostic>
+		<diagnostic id="ND-PostAwardProcess" see="node:ND-PostAwardProcess">cac:PostAwardProcess</diagnostic>
+		<diagnostic id="ND-Prize" see="node:ND-Prize">cac:Prize</diagnostic>
+		<diagnostic id="ND-ProcedureAcceleratedUnpublish" see="node:ND-ProcedureAcceleratedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ProcedurePlacePerformanceAdditionalInformation" see="node:ND-ProcedurePlacePerformanceAdditionalInformation">cac:RealizedLocation</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope" see="node:ND-ProcedureProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-262-Procedure" see="field:BT-262-Procedure">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-263-Procedure" see="field:BT-263-Procedure">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-271-Procedure" see="field:BT-271-Procedure">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-531-Procedure" see="field:BT-531-Procedure">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_OPP-040-Procedure" see="field:OPP-040-Procedure">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='transport-service']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-ProcedureTenderingProcess" see="node:ND-ProcedureTenderingProcess">cac:TenderingProcess</diagnostic>
+		<diagnostic id="ND-ProcedureTenderingProcess_OPP-090-Procedure" see="field:OPP-090-Procedure">cac:NoticeDocumentReference/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms" see="node:ND-ProcedureTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-01_c_-Procedure" see="field:BT-01(c)-Procedure">cac:ProcurementLegislationDocumentReference[not(cbc:ID/text()=('CrossBorderLaw','LocalLegalBasis'))]/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-01_e_-Procedure" see="field:BT-01(e)-Procedure">cac:ProcurementLegislationDocumentReference[cbc:ID/text()='LocalLegalBasis']/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-09_a_-Procedure" see="field:BT-09(a)-Procedure">cac:ProcurementLegislationDocumentReference[cbc:ID/text()='CrossBorderLaw']/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTypeUnpublish" see="node:ND-ProcedureTypeUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ProcedureValueEstimate" see="node:ND-ProcedureValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-PublicOpening" see="node:ND-PublicOpening">cac:OpenTenderEvent</diagnostic>
+		<diagnostic id="ND-PublicOpening_BT-133-Lot" see="field:BT-133-Lot">cac:OccurenceLocation/cbc:Description</diagnostic>
+		<diagnostic id="ND-ReceivedSubmissions" see="node:ND-ReceivedSubmissions">efac:ReceivedSubmissionsStatistics</diagnostic>
+		<diagnostic id="ND-ReviewRequests" see="node:ND-ReviewRequests">efac:AppealsInformation</diagnostic>
+		<diagnostic id="ND-ReviewRequestsStatistics" see="node:ND-ReviewRequestsStatistics">efac:AppealRequestsStatistics</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-786-Review" see="field:BT-786-Review">efac:AppealedItem/cbc:ID</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-790-Review" see="field:BT-790-Review">efac:AppealDecision/efbc:DecisionTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-791-Review" see="field:BT-791-Review">efac:AppealIrregularity/efbc:IrregularityTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-792-Review" see="field:BT-792-Review">efac:AppealRemedy/efbc:RemedyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-799-ReviewBody" see="field:BT-799-ReviewBody">efac:AppealProcessingParty/efbc:AppealProcessingPartyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-091-ReviewReq" see="field:OPT-091-ReviewReq">efac:AppealingParty/efbc:AppealingPartyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-092-ReviewBody" see="field:OPT-092-ReviewBody">efac:AppealProcessingParty/efbc:AppealProcessingPartyTypeDescription</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-301-ReviewBody" see="field:OPT-301-ReviewBody">efac:AppealProcessingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-301-ReviewReq" see="field:OPT-301-ReviewReq">efac:AppealingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-RootExtension" see="node:ND-RootExtension">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-010-notice" see="field:OPP-010-notice">efac:Publication/efbc:NoticePublicationID[@schemeName='ojs-notice-id']</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-011-notice" see="field:OPP-011-notice">efac:Publication/efbc:GazetteID[@schemeName='ojs-id']</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-012-notice" see="field:OPP-012-notice">efac:Publication/efbc:PublicationDate</diagnostic>
+		<diagnostic id="ND-Root_OPP-105-Business" see="field:OPP-105-Business">cac:BusinessCapability/cbc:CapabilityTypeCode</diagnostic>
+		<diagnostic id="ND-Root_OPT-300-Procedure-Buyer" see="field:OPT-300-Procedure-Buyer">cac:ContractingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-SecondStage" see="node:ND-SecondStage">cac:EconomicOperatorShortList</diagnostic>
+		<diagnostic id="ND-SecondStageWeightCriterionParameter" see="node:ND-SecondStageWeightCriterionParameter">efac:CriterionParameter</diagnostic>
+		<diagnostic id="ND-SecurityClearanceTerms" see="node:ND-SecurityClearanceTerms">cac:SecurityClearanceTerm</diagnostic>
+		<diagnostic id="ND-SelectionCriteria" see="node:ND-SelectionCriteria">efac:SelectionCriteria</diagnostic>
+		<diagnostic id="ND-SelectionCriteria_BT-752-Lot-ThresholdNumber" see="field:BT-752-Lot-ThresholdNumber">efac:CriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-SelectionCriteria_BT-752-Lot-WeightNumber" see="field:BT-752-Lot-WeightNumber">efac:CriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-SenderContact" see="node:ND-SenderContact">cac:SenderParty/cac:Contact</diagnostic>
+		<diagnostic id="ND-SettledContract" see="node:ND-SettledContract">efac:SettledContract</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-3202-Contract" see="field:BT-3202-Contract">efac:LotTender/cbc:ID</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-5011-Contract" see="field:BT-5011-Contract">efac:Funding/efbc:FinancingIdentifier</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-722-Contract" see="field:BT-722-Contract">efac:Funding/cbc:FundingProgramCode</diagnostic>
+		<diagnostic id="ND-SettledContract_OPT-300-Contract-Signatory" see="field:OPT-300-Contract-Signatory">cac:SignatoryParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-StrategicProcurementLot" see="node:ND-StrategicProcurementLot">efac:StrategicProcurement</diagnostic>
+		<diagnostic id="ND-StrategicProcurementLotResult" see="node:ND-StrategicProcurementLotResult">efac:StrategicProcurement</diagnostic>
+		<diagnostic id="ND-SubContractor_OPT-301-Tenderer-MainCont" see="field:OPT-301-Tenderer-MainCont">efac:MainContractor/cbc:ID</diagnostic>
+		<diagnostic id="ND-SubcontractedContract" see="node:ND-SubcontractedContract">efac:SubcontractingTerm</diagnostic>
+		<diagnostic id="ND-SubcontractingObligation" see="node:ND-SubcontractingObligation">cac:AllowedSubcontractTerms</diagnostic>
+		<diagnostic id="ND-TendererQualificationRequest" see="node:ND-TendererQualificationRequest">cac:TendererQualificationRequest</diagnostic>
+		<diagnostic id="ND-TenderingParty_OPT-300-Tenderer" see="field:OPT-300-Tenderer">efac:Tenderer/cbc:ID</diagnostic>
+		<diagnostic id="ND-TenderingParty_OPT-301-Tenderer-SubCont" see="field:OPT-301-Tenderer-SubCont">efac:SubContractor/cbc:ID</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-16-Organization-TouchPoint" see="field:BT-16-Organization-TouchPoint">cac:PostalAddress/cbc:Department</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-502-Organization-TouchPoint" see="field:BT-502-Organization-TouchPoint">cac:Contact/cbc:Name</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-503-Organization-TouchPoint" see="field:BT-503-Organization-TouchPoint">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-506-Organization-TouchPoint" see="field:BT-506-Organization-TouchPoint">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-507-Organization-TouchPoint" see="field:BT-507-Organization-TouchPoint">cac:PostalAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_a_-Organization-TouchPoint" see="field:BT-510(a)-Organization-TouchPoint">cac:PostalAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_b_-Organization-TouchPoint" see="field:BT-510(b)-Organization-TouchPoint">cac:PostalAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_c_-Organization-TouchPoint" see="field:BT-510(c)-Organization-TouchPoint">cac:PostalAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-512-Organization-TouchPoint" see="field:BT-512-Organization-TouchPoint">cac:PostalAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-513-Organization-TouchPoint" see="field:BT-513-Organization-TouchPoint">cac:PostalAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-514-Organization-TouchPoint" see="field:BT-514-Organization-TouchPoint">cac:PostalAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-739-Organization-TouchPoint" see="field:BT-739-Organization-TouchPoint">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-UBO_BT-503-UBO" see="field:BT-503-UBO">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-UBO_BT-506-UBO" see="field:BT-506-UBO">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-UBO_BT-507-UBO" see="field:BT-507-UBO">cac:ResidenceAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_a_-UBO" see="field:BT-510(a)-UBO">cac:ResidenceAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_b_-UBO" see="field:BT-510(b)-UBO">cac:ResidenceAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_c_-UBO" see="field:BT-510(c)-UBO">cac:ResidenceAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-UBO_BT-512-UBO" see="field:BT-512-UBO">cac:ResidenceAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-UBO_BT-513-UBO" see="field:BT-513-UBO">cac:ResidenceAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-UBO_BT-514-UBO" see="field:BT-514-UBO">cac:ResidenceAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-UBO_BT-706-UBO" see="field:BT-706-UBO">efac:Nationality/cbc:NationalityID</diagnostic>
+		<diagnostic id="ND-UBO_BT-739-UBO" see="field:BT-739-UBO">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-WinnerChosenUnpublish" see="node:ND-WinnerChosenUnpublish">efac:FieldsPrivacy</diagnostic>
+	</diagnostics>
+</schema>
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/config.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/config.sch
new file mode 100644
index 0000000..bb6e87b
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/config.sch
@@ -0,0 +1,5 @@
+<?xml version="1.0" encoding="UTF-8"?>
+<!-- URL prefix of the service to fetch a notice.
+	 The value must be between single quotes.
+	 The notice identifier will be appended, to build the URL used to fetch the corresponding notice XML. -->
+<let xmlns="http://purl.oclc.org/dsdl/schematron" name="urlPrefix" value="'http://localhost:8080/notices/'"/>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1a.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1a.sch
new file mode 100644
index 0000000..9ab9877
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1a.sch
@@ -0,0 +1,21 @@
+<?xml version="1.0" encoding="UTF-8"?>
+<pattern id="EFORMS-validation-stage-1a" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*">
+		<assert id="P-0001" role="ERROR" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NoticeSubType/cbc:SubTypeCode) &gt; 0">
+			rule|text|P-0001
+		</assert>
+		<assert id="P-0002" role="ERROR" test="($noticeSubType = ('1', '2', '3', 'X01', 'X02') and count(cac:ProcurementProjectLot) = 0) or (not(cbc:NoticeTypeCode/text() = ('1', '2', '3', 'X01', 'X02')) and count(cac:ProcurementProjectLot) > 0)">
+			rule|text|P-0002
+		</assert>
+	</rule>
+	<rule context="cac:ProcurementProjectLot/cbc:ID">
+		<assert id="P-0004" role="ERROR" test="@schemeName">
+			rule|text|P-0004
+		</assert>
+	</rule>
+	<rule context="cac:ProcurementProjectLot/cbc:ID/@schemeName">
+		<assert id="P-0005" role="ERROR" test="normalize-space(.) = ('Part', 'Lot', 'LotsGroup')">
+			rule|text|P-0005
+		</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1b-1.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1b-1.sch
new file mode 100644
index 0000000..e51be47
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1b-1.sch
@@ -0,0 +1,40 @@
+<?xml version="1.0" encoding="UTF-8" ?>
+<!--File generated from metadata database-->
+<pattern id="EFORMS-validation-stage-1b-1" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*[$noticeSubType = '1']">
+		<assert id="ND-BusinessParty-1" role="ERROR" diagnostics="ND-BusinessParty" test="count(cac:BusinessParty) = 0">rule|text|ND-BusinessParty-1</assert>
+		<assert id="ND-ContractingParty-1" role="ERROR" diagnostics="ND-ContractingParty" test="count(cac:ContractingParty) &gt; 0">rule|text|ND-ContractingParty-1</assert>
+		<assert id="ND-GazetteReference-1" role="ERROR" diagnostics="ND-GazetteReference" test="count(cac:AdditionalDocumentReference) = 0">rule|text|ND-GazetteReference-1</assert>
+		<assert id="ND-OperationType-1" role="ERROR" diagnostics="ND-OperationType" test="count(efac:NoticePurpose) = 0">rule|text|ND-OperationType-1</assert>
+		<assert id="ND-Part-1" role="ERROR" diagnostics="ND-Part" test="count(cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']) = 0">rule|text|ND-Part-1</assert>
+		<assert id="ND-ProcedureProcurementScope-1" role="ERROR" diagnostics="ND-ProcedureProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-ProcedureProcurementScope-1</assert>
+		<assert id="ND-ProcedureTenderingProcess-1" role="ERROR" diagnostics="ND-ProcedureTenderingProcess" test="count(cac:TenderingProcess) = 0">rule|text|ND-ProcedureTenderingProcess-1</assert>
+		<assert id="ND-RootExtension-1" role="ERROR" diagnostics="ND-RootExtension" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-RootExtension-1</assert>
+		<assert id="ND-SenderContact-1" role="ERROR" diagnostics="ND-SenderContact" test="count(cac:SenderParty/cac:Contact) = 0">rule|text|ND-SenderContact-1</assert>
+	</rule>
+	<rule context="/*/cac:ContractingParty[$noticeSubType = '1']">
+		<assert id="ND-Buyer-1" role="ERROR" diagnostics="ND-Buyer" test="count(cac:Party) &gt; 0">rule|text|ND-Buyer-1</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProject[$noticeSubType = '1']">
+		<assert id="ND-ProcedureValueEstimate-1" role="ERROR" diagnostics="ND-ProcedureValueEstimate" test="count(cac:RequestedTenderTotal) = 0">rule|text|ND-ProcedureValueEstimate-1</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms[$noticeSubType = '1']">
+		<assert id="ND-LotDistribution-1" role="ERROR" diagnostics="ND-LotDistribution" test="count(cac:LotDistribution) = 0">rule|text|ND-LotDistribution-1</assert>
+		<assert id="ND-TendererQualificationRequest-1" role="ERROR" diagnostics="ND-TendererQualificationRequest" test="count(cac:TendererQualificationRequest) = 0">rule|text|ND-TendererQualificationRequest-1</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:ProcurementLegislationDocumentReference[$noticeSubType = '1']">
+		<assert id="ND-CrossBorderLawUnpublish-1" role="ERROR" diagnostics="ND-CrossBorderLawUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-CrossBorderLawUnpublish-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '1']">
+		<assert id="ND-ContractModification-1" role="ERROR" diagnostics="ND-ContractModification" test="count(efac:ContractModification) = 0">rule|text|ND-ContractModification-1</assert>
+		<assert id="ND-NoticeResult-1" role="ERROR" diagnostics="ND-NoticeResult" test="count(efac:NoticeResult) = 0">rule|text|ND-NoticeResult-1</assert>
+		<assert id="ND-Organizations-1" role="ERROR" diagnostics="ND-Organizations" test="count(efac:Organizations) &gt; 0">rule|text|ND-Organizations-1</assert>
+		<assert id="ND-ReviewRequests-1" role="ERROR" diagnostics="ND-ReviewRequests" test="count(efac:AppealsInformation) = 0">rule|text|ND-ReviewRequests-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations[$noticeSubType = '1']">
+		<assert id="ND-Organization-1" role="ERROR" diagnostics="ND-Organization" test="count(efac:Organization) &gt; 0">rule|text|ND-Organization-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations/efac:Organization[$noticeSubType = '1']">
+		<assert id="ND-Company-1" role="ERROR" diagnostics="ND-Company" test="count(efac:Company) &gt; 0">rule|text|ND-Company-1</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1b-16.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1b-16.sch
new file mode 100644
index 0000000..67d8951
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/dynamic/validation-stage-1b-16.sch
@@ -0,0 +1,85 @@
+<?xml version="1.0" encoding="UTF-8" ?>
+<!--File generated from metadata database-->
+<pattern id="EFORMS-validation-stage-1b-16" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*[$noticeSubType = '16']">
+		<assert id="ND-BusinessParty-16" role="ERROR" diagnostics="ND-BusinessParty" test="count(cac:BusinessParty) = 0">rule|text|ND-BusinessParty-16</assert>
+		<assert id="ND-ContractingParty-16" role="ERROR" diagnostics="ND-ContractingParty" test="count(cac:ContractingParty) &gt; 0">rule|text|ND-ContractingParty-16</assert>
+		<assert id="ND-GazetteReference-16" role="ERROR" diagnostics="ND-GazetteReference" test="count(cac:AdditionalDocumentReference) = 0">rule|text|ND-GazetteReference-16</assert>
+		<assert id="ND-OperationType-16" role="ERROR" diagnostics="ND-OperationType" test="count(efac:NoticePurpose) = 0">rule|text|ND-OperationType-16</assert>
+		<assert id="ND-Part-16" role="ERROR" diagnostics="ND-Part" test="count(cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']) = 0">rule|text|ND-Part-16</assert>
+		<assert id="ND-ProcedureProcurementScope-16" role="ERROR" diagnostics="ND-ProcedureProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-ProcedureProcurementScope-16</assert>
+		<assert id="ND-ProcedureTenderingProcess-16" role="ERROR" diagnostics="ND-ProcedureTenderingProcess" test="count(cac:TenderingProcess) &gt; 0">rule|text|ND-ProcedureTenderingProcess-16</assert>
+		<assert id="ND-ProcedureTerms-16" role="ERROR" diagnostics="ND-ProcedureTerms" test="count(cac:TenderingTerms) &gt; 0">rule|text|ND-ProcedureTerms-16</assert>
+		<assert id="ND-RootExtension-16" role="ERROR" diagnostics="ND-RootExtension" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-RootExtension-16</assert>
+		<assert id="ND-SenderContact-16" role="ERROR" diagnostics="ND-SenderContact" test="count(cac:SenderParty/cac:Contact) = 0">rule|text|ND-SenderContact-16</assert>
+	</rule>
+	<rule context="/*/cac:ContractingParty[$noticeSubType = '16']">
+		<assert id="ND-Buyer-16" role="ERROR" diagnostics="ND-Buyer" test="count(cac:Party) &gt; 0">rule|text|ND-Buyer-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot'][$noticeSubType = '16']">
+		<assert id="ND-LotProcurementScope-16" role="ERROR" diagnostics="ND-LotProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-LotProcurementScope-16</assert>
+		<assert id="ND-LotTenderingProcess-16" role="ERROR" diagnostics="ND-LotTenderingProcess" test="count(cac:TenderingProcess) &gt; 0">rule|text|ND-LotTenderingProcess-16</assert>
+		<assert id="ND-LotTenderingTerms-16" role="ERROR" diagnostics="ND-LotTenderingTerms" test="count(cac:TenderingTerms) &gt; 0">rule|text|ND-LotTenderingTerms-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingProcess[$noticeSubType = '16']">
+		<assert id="ND-AuctionTerms-16" role="ERROR" diagnostics="ND-AuctionTerms" test="count(cac:AuctionTerms) &gt; 0">rule|text|ND-AuctionTerms-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingProcess/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-InterestExpressionReceptionPeriod-16" role="ERROR" diagnostics="ND-InterestExpressionReceptionPeriod" test="count(efac:InterestExpressionReceptionPeriod) = 0">rule|text|ND-InterestExpressionReceptionPeriod-16</assert>
+		<assert id="ND-PMCAnswersDeadline-16" role="ERROR" diagnostics="ND-PMCAnswersDeadline" test="count(efac:AnswerReceptionPeriod) = 0">rule|text|ND-PMCAnswersDeadline-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms[$noticeSubType = '16']">
+		<assert id="ND-LotProcurementDocument-16" role="ERROR" diagnostics="ND-LotProcurementDocument" test="count(cac:CallForTendersDocumentReference) &gt; 0">rule|text|ND-LotProcurementDocument-16</assert>
+		<assert id="ND-LotReservedParticipation-16" role="ERROR" diagnostics="ND-LotReservedParticipation" test="count(cac:TendererQualificationRequest) &gt; 0">rule|text|ND-LotReservedParticipation-16</assert>
+		<assert id="ND-LotReviewTerms-16" role="ERROR" diagnostics="ND-LotReviewTerms" test="count(cac:AppealTerms) &gt; 0">rule|text|ND-LotReviewTerms-16</assert>
+		<assert id="ND-NonUBLTenderingTerms-16" role="ERROR" diagnostics="ND-NonUBLTenderingTerms" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-NonUBLTenderingTerms-16</assert>
+		<assert id="ND-Participants-16" role="ERROR" diagnostics="ND-Participants" test="count(cac:EconomicOperatorShortList) = 0">rule|text|ND-Participants-16</assert>
+		<assert id="ND-PostAwardProcess-16" role="ERROR" diagnostics="ND-PostAwardProcess" test="count(cac:PostAwardProcess) &gt; 0">rule|text|ND-PostAwardProcess-16</assert>
+		<assert id="ND-SubcontractingObligation-16" role="ERROR" diagnostics="ND-SubcontractingObligation" test="count(cac:AllowedSubcontractTerms) = 0">rule|text|ND-SubcontractingObligation-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionNumberComplicatedUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionNumberComplicatedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionNumberComplicatedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionTypeUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionTypeUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:AwardCriterionParameter[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionFixNumberUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionFixNumberUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionFixNumberUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionNumberComplicatedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionTypeUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionTypeUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:AwardCriterionParameter[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionFixNumberUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionFixNumberUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionFixNumberUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingProcess[$noticeSubType = '16']">
+		<assert id="ND-ProcedureTypeUnpublish-16" role="ERROR" diagnostics="ND-ProcedureTypeUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-ProcedureTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingProcess/cac:ProcessJustification[$noticeSubType = '16']">
+		<assert id="ND-ProcedureAcceleratedUnpublish-16" role="ERROR" diagnostics="ND-ProcedureAcceleratedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-ProcedureAcceleratedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms[$noticeSubType = '16']">
+		<assert id="ND-TendererQualificationRequest-16" role="ERROR" diagnostics="ND-TendererQualificationRequest" test="count(cac:TendererQualificationRequest) &gt; 0">rule|text|ND-TendererQualificationRequest-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:ProcurementLegislationDocumentReference[$noticeSubType = '16']">
+		<assert id="ND-CrossBorderLawUnpublish-16" role="ERROR" diagnostics="ND-CrossBorderLawUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-CrossBorderLawUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:TendererQualificationRequest[$noticeSubType = '16']">
+		<assert id="ND-ExclusionGrounds-16" role="ERROR" diagnostics="ND-ExclusionGrounds" test="count(cac:SpecificTendererRequirement) &gt; 0">rule|text|ND-ExclusionGrounds-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-ContractModification-16" role="ERROR" diagnostics="ND-ContractModification" test="count(efac:ContractModification) = 0">rule|text|ND-ContractModification-16</assert>
+		<assert id="ND-NoticeResult-16" role="ERROR" diagnostics="ND-NoticeResult" test="count(efac:NoticeResult) = 0">rule|text|ND-NoticeResult-16</assert>
+		<assert id="ND-Organizations-16" role="ERROR" diagnostics="ND-Organizations" test="count(efac:Organizations) &gt; 0">rule|text|ND-Organizations-16</assert>
+		<assert id="ND-ReviewRequests-16" role="ERROR" diagnostics="ND-ReviewRequests" test="count(efac:AppealsInformation) = 0">rule|text|ND-ReviewRequests-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations[$noticeSubType = '16']">
+		<assert id="ND-Organization-16" role="ERROR" diagnostics="ND-Organization" test="count(efac:Organization) &gt; 0">rule|text|ND-Organization-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations/efac:Organization[$noticeSubType = '16']">
+		<assert id="ND-Company-16" role="ERROR" diagnostics="ND-Company" test="count(efac:Company) &gt; 0">rule|text|ND-Company-16</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/complete-validation.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/complete-validation.sch
new file mode 100644
index 0000000..4c2ca60
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/complete-validation.sch
@@ -0,0 +1,316 @@
+<?xml version="1.0" encoding="utf-8" ?>
+<!--File generated from metadata database-->
+<schema xmlns="http://purl.oclc.org/dsdl/schematron" queryBinding="xslt2">
+	
+	<title>eForms schematron rules</title>
+
+	<ns prefix="xs" uri="http://www.w3.org/2001/XMLSchema" />
+	<ns prefix="sch" uri="http://purl.oclc.org/dsdl/schematron" />
+	<ns prefix="cbc" uri='urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2' />
+	<ns prefix="cac" uri="urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2" />
+	<ns prefix="ext" uri="urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2" />
+	<ns prefix="efac" uri="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1" />
+	<ns prefix="efext" uri="http://data.europa.eu/p27/eforms-ubl-extensions/1" />
+	<ns prefix="efbc" uri="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1" />
+	<ns prefix="can" uri="urn:oasis:names:specification:ubl:schema:xsd:ContractAwardNotice-2" />
+	<ns prefix="cn" uri="urn:oasis:names:specification:ubl:schema:xsd:ContractNotice-2" />
+	<ns prefix="pin" uri="urn:oasis:names:specification:ubl:schema:xsd:PriorInformationNotice-2" />
+	<ns prefix="fn" uri="http://www.w3.org/2005/xpath-functions" />
+	
+	<let name="noticeSubType" value="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NoticeSubType/cbc:SubTypeCode/text()"/>
+
+	<!-- True if the current notice is a change notice. -->
+	<let name="isChangeNotice" value="boolean(/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Changes/efbc:ChangedNoticeIdentifier)"/>
+
+	<phase id="eforms-1">
+		<active pattern="EFORMS-validation-stage-1a" />
+		<active pattern="EFORMS-validation-stage-1b-1" />
+	</phase>
+	<phase id="eforms-16">
+		<active pattern="EFORMS-validation-stage-1a" />
+		<active pattern="EFORMS-validation-stage-1b-16" />
+	</phase>
+
+	<include href="validation-stage-1a.sch"/>
+	<include href="validation-stage-1b-1.sch"/>
+	<include href="validation-stage-1b-16.sch"/>
+
+	<diagnostics>
+		<diagnostic id="ND-AcceleratedProcedure" see="node:ND-AcceleratedProcedure">cac:ProcessJustification</diagnostic>
+		<diagnostic id="ND-AuctionTerms" see="node:ND-AuctionTerms">cac:AuctionTerms</diagnostic>
+		<diagnostic id="ND-AwardingTerms" see="node:ND-AwardingTerms">cac:AwardingTerms</diagnostic>
+		<diagnostic id="ND-AwardingTerms_BT-46-Lot" see="field:BT-46-Lot">cac:TechnicalCommitteePerson/cbc:FamilyName</diagnostic>
+		<diagnostic id="ND-BusinessAddress" see="node:ND-BusinessAddress">cac:PostalAddress</diagnostic>
+		<diagnostic id="ND-BusinessContact" see="node:ND-BusinessContact">cac:Contact</diagnostic>
+		<diagnostic id="ND-BusinessParty" see="node:ND-BusinessParty">cac:BusinessParty</diagnostic>
+		<diagnostic id="ND-BusinessParty_BT-501-Business-European" see="field:BT-501-Business-European">cac:PartyLegalEntity[cbc:CompanyID/@schemeName = 'EU']/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-BusinessParty_BT-501-Business-National" see="field:BT-501-Business-National">cac:PartyLegalEntity[cbc:CompanyID/@schemeName = 'national']/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-Buyer" see="node:ND-Buyer">cac:Party</diagnostic>
+		<diagnostic id="ND-Buyer_OPT-300-Procedure-SProvider" see="field:OPT-300-Procedure-SProvider">cac:ServiceProviderParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-Change" see="node:ND-Change">efac:Change</diagnostic>
+		<diagnostic id="ND-Company" see="node:ND-Company">efac:Company</diagnostic>
+		<diagnostic id="ND-Company_BT-16-Organization-Company" see="field:BT-16-Organization-Company">cac:PostalAddress/cbc:Department</diagnostic>
+		<diagnostic id="ND-Company_BT-501-Organization-Company" see="field:BT-501-Organization-Company">cac:PartyLegalEntity/cbc:CompanyID</diagnostic>
+		<diagnostic id="ND-Company_BT-502-Organization-Company" see="field:BT-502-Organization-Company">cac:Contact/cbc:Name</diagnostic>
+		<diagnostic id="ND-Company_BT-503-Organization-Company" see="field:BT-503-Organization-Company">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-Company_BT-506-Organization-Company" see="field:BT-506-Organization-Company">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-Company_BT-507-Organization-Company" see="field:BT-507-Organization-Company">cac:PostalAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-Company_BT-510_a_-Organization-Company" see="field:BT-510(a)-Organization-Company">cac:PostalAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-Company_BT-510_b_-Organization-Company" see="field:BT-510(b)-Organization-Company">cac:PostalAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-Company_BT-510_c_-Organization-Company" see="field:BT-510(c)-Organization-Company">cac:PostalAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-Company_BT-512-Organization-Company" see="field:BT-512-Organization-Company">cac:PostalAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-Company_BT-513-Organization-Company" see="field:BT-513-Organization-Company">cac:PostalAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-Company_BT-514-Organization-Company" see="field:BT-514-Organization-Company">cac:PostalAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-Company_BT-739-Organization-Company" see="field:BT-739-Organization-Company">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-ConcessionRevenue" see="node:ND-ConcessionRevenue">efac:ConcessionRevenue</diagnostic>
+		<diagnostic id="ND-ContractEUFunds" see="node:ND-ContractEUFunds">efac:Funding</diagnostic>
+		<diagnostic id="ND-ContractModification" see="node:ND-ContractModification">efac:ContractModification</diagnostic>
+		<diagnostic id="ND-ContractModification_BT-1501_s_-Contract" see="field:BT-1501(s)-Contract">efac:Change/efac:ChangedSection/efbc:ChangedSectionIdentifier</diagnostic>
+		<diagnostic id="ND-ContractingParty" see="node:ND-ContractingParty">cac:ContractingParty</diagnostic>
+		<diagnostic id="ND-CrossBorderLawUnpublish" see="node:ND-CrossBorderLawUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ExclusionGrounds" see="node:ND-ExclusionGrounds">cac:SpecificTendererRequirement</diagnostic>
+		<diagnostic id="ND-ExecutionRequirements" see="node:ND-ExecutionRequirements">cac:ContractExecutionRequirement</diagnostic>
+		<diagnostic id="ND-ExtendedDurationJustification" see="node:ND-ExtendedDurationJustification">efac:DurationJustification</diagnostic>
+		<diagnostic id="ND-FA" see="node:ND-FA">cac:FrameworkAgreement</diagnostic>
+		<diagnostic id="ND-Funding" see="node:ND-Funding">efac:Funding</diagnostic>
+		<diagnostic id="ND-GazetteReference" see="node:ND-GazetteReference">cac:AdditionalDocumentReference</diagnostic>
+		<diagnostic id="ND-GroupComposition" see="node:ND-GroupComposition">cac:LotsGroup</diagnostic>
+		<diagnostic id="ND-GroupComposition_BT-1375-Procedure" see="field:BT-1375-Procedure">cac:ProcurementProjectLotReference/cbc:ID[@schemeName='Lot']</diagnostic>
+		<diagnostic id="ND-InterestExpressionReceptionPeriod" see="node:ND-InterestExpressionReceptionPeriod">efac:InterestExpressionReceptionPeriod</diagnostic>
+		<diagnostic id="ND-LocalEntity" see="node:ND-LocalEntity">cac:PartyLegalEntity</diagnostic>
+		<diagnostic id="ND-LotAwardCriteria" see="node:ND-LotAwardCriteria">cac:AwardingCriterion</diagnostic>
+		<diagnostic id="ND-LotAwardCriteria_BT-539-Lot" see="field:BT-539-Lot">cac:SubordinateAwardingCriterion/cbc:AwardingCriterionTypeCode[@listName='award-criterion-type']</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionFixNumberUnpublish" see="node:ND-LotAwardCriterionFixNumberUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionNumberComplicatedUnpublish" see="node:ND-LotAwardCriterionNumberComplicatedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-FixedNumber" see="field:BT-541-Lot-FixedNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-fixed']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-ThresholdNumber" see="field:BT-541-Lot-ThresholdNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionParameters_BT-541-Lot-WeightNumber" see="field:BT-541-Lot-WeightNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotAwardCriterionTypeUnpublish" see="node:ND-LotAwardCriterionTypeUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotDistribution" see="node:ND-LotDistribution">cac:LotDistribution</diagnostic>
+		<diagnostic id="ND-LotDistribution_BT-330-Procedure" see="field:BT-330-Procedure">cac:LotsGroup/cbc:LotsGroupID</diagnostic>
+		<diagnostic id="ND-LotDuration" see="node:ND-LotDuration">cac:PlannedPeriod</diagnostic>
+		<diagnostic id="ND-LotEmploymentLegislation" see="node:ND-LotEmploymentLegislation">cac:EmploymentLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotEnvironmentalLegislation" see="node:ND-LotEnvironmentalLegislation">cac:EnvironmentalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotFiscalLegislation" see="node:ND-LotFiscalLegislation">cac:FiscalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5071-Lot" see="field:BT-5071-Lot">cac:Address/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_a_-Lot" see="field:BT-5101(a)-Lot">cac:Address/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_b_-Lot" see="field:BT-5101(b)-Lot">cac:Address/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5101_c_-Lot" see="field:BT-5101(c)-Lot">cac:Address/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5121-Lot" see="field:BT-5121-Lot">cac:Address/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5131-Lot" see="field:BT-5131-Lot">cac:Address/cbc:CityName</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-5141-Lot" see="field:BT-5141-Lot">cac:Address/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-LotPlacePerformance_BT-727-Lot" see="field:BT-727-Lot">cac:Address/cbc:Region</diagnostic>
+		<diagnostic id="ND-LotPreviousPlanning" see="node:ND-LotPreviousPlanning">cac:NoticeDocumentReference</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument" see="node:ND-LotProcurementDocument">cac:CallForTendersDocumentReference</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument_BT-708-Lot" see="field:BT-708-Lot">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:OfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotProcurementDocument_BT-737-Lot" see="field:BT-737-Lot">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NonOfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotProcurementScope" see="node:ND-LotProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-06-Lot" see="field:BT-06-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='strategic-procurement']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-262-Lot" see="field:BT-262-Lot">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-263-Lot" see="field:BT-263-Lot">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-271-Lot" see="field:BT-271-Lot">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-531-Lot" see="field:BT-531-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-754-Lot" see="field:BT-754-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='accessibility']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-774-Lot" see="field:BT-774-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='environmental-impact']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-775-Lot" see="field:BT-775-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='social-objective']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-776-Lot" see="field:BT-776-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='innovative-acquisition']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotProcurementScope_BT-805-Lot" see="field:BT-805-Lot">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='gpp-criteria']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-LotReservedParticipation" see="node:ND-LotReservedParticipation">cac:TendererQualificationRequest</diagnostic>
+		<diagnostic id="ND-LotReservedParticipation_BT-71-Lot" see="field:BT-71-Lot">cac:SpecificTendererRequirement[cbc:TendererRequirementTypeCode/@listName='reserved-procurement']/cbc:TendererRequirementTypeCode</diagnostic>
+		<diagnostic id="ND-LotResult" see="node:ND-LotResult">efac:LotResult</diagnostic>
+		<diagnostic id="ND-LotResultFAValues" see="node:ND-LotResultFAValues">efac:FrameworkAgreementValues</diagnostic>
+		<diagnostic id="ND-LotResult_BT-636-LotResult" see="field:BT-636-LotResult">efac:AppealRequestsStatistics[efbc:StatisticsCode/@listName='irregularity-type']/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_BT-712_a_-LotResult" see="field:BT-712(a)-LotResult">efac:AppealRequestsStatistics[efbc:StatisticsCode/@listName='review-type']/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_BT-759-LotResult" see="field:BT-759-LotResult">efac:ReceivedSubmissionsStatistics/efbc:StatisticsNumeric</diagnostic>
+		<diagnostic id="ND-LotResult_BT-760-LotResult" see="field:BT-760-LotResult">efac:ReceivedSubmissionsStatistics/efbc:StatisticsCode</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-301-LotResult-Financing" see="field:OPT-301-LotResult-Financing">cac:FinancingParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-301-LotResult-Paying" see="field:OPT-301-LotResult-Paying">cac:PayerParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-315-LotResult" see="field:OPT-315-LotResult">efac:SettledContract/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotResult_OPT-320-LotResult" see="field:OPT-320-LotResult">efac:LotTender/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotReviewTerms" see="node:ND-LotReviewTerms">cac:AppealTerms</diagnostic>
+		<diagnostic id="ND-LotReviewTerms_BT-99-Lot" see="field:BT-99-Lot">cac:PresentationPeriod/cbc:Description</diagnostic>
+		<diagnostic id="ND-LotTender" see="node:ND-LotTender">efac:LotTender</diagnostic>
+		<diagnostic id="ND-LotTenderOriginCountry" see="node:ND-LotTenderOriginCountry">efac:Origin</diagnostic>
+		<diagnostic id="ND-LotTender_BT-191-Tender" see="field:BT-191-Tender">efac:Origin/efbc:AreaCode</diagnostic>
+		<diagnostic id="ND-LotTender_BT-779-Tender" see="field:BT-779-Tender">efac:AggregatedAmounts/cbc:PaidAmount</diagnostic>
+		<diagnostic id="ND-LotTender_BT-780-Tender" see="field:BT-780-Tender">efac:AggregatedAmounts/efbc:PaidAmountDescription</diagnostic>
+		<diagnostic id="ND-LotTender_BT-782-Tender" see="field:BT-782-Tender">efac:AggregatedAmounts/efbc:PenaltiesAmount</diagnostic>
+		<diagnostic id="ND-LotTender_OPP-030-Tender" see="field:OPP-030-Tender">efac:ContractTerm[not(efbc:TermCode/text()='all-rev-tic')][efbc:TermCode/@listName='contract-detail']/efbc:TermCode</diagnostic>
+		<diagnostic id="ND-LotTender_OPP-033-Tender" see="field:OPP-033-Tender">efac:ContractTerm[efbc:TermCode/@listName='rewards-penalties']/efbc:TermCode</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess" see="node:ND-LotTenderingProcess">cac:TenderingProcess</diagnostic>
+		<diagnostic id="ND-LotTenderingProcessExtension" see="node:ND-LotTenderingProcessExtension">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1251-Lot" see="field:BT-1251-Lot">cac:NoticeDocumentReference/cbc:ReferencedDocumentInternalAddress</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1311_d_-Lot" see="field:BT-1311(d)-Lot">cac:ParticipationRequestReceptionPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-1311_t_-Lot" see="field:BT-1311(t)-Lot">cac:ParticipationRequestReceptionPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-131_d_-Lot" see="field:BT-131(d)-Lot">cac:TenderSubmissionDeadlinePeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-131_t_-Lot" see="field:BT-131(t)-Lot">cac:TenderSubmissionDeadlinePeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-132_d_-Lot" see="field:BT-132(d)-Lot">cac:OpenTenderEvent/cbc:OccurrenceDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-13_d_-Lot" see="field:BT-13(d)-Lot">cac:AdditionalInformationRequestPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-13_t_-Lot" see="field:BT-13(t)-Lot">cac:AdditionalInformationRequestPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-765-Lot" see="field:BT-765-Lot">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='framework-agreement']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-LotTenderingProcess_BT-766-Lot" see="field:BT-766-Lot">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='dps-usage']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms" see="node:ND-LotTenderingTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-18-Lot" see="field:BT-18-Lot">cac:TenderRecipientParty/cbc:EndpointID</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-65-Lot" see="field:BT-65-Lot">cac:AllowedSubcontractTerms[cbc:SubcontractingConditionsCode/@listName='subcontracting-obligation']/cbc:SubcontractingConditionsCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-736-Lot" see="field:BT-736-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='reserved-execution']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-743-Lot" see="field:BT-743-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='einvoicing']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-744-Lot" see="field:BT-744-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='esignature-submission']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-75-Lot" see="field:BT-75-Lot">cac:RequiredFinancialGuarantee/cbc:Description</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-751-Lot" see="field:BT-751-Lot">cac:RequiredFinancialGuarantee/cbc:GuaranteeTypeCode[@listName='tender-guarantee-required']</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-76-Lot" see="field:BT-76-Lot">cac:TendererQualificationRequest[not(cac:SpecificTendererRequirement)]/cbc:CompanyLegalForm</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-761-Lot" see="field:BT-761-Lot">cac:TendererQualificationRequest[not(cac:SpecificTendererRequirement)]/cbc:CompanyLegalFormCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-764-Lot" see="field:BT-764-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='ecatalog-submission']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-801-Lot" see="field:BT-801-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='nda']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_BT-97-Lot" see="field:BT-97-Lot">cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-060-Lot" see="field:OPT-060-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='conditions']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-071-Lot" see="field:OPT-071-Lot">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='customer-service']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-LotTenderingTerms_OPT-301-Lot-TenderReceipt" see="field:OPT-301-Lot-TenderReceipt">cac:TenderRecipientParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-LotValueEstimate" see="node:ND-LotValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriteria_BT-539-LotsGroup" see="field:BT-539-LotsGroup">cac:SubordinateAwardingCriterion/cbc:AwardingCriterionTypeCode[@listName='award-criterion-type']</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionFixNumberUnpublish" see="node:ND-LotsGroupAwardCriterionFixNumberUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish" see="node:ND-LotsGroupAwardCriterionNumberComplicatedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-FixedNumber" see="field:BT-541-LotsGroup-FixedNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-fixed']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-ThresholdNumber" see="field:BT-541-LotsGroup-ThresholdNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionParameters_BT-541-LotsGroup-WeightNumber" see="field:BT-541-LotsGroup-WeightNumber">efac:AwardCriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardCriterionTypeUnpublish" see="node:ND-LotsGroupAwardCriterionTypeUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-LotsGroupAwardingTerms" see="node:ND-LotsGroupAwardingTerms">cac:TenderingTerms/cac:AwardingTerms</diagnostic>
+		<diagnostic id="ND-LotsGroupFA" see="node:ND-LotsGroupFA">cac:TenderingProcess/cac:FrameworkAgreement</diagnostic>
+		<diagnostic id="ND-LotsGroupProcurementScope_BT-271-LotsGroup" see="field:BT-271-LotsGroup">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-LotsGroupValueEstimate" see="node:ND-LotsGroupValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-Modification" see="node:ND-Modification">efac:Change</diagnostic>
+		<diagnostic id="ND-ModificationReason" see="node:ND-ModificationReason">efac:ChangeReason</diagnostic>
+		<diagnostic id="ND-ModifiedSection" see="node:ND-ModifiedSection">efac:ChangedSection</diagnostic>
+		<diagnostic id="ND-NonEsubmission" see="node:ND-NonEsubmission">cac:ProcessJustification</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms" see="node:ND-NonUBLTenderingTerms">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-5010-Lot" see="field:BT-5010-Lot">efac:Funding/efbc:FinancingIdentifier</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-651-Lot" see="field:BT-651-Lot">efac:TenderSubcontractingRequirements/efbc:TenderSubcontractingRequirementsCode</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-7220-Lot" see="field:BT-7220-Lot">efac:Funding/cbc:FundingProgramCode</diagnostic>
+		<diagnostic id="ND-NonUBLTenderingTerms_BT-747-Lot" see="field:BT-747-Lot">efac:SelectionCriteria/cbc:CriterionTypeCode[@listName='selection-criterion']</diagnostic>
+		<diagnostic id="ND-NotAwardedReasonUnpublish" see="node:ND-NotAwardedReasonUnpublish">efac:DecisionReason/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-NoticeApproximateValueUnpublish" see="node:ND-NoticeApproximateValueUnpublish">efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-NoticeResult" see="node:ND-NoticeResult">efac:NoticeResult</diagnostic>
+		<diagnostic id="ND-NoticeResultGroupFA" see="node:ND-NoticeResultGroupFA">efac:GroupFramework</diagnostic>
+		<diagnostic id="ND-OperationType" see="node:ND-OperationType">efac:NoticePurpose</diagnostic>
+		<diagnostic id="ND-OptionsAndRenewals" see="node:ND-OptionsAndRenewals">cac:ContractExtension</diagnostic>
+		<diagnostic id="ND-OptionsAndRenewals_BT-57-Lot" see="field:BT-57-Lot">cac:Renewal/cac:Period/cbc:Description</diagnostic>
+		<diagnostic id="ND-Organization" see="node:ND-Organization">efac:Organization</diagnostic>
+		<diagnostic id="ND-Organization_OPT-201-Organization-TouchPoint" see="field:OPT-201-Organization-TouchPoint">efac:TouchPoint/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-Organization_OPT-302-Organization" see="field:OPT-302-Organization">efac:UltimateBeneficialOwner/cbc:ID</diagnostic>
+		<diagnostic id="ND-Organizations" see="node:ND-Organizations">efac:Organizations</diagnostic>
+		<diagnostic id="ND-Organizations_OPT-202-UBO" see="field:OPT-202-UBO">efac:UltimateBeneficialOwner/cbc:ID</diagnostic>
+		<diagnostic id="ND-OtherContractExecutionConditions" see="node:ND-OtherContractExecutionConditions">efac:ContractTerm</diagnostic>
+		<diagnostic id="ND-PMCAnswersDeadline" see="node:ND-PMCAnswersDeadline">efac:AnswerReceptionPeriod</diagnostic>
+		<diagnostic id="ND-Part" see="node:ND-Part">cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']</diagnostic>
+		<diagnostic id="ND-PartEmploymentLegislation" see="node:ND-PartEmploymentLegislation">cac:EmploymentLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartEnvironmentalLegislation" see="node:ND-PartEnvironmentalLegislation">cac:EnvironmentalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartFiscalLegislation" see="node:ND-PartFiscalLegislation">cac:FiscalLegislationDocumentReference</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5071-Part" see="field:BT-5071-Part">cac:Address/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_a_-Part" see="field:BT-5101(a)-Part">cac:Address/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_b_-Part" see="field:BT-5101(b)-Part">cac:Address/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5101_c_-Part" see="field:BT-5101(c)-Part">cac:Address/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5121-Part" see="field:BT-5121-Part">cac:Address/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5131-Part" see="field:BT-5131-Part">cac:Address/cbc:CityName</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-5141-Part" see="field:BT-5141-Part">cac:Address/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-PartPlacePerformance_BT-727-Part" see="field:BT-727-Part">cac:Address/cbc:Region</diagnostic>
+		<diagnostic id="ND-PartProcurementDocument_BT-708-Part" see="field:BT-708-Part">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:OfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-PartProcurementDocument_BT-737-Part" see="field:BT-737-Part">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NonOfficialLanguages/cac:Language/cbc:ID</diagnostic>
+		<diagnostic id="ND-PartProcurementScope" see="node:ND-PartProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-262-Part" see="field:BT-262-Part">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-263-Part" see="field:BT-263-Part">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-PartProcurementScope_BT-531-Part" see="field:BT-531-Part">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-PartReservedParticipation_BT-71-Part" see="field:BT-71-Part">cac:SpecificTendererRequirement[cbc:TendererRequirementTypeCode/@listName='reserved-procurement']/cbc:TendererRequirementTypeCode</diagnostic>
+		<diagnostic id="ND-PartReviewTerms" see="node:ND-PartReviewTerms">cac:AppealTerms</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-1251-Part" see="field:BT-1251-Part">cac:NoticeDocumentReference/cbc:ReferencedDocumentInternalAddress</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-13_d_-Part" see="field:BT-13(d)-Part">cac:AdditionalInformationRequestPeriod/cbc:EndDate</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-13_t_-Part" see="field:BT-13(t)-Part">cac:AdditionalInformationRequestPeriod/cbc:EndTime</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-765-Part" see="field:BT-765-Part">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='framework-agreement']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-PartTenderingProcess_BT-766-Part" see="field:BT-766-Part">cac:ContractingSystem[cbc:ContractingSystemTypeCode/@listName='dps-usage']/cbc:ContractingSystemTypeCode</diagnostic>
+		<diagnostic id="ND-PartTenderingTerms" see="node:ND-PartTenderingTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-PartTenderingTerms_BT-736-Part" see="field:BT-736-Part">cac:ContractExecutionRequirement[cbc:ExecutionRequirementCode/@listName='reserved-execution']/cbc:ExecutionRequirementCode</diagnostic>
+		<diagnostic id="ND-Participants" see="node:ND-Participants">cac:EconomicOperatorShortList</diagnostic>
+		<diagnostic id="ND-Participants_BT-47-Lot" see="field:BT-47-Lot">cac:PreSelectedParty/cac:PartyName/cbc:Name</diagnostic>
+		<diagnostic id="ND-PaymentTerms" see="node:ND-PaymentTerms">cac:PaymentTerms</diagnostic>
+		<diagnostic id="ND-PostAwardProcess" see="node:ND-PostAwardProcess">cac:PostAwardProcess</diagnostic>
+		<diagnostic id="ND-Prize" see="node:ND-Prize">cac:Prize</diagnostic>
+		<diagnostic id="ND-ProcedureAcceleratedUnpublish" see="node:ND-ProcedureAcceleratedUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ProcedurePlacePerformanceAdditionalInformation" see="node:ND-ProcedurePlacePerformanceAdditionalInformation">cac:RealizedLocation</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope" see="node:ND-ProcedureProcurementScope">cac:ProcurementProject</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-262-Procedure" see="field:BT-262-Procedure">cac:MainCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-263-Procedure" see="field:BT-263-Procedure">cac:AdditionalCommodityClassification/cbc:ItemClassificationCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-271-Procedure" see="field:BT-271-Procedure">cac:RequestedTenderTotal/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efbc:FrameworkMaximumAmount</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_BT-531-Procedure" see="field:BT-531-Procedure">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='contract-nature']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-ProcedureProcurementScope_OPP-040-Procedure" see="field:OPP-040-Procedure">cac:ProcurementAdditionalType[cbc:ProcurementTypeCode/@listName='transport-service']/cbc:ProcurementTypeCode</diagnostic>
+		<diagnostic id="ND-ProcedureTenderingProcess" see="node:ND-ProcedureTenderingProcess">cac:TenderingProcess</diagnostic>
+		<diagnostic id="ND-ProcedureTenderingProcess_OPP-090-Procedure" see="field:OPP-090-Procedure">cac:NoticeDocumentReference/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms" see="node:ND-ProcedureTerms">cac:TenderingTerms</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-01_c_-Procedure" see="field:BT-01(c)-Procedure">cac:ProcurementLegislationDocumentReference[not(cbc:ID/text()=('CrossBorderLaw','LocalLegalBasis'))]/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-01_e_-Procedure" see="field:BT-01(e)-Procedure">cac:ProcurementLegislationDocumentReference[cbc:ID/text()='LocalLegalBasis']/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTerms_BT-09_a_-Procedure" see="field:BT-09(a)-Procedure">cac:ProcurementLegislationDocumentReference[cbc:ID/text()='CrossBorderLaw']/cbc:ID</diagnostic>
+		<diagnostic id="ND-ProcedureTypeUnpublish" see="node:ND-ProcedureTypeUnpublish">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy</diagnostic>
+		<diagnostic id="ND-ProcedureValueEstimate" see="node:ND-ProcedureValueEstimate">cac:RequestedTenderTotal</diagnostic>
+		<diagnostic id="ND-PublicOpening" see="node:ND-PublicOpening">cac:OpenTenderEvent</diagnostic>
+		<diagnostic id="ND-PublicOpening_BT-133-Lot" see="field:BT-133-Lot">cac:OccurenceLocation/cbc:Description</diagnostic>
+		<diagnostic id="ND-ReceivedSubmissions" see="node:ND-ReceivedSubmissions">efac:ReceivedSubmissionsStatistics</diagnostic>
+		<diagnostic id="ND-ReviewRequests" see="node:ND-ReviewRequests">efac:AppealsInformation</diagnostic>
+		<diagnostic id="ND-ReviewRequestsStatistics" see="node:ND-ReviewRequestsStatistics">efac:AppealRequestsStatistics</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-786-Review" see="field:BT-786-Review">efac:AppealedItem/cbc:ID</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-790-Review" see="field:BT-790-Review">efac:AppealDecision/efbc:DecisionTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-791-Review" see="field:BT-791-Review">efac:AppealIrregularity/efbc:IrregularityTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-792-Review" see="field:BT-792-Review">efac:AppealRemedy/efbc:RemedyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_BT-799-ReviewBody" see="field:BT-799-ReviewBody">efac:AppealProcessingParty/efbc:AppealProcessingPartyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-091-ReviewReq" see="field:OPT-091-ReviewReq">efac:AppealingParty/efbc:AppealingPartyTypeCode</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-092-ReviewBody" see="field:OPT-092-ReviewBody">efac:AppealProcessingParty/efbc:AppealProcessingPartyTypeDescription</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-301-ReviewBody" see="field:OPT-301-ReviewBody">efac:AppealProcessingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-ReviewStatus_OPT-301-ReviewReq" see="field:OPT-301-ReviewReq">efac:AppealingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-RootExtension" see="node:ND-RootExtension">ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-010-notice" see="field:OPP-010-notice">efac:Publication/efbc:NoticePublicationID[@schemeName='ojs-notice-id']</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-011-notice" see="field:OPP-011-notice">efac:Publication/efbc:GazetteID[@schemeName='ojs-id']</diagnostic>
+		<diagnostic id="ND-RootExtension_OPP-012-notice" see="field:OPP-012-notice">efac:Publication/efbc:PublicationDate</diagnostic>
+		<diagnostic id="ND-Root_OPP-105-Business" see="field:OPP-105-Business">cac:BusinessCapability/cbc:CapabilityTypeCode</diagnostic>
+		<diagnostic id="ND-Root_OPT-300-Procedure-Buyer" see="field:OPT-300-Procedure-Buyer">cac:ContractingParty/cac:Party/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-SecondStage" see="node:ND-SecondStage">cac:EconomicOperatorShortList</diagnostic>
+		<diagnostic id="ND-SecondStageWeightCriterionParameter" see="node:ND-SecondStageWeightCriterionParameter">efac:CriterionParameter</diagnostic>
+		<diagnostic id="ND-SecurityClearanceTerms" see="node:ND-SecurityClearanceTerms">cac:SecurityClearanceTerm</diagnostic>
+		<diagnostic id="ND-SelectionCriteria" see="node:ND-SelectionCriteria">efac:SelectionCriteria</diagnostic>
+		<diagnostic id="ND-SelectionCriteria_BT-752-Lot-ThresholdNumber" see="field:BT-752-Lot-ThresholdNumber">efac:CriterionParameter[efbc:ParameterCode/@listName='number-threshold']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-SelectionCriteria_BT-752-Lot-WeightNumber" see="field:BT-752-Lot-WeightNumber">efac:CriterionParameter[efbc:ParameterCode/@listName='number-weight']/efbc:ParameterNumeric</diagnostic>
+		<diagnostic id="ND-SenderContact" see="node:ND-SenderContact">cac:SenderParty/cac:Contact</diagnostic>
+		<diagnostic id="ND-SettledContract" see="node:ND-SettledContract">efac:SettledContract</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-3202-Contract" see="field:BT-3202-Contract">efac:LotTender/cbc:ID</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-5011-Contract" see="field:BT-5011-Contract">efac:Funding/efbc:FinancingIdentifier</diagnostic>
+		<diagnostic id="ND-SettledContract_BT-722-Contract" see="field:BT-722-Contract">efac:Funding/cbc:FundingProgramCode</diagnostic>
+		<diagnostic id="ND-SettledContract_OPT-300-Contract-Signatory" see="field:OPT-300-Contract-Signatory">cac:SignatoryParty/cac:PartyIdentification/cbc:ID</diagnostic>
+		<diagnostic id="ND-StrategicProcurementLot" see="node:ND-StrategicProcurementLot">efac:StrategicProcurement</diagnostic>
+		<diagnostic id="ND-StrategicProcurementLotResult" see="node:ND-StrategicProcurementLotResult">efac:StrategicProcurement</diagnostic>
+		<diagnostic id="ND-SubContractor_OPT-301-Tenderer-MainCont" see="field:OPT-301-Tenderer-MainCont">efac:MainContractor/cbc:ID</diagnostic>
+		<diagnostic id="ND-SubcontractedContract" see="node:ND-SubcontractedContract">efac:SubcontractingTerm</diagnostic>
+		<diagnostic id="ND-SubcontractingObligation" see="node:ND-SubcontractingObligation">cac:AllowedSubcontractTerms</diagnostic>
+		<diagnostic id="ND-TendererQualificationRequest" see="node:ND-TendererQualificationRequest">cac:TendererQualificationRequest</diagnostic>
+		<diagnostic id="ND-TenderingParty_OPT-300-Tenderer" see="field:OPT-300-Tenderer">efac:Tenderer/cbc:ID</diagnostic>
+		<diagnostic id="ND-TenderingParty_OPT-301-Tenderer-SubCont" see="field:OPT-301-Tenderer-SubCont">efac:SubContractor/cbc:ID</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-16-Organization-TouchPoint" see="field:BT-16-Organization-TouchPoint">cac:PostalAddress/cbc:Department</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-502-Organization-TouchPoint" see="field:BT-502-Organization-TouchPoint">cac:Contact/cbc:Name</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-503-Organization-TouchPoint" see="field:BT-503-Organization-TouchPoint">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-506-Organization-TouchPoint" see="field:BT-506-Organization-TouchPoint">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-507-Organization-TouchPoint" see="field:BT-507-Organization-TouchPoint">cac:PostalAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_a_-Organization-TouchPoint" see="field:BT-510(a)-Organization-TouchPoint">cac:PostalAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_b_-Organization-TouchPoint" see="field:BT-510(b)-Organization-TouchPoint">cac:PostalAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-510_c_-Organization-TouchPoint" see="field:BT-510(c)-Organization-TouchPoint">cac:PostalAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-512-Organization-TouchPoint" see="field:BT-512-Organization-TouchPoint">cac:PostalAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-513-Organization-TouchPoint" see="field:BT-513-Organization-TouchPoint">cac:PostalAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-514-Organization-TouchPoint" see="field:BT-514-Organization-TouchPoint">cac:PostalAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-Touchpoint_BT-739-Organization-TouchPoint" see="field:BT-739-Organization-TouchPoint">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-UBO_BT-503-UBO" see="field:BT-503-UBO">cac:Contact/cbc:Telephone</diagnostic>
+		<diagnostic id="ND-UBO_BT-506-UBO" see="field:BT-506-UBO">cac:Contact/cbc:ElectronicMail</diagnostic>
+		<diagnostic id="ND-UBO_BT-507-UBO" see="field:BT-507-UBO">cac:ResidenceAddress/cbc:CountrySubentityCode</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_a_-UBO" see="field:BT-510(a)-UBO">cac:ResidenceAddress/cbc:StreetName</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_b_-UBO" see="field:BT-510(b)-UBO">cac:ResidenceAddress/cbc:AdditionalStreetName</diagnostic>
+		<diagnostic id="ND-UBO_BT-510_c_-UBO" see="field:BT-510(c)-UBO">cac:ResidenceAddress/cac:AddressLine/cbc:Line</diagnostic>
+		<diagnostic id="ND-UBO_BT-512-UBO" see="field:BT-512-UBO">cac:ResidenceAddress/cbc:PostalZone</diagnostic>
+		<diagnostic id="ND-UBO_BT-513-UBO" see="field:BT-513-UBO">cac:ResidenceAddress/cbc:CityName</diagnostic>
+		<diagnostic id="ND-UBO_BT-514-UBO" see="field:BT-514-UBO">cac:ResidenceAddress/cac:Country/cbc:IdentificationCode</diagnostic>
+		<diagnostic id="ND-UBO_BT-706-UBO" see="field:BT-706-UBO">efac:Nationality/cbc:NationalityID</diagnostic>
+		<diagnostic id="ND-UBO_BT-739-UBO" see="field:BT-739-UBO">cac:Contact/cbc:Telefax</diagnostic>
+		<diagnostic id="ND-WinnerChosenUnpublish" see="node:ND-WinnerChosenUnpublish">efac:FieldsPrivacy</diagnostic>
+	</diagnostics>
+</schema>
\ No newline at end of file
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1a.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1a.sch
new file mode 100644
index 0000000..9ab9877
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1a.sch
@@ -0,0 +1,21 @@
+<?xml version="1.0" encoding="UTF-8"?>
+<pattern id="EFORMS-validation-stage-1a" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*">
+		<assert id="P-0001" role="ERROR" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:NoticeSubType/cbc:SubTypeCode) &gt; 0">
+			rule|text|P-0001
+		</assert>
+		<assert id="P-0002" role="ERROR" test="($noticeSubType = ('1', '2', '3', 'X01', 'X02') and count(cac:ProcurementProjectLot) = 0) or (not(cbc:NoticeTypeCode/text() = ('1', '2', '3', 'X01', 'X02')) and count(cac:ProcurementProjectLot) > 0)">
+			rule|text|P-0002
+		</assert>
+	</rule>
+	<rule context="cac:ProcurementProjectLot/cbc:ID">
+		<assert id="P-0004" role="ERROR" test="@schemeName">
+			rule|text|P-0004
+		</assert>
+	</rule>
+	<rule context="cac:ProcurementProjectLot/cbc:ID/@schemeName">
+		<assert id="P-0005" role="ERROR" test="normalize-space(.) = ('Part', 'Lot', 'LotsGroup')">
+			rule|text|P-0005
+		</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1b-1.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1b-1.sch
new file mode 100644
index 0000000..e51be47
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1b-1.sch
@@ -0,0 +1,40 @@
+<?xml version="1.0" encoding="UTF-8" ?>
+<!--File generated from metadata database-->
+<pattern id="EFORMS-validation-stage-1b-1" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*[$noticeSubType = '1']">
+		<assert id="ND-BusinessParty-1" role="ERROR" diagnostics="ND-BusinessParty" test="count(cac:BusinessParty) = 0">rule|text|ND-BusinessParty-1</assert>
+		<assert id="ND-ContractingParty-1" role="ERROR" diagnostics="ND-ContractingParty" test="count(cac:ContractingParty) &gt; 0">rule|text|ND-ContractingParty-1</assert>
+		<assert id="ND-GazetteReference-1" role="ERROR" diagnostics="ND-GazetteReference" test="count(cac:AdditionalDocumentReference) = 0">rule|text|ND-GazetteReference-1</assert>
+		<assert id="ND-OperationType-1" role="ERROR" diagnostics="ND-OperationType" test="count(efac:NoticePurpose) = 0">rule|text|ND-OperationType-1</assert>
+		<assert id="ND-Part-1" role="ERROR" diagnostics="ND-Part" test="count(cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']) = 0">rule|text|ND-Part-1</assert>
+		<assert id="ND-ProcedureProcurementScope-1" role="ERROR" diagnostics="ND-ProcedureProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-ProcedureProcurementScope-1</assert>
+		<assert id="ND-ProcedureTenderingProcess-1" role="ERROR" diagnostics="ND-ProcedureTenderingProcess" test="count(cac:TenderingProcess) = 0">rule|text|ND-ProcedureTenderingProcess-1</assert>
+		<assert id="ND-RootExtension-1" role="ERROR" diagnostics="ND-RootExtension" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-RootExtension-1</assert>
+		<assert id="ND-SenderContact-1" role="ERROR" diagnostics="ND-SenderContact" test="count(cac:SenderParty/cac:Contact) = 0">rule|text|ND-SenderContact-1</assert>
+	</rule>
+	<rule context="/*/cac:ContractingParty[$noticeSubType = '1']">
+		<assert id="ND-Buyer-1" role="ERROR" diagnostics="ND-Buyer" test="count(cac:Party) &gt; 0">rule|text|ND-Buyer-1</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProject[$noticeSubType = '1']">
+		<assert id="ND-ProcedureValueEstimate-1" role="ERROR" diagnostics="ND-ProcedureValueEstimate" test="count(cac:RequestedTenderTotal) = 0">rule|text|ND-ProcedureValueEstimate-1</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms[$noticeSubType = '1']">
+		<assert id="ND-LotDistribution-1" role="ERROR" diagnostics="ND-LotDistribution" test="count(cac:LotDistribution) = 0">rule|text|ND-LotDistribution-1</assert>
+		<assert id="ND-TendererQualificationRequest-1" role="ERROR" diagnostics="ND-TendererQualificationRequest" test="count(cac:TendererQualificationRequest) = 0">rule|text|ND-TendererQualificationRequest-1</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:ProcurementLegislationDocumentReference[$noticeSubType = '1']">
+		<assert id="ND-CrossBorderLawUnpublish-1" role="ERROR" diagnostics="ND-CrossBorderLawUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-CrossBorderLawUnpublish-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '1']">
+		<assert id="ND-ContractModification-1" role="ERROR" diagnostics="ND-ContractModification" test="count(efac:ContractModification) = 0">rule|text|ND-ContractModification-1</assert>
+		<assert id="ND-NoticeResult-1" role="ERROR" diagnostics="ND-NoticeResult" test="count(efac:NoticeResult) = 0">rule|text|ND-NoticeResult-1</assert>
+		<assert id="ND-Organizations-1" role="ERROR" diagnostics="ND-Organizations" test="count(efac:Organizations) &gt; 0">rule|text|ND-Organizations-1</assert>
+		<assert id="ND-ReviewRequests-1" role="ERROR" diagnostics="ND-ReviewRequests" test="count(efac:AppealsInformation) = 0">rule|text|ND-ReviewRequests-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations[$noticeSubType = '1']">
+		<assert id="ND-Organization-1" role="ERROR" diagnostics="ND-Organization" test="count(efac:Organization) &gt; 0">rule|text|ND-Organization-1</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations/efac:Organization[$noticeSubType = '1']">
+		<assert id="ND-Company-1" role="ERROR" diagnostics="ND-Company" test="count(efac:Company) &gt; 0">rule|text|ND-Company-1</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1b-16.sch b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1b-16.sch
new file mode 100644
index 0000000..67d8951
--- /dev/null
+++ b/src/test/resources/eforms-sdk-tests/tedefo-2768/valid/schematrons/static/validation-stage-1b-16.sch
@@ -0,0 +1,85 @@
+<?xml version="1.0" encoding="UTF-8" ?>
+<!--File generated from metadata database-->
+<pattern id="EFORMS-validation-stage-1b-16" xmlns="http://purl.oclc.org/dsdl/schematron">
+	<rule context="/*[$noticeSubType = '16']">
+		<assert id="ND-BusinessParty-16" role="ERROR" diagnostics="ND-BusinessParty" test="count(cac:BusinessParty) = 0">rule|text|ND-BusinessParty-16</assert>
+		<assert id="ND-ContractingParty-16" role="ERROR" diagnostics="ND-ContractingParty" test="count(cac:ContractingParty) &gt; 0">rule|text|ND-ContractingParty-16</assert>
+		<assert id="ND-GazetteReference-16" role="ERROR" diagnostics="ND-GazetteReference" test="count(cac:AdditionalDocumentReference) = 0">rule|text|ND-GazetteReference-16</assert>
+		<assert id="ND-OperationType-16" role="ERROR" diagnostics="ND-OperationType" test="count(efac:NoticePurpose) = 0">rule|text|ND-OperationType-16</assert>
+		<assert id="ND-Part-16" role="ERROR" diagnostics="ND-Part" test="count(cac:ProcurementProjectLot[cbc:ID/@schemeName='Part']) = 0">rule|text|ND-Part-16</assert>
+		<assert id="ND-ProcedureProcurementScope-16" role="ERROR" diagnostics="ND-ProcedureProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-ProcedureProcurementScope-16</assert>
+		<assert id="ND-ProcedureTenderingProcess-16" role="ERROR" diagnostics="ND-ProcedureTenderingProcess" test="count(cac:TenderingProcess) &gt; 0">rule|text|ND-ProcedureTenderingProcess-16</assert>
+		<assert id="ND-ProcedureTerms-16" role="ERROR" diagnostics="ND-ProcedureTerms" test="count(cac:TenderingTerms) &gt; 0">rule|text|ND-ProcedureTerms-16</assert>
+		<assert id="ND-RootExtension-16" role="ERROR" diagnostics="ND-RootExtension" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-RootExtension-16</assert>
+		<assert id="ND-SenderContact-16" role="ERROR" diagnostics="ND-SenderContact" test="count(cac:SenderParty/cac:Contact) = 0">rule|text|ND-SenderContact-16</assert>
+	</rule>
+	<rule context="/*/cac:ContractingParty[$noticeSubType = '16']">
+		<assert id="ND-Buyer-16" role="ERROR" diagnostics="ND-Buyer" test="count(cac:Party) &gt; 0">rule|text|ND-Buyer-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot'][$noticeSubType = '16']">
+		<assert id="ND-LotProcurementScope-16" role="ERROR" diagnostics="ND-LotProcurementScope" test="count(cac:ProcurementProject) &gt; 0">rule|text|ND-LotProcurementScope-16</assert>
+		<assert id="ND-LotTenderingProcess-16" role="ERROR" diagnostics="ND-LotTenderingProcess" test="count(cac:TenderingProcess) &gt; 0">rule|text|ND-LotTenderingProcess-16</assert>
+		<assert id="ND-LotTenderingTerms-16" role="ERROR" diagnostics="ND-LotTenderingTerms" test="count(cac:TenderingTerms) &gt; 0">rule|text|ND-LotTenderingTerms-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingProcess[$noticeSubType = '16']">
+		<assert id="ND-AuctionTerms-16" role="ERROR" diagnostics="ND-AuctionTerms" test="count(cac:AuctionTerms) &gt; 0">rule|text|ND-AuctionTerms-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingProcess/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-InterestExpressionReceptionPeriod-16" role="ERROR" diagnostics="ND-InterestExpressionReceptionPeriod" test="count(efac:InterestExpressionReceptionPeriod) = 0">rule|text|ND-InterestExpressionReceptionPeriod-16</assert>
+		<assert id="ND-PMCAnswersDeadline-16" role="ERROR" diagnostics="ND-PMCAnswersDeadline" test="count(efac:AnswerReceptionPeriod) = 0">rule|text|ND-PMCAnswersDeadline-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms[$noticeSubType = '16']">
+		<assert id="ND-LotProcurementDocument-16" role="ERROR" diagnostics="ND-LotProcurementDocument" test="count(cac:CallForTendersDocumentReference) &gt; 0">rule|text|ND-LotProcurementDocument-16</assert>
+		<assert id="ND-LotReservedParticipation-16" role="ERROR" diagnostics="ND-LotReservedParticipation" test="count(cac:TendererQualificationRequest) &gt; 0">rule|text|ND-LotReservedParticipation-16</assert>
+		<assert id="ND-LotReviewTerms-16" role="ERROR" diagnostics="ND-LotReviewTerms" test="count(cac:AppealTerms) &gt; 0">rule|text|ND-LotReviewTerms-16</assert>
+		<assert id="ND-NonUBLTenderingTerms-16" role="ERROR" diagnostics="ND-NonUBLTenderingTerms" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension) &gt; 0">rule|text|ND-NonUBLTenderingTerms-16</assert>
+		<assert id="ND-Participants-16" role="ERROR" diagnostics="ND-Participants" test="count(cac:EconomicOperatorShortList) = 0">rule|text|ND-Participants-16</assert>
+		<assert id="ND-PostAwardProcess-16" role="ERROR" diagnostics="ND-PostAwardProcess" test="count(cac:PostAwardProcess) &gt; 0">rule|text|ND-PostAwardProcess-16</assert>
+		<assert id="ND-SubcontractingObligation-16" role="ERROR" diagnostics="ND-SubcontractingObligation" test="count(cac:AllowedSubcontractTerms) = 0">rule|text|ND-SubcontractingObligation-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionNumberComplicatedUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionNumberComplicatedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionNumberComplicatedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionTypeUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionTypeUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='Lot']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:AwardCriterionParameter[$noticeSubType = '16']">
+		<assert id="ND-LotAwardCriterionFixNumberUnpublish-16" role="ERROR" diagnostics="ND-LotAwardCriterionFixNumberUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotAwardCriterionFixNumberUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionNumberComplicatedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionNumberComplicatedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionTypeUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionTypeUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:ProcurementProjectLot[cbc:ID/@schemeName='LotsGroup']/cac:TenderingTerms/cac:AwardingTerms/cac:AwardingCriterion/cac:SubordinateAwardingCriterion/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:AwardCriterionParameter[$noticeSubType = '16']">
+		<assert id="ND-LotsGroupAwardCriterionFixNumberUnpublish-16" role="ERROR" diagnostics="ND-LotsGroupAwardCriterionFixNumberUnpublish" test="count(efac:FieldsPrivacy) = 0">rule|text|ND-LotsGroupAwardCriterionFixNumberUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingProcess[$noticeSubType = '16']">
+		<assert id="ND-ProcedureTypeUnpublish-16" role="ERROR" diagnostics="ND-ProcedureTypeUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-ProcedureTypeUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingProcess/cac:ProcessJustification[$noticeSubType = '16']">
+		<assert id="ND-ProcedureAcceleratedUnpublish-16" role="ERROR" diagnostics="ND-ProcedureAcceleratedUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-ProcedureAcceleratedUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms[$noticeSubType = '16']">
+		<assert id="ND-TendererQualificationRequest-16" role="ERROR" diagnostics="ND-TendererQualificationRequest" test="count(cac:TendererQualificationRequest) &gt; 0">rule|text|ND-TendererQualificationRequest-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:ProcurementLegislationDocumentReference[$noticeSubType = '16']">
+		<assert id="ND-CrossBorderLawUnpublish-16" role="ERROR" diagnostics="ND-CrossBorderLawUnpublish" test="count(ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:FieldsPrivacy) = 0">rule|text|ND-CrossBorderLawUnpublish-16</assert>
+	</rule>
+	<rule context="/*/cac:TenderingTerms/cac:TendererQualificationRequest[$noticeSubType = '16']">
+		<assert id="ND-ExclusionGrounds-16" role="ERROR" diagnostics="ND-ExclusionGrounds" test="count(cac:SpecificTendererRequirement) &gt; 0">rule|text|ND-ExclusionGrounds-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension[$noticeSubType = '16']">
+		<assert id="ND-ContractModification-16" role="ERROR" diagnostics="ND-ContractModification" test="count(efac:ContractModification) = 0">rule|text|ND-ContractModification-16</assert>
+		<assert id="ND-NoticeResult-16" role="ERROR" diagnostics="ND-NoticeResult" test="count(efac:NoticeResult) = 0">rule|text|ND-NoticeResult-16</assert>
+		<assert id="ND-Organizations-16" role="ERROR" diagnostics="ND-Organizations" test="count(efac:Organizations) &gt; 0">rule|text|ND-Organizations-16</assert>
+		<assert id="ND-ReviewRequests-16" role="ERROR" diagnostics="ND-ReviewRequests" test="count(efac:AppealsInformation) = 0">rule|text|ND-ReviewRequests-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations[$noticeSubType = '16']">
+		<assert id="ND-Organization-16" role="ERROR" diagnostics="ND-Organization" test="count(efac:Organization) &gt; 0">rule|text|ND-Organization-16</assert>
+	</rule>
+	<rule context="/*/ext:UBLExtensions/ext:UBLExtension/ext:ExtensionContent/efext:EformsExtension/efac:Organizations/efac:Organization[$noticeSubType = '16']">
+		<assert id="ND-Company-16" role="ERROR" diagnostics="ND-Company" test="count(efac:Company) &gt; 0">rule|text|ND-Company-16</assert>
+	</rule>
+</pattern>
diff --git a/src/test/resources/eu/europa/ted/eforms/sdk/analysis/cucumber/tedefo-2768.feature b/src/test/resources/eu/europa/ted/eforms/sdk/analysis/cucumber/tedefo-2768.feature
new file mode 100644
index 0000000..58c1ea1
--- /dev/null
+++ b/src/test/resources/eu/europa/ted/eforms/sdk/analysis/cucumber/tedefo-2768.feature
@@ -0,0 +1,31 @@
+@tedefo-2768
+Feature: Schematron files - Consistency validation
+  TEDEFO-2768: Check schematron files are complete and consistent
+  Test files under "src/test/resources/eforms-sdk-tests/tedefo-2768"
+
+  Background:
+    Given The following rules
+      | All expected phases are present |
+      | Every pattern is part of at least one phase |
+      | Every assert diagnostics is defined in the schematron file |
+
+  Scenario: All schematron files are consistent
+    Given A "tedefo-2768" folder with "valid" files
+    When I load all schematron files
+    And I load all notice types
+    And I execute validation
+    Then I should get 0 SDK validation errors
+
+  Scenario Outline: Some schematron files are inconsistent
+    Given A "tedefo-2768" folder with "invalid" files
+    When I load all schematron files
+    And I load all notice types
+    And I execute validation
+    Then Rule "<expected rule>" should have been fired
+    And I should get 5 SDK validation errors
+
+    Examples:
+      | expected rule                      |
+      | All expected phases are present |
+      | Every pattern is part of at least one phase |
+      | Every assert diagnostics is defined in the schematron file |

From dc1ae1664e835073ad7f046d935053f5cd9f4fe6 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Mon, 12 Aug 2024 10:35:09 +0200
Subject: [PATCH 07/22] schematron: Move calculation of missing diagnostics to
 Java code

Doing this in Drools causes very high memory usage (over 5GB) when run
on the SDK, probably because of the high number of asserts.
---
 .../sdk/analysis/fact/SchematronFileFact.java   | 17 +++++++++++++++++
 .../sdk/analysis/drools/schematronRules.drl     |  5 ++---
 2 files changed, 19 insertions(+), 3 deletions(-)

diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/SchematronFileFact.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/SchematronFileFact.java
index 76be4ad..97140a7 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/SchematronFileFact.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/fact/SchematronFileFact.java
@@ -46,6 +46,23 @@ public List<String> getDuplicateAssertIds() {
         .collect(Collectors.toList());
   }
 
+  /**
+   * Returns the list of diagnostic identifiers that are referenced in an assert but not defined by
+   * a diagnostic element.
+   * 
+   * @return List of diagnostic identifiers missing a definition.
+   */
+  public List<String> getMissingDiagnostics() {
+    Set<String> definedDiagnosticIds = getDiagnostics().stream()
+        .map(SchematronDiagnostic::getId)
+        .collect(Collectors.toSet());
+
+    return getAsserts().stream()
+        .map(SchematronAssert::getDiagnostics)
+        .filter(id -> !definedDiagnosticIds.contains(id))
+        .collect(Collectors.toList());
+  }
+
   @Override
   public String getId() {
       return schematronFile.getPath().toString();
diff --git a/src/main/resources/eu/europa/ted/eforms/sdk/analysis/drools/schematronRules.drl b/src/main/resources/eu/europa/ted/eforms/sdk/analysis/drools/schematronRules.drl
index 900e180..47d4c54 100644
--- a/src/main/resources/eu/europa/ted/eforms/sdk/analysis/drools/schematronRules.drl
+++ b/src/main/resources/eu/europa/ted/eforms/sdk/analysis/drools/schematronRules.drl
@@ -35,8 +35,7 @@ end
 
 rule "Every assert diagnostics is defined in the schematron file"
 when
-  /schematrons[ $sch: this, $schId: id ]/asserts[ $diagnosticId: diagnostics, diagnostics != null ]
-  not (exists /schematrons[ id == $schId ]/diagnostics[ id == $diagnosticId ])
+  $missing : /schematrons[ $sch: this]/missingDiagnostics
 then
-  results.add(new ValidationResult($sch, "Schematron is missing diagnostic definitions for: " + $diagnosticId, ValidationStatusEnum.ERROR));
+  results.add(new ValidationResult($sch, "Schematron is missing diagnostic definitions for: " + $missing, ValidationStatusEnum.ERROR));
 end

From 19259fb57b99adba8bcfe37c89265f163a014c06 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 30 Aug 2024 11:33:16 +0200
Subject: [PATCH 08/22] Output validation results earlier (TEDEFO-3685)

Log errors and warning after each validator is run, to know
earlier when problems are found.
Move the slowest validator (EFX) to the end to not delay the others.

The complete list of warnings and errors is still logged at the end, as
it was before, to get everyting in one place.
---
 .../ted/eforms/sdk/analysis/SdkAnalyzer.java  | 31 +++++++++++++------
 .../sdk/analysis/validator/Validator.java     | 17 ++++------
 .../analysis/cucumber/SdkValidationSteps.java | 12 +++----
 3 files changed, 34 insertions(+), 26 deletions(-)

diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/SdkAnalyzer.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/SdkAnalyzer.java
index db535e2..676f056 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/SdkAnalyzer.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/SdkAnalyzer.java
@@ -2,8 +2,8 @@
 
 import java.nio.file.Path;
 import java.util.ArrayList;
-import java.util.Arrays;
 import java.util.List;
+import java.util.Set;
 import org.apache.commons.lang3.StringUtils;
 import org.slf4j.Logger;
 import org.slf4j.LoggerFactory;
@@ -13,6 +13,7 @@
 import eu.europa.ted.eforms.sdk.analysis.validator.TextValidator;
 import eu.europa.ted.eforms.sdk.analysis.validator.Validator;
 import eu.europa.ted.eforms.sdk.analysis.validator.XmlSchemaValidator;
+import eu.europa.ted.eforms.sdk.analysis.vo.ValidationResult;
 
 public class SdkAnalyzer {
   private static final Logger logger = LoggerFactory.getLogger(SdkAnalyzer.class);
@@ -22,29 +23,41 @@ private SdkAnalyzer() {}
   public static int analyze(final Path sdkRoot) throws Exception {
     logger.info("Analyzing SDK under folder [{}]", sdkRoot);
 
-    List<String> warnings = new ArrayList<>();
-    List<String> errors = new ArrayList<>();
+    List<ValidationResult> warnings = new ArrayList<>();
+    List<ValidationResult> errors = new ArrayList<>();
 
     List<Validator> validators = List.of(
         new XmlSchemaValidator(sdkRoot),
-        new EfxValidator(sdkRoot),
         new TextValidator(sdkRoot),
         new SchematronValidator(sdkRoot),
-        new SdkValidator(sdkRoot));
+        new SdkValidator(sdkRoot),
+        new EfxValidator(sdkRoot));
     
     for (Validator validator : validators) {
+      String validatorName = validator.getClass().getSimpleName();
+      logger.info("Starting validation with {}", validatorName);
       validator.validate();
-      warnings.addAll(Arrays.asList(validator.getWarnings()));
-      errors.addAll(Arrays.asList(validator.getErrors()));      
+
+      Set<ValidationResult> foundWarnings = validator.getWarnings();
+      if (!foundWarnings.isEmpty()) {
+        logger.warn("Warnings from {}:\n{}", validatorName, StringUtils.join(foundWarnings, '\n'));
+      }
+      Set<ValidationResult> foundErrors = validator.getErrors();
+      if (!foundErrors.isEmpty()) {
+        logger.error("Errors from {}:\n{}", validatorName, StringUtils.join(foundErrors, '\n'));
+      }
+
+      warnings.addAll(foundWarnings);
+      errors.addAll(foundErrors);
     }
 
     if (!warnings.isEmpty() && logger.isWarnEnabled()) {
-      logger.warn("Validation warnings:\n{}", StringUtils.join(warnings, '\n'));
+      logger.warn("All validation warnings:\n{}", StringUtils.join(warnings, '\n'));
       logger.warn("Total number of validation warnings: {}", warnings.size());
     }
 
     if (!errors.isEmpty() && logger.isErrorEnabled()) {
-      logger.error("Validation errors:\n{}", StringUtils.join(errors, '\n'));
+      logger.error("All validation errors:\n{}", StringUtils.join(errors, '\n'));
       logger.error("Total number of validation errors: {}", errors.size());
     }
 
diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/validator/Validator.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/validator/Validator.java
index 88d531c..8ccf8f8 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/validator/Validator.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/validator/Validator.java
@@ -4,7 +4,6 @@
 import java.util.Set;
 import java.util.stream.Collectors;
 import org.apache.commons.collections4.CollectionUtils;
-import org.apache.commons.lang3.ArrayUtils;
 import eu.europa.ted.eforms.sdk.analysis.enums.ValidationStatusEnum;
 import eu.europa.ted.eforms.sdk.analysis.vo.ValidationResult;
 
@@ -24,23 +23,19 @@ default Set<ValidationResult> getResults(EnumSet<ValidationStatusEnum> statuses)
         .collect(Collectors.toSet());
   }
 
-  default String[] getWarnings() {
-    return getResults(EnumSet.of(ValidationStatusEnum.WARNING)).stream()
-        .map(ValidationResult::toString)
-        .toArray(String[]::new);
+  default Set<ValidationResult> getWarnings() {
+    return getResults(EnumSet.of(ValidationStatusEnum.WARNING));
   }
 
-  default String[] getErrors() {
-    return getResults(EnumSet.of(ValidationStatusEnum.ERROR)).stream()
-        .map(ValidationResult::toString)
-        .toArray(String[]::new);
+  default Set<ValidationResult> getErrors() {
+    return getResults(EnumSet.of(ValidationStatusEnum.ERROR));
   }
 
   default boolean hasWarnings() {
-    return ArrayUtils.isNotEmpty(getWarnings());
+    return CollectionUtils.isNotEmpty(getWarnings());
   }
 
   default boolean hasErrors() {
-    return ArrayUtils.isNotEmpty(getErrors());
+    return CollectionUtils.isNotEmpty(getErrors());
   }
 }
diff --git a/src/test/java/eu/europa/ted/eforms/sdk/analysis/cucumber/SdkValidationSteps.java b/src/test/java/eu/europa/ted/eforms/sdk/analysis/cucumber/SdkValidationSteps.java
index 17f40c8..ed7d5c3 100644
--- a/src/test/java/eu/europa/ted/eforms/sdk/analysis/cucumber/SdkValidationSteps.java
+++ b/src/test/java/eu/europa/ted/eforms/sdk/analysis/cucumber/SdkValidationSteps.java
@@ -262,32 +262,32 @@ public void rule_should_have_been_fired(String expectedRule) {
 
   @Then("^I should get (.*) SDK validation errors?$")
   public void i_should_get_sdk_validation_errors(int errorsCount) {
-    assertEquals(errorsCount, sdkValidator.getErrors().length);
+    assertEquals(errorsCount, sdkValidator.getErrors().size());
   }
 
   @Then("^I should get (.*) SDK validation warnings?$")
   public void i_should_get_sdk_validation_warnings(int warningsCount) {
-    assertEquals(warningsCount, sdkValidator.getWarnings().length);
+    assertEquals(warningsCount, sdkValidator.getWarnings().size());
   }
 
   @Then("^I should get (.*) EFX validation errors?$")
   public void i_should_get_efx_validation_errors(int errorsCount) {
-    assertEquals(errorsCount, efxValidator.getErrors().length);
+    assertEquals(errorsCount, efxValidator.getErrors().size());
   }
 
   @Then("^I should get (.*) schema validation errors?$")
   public void i_should_get_schema_validation_errors(int errorsCount) {
-    assertEquals(errorsCount, schemaValidator.getErrors().length);
+    assertEquals(errorsCount, schemaValidator.getErrors().size());
   }
 
   @Then("^I should get (.*) text validation errors?$")
   public void i_should_get_text_validation_errors(int errorsCount) {
-    assertEquals(errorsCount, textValidator.getErrors().length);
+    assertEquals(errorsCount, textValidator.getErrors().size());
   }
 
   @Then("^I should get (.*) schematron validation errors?$")
   public void i_should_get_schematron_validation_errors(int errorsCount) {
-    assertEquals(errorsCount, schematronValidator.getErrors().length);
+    assertEquals(errorsCount, schematronValidator.getErrors().size());
   }
 
   @Then("I should get not found exception for file {string}")

From ab8fa33028bd9d7a416138e5958880612a33f1f9 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Tue, 3 Sep 2024 17:46:52 +0200
Subject: [PATCH 09/22] pom: Update ph-schematron dependency to latest version

We need the bugfixes included in that version.
---
 pom.xml | 2 +-
 1 file changed, 1 insertion(+), 1 deletion(-)

diff --git a/pom.xml b/pom.xml
index 6e50bc6..ef9d167 100644
--- a/pom.xml
+++ b/pom.xml
@@ -53,7 +53,7 @@
     <version.logback>1.4.14</version.logback>
     <version.maven-model>3.9.1</version.maven-model>
     <version.picocli>4.6.3</version.picocli>
-    <version.ph-schematron>8.0.0</version.ph-schematron>
+    <version.ph-schematron>8.0.3</version.ph-schematron>
     <version.semver4j>3.1.0</version.semver4j>
     <version.slf4j>2.0.3</version.slf4j>
     <version.xmlschema>2.3.0</version.xmlschema>

From 027a060f78bcc2523e504381f6666f10c5c102f2 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Thu, 5 Sep 2024 09:48:13 +0200
Subject: [PATCH 10/22] Add new command to run benchmark of Schematron rules
 (TEDEFO-3637)

Use JMH to run the Schematron rules of the SDK being analyzed against
a set of large XML notices, and write the results to a JSON file.
This allows detecting when a change in the rules makes them slower, by
comparing with results from another run.

The notices used in the benchmark are included as resources, as we need
them to be always the same, and to be large enough to make slowdowns
noticeable. So we can't use the notice examples from the SDK being
analyzed.
---
 README.md                                     |    18 +-
 pom.xml                                       |    29 +-
 .../ted/eforms/sdk/analysis/CliCommand.java   |     8 +-
 .../sdk/analysis/SchematronBenchmark.java     |    95 +
 src/main/resources/benchmark/notices/16.xml   | 45613 ++++++++++
 src/main/resources/benchmark/notices/29.xml   | 70113 ++++++++++++++++
 6 files changed, 115872 insertions(+), 4 deletions(-)
 create mode 100644 src/main/java/eu/europa/ted/eforms/sdk/analysis/SchematronBenchmark.java
 create mode 100644 src/main/resources/benchmark/notices/16.xml
 create mode 100644 src/main/resources/benchmark/notices/29.xml

diff --git a/README.md b/README.md
index 493a8b8..874ec12 100644
--- a/README.md
+++ b/README.md
@@ -3,6 +3,8 @@
 The eForms SDK Analyzer is a command-line application for the static analysis of the content of the eForms SDK.
 It loads the files from the eForms SDK, and applies various checks and verifications, to try to ensure that their content is correct and consistent.
 
+It can also run a benchmark of the Schematron rules in an eForms SDK, to help detect potential performance issues in those validation rules.
+
 ## Building
 
 Requirements:
@@ -18,7 +20,9 @@ mvn clean package
 
 ## Usage
 
-To run the application, execute the runnable JAR built as described above, indicating the path to the folder containing the eForms-SDK:
+### SDK Analysis
+
+To analyze the content of an eForms SDK, execute the runnable JAR built as described above, indicating the path to the folder containing the eForms SDK:
 
 ```shell
 java -jar target/eforms-sdk-analyzer-1.8.0-SNAPSHOT.jar path/to/eforms-sdk
@@ -28,6 +32,18 @@ This will return the exit code 0 if no errors are found, and 1 otherwise.
 
 Any error or warning found during the analysis will be logged at the corresponding level. By default, logs go to the standard output.
 
+### Schematron rules benchmark
+
+To run the benchmark of the Schematron rules in an eForms SDK, execute the runnable JAR built as described above, indicating the path to the folder containing the eForms SDK and the command `benchmark`:
+
+```shell
+java -jar target/eforms-sdk-analyzer-1.8.0-SNAPSHOT.jar path/to/eforms-sdk benchmark
+```
+
+This will execute the Schematron rules on a few large XML notices included as resources in this project, with an appropriate warm-up and number of iterations. The results are written to a JSON file.
+
+You can compare those results with the ones from another SDK version, to detect whether the rules have become slower to execute.
+
 ## Contributing
 
 ### Adding a check
diff --git a/pom.xml b/pom.xml
index ef9d167..9eae88c 100644
--- a/pom.xml
+++ b/pom.xml
@@ -49,6 +49,7 @@
     <version.jackson>2.14.1</version.jackson>
     <version.jaxb-bind-api>4.0.0</version.jaxb-bind-api>
     <version.jaxb-impl>4.0.4</version.jaxb-impl>
+    <jmh.version>1.37</jmh.version>
     <version.junit>5.9.2</version.junit>
     <version.logback>1.4.14</version.logback>
     <version.maven-model>3.9.1</version.maven-model>
@@ -164,6 +165,17 @@
       </dependency>
 
       <!-- Other -->
+      <dependency>
+        <groupId>org.openjdk.jmh</groupId>
+        <artifactId>jmh-core</artifactId>
+        <version>${jmh.version}</version>
+      </dependency>
+      <dependency>
+        <groupId>org.openjdk.jmh</groupId>
+        <artifactId>jmh-generator-annprocess</artifactId>
+        <version>${jmh.version}</version>
+        <scope>provided</scope>
+      </dependency>
       <dependency>
         <groupId>ch.qos.logback</groupId>
         <artifactId>logback-classic</artifactId>
@@ -322,6 +334,14 @@
     </dependency>
 
     <!-- Other -->
+    <dependency>
+      <groupId>org.openjdk.jmh</groupId>
+      <artifactId>jmh-core</artifactId>
+    </dependency>
+    <dependency>
+      <groupId>org.openjdk.jmh</groupId>
+      <artifactId>jmh-generator-annprocess</artifactId>
+    </dependency>
     <dependency>
       <groupId>ch.qos.logback</groupId>
       <artifactId>logback-classic</artifactId>
@@ -411,11 +431,16 @@
         <artifactId>maven-compiler-plugin</artifactId>
         <configuration>
           <annotationProcessorPaths>
-            <annotationProcessorPath>
+            <path>
               <groupId>info.picocli</groupId>
               <artifactId>picocli-codegen</artifactId>
               <version>${version.picocli}</version>
-            </annotationProcessorPath>
+            </path>
+            <path>
+              <groupId>org.openjdk.jmh</groupId>
+              <artifactId>jmh-generator-annprocess</artifactId>
+              <version>${version.jmh}</version>
+            </path>
           </annotationProcessorPaths>
         </configuration>
       </plugin>
diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/CliCommand.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/CliCommand.java
index 0bd7a89..0ae39e4 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/CliCommand.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/CliCommand.java
@@ -30,9 +30,15 @@ public Integer call() throws Exception {
     return SdkAnalyzer.analyze(sdkRoot);
   }
 
+  @Command(name = "benchmark", mixinStandardHelpOptions = true, 
+      description = "Run benchmark of Schematron rules")
+  public int runBenchmark() throws Exception {
+    return SchematronBenchmark.run(sdkRoot);
+  }
+
   /**
    * {@link IVersionProvider} implementation that returns version information from the
-   * picocli-x.x.jar file's {@code /META-INF/MANIFEST.MF} file.
+   * built JAR file's {@code /META-INF/MANIFEST.MF} file.
    */
   static class ManifestVersionProvider implements IVersionProvider {
     public String[] getVersion() throws Exception {
diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/SchematronBenchmark.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/SchematronBenchmark.java
new file mode 100644
index 0000000..a3a5d57
--- /dev/null
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/SchematronBenchmark.java
@@ -0,0 +1,95 @@
+package eu.europa.ted.eforms.sdk.analysis;
+
+import java.io.FileNotFoundException;
+import java.io.InputStream;
+import java.nio.file.Files;
+import java.nio.file.Path;
+import java.text.MessageFormat;
+
+import javax.xml.transform.Source;
+import javax.xml.transform.stream.StreamSource;
+
+import org.apache.commons.lang3.Validate;
+import org.openjdk.jmh.annotations.Benchmark;
+import org.openjdk.jmh.annotations.BenchmarkMode;
+import org.openjdk.jmh.annotations.Fork;
+import org.openjdk.jmh.annotations.Measurement;
+import org.openjdk.jmh.annotations.Mode;
+import org.openjdk.jmh.annotations.Param;
+import org.openjdk.jmh.annotations.Scope;
+import org.openjdk.jmh.annotations.Setup;
+import org.openjdk.jmh.annotations.State;
+import org.openjdk.jmh.annotations.Warmup;
+import org.openjdk.jmh.results.format.ResultFormatType;
+import org.openjdk.jmh.runner.Runner;
+import org.openjdk.jmh.runner.options.Options;
+import org.openjdk.jmh.runner.options.OptionsBuilder;
+import org.slf4j.Logger;
+import org.slf4j.LoggerFactory;
+
+import com.helger.commons.io.resource.FileSystemResource;
+import com.helger.commons.io.resource.IReadableResource;
+import com.helger.schematron.ISchematronResource;
+import com.helger.schematron.pure.SchematronResourcePure;
+
+@State(Scope.Benchmark)
+public class SchematronBenchmark {
+  private static final Logger logger = LoggerFactory.getLogger(SchematronBenchmark.class);
+
+  // Path to the root of the eForms SDK, overriden with the path given on the command line
+  @Param("../eforms-sdk")
+  public String sdkRootPath;
+
+  // Filenames of XML notices included as resources in this project
+  @Param({"16.xml", "29.xml"})
+  public String noticeFilename;
+
+  private ISchematronResource phSchematron;
+
+  public static int run(final Path sdkRoot) throws Exception {
+    logger.warn("Benchmarking Schematron rules from SDK under folder [{}]", sdkRoot);
+
+    Validate.notNull(sdkRoot, "Undefined SDK root path");
+    if (!Files.isDirectory(sdkRoot)) {
+      throw new FileNotFoundException(sdkRoot.toString());
+    }
+
+    Options opt = new OptionsBuilder()
+                .include(SchematronBenchmark.class.getSimpleName())
+                .param("sdkRootPath", sdkRoot.toString())
+                .resultFormat(ResultFormatType.JSON)
+                .build();
+             
+    new Runner(opt).run();
+
+    return 0;
+  }
+
+  @Setup
+  public void setup() {
+    SdkLoader sdkLoader = new SdkLoader(Path.of(sdkRootPath));
+
+    // Use the first set of Schematron rules (dynamic/static)
+    // They are mostly identical, so it does not make a difference for the benchmark
+    Path file = sdkLoader.getSchematronFilesPaths().get(0);
+    IReadableResource schematron = new FileSystemResource(file);
+    phSchematron = new SchematronResourcePure(schematron);
+  }
+
+  @Benchmark
+  @Fork(1)
+  @Warmup(iterations = 1)
+  @Measurement(iterations = 3)
+  @BenchmarkMode(Mode.AverageTime)
+  public int executeValidation() throws Exception {
+
+    String resourceName = MessageFormat.format("benchmark/notices/{0}", noticeFilename);
+    InputStream stream = this.getClass().getClassLoader().getResourceAsStream(resourceName);
+    Validate.notNull(stream, "Notice file not found in resources: " + resourceName);
+
+    Source source = new StreamSource(stream);
+    phSchematron.applySchematronValidation(source);
+    
+    return 0;
+  }
+}
diff --git a/src/main/resources/benchmark/notices/16.xml b/src/main/resources/benchmark/notices/16.xml
new file mode 100644
index 0000000..bfec3f0
--- /dev/null
+++ b/src/main/resources/benchmark/notices/16.xml
@@ -0,0 +1,45613 @@
+<?xml version="1.0" encoding="UTF-8"?>
+<ContractNotice xmlns="urn:oasis:names:specification:ubl:schema:xsd:ContractNotice-2"
+                 xmlns:cac="urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2"
+                 xmlns:cbc="urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2"
+                 xmlns:efac="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1"
+                 xmlns:efbc="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1"
+                 xmlns:efext="http://data.europa.eu/p27/eforms-ubl-extensions/1"
+                 xmlns:ext="urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2"
+                 >
+   <ext:UBLExtensions>
+      <ext:UBLExtension>
+         <ext:ExtensionContent>
+            <efext:EformsExtension>
+               <efac:NoticeSubType>
+                  <cbc:SubTypeCode listName="notice-subtype">16</cbc:SubTypeCode>
+               </efac:NoticeSubType>
+               <efac:Organizations>
+                  <efac:Organization>
+                     <efbc:AwardingCPBIndicator>true</efbc:AwardingCPBIndicator>
+                     <efac:Company>
+                        <cbc:WebsiteURI>https://www.zenithnovainnovations.com</cbc:WebsiteURI>
+                        <cbc:EndpointID>https://www.zenithnovainnovations.com/info-exchange</cbc:EndpointID>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0001</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="ENG">ZenithNova Innovations</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>ZenithNova Innovations 45 Future Boulevard New Horizons, CA 90210 United States of America</cbc:StreetName>
+                           <cbc:AdditionalStreetName>ZenithNova Innovations 45 Future Boulevard New Horizons, CA 90210 United States of America</cbc:AdditionalStreetName>
+                           <cbc:Department>Future Solutions Division</cbc:Department>
+                           <cbc:CityName>New Horizons, CA</cbc:CityName>
+                           <cbc:PostalZone>90210</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">EL303</cbc:CountrySubentityCode>
+                           <cac:AddressLine>
+                              <cbc:Line>ZenithNova Innovations 45 Future Boulevard New Horizons, CA 90210 United States of America</cbc:Line>
+                           </cac:AddressLine>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">GRC</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>ABE</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Name>Info</cbc:Name>
+                           <cbc:Telephone>+1 (555) 123-4567</cbc:Telephone>
+                           <cbc:Telefax>+1 (555) 123-4567</cbc:Telefax>
+                           <cbc:ElectronicMail>info@zenithnovainnovations.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                     <efac:TouchPoint>
+                        <cbc:WebsiteURI>https://www.zenithnovainnovations.com/contact-us/katerina-lisa</cbc:WebsiteURI>
+                        <cbc:EndpointID>https://www.zenithnovainnovations.com/info-exchange/katerina-lisa</cbc:EndpointID>
+                        <cac:PartyIdentification>
+                           <cbc:ID>TPO-0001</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="ENG">Katerina Lisa</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:Department>Future Solutions Division</cbc:Department>
+                        </cac:PostalAddress>
+                     </efac:TouchPoint>
+                  </efac:Organization>
+               </efac:Organizations>
+            </efext:EformsExtension>
+         </ext:ExtensionContent>
+      </ext:UBLExtension>
+   </ext:UBLExtensions>
+   <cbc:UBLVersionID>2.3</cbc:UBLVersionID>
+   <cbc:CustomizationID>eforms-sdk-1.10</cbc:CustomizationID>
+   <cbc:ID schemeName="notice-id">0491ebbe-4e45-4c38-8a4e-722a5159d809</cbc:ID>
+   <cbc:ContractFolderID>b47fd31a-a9e4-4680-a50d-0e577ffcbdf3</cbc:ContractFolderID>
+   <cbc:IssueDate>2023-12-14Z</cbc:IssueDate>
+   <cbc:IssueTime>07:37:54Z</cbc:IssueTime>
+   <cbc:VersionID>01</cbc:VersionID>
+   <cbc:RegulatoryDomain>32014L0024</cbc:RegulatoryDomain>
+   <cbc:NoticeTypeCode listName="competition">cn-standard</cbc:NoticeTypeCode>
+   <cbc:NoticeLanguageCode listName="language">ENG</cbc:NoticeLanguageCode>
+   <cac:ContractingParty>
+      <cbc:BuyerProfileURI>https://duckduckgo.com</cbc:BuyerProfileURI>
+      <cac:ContractingPartyType>
+         <cbc:PartyTypeCode listName="buyer-legal-type">pub-undert-cga</cbc:PartyTypeCode>
+      </cac:ContractingPartyType>
+      <cac:ContractingActivity>
+         <cbc:ActivityTypeCode listName="authority-activity">rcr</cbc:ActivityTypeCode>
+      </cac:ContractingActivity>
+      <cac:Party>
+         <cac:PartyIdentification>
+            <cbc:ID>ORG-0001</cbc:ID>
+         </cac:PartyIdentification>
+      </cac:Party>
+   </cac:ContractingParty>
+   <cac:TenderingTerms>
+      <cac:TendererQualificationRequest>
+         <cac:SpecificTendererRequirement>
+            <cbc:TendererRequirementTypeCode listName="exclusion-ground">corruption</cbc:TendererRequirementTypeCode>
+            <cbc:Description languageID="ENG">If any of the participants are corrupted then they are excluded from the tendering process</cbc:Description>
+         </cac:SpecificTendererRequirement>
+      </cac:TendererQualificationRequest>
+   </cac:TenderingTerms>
+   <cac:TenderingProcess>
+      <cbc:ProcedureCode listName="procurement-procedure-type">open</cbc:ProcedureCode>
+   </cac:TenderingProcess>
+   <cac:ProcurementProject>
+      <cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+      <cbc:Description languageID="ENG">Poor Things is a 2023 surrealist[3] steampunk[4][5] black comedy film directed by Yorgos Lanthimos from a screenplay by Tony McNamara.[6] It is based on the 1992 novel of the same name by Alasdair Gray, and stars Emma Stone alongside Mark Ruffalo, Willem Dafoe, Ramy Youssef, Christopher Abbott, and Jerrod Carmichael. The plot follows a young Victorian woman who, after being crudely resurrected by a scientist following her suicide, runs off with a debauched lawyer to embark on an odyssey of self-discovery and sexual liberation.
+Development on the film began as early as 2009, when Lanthimos visited Gray in his Scotland home to acquire the rights to the novel. Following a period in development hell, the director revisited Poor Things while filming The Favourite (2018), which starred Stone, and approached her with the lead role. The remaining cast joined the project in 2021, with principal photography occurring in Hungary from August to December of that year.
+Poor Things premiered at the 80th Venice International Film Festival on September 1, 2023, where it won the Golden Lion. The film is scheduled to be theatrically released by Searchlight Pictures in the United States on December 8, 2023, and in the United Kingdom on January 12, 2024.</cbc:Description>
+      <cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+      <cac:MainCommodityClassification>
+         <cbc:ItemClassificationCode listName="cpv">50000000</cbc:ItemClassificationCode>
+      </cac:MainCommodityClassification>
+   </cac:ProcurementProject>
+    <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0001</cbc:ID>
+      <cac:TenderingTerms>
+         <ext:UBLExtensions>
+            <ext:UBLExtension>
+               <ext:ExtensionContent>
+                  <efext:EformsExtension>
+                     <efac:SelectionCriteria>
+                        <cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+                     </efac:SelectionCriteria>
+                  </efext:EformsExtension>
+               </ext:ExtensionContent>
+            </ext:UBLExtension>
+         </ext:UBLExtensions>
+         <cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+         <cac:CallForTendersDocumentReference>
+            <cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+            <cbc:DocumentType>restricted-document</cbc:DocumentType>
+            <cac:Attachment>
+               <cac:ExternalReference>
+                  <cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+               </cac:ExternalReference>
+            </cac:Attachment>
+         </cac:CallForTendersDocumentReference>
+         <cac:TendererQualificationRequest>
+            <cac:SpecificTendererRequirement>
+               <cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+            </cac:SpecificTendererRequirement>
+         </cac:TendererQualificationRequest>
+         <cac:ContractExecutionRequirement>
+            <cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+         </cac:ContractExecutionRequirement>
+         <cac:ContractExecutionRequirement>
+            <cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+         </cac:ContractExecutionRequirement>
+         <cac:ContractExecutionRequirement>
+            <cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+         </cac:ContractExecutionRequirement>
+         <cac:AppealTerms>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>TPO-0001</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+         <cac:Language>
+            <cbc:ID>ELL</cbc:ID>
+         </cac:Language>
+         <cac:PostAwardProcess>
+            <cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+            <cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+         </cac:PostAwardProcess>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+         <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:TenderSubmissionDeadlinePeriod>
+            <cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+            <cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+         </cac:TenderSubmissionDeadlinePeriod>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>ABE LOT-0001</cbc:ID>
+         <cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+         <cbc:Description languageID="ENG">Premise
+A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+Development
+Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+Pre-production
+Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:PlannedPeriod>
+            <cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+         </cac:PlannedPeriod>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+    <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0002</cbc:ID>
+      <cac:TenderingTerms>
+         <ext:UBLExtensions>
+            <ext:UBLExtension>
+               <ext:ExtensionContent>
+                  <efext:EformsExtension>
+                     <efac:SelectionCriteria>
+                        <cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+                     </efac:SelectionCriteria>
+                  </efext:EformsExtension>
+               </ext:ExtensionContent>
+            </ext:UBLExtension>
+         </ext:UBLExtensions>
+         <cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+         <cac:CallForTendersDocumentReference>
+            <cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+            <cbc:DocumentType>restricted-document</cbc:DocumentType>
+            <cac:Attachment>
+               <cac:ExternalReference>
+                  <cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+               </cac:ExternalReference>
+            </cac:Attachment>
+         </cac:CallForTendersDocumentReference>
+         <cac:TendererQualificationRequest>
+            <cac:SpecificTendererRequirement>
+               <cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+            </cac:SpecificTendererRequirement>
+         </cac:TendererQualificationRequest>
+         <cac:ContractExecutionRequirement>
+            <cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+         </cac:ContractExecutionRequirement>
+         <cac:ContractExecutionRequirement>
+            <cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+         </cac:ContractExecutionRequirement>
+         <cac:ContractExecutionRequirement>
+            <cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+         </cac:ContractExecutionRequirement>
+         <cac:AppealTerms>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>TPO-0001</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+         <cac:Language>
+            <cbc:ID>ELL</cbc:ID>
+         </cac:Language>
+         <cac:PostAwardProcess>
+            <cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+            <cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+         </cac:PostAwardProcess>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+         <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:TenderSubmissionDeadlinePeriod>
+            <cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+            <cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+         </cac:TenderSubmissionDeadlinePeriod>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>ABE LOT-0002</cbc:ID>
+         <cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+         <cbc:Description languageID="ENG">Premise
+A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+Development
+Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+Pre-production
+Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:PlannedPeriod>
+            <cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+         </cac:PlannedPeriod>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0003</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0003</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0004</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0004</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0005</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0005</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0006</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0006</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0007</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0007</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0008</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0008</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0009</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0009</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0010</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0010</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0011</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0011</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0012</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0012</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0013</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0013</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0014</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0014</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0015</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0015</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0016</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0016</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0017</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0017</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0018</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0018</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0019</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0019</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0020</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0020</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0021</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0021</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0022</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0022</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0023</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0023</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0024</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0024</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0025</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0025</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0026</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0026</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0027</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0027</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0028</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0028</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0029</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0029</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0030</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0030</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0031</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0031</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0032</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0032</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0033</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0033</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0034</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0034</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0035</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0035</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0036</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0036</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0037</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0037</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0038</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0038</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0039</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0039</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0040</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0040</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0041</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0041</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0042</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0042</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0043</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0043</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0044</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0044</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0045</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0045</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0046</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0046</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0047</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0047</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0048</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0048</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0049</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0049</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0050</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0050</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0051</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0051</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0052</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0052</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0053</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0053</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0054</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0054</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0055</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0055</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0056</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0056</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0057</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0057</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0058</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0058</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0059</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0059</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0060</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0060</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0061</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0061</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0062</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0062</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0063</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0063</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0064</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0064</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0065</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0065</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0066</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0066</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0067</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0067</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0068</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0068</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0069</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0069</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0070</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0070</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0071</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0071</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0072</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0072</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0073</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0073</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0074</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0074</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0075</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0075</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0076</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0076</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0077</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0077</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0078</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0078</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0079</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0079</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0080</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0080</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0081</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0081</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0082</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0082</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0083</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0083</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0084</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0084</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0085</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0085</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0086</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0086</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0087</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0087</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0088</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0088</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0089</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0089</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0090</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0090</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0091</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0091</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0092</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0092</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0093</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0093</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0094</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0094</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0095</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0095</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0096</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0096</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0097</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0097</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0098</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0098</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0099</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0099</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0100</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0100</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0101</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0101</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0102</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0102</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0103</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0103</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0104</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0104</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0105</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0105</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0106</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0106</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0107</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0107</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0108</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0108</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0109</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0109</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0110</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0110</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0111</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0111</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0112</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0112</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0113</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0113</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0114</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0114</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0115</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0115</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0116</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0116</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0117</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0117</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0118</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0118</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0119</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0119</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0120</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0120</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0121</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0121</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0122</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0122</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0123</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0123</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0124</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0124</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0125</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0125</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0126</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0126</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0127</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0127</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0128</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0128</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0129</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0129</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0130</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0130</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0131</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0131</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0132</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0132</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0133</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0133</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0134</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0134</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0135</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0135</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0136</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0136</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0137</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0137</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0138</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0138</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0139</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0139</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0140</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0140</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0141</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0141</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0142</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0142</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0143</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0143</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0144</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0144</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0145</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0145</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0146</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0146</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0147</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0147</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0148</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0148</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0149</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0149</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0150</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0150</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0151</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0151</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0152</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0152</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0153</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0153</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0154</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0154</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0155</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0155</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0156</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0156</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0157</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0157</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0158</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0158</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0159</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0159</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0160</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0160</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0161</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0161</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0162</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0162</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0163</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0163</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0164</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0164</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0165</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0165</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0166</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0166</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0167</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0167</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0168</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0168</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0169</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0169</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0170</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0170</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0171</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0171</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0172</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0172</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0173</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0173</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0174</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0174</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0175</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0175</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0176</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0176</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0177</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0177</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0178</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0178</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0179</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0179</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0180</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0180</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0181</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0181</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0182</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0182</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0183</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0183</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0184</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0184</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0185</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0185</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0186</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0186</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0187</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0187</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0188</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0188</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0189</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0189</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0190</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0190</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0191</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0191</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0192</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0192</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0193</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0193</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0194</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0194</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0195</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0195</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0196</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0196</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0197</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0197</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0198</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0198</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0199</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0199</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0200</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0200</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0201</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0201</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0202</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0202</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0203</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0203</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0204</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0204</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0205</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0205</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0206</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0206</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0207</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0207</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0208</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0208</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0209</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0209</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0210</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0210</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0211</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0211</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0212</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0212</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0213</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0213</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0214</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0214</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0215</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0215</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0216</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0216</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0217</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0217</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0218</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0218</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0219</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0219</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0220</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0220</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0221</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0221</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0222</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0222</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0223</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0223</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0224</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0224</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0225</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0225</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0226</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0226</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0227</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0227</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0228</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0228</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0229</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0229</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0230</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0230</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0231</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0231</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0232</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0232</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0233</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0233</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0234</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0234</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0235</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0235</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0236</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0236</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0237</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0237</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0238</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0238</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0239</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0239</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0240</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0240</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0241</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0241</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0242</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0242</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0243</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0243</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0244</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0244</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0245</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0245</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0246</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0246</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0247</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0247</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0248</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0248</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0249</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0249</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0250</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0250</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0251</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0251</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0252</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0252</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0253</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0253</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0254</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0254</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0255</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0255</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0256</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0256</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0257</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0257</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0258</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0258</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0259</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0259</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0260</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0260</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0261</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0261</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0262</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0262</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0263</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0263</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0264</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0264</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0265</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0265</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0266</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0266</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0267</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0267</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0268</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0268</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0269</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0269</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0270</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0270</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0271</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0271</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0272</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0272</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0273</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0273</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0274</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0274</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0275</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0275</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0276</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0276</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0277</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0277</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0278</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0278</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0279</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0279</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0280</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0280</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0281</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0281</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0282</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0282</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0283</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0283</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0284</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0284</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0285</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0285</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0286</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0286</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0287</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0287</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0288</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0288</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0289</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0289</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0290</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0290</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0291</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0291</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0292</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0292</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0293</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0293</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0294</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0294</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0295</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0295</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0296</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0296</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0297</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0297</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0298</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0298</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0299</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0299</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0300</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0300</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0301</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0301</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0302</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0302</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0303</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0303</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0304</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0304</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0305</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0305</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0306</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0306</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0307</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0307</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0308</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0308</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0309</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0309</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0310</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0310</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0311</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0311</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0312</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0312</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0313</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0313</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0314</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0314</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0315</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0315</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0316</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0316</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0317</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0317</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0318</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0318</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0319</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0319</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0320</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0320</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0321</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0321</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0322</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0322</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0323</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0323</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0324</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0324</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0325</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0325</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0326</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0326</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0327</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0327</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0328</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0328</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0329</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0329</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0330</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0330</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0331</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0331</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0332</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0332</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0333</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0333</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0334</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0334</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0335</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0335</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0336</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0336</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0337</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0337</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0338</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0338</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0339</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0339</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0340</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0340</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0341</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0341</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0342</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0342</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0343</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0343</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0344</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0344</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0345</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0345</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0346</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0346</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0347</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0347</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0348</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0348</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0349</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0349</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0350</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0350</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0351</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0351</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0352</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0352</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0353</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0353</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0354</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0354</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0355</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0355</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0356</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0356</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0357</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0357</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0358</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0358</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0359</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0359</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0360</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0360</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0361</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0361</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0362</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0362</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0363</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0363</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0364</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0364</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0365</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0365</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0366</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0366</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0367</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0367</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0368</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0368</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0369</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0369</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0370</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0370</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0371</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0371</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0372</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0372</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0373</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0373</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0374</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0374</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0375</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0375</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0376</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0376</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0377</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0377</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0378</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0378</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0379</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0379</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0380</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0380</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0381</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0381</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0382</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0382</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0383</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0383</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0384</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0384</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0385</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0385</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0386</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0386</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0387</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0387</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0388</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0388</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0389</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0389</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0390</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0390</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0391</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0391</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0392</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0392</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0393</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0393</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0394</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0394</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0395</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0395</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0396</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0396</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0397</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0397</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0398</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0398</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0399</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0399</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0400</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0400</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0401</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0401</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0402</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0402</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0403</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0403</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0404</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0404</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0405</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0405</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0406</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0406</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0407</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0407</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0408</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0408</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0409</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0409</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0410</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0410</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0411</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0411</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0412</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0412</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0413</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0413</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0414</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0414</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0415</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0415</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0416</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0416</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0417</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0417</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0418</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0418</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0419</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0419</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0420</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0420</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0421</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0421</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0422</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0422</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0423</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0423</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0424</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0424</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0425</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0425</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0426</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0426</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0427</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0427</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0428</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0428</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0429</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0429</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0430</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0430</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0431</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0431</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0432</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0432</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0433</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0433</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0434</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0434</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0435</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0435</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0436</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0436</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0437</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0437</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0438</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0438</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0439</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0439</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0440</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0440</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0441</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0441</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0442</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0442</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0443</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0443</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0444</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0444</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0445</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0445</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0446</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0446</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0447</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0447</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0448</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0448</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0449</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0449</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0450</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0450</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0451</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0451</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0452</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0452</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0453</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0453</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0454</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0454</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0455</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0455</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0456</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0456</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0457</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0457</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0458</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0458</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0459</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0459</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0460</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0460</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0461</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0461</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0462</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0462</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0463</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0463</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0464</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0464</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0465</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0465</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0466</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0466</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0467</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0467</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0468</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0468</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0469</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0469</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0470</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0470</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0471</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0471</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0472</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0472</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0473</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0473</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0474</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0474</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0475</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0475</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0476</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0476</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0477</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0477</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0478</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0478</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0479</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0479</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0480</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0480</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0481</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0481</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0482</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0482</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0483</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0483</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0484</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0484</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0485</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0485</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0486</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0486</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0487</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0487</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0488</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0488</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0489</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0489</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0490</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0490</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0491</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0491</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0492</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0492</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0493</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0493</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0494</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0494</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0495</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0495</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0496</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0496</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0497</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0497</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0498</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0498</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0499</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0499</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0500</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:AppealTerms>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0500</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+</ContractNotice>
\ No newline at end of file
diff --git a/src/main/resources/benchmark/notices/29.xml b/src/main/resources/benchmark/notices/29.xml
new file mode 100644
index 0000000..ec8dddf
--- /dev/null
+++ b/src/main/resources/benchmark/notices/29.xml
@@ -0,0 +1,70113 @@
+<?xml version="1.0" encoding="UTF-8"?>
+<ContractAwardNotice xmlns="urn:oasis:names:specification:ubl:schema:xsd:ContractAwardNotice-2" xmlns:cac="urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2" xmlns:cbc="urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2" xmlns:efac="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1" xmlns:efbc="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1" xmlns:efext="http://data.europa.eu/p27/eforms-ubl-extensions/1" xmlns:ext="urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
+   <ext:UBLExtensions>
+      <ext:UBLExtension>
+         <ext:ExtensionContent>
+            <efext:EformsExtension>
+               <efbc:TransmissionDate>2024-03-22Z</efbc:TransmissionDate>
+               <efbc:TransmissionTime>15:29:59Z</efbc:TransmissionTime>
+               <efac:NoticeResult>
+                  <efbc:OverallApproximateFrameworkContractsAmount currencyID="EUR">1000000</efbc:OverallApproximateFrameworkContractsAmount>
+                  <efbc:OverallMaximumFrameworkContractsAmount currencyID="EUR">1000000</efbc:OverallMaximumFrameworkContractsAmount>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0001</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0001</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0002</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0001</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0001</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0002</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0003</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0002</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0002</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0003</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0004</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0003</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0003</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0004</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0005</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0004</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0004</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0005</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0006</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0005</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0005</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0006</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0007</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0006</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0006</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0007</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0008</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0007</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0007</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0008</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0009</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0008</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0008</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0009</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0010</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0009</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0009</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0010</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0011</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0010</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0010</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0011</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0012</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0011</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0011</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0012</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0013</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0012</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0012</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0013</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0014</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0013</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0013</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0014</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0015</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0014</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0014</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0015</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0016</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0015</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0015</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0016</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0017</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0016</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0016</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0017</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0018</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0017</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0017</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0018</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0019</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0018</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0018</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0019</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0020</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0019</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0019</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0020</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0021</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0020</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0020</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0021</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0022</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0021</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0021</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0022</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0023</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0022</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0022</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0023</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0024</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0023</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0023</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0024</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0025</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0024</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0024</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0025</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0026</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0025</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0025</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0026</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0027</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0026</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0026</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0027</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0028</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0027</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0027</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0028</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0029</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0028</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0028</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0029</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0030</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0029</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0029</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0030</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0031</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0030</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0030</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0031</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0032</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0031</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0031</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0032</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0033</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0033</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0034</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0032</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0032</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0034</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0035</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0033</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0033</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0035</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0036</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0034</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0034</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0036</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0037</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0035</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0035</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0037</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0038</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0036</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0036</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0038</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0039</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0037</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0037</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0039</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0040</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0038</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0038</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0040</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0041</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0039</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0039</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0041</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0042</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0040</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0040</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0042</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0043</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0041</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0041</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0043</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0044</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0042</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0042</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0044</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0045</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0043</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0043</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0045</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0046</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0044</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0044</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0046</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0047</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0045</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0045</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0047</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0048</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0046</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0046</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0048</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0049</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0047</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0047</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0049</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0050</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0048</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0048</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0050</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0051</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0049</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0049</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0051</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0052</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0050</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0050</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0052</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0053</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0051</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0051</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0053</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0054</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0052</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0052</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0054</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0055</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0053</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0053</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0055</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0056</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0054</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0054</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0056</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0057</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0055</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0055</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0057</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0058</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0056</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0056</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0058</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0059</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0057</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0057</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0059</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0060</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0058</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0058</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0060</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0061</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0059</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0059</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0061</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0062</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0060</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0060</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0062</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0063</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0061</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0061</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0063</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0064</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0062</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0062</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0064</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0065</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0063</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0063</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0065</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0066</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0064</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0064</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0066</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0067</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0065</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0065</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0067</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0068</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0066</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0066</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0068</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0069</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0067</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0067</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0069</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0070</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0068</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0068</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0070</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0071</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0069</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0069</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0071</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0072</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0070</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0070</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0072</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0073</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0071</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0071</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0073</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0074</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0072</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0072</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0074</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0075</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0073</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0073</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0075</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0076</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0074</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0074</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0076</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0077</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0075</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0075</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0077</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0078</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0076</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0076</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0078</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0079</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0077</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0077</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0079</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0080</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0078</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0078</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0080</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0081</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0081</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0082</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0079</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0079</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0082</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0083</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0080</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0080</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0083</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0084</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0081</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0081</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0084</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0085</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0082</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0082</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0085</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0086</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0083</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0083</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0086</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0087</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0084</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0084</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0087</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0088</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0085</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0085</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0088</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0089</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0086</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0086</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0089</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0090</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0087</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0087</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0090</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0091</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0088</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0088</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0091</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0092</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0089</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0089</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0092</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0093</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0090</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0090</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0093</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0094</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0091</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0091</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0094</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0095</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0092</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0092</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0095</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0096</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0093</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0093</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0096</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0097</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0094</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0094</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0097</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0098</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0095</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0095</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0098</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0099</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0096</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0096</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0099</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0100</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0097</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0097</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0100</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0101</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0098</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0098</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0101</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0102</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0099</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0099</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0102</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0103</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0100</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0100</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0103</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0104</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0101</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0101</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0104</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0105</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0102</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0102</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0105</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0106</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0103</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0103</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0106</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0107</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0104</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0104</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0107</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0108</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0105</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0105</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0108</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0109</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0106</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0106</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0109</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0110</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0107</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0107</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0110</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0111</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0111</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0112</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0108</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0108</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0112</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0113</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0109</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0109</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0113</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0114</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0110</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0110</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0114</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0115</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0111</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0111</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0115</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0116</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0112</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0112</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0116</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0117</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0113</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0113</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0117</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0118</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0114</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0114</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0118</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0119</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0115</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0115</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0119</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0120</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0116</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0116</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0120</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0121</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0117</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0117</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0121</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0122</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0118</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0118</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0122</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0123</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0119</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0119</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0123</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0124</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0120</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0120</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0124</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0125</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0121</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0121</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0125</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0126</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0122</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0122</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0126</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0127</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0123</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0123</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0127</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0128</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0124</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0124</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0128</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0129</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0125</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0125</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0129</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0130</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0126</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0126</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0130</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0131</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0127</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0127</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0131</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0132</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0128</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0128</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0132</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0133</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0129</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0129</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0133</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0134</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0134</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0135</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0130</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0130</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0135</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0136</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0131</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0131</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0136</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0137</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0132</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0132</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0137</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0138</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0133</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0133</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0138</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0139</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0134</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0134</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0139</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0140</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0135</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0135</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0140</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0141</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0136</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0136</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0141</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0142</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0137</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0137</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0142</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0143</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0138</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0138</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0143</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0144</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0139</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0139</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0144</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0145</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0140</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0140</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0145</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0146</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0141</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0141</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0146</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0147</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0142</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0142</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0147</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0148</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0143</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0143</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0148</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0149</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0149</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0150</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0144</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0144</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0150</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0151</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0145</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0145</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0151</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0152</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0146</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0146</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0152</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0153</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0147</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0147</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0153</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0154</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0148</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0148</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0154</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0155</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0149</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0149</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0155</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0156</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0150</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0150</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0156</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0157</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0151</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0151</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0157</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0158</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0158</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0159</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0152</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0152</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0159</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0160</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0153</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0153</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0160</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0161</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0154</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0154</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0161</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0162</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0155</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0155</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0162</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0163</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0156</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0156</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0163</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0164</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0157</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0157</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0164</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0165</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0158</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0158</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0165</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0166</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0159</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0159</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0166</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0167</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0160</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0160</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0167</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0168</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0161</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0161</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0168</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0169</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0162</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0162</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0169</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0170</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0163</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0163</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0170</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0171</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0164</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0164</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0171</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0172</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0165</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0165</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0172</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0173</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0173</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0174</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0166</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0166</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0174</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0175</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0175</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0176</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0167</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0167</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0176</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0177</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0168</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0168</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0177</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0178</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0169</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0169</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0178</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0179</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0170</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0170</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0179</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0180</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0171</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0171</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0180</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0181</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0181</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0182</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0172</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0172</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0182</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0183</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0173</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0173</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0183</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0184</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0174</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>6</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>6</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0174</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0184</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0185</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0175</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0175</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0185</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0186</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0176</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0176</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0186</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0187</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0177</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0177</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0187</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0188</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0178</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0178</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0188</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0189</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0179</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0179</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0189</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0190</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0180</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0180</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0190</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0191</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0181</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0181</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0191</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0192</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0182</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0182</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0192</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0193</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0183</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0183</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0193</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0194</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0184</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0184</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0194</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0195</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0185</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0185</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0195</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0196</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0186</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0186</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0196</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0197</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0187</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0187</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0197</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0198</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0198</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0199</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0199</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0200</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0188</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0188</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0200</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0201</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0189</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0189</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0201</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0202</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0190</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0190</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0202</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0203</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0191</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0191</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0203</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0204</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0192</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0192</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0204</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0205</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0193</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0193</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0205</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0206</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0194</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0194</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0206</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0207</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0195</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0195</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0207</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0208</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0196</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0196</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0208</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0209</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0197</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0197</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0209</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0210</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0198</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0198</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0210</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0211</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0199</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0199</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0211</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0212</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0200</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0200</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0212</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0213</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0201</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0201</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0213</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0214</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0202</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0202</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0214</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0215</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0203</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0203</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0215</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0216</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0204</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0204</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0216</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0217</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0205</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0205</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0217</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0218</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0206</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0206</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0218</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0219</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0207</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0207</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0219</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0220</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0208</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0208</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0220</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0221</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0209</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0209</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0221</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0222</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0210</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>7</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>7</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0210</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0222</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0223</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0211</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0211</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0223</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0224</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0212</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0212</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0224</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0225</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0213</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0213</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0225</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0226</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0214</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0214</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0226</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0227</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0215</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0215</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0227</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0228</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0216</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0216</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0228</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0229</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0217</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0217</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0229</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0230</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0218</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>5</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0218</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0230</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0231</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0219</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0219</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0231</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0232</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0220</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0220</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0232</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0233</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0233</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0234</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0221</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0221</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0234</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0235</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0222</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0222</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0235</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0236</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0223</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0223</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0236</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0237</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0224</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0224</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0237</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0238</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0225</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0225</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0238</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0239</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0226</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0226</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0239</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0240</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0227</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0227</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0240</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0241</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0228</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0228</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0241</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0242</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0229</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0229</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0242</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0243</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0230</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0230</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0243</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0244</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0231</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0231</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0244</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0245</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0232</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0232</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0245</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0246</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0233</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0233</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0246</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0247</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0234</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0234</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0247</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0248</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0235</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0235</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0248</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0249</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0236</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0236</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0249</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0250</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0237</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0237</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0250</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0251</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0251</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0252</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0238</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0238</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0252</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0253</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0239</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0239</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0253</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0254</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0254</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0255</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0240</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0240</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0255</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0256</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0241</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0241</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0256</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0257</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0242</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0242</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0257</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0258</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0243</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0243</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0258</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0259</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0244</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0244</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0259</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0260</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0245</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0245</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0260</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0261</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0246</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0246</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0261</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0262</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0247</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0247</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0262</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0263</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0248</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0248</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0263</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0264</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0249</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0249</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0264</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0265</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0250</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0250</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0265</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0266</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0251</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0251</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0266</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0267</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0252</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0252</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0267</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0268</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0253</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0253</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0268</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0269</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0254</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0254</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0269</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0270</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0270</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0271</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0255</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0255</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0271</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0272</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0256</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0256</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0272</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0273</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0257</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0257</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0273</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0274</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0258</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0258</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0274</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0275</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0259</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0259</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0275</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0276</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0260</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0260</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0276</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0277</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0261</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0261</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0277</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0278</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0262</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0262</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0278</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0279</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0279</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0280</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0280</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0281</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0263</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0263</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0281</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0282</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0264</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0264</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0282</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0283</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0283</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0284</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0265</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0265</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0284</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0285</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0266</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0266</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0285</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0286</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0267</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0267</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0286</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0287</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0268</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0268</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0287</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0288</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0269</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0269</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0288</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0289</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0270</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0270</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0289</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0290</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0271</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0271</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0290</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0291</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0272</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0272</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0291</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0292</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0292</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0293</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0293</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0294</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0294</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0295</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0273</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0273</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0295</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0296</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0274</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0274</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0296</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0297</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0275</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0275</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0297</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0298</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0276</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0276</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0298</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0299</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0277</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0277</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0299</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0300</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0278</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0278</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0300</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0301</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0279</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0279</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0301</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0302</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0302</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0303</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0280</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0280</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0303</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0304</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0304</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0305</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0305</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0306</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0306</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0307</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0307</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0308</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0308</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0309</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0309</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0310</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0310</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0311</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0311</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0312</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0312</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0313</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0313</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0314</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0314</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0315</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0315</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0316</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0316</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0317</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0317</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0318</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0318</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0319</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0319</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0320</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0320</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0321</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0321</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0322</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0322</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0323</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0323</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0324</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0324</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0325</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0325</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0326</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0326</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0327</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0327</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0328</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0328</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0329</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0329</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0330</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0330</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0331</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0331</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0332</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0332</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0333</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0333</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0334</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0334</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0335</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0335</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0336</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0336</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0337</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0337</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0338</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0338</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0339</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0339</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0340</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0340</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0341</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0341</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0342</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0342</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0343</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0343</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0344</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0344</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0345</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0345</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0346</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0346</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0347</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0347</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0348</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0348</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0349</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0281</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0281</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0349</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0350</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0282</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0282</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0350</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0351</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0351</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0352</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0352</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0353</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0353</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0354</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0354</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0355</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0355</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0356</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0283</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0283</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0356</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0357</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0284</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">10450</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">10450</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>2</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0284</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0357</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0358</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0358</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0359</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0359</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0360</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0360</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0361</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0361</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0362</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0362</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0363</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0363</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0364</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0364</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0365</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0365</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0366</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0366</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0367</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0367</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0368</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0368</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0369</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0369</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0370</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0370</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0371</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0371</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0372</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0372</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0373</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0373</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0374</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0374</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0375</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0375</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0376</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0376</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0377</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0377</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0378</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0378</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0379</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0379</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0380</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0380</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0381</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0381</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0382</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0382</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0383</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
+                     <efac:DecisionReason>
+                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                     </efac:DecisionReason>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0383</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotResult>
+                     <cbc:ID schemeName="result">RES-0384</cbc:ID>
+                     <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
+                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0285</cbc:ID>
+                     </efac:LotTender>
+                     <efac:FrameworkAgreementValues>
+                        <cbc:MaximumValueAmount currencyID="EUR">32200</cbc:MaximumValueAmount>
+                        <efbc:ReestimatedValueAmount currencyID="EUR">32200</efbc:ReestimatedValueAmount>
+                     </efac:FrameworkAgreementValues>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-sme</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-micro</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-small</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>1</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-med</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-oth-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-eea</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>3</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-verif-inad-low</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-no-verif</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>0</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:ReceivedSubmissionsStatistics>
+                        <efbc:StatisticsCode listName="received-submission-type">t-esubm</efbc:StatisticsCode>
+                        <efbc:StatisticsNumeric>4</efbc:StatisticsNumeric>
+                     </efac:ReceivedSubmissionsStatistics>
+                     <efac:SettledContract>
+                        <cbc:ID schemeName="contract">CON-0285</cbc:ID>
+                     </efac:SettledContract>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0384</cbc:ID>
+                     </efac:TenderLot>
+                  </efac:LotResult>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0001</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0001</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0002</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0002</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0002</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0003</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0003</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0003</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0004</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0004</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0004</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0005</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0005</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0005</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0006</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0006</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0006</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0007</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0007</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0007</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0008</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0008</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0008</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0009</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0009</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0009</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0010</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0010</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0010</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0011</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0011</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0011</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0012</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0012</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0012</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0013</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0013</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0013</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0014</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0014</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0014</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0015</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0015</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0015</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0016</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0016</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0016</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0017</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0017</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0017</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0018</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0018</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0018</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0019</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0019</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0019</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0020</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0020</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0020</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0021</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0021</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0021</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0022</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0022</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0022</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0023</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0023</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0023</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0024</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0024</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0024</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0025</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0025</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0025</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0026</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0026</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0026</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0027</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0027</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0027</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0028</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0028</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0028</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0029</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0029</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0029</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0030</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0030</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0030</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0031</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0031</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0031</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0032</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0032</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0032</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0034</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0033</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0033</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0035</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0034</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0034</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0036</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0035</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0035</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0037</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0036</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0036</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0038</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0037</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0037</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0039</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0038</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0038</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0040</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0039</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0039</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0041</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0040</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0040</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0042</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0041</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0041</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0043</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0042</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0042</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0044</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0043</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0043</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0045</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0044</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0044</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0046</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0045</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0045</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0047</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0046</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0046</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0048</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0047</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0047</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0049</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0048</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0048</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0050</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0049</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0049</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0051</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0050</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0050</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0052</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0051</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0051</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0053</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0052</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0052</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0054</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0053</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0053</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0055</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0054</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0054</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0056</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0055</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0055</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0057</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0056</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0056</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0058</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0057</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0057</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0059</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0058</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0058</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0060</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0059</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0059</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0061</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0060</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0060</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0062</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0061</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0061</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0063</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0062</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0062</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0064</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0063</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0063</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0065</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0064</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0064</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0066</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0065</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0065</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0067</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0066</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0066</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0068</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0067</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0067</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0069</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0068</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0068</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0070</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0069</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0069</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0071</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0070</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0070</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0072</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0071</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0071</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0073</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0072</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0072</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0074</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0073</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0073</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0075</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0074</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0074</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0076</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0075</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0075</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0077</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0076</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0076</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0078</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0077</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0077</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0079</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0078</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0078</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0080</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0079</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0079</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0082</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0080</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0080</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0083</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0081</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0081</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0084</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0082</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0082</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0085</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0083</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0083</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0086</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0084</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0084</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0087</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0085</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0085</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0088</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0086</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0086</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0089</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0087</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0087</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0090</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0088</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0088</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0091</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0089</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0089</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0092</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0090</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0090</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0093</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0091</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0091</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0094</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0092</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0092</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0095</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0093</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0093</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0096</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0094</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0094</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0097</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0095</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0095</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0098</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0096</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0096</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0099</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0097</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0097</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0100</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0098</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0098</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0101</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0099</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0099</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0102</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0100</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0100</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0103</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0101</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0101</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0104</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0102</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0102</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0105</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0103</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0103</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0106</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0104</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0104</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0107</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0105</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0105</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0108</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0106</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0106</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0109</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0107</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0107</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0110</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0108</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0108</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0112</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0109</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0109</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0113</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0110</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0110</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0114</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0111</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0111</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0115</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0112</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0112</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0116</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0113</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0113</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0117</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0114</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0114</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0118</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0115</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0115</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0119</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0116</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0116</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0120</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0117</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0117</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0121</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0118</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0118</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0122</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0119</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0119</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0123</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0120</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0120</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0124</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0121</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0121</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0125</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0122</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0122</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0126</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0123</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0123</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0127</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0124</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0124</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0128</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0125</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0125</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0129</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0126</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0126</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0130</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0127</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0127</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0131</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0128</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0128</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0132</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0129</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0129</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0133</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0130</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0130</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0135</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0131</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0131</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0136</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0132</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0132</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0137</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0133</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0133</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0138</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0134</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0134</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0139</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0135</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0135</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0140</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0136</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0136</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0141</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0137</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0137</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0142</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0138</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0138</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0143</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0139</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0139</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0144</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0140</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0140</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0145</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0141</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0141</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0146</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0142</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0142</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0147</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0143</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0143</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0148</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0144</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0144</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0150</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0145</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0145</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0151</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0146</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0146</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0152</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0147</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0147</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0153</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0148</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0148</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0154</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0149</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0149</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0155</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0150</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0150</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0156</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0151</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0151</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0157</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0152</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0152</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0159</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0153</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0153</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0160</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0154</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0154</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0161</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0155</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0155</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0162</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0156</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0156</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0163</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0157</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0157</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0164</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0158</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0158</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0165</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0159</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0159</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0166</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0160</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0160</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0167</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0161</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0161</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0168</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0162</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0162</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0169</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0163</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0163</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0170</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0164</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0164</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0171</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0165</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0165</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0172</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0166</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0166</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0174</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0167</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0167</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0176</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0168</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0168</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0177</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0169</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0169</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0178</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0170</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0170</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0179</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0171</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0171</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0180</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0172</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0172</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0182</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0173</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0173</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0183</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0174</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0174</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0184</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0175</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0175</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0185</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0176</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0176</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0186</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0177</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0177</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0187</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0178</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0178</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0188</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0179</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0179</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0189</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0180</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0180</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0190</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0181</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0181</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0191</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0182</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0182</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0192</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0183</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0183</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0193</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0184</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0184</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0194</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0185</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0185</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0195</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0186</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0186</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0196</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0187</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0187</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0197</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0188</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0188</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0200</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0189</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0189</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0201</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0190</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0190</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0202</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0191</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0191</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0203</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0192</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0192</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0204</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0193</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0193</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0205</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0194</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0194</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0206</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0195</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0195</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0207</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0196</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0196</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0208</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0197</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0197</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0209</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0198</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0198</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0210</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0199</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0199</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0211</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0200</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0200</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0212</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0201</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0201</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0213</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0202</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0202</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0214</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0203</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0203</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0215</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0204</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0204</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0216</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0205</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0205</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0217</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0206</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0206</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0218</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0207</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0207</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0219</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0208</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0208</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0220</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0209</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0209</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0221</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0210</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0210</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0222</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0211</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0211</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0223</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0212</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">yes</efbc:TermCode>
+                        <efbc:PercentageKnownIndicator>false</efbc:PercentageKnownIndicator>
+                        <efbc:ValueKnownIndicator>false</efbc:ValueKnownIndicator>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0212</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0224</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0213</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0213</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0225</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0214</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0214</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0226</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0215</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0215</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0227</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0216</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0216</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0228</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0217</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0217</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0229</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0218</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0218</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0230</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0219</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0219</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0231</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0220</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0220</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0232</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0221</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0221</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0234</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0222</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0222</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0235</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0223</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0223</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0236</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0224</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0224</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0237</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0225</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0225</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0238</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0226</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0226</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0239</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0227</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0227</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0240</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0228</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0228</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0241</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0229</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0229</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0242</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0230</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0230</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0243</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0231</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0231</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0244</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0232</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0232</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0245</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0233</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0233</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0246</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0234</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0234</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0247</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0235</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0235</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0248</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0236</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0236</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0249</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0237</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0237</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0250</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0238</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0238</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0252</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0239</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0239</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0253</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0240</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0240</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0255</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0241</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0241</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0256</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0242</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0242</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0257</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0243</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0243</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0258</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0244</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0244</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0259</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0245</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0245</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0260</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0246</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0246</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0261</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0247</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0247</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0262</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0248</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0248</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0263</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0249</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0249</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0264</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0250</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0250</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0265</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0251</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0251</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0266</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0252</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0252</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0267</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0253</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0253</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0268</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0254</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0254</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0269</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0255</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0255</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0271</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0256</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0256</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0272</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0257</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0257</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0273</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0258</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0258</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0274</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0259</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0259</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0275</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0260</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0260</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0276</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0261</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0261</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0277</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0262</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0262</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0278</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0263</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0263</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0281</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0264</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0264</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0282</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0265</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0265</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0284</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0266</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0266</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0285</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0267</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0267</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0286</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0268</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0268</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0287</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0269</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0269</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0288</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0270</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0270</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0289</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0271</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0271</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0290</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0272</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0272</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0291</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0273</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0273</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0295</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0274</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0274</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0296</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0275</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0275</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0297</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0276</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0276</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0298</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0277</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0277</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0299</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0278</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0278</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0300</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0279</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0279</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0301</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0280</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0280</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0303</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0281</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0281</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0349</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0282</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0282</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0350</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0283</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0283</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0356</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0284</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0284</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0357</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:LotTender>
+                     <cbc:ID schemeName="tender">TEN-0285</cbc:ID>
+                     <efac:SubcontractingTerm>
+                        <efbc:TermCode listName="applicability">no</efbc:TermCode>
+                     </efac:SubcontractingTerm>
+                     <efac:TenderingParty>
+                        <cbc:ID schemeName="tendering-party">TPA-0285</cbc:ID>
+                     </efac:TenderingParty>
+                     <efac:TenderLot>
+                        <cbc:ID schemeName="Lot">LOT-0384</cbc:ID>
+                     </efac:TenderLot>
+                     <efac:TenderReference>
+                        <cbc:ID>1</cbc:ID>
+                     </efac:TenderReference>
+                  </efac:LotTender>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0001</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Triamcinolone acetonide ,demeclocycline hydrochloride (Ledermix)</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0001</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0002</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Lidocaini hydrochloridum, Matricariae extractum fluidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0002</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0003</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Omeprazolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0003</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0004</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Pantoprazolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0004</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0005</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Drotaverini hydrochlorium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0005</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0006</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Atropini sulfas </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0006</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0007</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Butylscopolamini bromidum </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0007</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0008</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Metoclopramidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0008</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0009</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ondansetronum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0009</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0010</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Bisacodilum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0010</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0011</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Lactulosum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0011</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0012</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Sorbitolum, Natrii citras, Natrii laurilsulfoacetas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0012</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0013</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Loperamidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0013</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0014</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Insulinum lispro - ātras darbības insulīni, to analogi</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0014</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0015</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Insulinum aspartum - ātras darbības insulīni, to analogi</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0015</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0016</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Insulinum glarginum - garas darbības insulīni, to analogi</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0016</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0017</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Metformini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0017</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0018</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Metformini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0018</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0019</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Thiamini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0019</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0020</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Pyridoxini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0020</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0021</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Calcii gluconas </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0021</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0022</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Heparinum natricum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0022</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0023</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Heparinum natricum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0023</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0024</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Bemiparinum natrium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0024</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0025</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Bemiparinum natrium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0025</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0026</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Nadroparinum calcicum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0026</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0027</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Nadroparinum calcicum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0027</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0028</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Acidum acetylsalicylicum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0028</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0029</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Rivaroxabanum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0029</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0030</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Etamsylatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0030</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0031</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Acidum tranexamicum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0031</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0032</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Phytomenadionum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0032</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0033</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Phytomenadionum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0033</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0034</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Cyanocobolaminum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0034</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0035</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Elektrolītu šķīdums (Ringera) </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0035</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0036</cbc:ID>
+                     <cbc:IssueDate>2023-11-06+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">**Elektrolītu šķīdums (Ringera) </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0036</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0037</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Elektrolītu šķīdums (Ringera) </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0037</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0038</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">**Elektrolītu šķīdums (Ringera) </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0038</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0039</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0039</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0040</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0040</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0041</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Glucosum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0041</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0042</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">**Glucosum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0042</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0043</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Glucosum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0043</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0044</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">**Glucosum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0044</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0045</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Glucosum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0045</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0046</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Glucosum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0046</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0047</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Glucosum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0047</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0048</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Gelatinum succinas, Natrii chloridum, Natrii hydroxidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0048</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0049</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Central emulsija infūzijāmTrīskambaru maisu sistēma ar kopējo tilpumu 493 ml, kas sastāv no glikozes 42% šķīduma, aminoskābes šķīduma ar elektrolītiem un tauku emulsijas, kas bagātināta ar omega 3 taukskābēm, parenterālai barošanai centrālā vēnā. Osmolaritāte 1500 mosmol/l, kopējais enerģijas daudzums 550 kcal.</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0049</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0050</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Peripheral emulsija infūzijām,Trīskambaru maisu sistēma ar kopējo tilpumu 1904 ml, kas sastāv no glikozes 13% šķīduma, aminoskābes šķīduma ar elektrolītiem un tauku emulsijas, kas bagātināta ar omega 3 taukskābēm, parenterālai barošanai perifērā vēnā. Osmolaritāte 850 mosmol/l, kopējais enerģijas daudzums 1300 kcal.</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0050</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0051</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Mannitolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0051</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0052</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Kalii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0052</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0053</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Kalii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0053</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0054</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0054</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0055</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0055</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0056</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0056</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0057</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0057</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0058</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0058</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0059</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0059</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0060</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0060</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0061</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0061</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0062</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0062</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0063</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0063</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0064</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">*Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0064</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0065</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0065</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0066</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0066</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0067</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0067</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0068</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0068</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0069</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Natrii hydrocarbonas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0069</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0070</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Natrii hydrocarbonas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0070</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0071</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Magnesii sulfas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0071</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0072</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Digoxinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0072</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0073</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Amiodaronum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0073</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0074</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Norepinephrinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0074</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0075</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ephedrini hydrohloridum </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0075</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0076</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dopamini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0076</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0077</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dobutaminum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0077</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0078</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Epinephrinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0078</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0079</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Glyceroli trinitras</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0079</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0080</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Meldonium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0080</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0081</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Adenosinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0081</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0082</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ivabradinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0082</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0083</cbc:ID>
+                     <cbc:IssueDate>2023-10-26+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Clonidinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0083</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0084</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Clonidinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0084</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0085</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Furosemidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0085</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0086</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Furosemidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0086</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0087</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Torasemidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0087</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0088</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Spironolactonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0088</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0089</cbc:ID>
+                     <cbc:IssueDate>2023-10-11+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Pentoxifyllinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0089</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0090</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Xylocain</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0090</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0091</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Xylocain</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0091</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0092</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Troxerutinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0092</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0093</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Polidocanolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0093</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0094</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Propranololum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0094</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0095</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Metoprololi tartras</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0095</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0096</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Bisoprololi fumaras</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0096</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0097</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Nebivololum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0097</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0098</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Labetalolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0098</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0099</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Amlodipinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0099</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0100</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Nitrendipinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0100</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0101</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Verapamili hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0101</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0102</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Captoprilum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0102</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0103</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Enalaprilum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0103</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0104</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Enalaprilatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0104</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0105</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Perindoprili argininum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0105</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0106</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Isoconazoli nitras, Diflucortoloni valeras</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0106</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0107</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Zinci oxydum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0107</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0108</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dexpanthenolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0108</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0109</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dexpanthenolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0109</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0110</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Acidum fusidicum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0110</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0111</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Acidum fusidicum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0111</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0112</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Methyluracilum, Lidocainum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0112</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0113</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Methyluracilum, Chloramphenicolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0113</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0114</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Hydrocortisonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0114</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0115</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Fluocinoloni acetonidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0115</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0116</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Fluocinoloni acetonidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0116</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0117</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Acidum boricum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0117</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0118</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Povidonum iodinatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0118</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0119</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Povidonum iodinatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0119</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0120</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Iodum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0120</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0121</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Viride nitens, sp.aethylicus</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0121</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0122</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Hydrogenii peroxidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0122</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0123</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">E vitamīna acetāts, bišu vasks</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0123</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0124</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Desmopressinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0124</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0125</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Oxytocinumum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0125</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0126</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Octreotidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0126</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0127</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dexamethasonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0127</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0128</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dexamethasonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0128</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0129</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Methylprednisoloni acetas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0129</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0130</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Methylprednisolonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0130</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0131</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Prednisolonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0131</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0132</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Hydrocortisonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0132</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0133</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Triamcinoloni acetonidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0133</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0134</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Thiamazolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0134</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0135</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Doxycyclinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0135</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0136</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Amoxicillinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0136</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0137</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Benzylpencillinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0137</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0138</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Amoxicillinum / Acidum clavulanicum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0138</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0139</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Piperacillinum / Tazobactamum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0139</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0140</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Cefazolinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0140</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0141</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ceftriaxonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0141</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0142</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Imipenemum / Cilastatinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0142</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0143</cbc:ID>
+                     <cbc:AwardDate>2023-10-11+02:00</cbc:AwardDate>
+                     <cbc:Title languageID="LAV">Sulfamethoxazolum, Trimethoprimum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0143</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0144</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Erythromycinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0144</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0145</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Erythromycinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0145</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0146</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Erythromycinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0146</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0147</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Gentamicinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0147</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0148</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ciprofloxacinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0148</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0149</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ciprofloxacinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0149</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0150</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ciprofloxacinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0150</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0151</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Metronidazolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0151</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0152</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Fluconazolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0152</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0153</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0153</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0154</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0154</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0155</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0155</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0156</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Viri hepatitidis A inactivatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0156</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0157</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum hepatitidis A inactivatum adsorbatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0157</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0158</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum hepatitidis B (ADNr)</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0158</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0159</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum papillomaviri humani 9-valent, (recombinantum, adsorbatum)</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0159</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0160</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum et poliomyelitidis inactivatum adsorbatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0160</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0161</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum pneumococcale polysaccharidicum coniugatum adsorbatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0161</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0162</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum hepatitidis A inactivatum et hepatitidis B (ADNr) adsorbatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0162</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0163</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Viri rabiei inactivatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0163</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0164</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum diphtheriae et tetani adsorbatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0164</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0165</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum morbillorum, parotitidis et rubellae vivum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0165</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0166</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum, antigeni-o(-is) minutum, adsorbatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0166</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0167</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Methotrexatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0167</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0168</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Mitomycinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0168</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0169</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Doxorubicinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0169</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0170</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Diclofenacum natrium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0170</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0171</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Diclofenacum natrium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0171</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0172</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Diclofenacum natrium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0172</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0173</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ketorolaci trometamolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0173</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0174</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ibuprofenum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0174</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0175</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dexketoprofenum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0175</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0176</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dexketoprofenum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0176</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0177</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Etoricoxibum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0177</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0178</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Suxamethonii chloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0178</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0179</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Atracurii besilas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0179</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0180</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Atracurii besilas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0180</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0181</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Mivacurium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0181</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0182</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Cisatracurium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0182</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0183</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Toxinum A Clostridii botulini haemagglutininum multiplex</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0183</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0184</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tizanidinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0184</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0185</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tolperisonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0185</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0186</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Sevofluranum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0186</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0187</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Thiopentalum natricum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0187</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0188</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Etomidatum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0188</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0189</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Propofolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0189</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0190</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Propofolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0190</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0191</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Bupivacaini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0191</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0192</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Bupivacaini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0192</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0193</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Bupivacaini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0193</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0194</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ropivacaini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0194</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0195</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Lidocaini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0195</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0196</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Lidocaini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0196</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0197</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Lidocaini hydrochloridum, Chlorhexidinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0197</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0198</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Prilocainum, Lidocainum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0198</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0199</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Morphini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0199</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0200</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Fentanylum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0200</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0201</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Trimeperidini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0201</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0202</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tramadoli hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0202</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0203</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tramadoli hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0203</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0204</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tramadoli hydrochloridum, Dexketoprofenum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0204</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0205</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Paracetamolum, Codeini phosphas hemihydricus</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0205</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0206</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Sumatriptanum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0206</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0207</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Metamizolum natricum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0207</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0208</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Metamizolum natricum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0208</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0209</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Acidum acetylsalicylicum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0209</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0210</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Paracetamolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0210</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0211</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Paracetamolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0211</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0212</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Clonazepamum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0212</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0213</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Gabapentinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0213</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0214</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Pregabalinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0214</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0215</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Carbamazepinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0215</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0216</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Trihexyphenidylum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0216</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0217</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Levodopum, Benserazidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0217</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0218</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Haloperidolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0218</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0219</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Haloperidolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0219</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0220</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Melperonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0220</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0221</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Diazepamum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0221</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0222</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Diazepamum (iepakojumā tika pa N10 ampulām)</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0222</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0223</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Bromazepamum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0223</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0224</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Quetiapinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0224</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0225</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Midazolamum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0225</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0226</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Midazolamum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0226</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0227</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Chlorprotixenum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0227</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0228</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Amitriptylinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0228</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0229</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Piracetamum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0229</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0230</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ipidacrinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0230</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0231</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Neostigmini methylsulfas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0231</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0232</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Metronidazolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0232</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0233</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Permethrinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0233</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0234</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Benzylii benzoas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0234</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0235</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Xylomethazolinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0235</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0236</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Xylomethazolinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0236</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0237</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Salbutamoli sulfas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0237</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0238</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Salbutamolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0238</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0239</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Ipratropii bromidum, Fenoteroli hydrobromidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0239</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0240</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Aminophyllinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0240</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0241</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Clemastinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0241</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0242</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Chloropyraminum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0242</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0243</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Chloropyraminum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0243</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0244</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Quifenadini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0244</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0245</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Solutio Ammoniae concentrata</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0245</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0246</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tobramycinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0246</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0247</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tobramycinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0247</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0248</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Acetazolamidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0248</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0249</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Moxifloxacinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0249</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0250</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Diclofenacum Natrium</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0250</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0251</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tobramycinum, Dexamethasonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0251</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0252</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tobramycinum, Dexamethasonum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0252</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0253</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dexamethasonum, Chloramphenicolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0253</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0254</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dexamethasonum, Chloramphenicolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0254</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0255</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Timololum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0255</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0256</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Timololum, Dorzolamidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0256</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0257</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Cyclopentolati hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0257</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0258</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tropicamidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0258</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0259</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Phenylephrinum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0259</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0260</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Proxymetacaini hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0260</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0261</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Dexpanthenolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0261</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0262</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Carbomerum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0262</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0263</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Naloxoni hydrochloridum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0263</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0264</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Protamini sulfas </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0264</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0265</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Natrii thiosulfas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0265</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0266</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Bleu patente</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0266</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0267</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Haemoderivatum deproteinatum sanguinis bovi</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0267</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0268</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Aqua destillata </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0268</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0269</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Aqua destillata </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0269</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0270</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Aqua destillata </cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0270</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0271</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0271</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0272</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0272</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0273</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Iopamidolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0273</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0274</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Gadobutrolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0274</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0275</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Gadobutrolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0275</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0276</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Gadobutrolum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0276</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0277</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Iopromidum</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0277</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0278</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV"> Dinatrii gadoxetas</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0278</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0279</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Granulēts aktivēts sorbents (sorbex)</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0279</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0280</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Spiritus aethylicus 960</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0280</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0281</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Tinctura Leonuri</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0281</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0282</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">TincturaValerianae</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0282</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0283</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Pretaizsvīšanas, pretaprasojuma līdzeklis visu veidu optikas izstrādājumiem, (Ultrastop)</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0283</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0284</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Prontosan -Sastāvā 0,1% undecilēnamidopropilbetaīns, 0,1% poliamīnopropilbiguanīds (poliheksanīds).Nekairinošs, nesausinošs, piemērots atkārtotai un ilgstošai lietošanai. Flakonu iespējams izmantot astoņas nedēļas pēc tā atvēršanas.</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0284</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:SettledContract>
+                     <cbc:ID schemeName="contract">CON-0285</cbc:ID>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="LAV">Enterālās barošanas līdzekļi</cbc:Title>
+                     <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:LotTender>
+                        <cbc:ID schemeName="tender">TEN-0285</cbc:ID>
+                     </efac:LotTender>
+                  </efac:SettledContract>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0001</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0003</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0002</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0004</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0003</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0005</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0004</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0006</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0005</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0007</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0006</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0008</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0007</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0009</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0008</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0010</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0009</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0011</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0010</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0012</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0011</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0013</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0012</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0014</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0013</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0015</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0014</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0016</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0015</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0017</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0016</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0018</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0017</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0019</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0018</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0020</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0019</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0021</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0020</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0022</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0021</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0023</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0022</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0024</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0023</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0025</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0024</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0026</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0025</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0027</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0026</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0028</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0027</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0029</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0028</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0030</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0029</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0031</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0030</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0032</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0031</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0033</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0032</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0034</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0033</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0035</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0034</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0036</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0035</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0037</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0036</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0038</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0037</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0039</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0038</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0040</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0039</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0041</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0040</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0042</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0041</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0043</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0042</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0044</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0043</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0045</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0044</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0046</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0045</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0047</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0046</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0048</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0047</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0049</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0048</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0050</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0049</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0051</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0050</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0052</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0051</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0053</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0052</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0054</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0053</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0055</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0054</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0056</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0055</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0057</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0056</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0058</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0057</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0059</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0058</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0060</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0059</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0061</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0060</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0062</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0061</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0063</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0062</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0064</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0063</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0065</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0064</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0066</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0065</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0067</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0066</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0068</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0067</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0069</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0068</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0070</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0069</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0071</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0070</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0072</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0071</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0073</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0072</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0074</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0073</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0075</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0074</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0076</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0075</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0077</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0076</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0078</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0077</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0079</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0078</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0080</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0079</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0081</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0080</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0082</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0081</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0083</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0082</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0084</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0083</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0085</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0084</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0086</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0085</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0087</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0086</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0088</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0087</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0089</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0088</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0090</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0089</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0091</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0090</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0092</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0091</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0093</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0092</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0094</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0093</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0095</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0094</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0096</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0095</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0097</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0096</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0098</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0097</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0099</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0098</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0100</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0099</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0101</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0100</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0102</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0101</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0103</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0102</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0104</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0103</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0105</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0104</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0106</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0105</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0107</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0106</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0108</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0107</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0109</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0108</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0110</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0109</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0111</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0110</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0112</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0111</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0113</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0112</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0114</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0113</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0115</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0114</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0116</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0115</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0117</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0116</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0118</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0117</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0119</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0118</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0120</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0119</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0121</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0120</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0122</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0121</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0123</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0122</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0124</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0123</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0125</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0124</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0126</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0125</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0127</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0126</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0128</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0127</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0129</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0128</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0130</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0129</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0131</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0130</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0132</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0131</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0133</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0132</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0134</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0133</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0135</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0134</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0136</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0135</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0137</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0136</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0138</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0137</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0139</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0138</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0140</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0139</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0141</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0140</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0142</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0141</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0143</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0142</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0144</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0143</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0145</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0144</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0146</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0145</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0147</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0146</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0148</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0147</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0149</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0148</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0150</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0149</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0151</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0150</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0152</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0151</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0153</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0152</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0154</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0153</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0155</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0154</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0156</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0155</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0157</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0156</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0158</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0157</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0159</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0158</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0160</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0159</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0161</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0160</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0162</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0161</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0163</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0162</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0164</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0163</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0165</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0164</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0166</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0165</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0167</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0166</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0168</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0167</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0169</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0168</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0170</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0169</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0171</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0170</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0172</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0171</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0173</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0172</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0174</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0173</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0175</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0174</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0176</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0175</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0177</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0176</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0178</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0177</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0179</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0178</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0180</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0179</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0181</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0180</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0182</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0181</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0183</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0182</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0184</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0183</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0185</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0184</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0186</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0185</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0187</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0186</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0188</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0187</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0189</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0188</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0190</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0189</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0191</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0190</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0192</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0191</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0193</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0192</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0194</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0193</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0195</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0194</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0196</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0195</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0197</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0196</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0198</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0197</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0199</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0198</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0200</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0199</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0201</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0200</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0202</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0201</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0203</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0202</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0204</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0203</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0205</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0204</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0206</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0205</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0207</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0206</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0208</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0207</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0209</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0208</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0210</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0209</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0211</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0210</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0212</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0211</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0213</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0212</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0214</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0213</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0215</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0214</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0216</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0215</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0217</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0216</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0218</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0217</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0219</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0218</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0220</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0219</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0221</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0220</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0222</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0221</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0223</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0222</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0224</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0223</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0225</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0224</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0226</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0225</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0227</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0226</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0228</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0227</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0229</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0228</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0230</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0229</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0231</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0230</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0232</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0231</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0233</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0232</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0234</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0233</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0235</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0234</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0236</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0235</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0237</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0236</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0238</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0237</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0239</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0238</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0240</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0239</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0241</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0240</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0242</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0241</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0243</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0242</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0244</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0243</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0245</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0244</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0246</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0245</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0247</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0246</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0248</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0247</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0249</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0248</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0250</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0249</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0251</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0250</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0252</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0251</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0253</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0252</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0254</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0253</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0255</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0254</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0256</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0255</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0257</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0256</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0258</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0257</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0259</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0258</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0260</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0259</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0261</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0260</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0262</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0261</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0263</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0262</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0264</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0263</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0265</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0264</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0266</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0265</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0267</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0266</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0268</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0267</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0269</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0268</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0270</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0269</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0271</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0270</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0272</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0271</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0273</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0272</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0274</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0273</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0275</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0274</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0276</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0275</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0277</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0276</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0278</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0277</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0279</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0278</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0280</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0279</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0281</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0280</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0282</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0281</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0283</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0282</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0284</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0283</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0285</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0284</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0286</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+                  <efac:TenderingParty>
+                     <cbc:ID schemeName="tendering-party">TPA-0285</cbc:ID>
+                     <efac:Tenderer>
+                        <cbc:ID schemeName="organization">ORG-0287</cbc:ID>
+                     </efac:Tenderer>
+                  </efac:TenderingParty>
+               </efac:NoticeResult>
+               <efac:NoticeSubType>
+                  <cbc:SubTypeCode>29</cbc:SubTypeCode>
+               </efac:NoticeSubType>
+               <efac:Organizations>
+                  <efac:Organization>
+                     <efac:Company>
+                        <cbc:WebsiteURI>https://www.1slimnica.lv/lv/</cbc:WebsiteURI>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0001</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Rīgas 1.slimnīca”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1001</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003439279</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Name>SIA "Rīgas 1.slimnīca"</cbc:Name>
+                           <cbc:Telephone>+37129439144</cbc:Telephone>
+                           <cbc:ElectronicMail>martins.pukinskis@1slimnica.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0003</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0004</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA "Oribalt Rīga"</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0005</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0006</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0007</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0008</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0009</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0010</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0011</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0012</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Aniss”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 19A</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103098468</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167242233</cbc:Telephone>
+                           <cbc:ElectronicMail>info@aniss.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0013</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1005</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103114438</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167517693</cbc:Telephone>
+                           <cbc:ElectronicMail>med@elpis.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0014</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0015</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0016</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0017</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0018</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0019</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0020</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0021</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0022</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0023</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0024</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0025</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0026</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0027</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0028</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0029</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0030</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0031</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0032</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0033</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0034</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0035</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0036</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0037</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0038</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0039</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0040</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0041</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0042</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0043</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0044</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0045</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0046</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0047</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0048</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0049</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0050</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0051</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0052</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0053</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0054</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0055</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0056</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0057</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0058</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0059</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0060</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0061</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0062</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0063</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0064</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0065</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0066</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0067</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0068</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0069</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0070</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0071</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0072</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0073</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0074</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0075</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0076</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unikmed Baltija”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ģertrūdes iela 33/35 – 2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1011</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40203040440</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37128625172</cbc:Telephone>
+                           <cbc:ElectronicMail>roman@umb.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0077</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unikmed Baltija”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ģertrūdes iela 33/35 – 2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1011</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40203040440</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37128625172</cbc:Telephone>
+                           <cbc:ElectronicMail>roman@umb.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0078</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0079</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0080</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0081</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0082</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
+                           <cbc:CityName>Olaine</cbc:CityName>
+                           <cbc:PostalZone>LV-2114</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003007246</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37129237033</cbc:Telephone>
+                           <cbc:ElectronicMail>aigars.enins@olainfarm.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0083</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0084</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0085</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1005</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103114438</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167517693</cbc:Telephone>
+                           <cbc:ElectronicMail>med@elpis.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0086</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0087</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0088</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
+                           <cbc:CityName>Olaine</cbc:CityName>
+                           <cbc:PostalZone>LV-2114</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003007246</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37129237033</cbc:Telephone>
+                           <cbc:ElectronicMail>aigars.enins@olainfarm.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0089</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0090</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0091</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0092</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1039</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003926635</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167436344</cbc:Telephone>
+                           <cbc:ElectronicMail>vineta.vucane@signamed.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0093</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1039</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003926635</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167436344</cbc:Telephone>
+                           <cbc:ElectronicMail>vineta.vucane@signamed.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0094</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0095</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0096</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
+                           <cbc:CityName>Olaine</cbc:CityName>
+                           <cbc:PostalZone>LV-2114</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003007246</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37129237033</cbc:Telephone>
+                           <cbc:ElectronicMail>aigars.enins@olainfarm.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0097</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0098</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0099</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0100</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0101</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0102</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0103</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1005</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103114438</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167517693</cbc:Telephone>
+                           <cbc:ElectronicMail>med@elpis.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0104</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0105</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0106</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0107</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0108</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0109</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0110</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0111</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0112</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1005</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103114438</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167517693</cbc:Telephone>
+                           <cbc:ElectronicMail>med@elpis.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0113</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0114</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0115</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Aniss”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 19A</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103098468</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167242233</cbc:Telephone>
+                           <cbc:ElectronicMail>info@aniss.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0116</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0117</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0118</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0119</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0120</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0121</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0122</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0123</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0124</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0125</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0126</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0127</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0128</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1005</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103114438</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167517693</cbc:Telephone>
+                           <cbc:ElectronicMail>med@elpis.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0129</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0130</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0131</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0132</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0133</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0134</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0135</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0136</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0137</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0138</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0139</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0140</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0141</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0142</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0143</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0144</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0145</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0146</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0147</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1039</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003926635</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167436344</cbc:Telephone>
+                           <cbc:ElectronicMail>vineta.vucane@signamed.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0148</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0149</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0150</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0151</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0152</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0153</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0154</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0155</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0156</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0157</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1006</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003551465</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167582948</cbc:Telephone>
+                           <cbc:ElectronicMail>marite@vakcinas.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0158</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1006</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003551465</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167582948</cbc:Telephone>
+                           <cbc:ElectronicMail>marite@vakcinas.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0159</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1006</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003551465</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167582948</cbc:Telephone>
+                           <cbc:ElectronicMail>marite@vakcinas.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0160</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1006</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003551465</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167582948</cbc:Telephone>
+                           <cbc:ElectronicMail>marite@vakcinas.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0161</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0162</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1006</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003551465</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167582948</cbc:Telephone>
+                           <cbc:ElectronicMail>marite@vakcinas.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0163</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0164</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1006</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003551465</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167582948</cbc:Telephone>
+                           <cbc:ElectronicMail>marite@vakcinas.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0165</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0166</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0167</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1006</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003551465</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167582948</cbc:Telephone>
+                           <cbc:ElectronicMail>marite@vakcinas.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0168</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1006</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003551465</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167582948</cbc:Telephone>
+                           <cbc:ElectronicMail>marite@vakcinas.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0169</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0170</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1039</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003926635</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167436344</cbc:Telephone>
+                           <cbc:ElectronicMail>vineta.vucane@signamed.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0171</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0172</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0173</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0174</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0175</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0176</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0177</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0178</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0179</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0180</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0181</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1005</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103114438</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167517693</cbc:Telephone>
+                           <cbc:ElectronicMail>med@elpis.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0182</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0183</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0184</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0185</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0186</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0187</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0188</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName> Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0189</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0190</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0191</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma"</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone> LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0192</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0193</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0194</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B, Rīga, LV-1004</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>Rīga</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0195</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0196</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0197</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0198</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “A.Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>arkaļu iela 13a</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1067</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103599415</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37125458388</cbc:Telephone>
+                           <cbc:ElectronicMail>info@amedical.eu</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0199</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Elvim”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Kurzemes prospekts 3G</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1067</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103040641</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167408858</cbc:Telephone>
+                           <cbc:ElectronicMail>market@elvim.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0200</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1005</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103114438</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167517693</cbc:Telephone>
+                           <cbc:ElectronicMail>med@elpis.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0201</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0202</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0203</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0204</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0205</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0206</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0207</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0208</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0209</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0210</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0211</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0212</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0213</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName> Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0214</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0215</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0216</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0217</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>ūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0218</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0219</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0220</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0221</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1005</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103114438</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167517693</cbc:Telephone>
+                           <cbc:ElectronicMail>med@elpis.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0222</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0223</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0224</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1024</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003472521</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167514388</cbc:Telephone>
+                           <cbc:ElectronicMail>tatjana.irgulska@unifarma.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0225</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0226</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0227</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “A.Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Varkaļu iela 13a</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1067</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103599415</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37125458388</cbc:Telephone>
+                           <cbc:ElectronicMail>info@amedical.eu</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0228</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0229</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0230</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0231</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0232</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
+                           <cbc:CityName>Olaine</cbc:CityName>
+                           <cbc:PostalZone>LV-2114</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003007246</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167013803</cbc:Telephone>
+                           <cbc:ElectronicMail>aigars.enins@olainfarm.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0233</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0234</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0235</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0236</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0237</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0238</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0239</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0240</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0241</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0242</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0243</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1039</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003926635</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167436344</cbc:Telephone>
+                           <cbc:ElectronicMail>vineta.vucane@signamed.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0244</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0245</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0246</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
+                           <cbc:CityName>Olaine</cbc:CityName>
+                           <cbc:PostalZone>LV-2114</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003007246</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167013803</cbc:Telephone>
+                           <cbc:ElectronicMail>aigars.enins@olainfarm.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0247</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0248</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0249</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0250</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0251</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0252</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0253</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0254</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0255</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0256</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0257</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0258</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0259</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0260</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0261</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1039</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003926635</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167436344</cbc:Telephone>
+                           <cbc:ElectronicMail>vineta.vucane@signamed.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0262</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0263</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0264</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0265</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0266</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1039</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003926635</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167436344</cbc:Telephone>
+                           <cbc:ElectronicMail>vineta.vucane@signamed.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0267</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Aniss”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 19A</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103098468</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167242233</cbc:Telephone>
+                           <cbc:ElectronicMail>info@aniss.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0268</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1039</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003926635</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167436344</cbc:Telephone>
+                           <cbc:ElectronicMail>vineta.vucane@signamed.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0269</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0270</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0271</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0272</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0273</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0274</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0275</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “A.Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Varkaļu iela 13a</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1067</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40103599415</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37125458388</cbc:Telephone>
+                           <cbc:ElectronicMail>info@amedical.eu</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0276</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0277</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0278</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0279</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0280</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0281</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0282</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0283</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0284</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1004</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003234547</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167626532</cbc:Telephone>
+                           <cbc:ElectronicMail>dzintra.dubinska@recipe.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0285</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1021</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003060393</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167718748</cbc:Telephone>
+                           <cbc:ElectronicMail>ilona.rukke@magnum.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0286</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1064</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>40003277955</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167819549</cbc:Telephone>
+                           <cbc:ElectronicMail>info.lv@bbraun.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
+                     <efac:Company>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0287</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
+                           <cbc:CityName>Mārupe</cbc:CityName>
+                           <cbc:PostalZone>LV-2167</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>50003199991</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Telephone>+37167840822</cbc:Telephone>
+                           <cbc:ElectronicMail>riga@oribalt.com</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+                  <efac:Organization>
+                     <efac:Company>
+                        <cbc:WebsiteURI>https://www.iub.gov.lv</cbc:WebsiteURI>
+                        <cbc:EndpointID>https://www.eis.gov.lv/EKEIS/Supplier/Organizer/472</cbc:EndpointID>
+                        <cac:PartyIdentification>
+                           <cbc:ID>ORG-0002</cbc:ID>
+                        </cac:PartyIdentification>
+                        <cac:PartyName>
+                           <cbc:Name languageID="LAV">Iepirkumu uzraudzības birojs</cbc:Name>
+                        </cac:PartyName>
+                        <cac:PostalAddress>
+                           <cbc:StreetName>Smilšu iela 1</cbc:StreetName>
+                           <cbc:CityName>Rīga</cbc:CityName>
+                           <cbc:PostalZone>LV-1919</cbc:PostalZone>
+                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cac:Country>
+                              <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+                           </cac:Country>
+                        </cac:PostalAddress>
+                        <cac:PartyLegalEntity>
+                           <cbc:CompanyID>90001263305</cbc:CompanyID>
+                        </cac:PartyLegalEntity>
+                        <cac:Contact>
+                           <cbc:Name>Juridiskais departaments</cbc:Name>
+                           <cbc:Telephone>+37122416641</cbc:Telephone>
+                           <cbc:ElectronicMail>pasts@iub.gov.lv</cbc:ElectronicMail>
+                        </cac:Contact>
+                     </efac:Company>
+                  </efac:Organization>
+               </efac:Organizations>
+               <efac:Publication>
+                  <efbc:NoticePublicationID schemeName="ojs-notice-id">00177148-2024</efbc:NoticePublicationID>
+                  <efbc:GazetteID schemeName="ojs-id">60/2024</efbc:GazetteID>
+                  <efbc:PublicationDate>2024-03-25Z</efbc:PublicationDate>
+               </efac:Publication>
+            </efext:EformsExtension>
+         </ext:ExtensionContent>
+      </ext:UBLExtension>
+   </ext:UBLExtensions>
+   <cbc:UBLVersionID>2.3</cbc:UBLVersionID>
+   <cbc:CustomizationID>eforms-sdk-1.10</cbc:CustomizationID>
+   <cbc:ID schemeName="notice-id">e1e0a80a-6a9e-42f4-ae18-e2b8bd91bbde</cbc:ID>
+   <cbc:ContractFolderID>e7902ce8-a88b-4470-9d0e-f4ae0729370c</cbc:ContractFolderID>
+   <cbc:IssueDate>2024-03-22Z</cbc:IssueDate>
+   <cbc:IssueTime>15:29:59Z</cbc:IssueTime>
+   <cbc:VersionID>01</cbc:VersionID>
+   <cbc:RegulatoryDomain>32014L0024</cbc:RegulatoryDomain>
+   <cbc:NoticeTypeCode listName="result">can-standard</cbc:NoticeTypeCode>
+   <cbc:NoticeLanguageCode>LAV</cbc:NoticeLanguageCode>
+   <cac:ContractingParty>
+      <cac:ContractingPartyType>
+         <cbc:PartyTypeCode listName="buyer-legal-type">pub-undert-la</cbc:PartyTypeCode>
+      </cac:ContractingPartyType>
+      <cac:ContractingActivity>
+         <cbc:ActivityTypeCode listName="authority-activity">health</cbc:ActivityTypeCode>
+      </cac:ContractingActivity>
+      <cac:Party>
+         <cac:PartyIdentification>
+            <cbc:ID>ORG-0001</cbc:ID>
+         </cac:PartyIdentification>
+      </cac:Party>
+   </cac:ContractingParty>
+   <cac:TenderingTerms>
+      <cac:ProcurementLegislationDocumentReference>
+         <cbc:ID schemeName="ELI">https://eur-lex.europa.eu/eli/dir/2014/24/oj</cbc:ID>
+      </cac:ProcurementLegislationDocumentReference>
+   </cac:TenderingTerms>
+   <cac:TenderingProcess>
+      <cbc:ProcedureCode listName="procurement-procedure-type">open</cbc:ProcedureCode>
+      <cac:ProcessJustification>
+         <cbc:ProcessReasonCode listName="accelerated-procedure">false</cbc:ProcessReasonCode>
+      </cac:ProcessJustification>
+   </cac:TenderingProcess>
+   <cac:ProcurementProject>
+      <cbc:ID schemeName="InternalID">R1S 2023/17-IEP</cbc:ID>
+      <cbc:Name languageID="LAV">Medikamentu iegāde</cbc:Name>
+      <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+      <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+      <cac:MainCommodityClassification>
+         <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+      </cac:MainCommodityClassification>
+   </cac:ProcurementProject>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0001</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">ord-imp</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>0</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP1</cbc:ID>
+         <cbc:Name languageID="LAV">Polidocanolum, Dialysatum deproteinatum sanguinis vituli</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0002</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP2</cbc:ID>
+         <cbc:Name languageID="LAV">Triamcinolone acetonide ,demeclocycline hydrochloride (Ledermix)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0003</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP3</cbc:ID>
+         <cbc:Name languageID="LAV">Lidocaini hydrochloridum, Matricariae extractum fluidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0004</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP4</cbc:ID>
+         <cbc:Name languageID="LAV">Omeprazolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0005</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP5</cbc:ID>
+         <cbc:Name languageID="LAV">Pantoprazolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0006</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP6</cbc:ID>
+         <cbc:Name languageID="LAV">Drotaverini hydrochlorium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0007</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP7</cbc:ID>
+         <cbc:Name languageID="LAV">Atropini sulfas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0008</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP8</cbc:ID>
+         <cbc:Name languageID="LAV">Butylscopolamini bromidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0009</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP9</cbc:ID>
+         <cbc:Name languageID="LAV">Metoclopramidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0010</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP10</cbc:ID>
+         <cbc:Name languageID="LAV">Ondansetronum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0011</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP11</cbc:ID>
+         <cbc:Name languageID="LAV">Bisacodilum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0012</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP12</cbc:ID>
+         <cbc:Name languageID="LAV">Lactulosum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0013</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP13</cbc:ID>
+         <cbc:Name languageID="LAV">Sorbitolum, Natrii citras, Natrii laurilsulfoacetas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0014</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP14</cbc:ID>
+         <cbc:Name languageID="LAV">Loperamidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0015</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP15</cbc:ID>
+         <cbc:Name languageID="LAV">Insulinum lispro - ātras darbības insulīni, to analogi</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0016</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP16</cbc:ID>
+         <cbc:Name languageID="LAV">Insulinum aspartum - ātras darbības insulīni, to analogi</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0017</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP17</cbc:ID>
+         <cbc:Name languageID="LAV">Insulinum glarginum - garas darbības insulīni, to analogi</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0018</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP18</cbc:ID>
+         <cbc:Name languageID="LAV">Metformini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0019</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP19</cbc:ID>
+         <cbc:Name languageID="LAV">Metformini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0020</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP20</cbc:ID>
+         <cbc:Name languageID="LAV">Thiamini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0021</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP21</cbc:ID>
+         <cbc:Name languageID="LAV">Pyridoxini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0022</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP22</cbc:ID>
+         <cbc:Name languageID="LAV">Calcii gluconas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0023</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP23</cbc:ID>
+         <cbc:Name languageID="LAV">Heparinum natricum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0024</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP24</cbc:ID>
+         <cbc:Name languageID="LAV">Heparinum natricum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0025</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP25</cbc:ID>
+         <cbc:Name languageID="LAV">Bemiparinum natrium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0026</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP26</cbc:ID>
+         <cbc:Name languageID="LAV">Bemiparinum natrium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0027</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP27</cbc:ID>
+         <cbc:Name languageID="LAV">Nadroparinum calcicum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0028</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP28</cbc:ID>
+         <cbc:Name languageID="LAV">Nadroparinum calcicum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0029</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP29</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum acetylsalicylicum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0030</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP30</cbc:ID>
+         <cbc:Name languageID="LAV">Rivaroxabanum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0031</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP31</cbc:ID>
+         <cbc:Name languageID="LAV">Etamsylatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0032</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP32</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum tranexamicum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0033</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP33</cbc:ID>
+         <cbc:Name languageID="LAV">Fibrinogenum humanum, Thrombinum humanum, 4,8cm*4,8cm *0,5cm</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0034</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP34</cbc:ID>
+         <cbc:Name languageID="LAV">Phytomenadionum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0035</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP35</cbc:ID>
+         <cbc:Name languageID="LAV">Phytomenadionum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0036</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP36</cbc:ID>
+         <cbc:Name languageID="LAV">Cyanocobolaminum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0037</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP37</cbc:ID>
+         <cbc:Name languageID="LAV">*Elektrolītu šķīdums (Ringera) </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0038</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP38</cbc:ID>
+         <cbc:Name languageID="LAV">**Elektrolītu šķīdums (Ringera) </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0039</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP39</cbc:ID>
+         <cbc:Name languageID="LAV">*Elektrolītu šķīdums (Ringera) </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0040</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP40</cbc:ID>
+         <cbc:Name languageID="LAV">**Elektrolītu šķīdums (Ringera) </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0041</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP41</cbc:ID>
+         <cbc:Name languageID="LAV">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0042</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP42</cbc:ID>
+         <cbc:Name languageID="LAV">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0043</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP43</cbc:ID>
+         <cbc:Name languageID="LAV">*Glucosum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0044</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP44</cbc:ID>
+         <cbc:Name languageID="LAV">**Glucosum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0045</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP45</cbc:ID>
+         <cbc:Name languageID="LAV">*Glucosum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0046</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP46</cbc:ID>
+         <cbc:Name languageID="LAV">**Glucosum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0047</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP47</cbc:ID>
+         <cbc:Name languageID="LAV">*Glucosum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0048</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP48</cbc:ID>
+         <cbc:Name languageID="LAV">Glucosum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0049</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP49</cbc:ID>
+         <cbc:Name languageID="LAV">Glucosum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0050</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP50</cbc:ID>
+         <cbc:Name languageID="LAV">Gelatinum succinas, Natrii chloridum, Natrii hydroxidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0051</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP51</cbc:ID>
+         <cbc:Name languageID="LAV">Central emulsija infūzijām</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0052</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP52</cbc:ID>
+         <cbc:Name languageID="LAV">Peripheral emulsija infūzijām</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0053</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP53</cbc:ID>
+         <cbc:Name languageID="LAV">*Mannitolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0054</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP54</cbc:ID>
+         <cbc:Name languageID="LAV">Kalii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0055</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP55</cbc:ID>
+         <cbc:Name languageID="LAV">Kalii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0056</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP56</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0057</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP57</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0058</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP58</cbc:ID>
+         <cbc:Name languageID="LAV">*Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0059</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP59</cbc:ID>
+         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0060</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP60</cbc:ID>
+         <cbc:Name languageID="LAV">*Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0061</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP61</cbc:ID>
+         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0062</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP62</cbc:ID>
+         <cbc:Name languageID="LAV">*Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0063</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP63</cbc:ID>
+         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0064</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP64</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0065</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP65</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0066</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP66</cbc:ID>
+         <cbc:Name languageID="LAV">*Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0067</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP67</cbc:ID>
+         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0068</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP68</cbc:ID>
+         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0069</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP69</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0070</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP70</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0071</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP71</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii hydrocarbonas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0072</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP72</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii hydrocarbonas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0073</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP73</cbc:ID>
+         <cbc:Name languageID="LAV">Magnesii sulfas </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0074</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP74</cbc:ID>
+         <cbc:Name languageID="LAV">Digoxinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0075</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP75</cbc:ID>
+         <cbc:Name languageID="LAV">Amiodaronum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0076</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP76</cbc:ID>
+         <cbc:Name languageID="LAV">Norepinephrinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0077</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP77</cbc:ID>
+         <cbc:Name languageID="LAV">Ephedrini hydrohloridum </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0078</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP78</cbc:ID>
+         <cbc:Name languageID="LAV">Dopamini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0079</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP79</cbc:ID>
+         <cbc:Name languageID="LAV">Dobutaminum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0080</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP80</cbc:ID>
+         <cbc:Name languageID="LAV">Epinephrinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0081</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP81</cbc:ID>
+         <cbc:Name languageID="LAV">Glyceroli trinitras</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0082</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP82</cbc:ID>
+         <cbc:Name languageID="LAV">Glyceroli trinitras</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0083</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP83</cbc:ID>
+         <cbc:Name languageID="LAV">Meldonium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0084</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP84</cbc:ID>
+         <cbc:Name languageID="LAV">Adenosinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0085</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP85</cbc:ID>
+         <cbc:Name languageID="LAV">Ivabradinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0086</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP86</cbc:ID>
+         <cbc:Name languageID="LAV">Clonidinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0087</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP87</cbc:ID>
+         <cbc:Name languageID="LAV">Clonidinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0088</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP88</cbc:ID>
+         <cbc:Name languageID="LAV">Furosemidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0089</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP89</cbc:ID>
+         <cbc:Name languageID="LAV">Furosemidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0090</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP90</cbc:ID>
+         <cbc:Name languageID="LAV">Torasemidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0091</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP91</cbc:ID>
+         <cbc:Name languageID="LAV">Spironolactonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0092</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP92</cbc:ID>
+         <cbc:Name languageID="LAV">Pentoxifyllinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0093</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP93</cbc:ID>
+         <cbc:Name languageID="LAV">Xylocain</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0094</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP94</cbc:ID>
+         <cbc:Name languageID="LAV">Xylocain</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0095</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP95</cbc:ID>
+         <cbc:Name languageID="LAV">Troxerutinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0096</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP96</cbc:ID>
+         <cbc:Name languageID="LAV">Polidocanolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0097</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP97</cbc:ID>
+         <cbc:Name languageID="LAV">Propranololum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0098</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP98</cbc:ID>
+         <cbc:Name languageID="LAV">Metoprololi tartras</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0099</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP99</cbc:ID>
+         <cbc:Name languageID="LAV">Bisoprololi fumaras</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0100</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP100</cbc:ID>
+         <cbc:Name languageID="LAV">Nebivololum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0101</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP101</cbc:ID>
+         <cbc:Name languageID="LAV">Labetalolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0102</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP102</cbc:ID>
+         <cbc:Name languageID="LAV">Amlodipinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0103</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP103</cbc:ID>
+         <cbc:Name languageID="LAV">Nitrendipinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0104</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP104</cbc:ID>
+         <cbc:Name languageID="LAV">Verapamili hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0105</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP105</cbc:ID>
+         <cbc:Name languageID="LAV">Captoprilum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0106</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP106</cbc:ID>
+         <cbc:Name languageID="LAV">Enalaprilum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0107</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP107</cbc:ID>
+         <cbc:Name languageID="LAV">Enalaprilatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0108</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP108</cbc:ID>
+         <cbc:Name languageID="LAV">Perindoprili argininum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0109</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP109</cbc:ID>
+         <cbc:Name languageID="LAV">Isoconazoli nitras, Diflucortoloni valeras</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0110</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP110</cbc:ID>
+         <cbc:Name languageID="LAV">Zinci oxydum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0111</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP111</cbc:ID>
+         <cbc:Name languageID="LAV">Sulfathiazolum argentum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0112</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP112</cbc:ID>
+         <cbc:Name languageID="LAV">Dexpanthenolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0113</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP113</cbc:ID>
+         <cbc:Name languageID="LAV">Dexpanthenolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0114</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP114</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum fusidicum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0115</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP115</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum fusidicum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0116</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP116</cbc:ID>
+         <cbc:Name languageID="LAV">Methyluracilum, Lidocainum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0117</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP117</cbc:ID>
+         <cbc:Name languageID="LAV">Methyluracilum, Chloramphenicolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0118</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP118</cbc:ID>
+         <cbc:Name languageID="LAV">Hydrocortisonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0119</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP119</cbc:ID>
+         <cbc:Name languageID="LAV">Fluocinoloni acetonidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0120</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP120</cbc:ID>
+         <cbc:Name languageID="LAV">Fluocinoloni acetonidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0121</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP121</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum boricum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0122</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP122</cbc:ID>
+         <cbc:Name languageID="LAV">Povidonum iodinatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0123</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP123</cbc:ID>
+         <cbc:Name languageID="LAV">Povidonum iodinatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0124</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP124</cbc:ID>
+         <cbc:Name languageID="LAV">Iodum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0125</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP125</cbc:ID>
+         <cbc:Name languageID="LAV">Viride nitens, sp.aethylicus</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0126</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP126</cbc:ID>
+         <cbc:Name languageID="LAV">Hydrogenii peroxidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0127</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP127</cbc:ID>
+         <cbc:Name languageID="LAV">E vitamīna acetāts, bišu vasks</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0128</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP128</cbc:ID>
+         <cbc:Name languageID="LAV">Desmopressinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0129</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP129</cbc:ID>
+         <cbc:Name languageID="LAV">Oxytocinumum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0130</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP130</cbc:ID>
+         <cbc:Name languageID="LAV">Octreotidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0131</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP131</cbc:ID>
+         <cbc:Name languageID="LAV">Dexamethasonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0132</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP132</cbc:ID>
+         <cbc:Name languageID="LAV">Dexamethasonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0133</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP133</cbc:ID>
+         <cbc:Name languageID="LAV">Methylprednisoloni acetas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0134</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP134</cbc:ID>
+         <cbc:Name languageID="LAV">Methylprednisolonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0135</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP135</cbc:ID>
+         <cbc:Name languageID="LAV">Methylprednisolonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0136</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP136</cbc:ID>
+         <cbc:Name languageID="LAV">Prednisolonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0137</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP137</cbc:ID>
+         <cbc:Name languageID="LAV">Hydrocortisonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0138</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP138</cbc:ID>
+         <cbc:Name languageID="LAV">Triamcinoloni acetonidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0139</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP139</cbc:ID>
+         <cbc:Name languageID="LAV">Thiamazolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0140</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP140</cbc:ID>
+         <cbc:Name languageID="LAV">Doxycyclinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0141</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP141</cbc:ID>
+         <cbc:Name languageID="LAV">Amoxicillinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0142</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP142</cbc:ID>
+         <cbc:Name languageID="LAV">Benzylpencillinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0143</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP143</cbc:ID>
+         <cbc:Name languageID="LAV">Amoxicillinum / Acidum clavulanicum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0144</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP144</cbc:ID>
+         <cbc:Name languageID="LAV">Piperacillinum / Tazobactamum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0145</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP145</cbc:ID>
+         <cbc:Name languageID="LAV">Cefazolinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0146</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP146</cbc:ID>
+         <cbc:Name languageID="LAV">Ceftriaxonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0147</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP147</cbc:ID>
+         <cbc:Name languageID="LAV">Imipenemum / Cilastatinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0148</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP148</cbc:ID>
+         <cbc:Name languageID="LAV">Sulfamethoxazolum, Trimethoprimum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0149</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP149</cbc:ID>
+         <cbc:Name languageID="LAV">Sulfamethoxazolum / Trimethoprimum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0150</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP150</cbc:ID>
+         <cbc:Name languageID="LAV">Erythromycinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0151</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP151</cbc:ID>
+         <cbc:Name languageID="LAV">Erythromycinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0152</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP152</cbc:ID>
+         <cbc:Name languageID="LAV">Erythromycinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0153</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP153</cbc:ID>
+         <cbc:Name languageID="LAV">Gentamicinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0154</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP154</cbc:ID>
+         <cbc:Name languageID="LAV">Ciprofloxacinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0155</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP155</cbc:ID>
+         <cbc:Name languageID="LAV">Ciprofloxacinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0156</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP156</cbc:ID>
+         <cbc:Name languageID="LAV">Ciprofloxacinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0157</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP157</cbc:ID>
+         <cbc:Name languageID="LAV">Metronidazolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0158</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP158</cbc:ID>
+         <cbc:Name languageID="LAV">Furaginum solubile</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0159</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP159</cbc:ID>
+         <cbc:Name languageID="LAV">Fluconazolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0160</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP160</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0161</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP161</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0162</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP162</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0163</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP163</cbc:ID>
+         <cbc:Name languageID="LAV">Viri hepatitidis A inactivatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0164</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP164</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum hepatitidis A inactivatum adsorbatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0165</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP165</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum hepatitidis B (ADNr)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0166</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP166</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum papillomaviri humani 9-valent, (recombinantum, adsorbatum)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0167</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP167</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum et poliomyelitidis inactivatum adsorbatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0168</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP168</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum pneumococcale polysaccharidicum coniugatum adsorbatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0169</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP169</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum hepatitidis A inactivatum et hepatitidis B (ADNr) adsorbatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0170</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP170</cbc:ID>
+         <cbc:Name languageID="LAV">Viri rabiei inactivatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0171</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP171</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum diphtheriae et tetani adsorbatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0172</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP172</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum morbillorum, parotitidis et rubellae vivum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0173</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP173</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum varicellae vivum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0174</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP174</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum, antigeni-o(-is) minutum, adsorbatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0175</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP175</cbc:ID>
+         <cbc:Name languageID="LAV">Vaccinum rotaviri vivum perorale</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0176</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP176</cbc:ID>
+         <cbc:Name languageID="LAV">Methotrexatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0177</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP177</cbc:ID>
+         <cbc:Name languageID="LAV">Mitomycinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0178</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP178</cbc:ID>
+         <cbc:Name languageID="LAV">Doxorubicinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0179</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP179</cbc:ID>
+         <cbc:Name languageID="LAV">Diclofenacum natrium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0180</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP180</cbc:ID>
+         <cbc:Name languageID="LAV">Diclofenacum natrium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0181</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP181</cbc:ID>
+         <cbc:Name languageID="LAV">Diclofenacum natrium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0182</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP182</cbc:ID>
+         <cbc:Name languageID="LAV">Diclofenacum natrium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0183</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP183</cbc:ID>
+         <cbc:Name languageID="LAV">Ketorolaci trometamolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0184</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP184</cbc:ID>
+         <cbc:Name languageID="LAV">Ibuprofenum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0185</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP185</cbc:ID>
+         <cbc:Name languageID="LAV">Dexketoprofenum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0186</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP186</cbc:ID>
+         <cbc:Name languageID="LAV">Dexketoprofenum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0187</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP187</cbc:ID>
+         <cbc:Name languageID="LAV">Etoricoxibum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0188</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP188</cbc:ID>
+         <cbc:Name languageID="LAV">Suxamethonii chloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0189</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP189</cbc:ID>
+         <cbc:Name languageID="LAV">Atracurii besilas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0190</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP190</cbc:ID>
+         <cbc:Name languageID="LAV">Atracurii besilas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0191</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP191</cbc:ID>
+         <cbc:Name languageID="LAV">Mivacurium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0192</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP192</cbc:ID>
+         <cbc:Name languageID="LAV">Cisatracurium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0193</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP193</cbc:ID>
+         <cbc:Name languageID="LAV">Toxinum A Clostridii botulini haemagglutininum multiplex</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0194</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP194</cbc:ID>
+         <cbc:Name languageID="LAV">Tizanidinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0195</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP195</cbc:ID>
+         <cbc:Name languageID="LAV">Tolperisonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0196</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP196</cbc:ID>
+         <cbc:Name languageID="LAV">Sevofluranum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0197</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP197</cbc:ID>
+         <cbc:Name languageID="LAV">Thiopentalum natricum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0198</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP198</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii oxybutyras</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0199</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP199</cbc:ID>
+         <cbc:Name languageID="LAV">Ketamini hydrochloridum </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0200</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP200</cbc:ID>
+         <cbc:Name languageID="LAV">Etomidatum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0201</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP201</cbc:ID>
+         <cbc:Name languageID="LAV">Propofolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0202</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP202</cbc:ID>
+         <cbc:Name languageID="LAV">Propofolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0203</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP203</cbc:ID>
+         <cbc:Name languageID="LAV">Bupivacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0204</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP204</cbc:ID>
+         <cbc:Name languageID="LAV">Bupivacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0205</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP205</cbc:ID>
+         <cbc:Name languageID="LAV">Bupivacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0206</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP206</cbc:ID>
+         <cbc:Name languageID="LAV">Ropivacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0207</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP207</cbc:ID>
+         <cbc:Name languageID="LAV">Lidocaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0208</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP208</cbc:ID>
+         <cbc:Name languageID="LAV">Lidocaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0209</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP209</cbc:ID>
+         <cbc:Name languageID="LAV">Lidocaini hydrochloridum, Chlorhexidinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0210</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP210</cbc:ID>
+         <cbc:Name languageID="LAV">Prilocainum, Lidocainum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0211</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP211</cbc:ID>
+         <cbc:Name languageID="LAV">Morphini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0212</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP212</cbc:ID>
+         <cbc:Name languageID="LAV">Fentanylum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0213</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP213</cbc:ID>
+         <cbc:Name languageID="LAV">Trimeperidini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0214</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP214</cbc:ID>
+         <cbc:Name languageID="LAV">Tramadoli hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0215</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP215</cbc:ID>
+         <cbc:Name languageID="LAV">Tramadoli hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0216</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP216</cbc:ID>
+         <cbc:Name languageID="LAV">Tramadoli hydrochloridum, Dexketoprofenum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0217</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP217</cbc:ID>
+         <cbc:Name languageID="LAV">Paracetamolum, Codeini phosphas hemihydricus</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0218</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP218</cbc:ID>
+         <cbc:Name languageID="LAV">Sumatriptanum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0219</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP219</cbc:ID>
+         <cbc:Name languageID="LAV">Metamizolum natricum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0220</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP220</cbc:ID>
+         <cbc:Name languageID="LAV">Metamizolum natricum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0221</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP221</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum acetylsalicylicum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0222</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP222</cbc:ID>
+         <cbc:Name languageID="LAV">Paracetamolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0223</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP223</cbc:ID>
+         <cbc:Name languageID="LAV">Paracetamolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0224</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP224</cbc:ID>
+         <cbc:Name languageID="LAV">Clonazepamum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0225</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP225</cbc:ID>
+         <cbc:Name languageID="LAV">Gabapentinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0226</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP226</cbc:ID>
+         <cbc:Name languageID="LAV">Pregabalinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0227</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP227</cbc:ID>
+         <cbc:Name languageID="LAV">Carbamazepinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0228</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP228</cbc:ID>
+         <cbc:Name languageID="LAV">Trihexyphenidylum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0229</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP229</cbc:ID>
+         <cbc:Name languageID="LAV">Levodopum, Benserazidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0230</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP230</cbc:ID>
+         <cbc:Name languageID="LAV">Haloperidolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0231</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP231</cbc:ID>
+         <cbc:Name languageID="LAV">Haloperidolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0232</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP232</cbc:ID>
+         <cbc:Name languageID="LAV">Melperonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0233</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP233</cbc:ID>
+         <cbc:Name languageID="LAV">Droperidolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0234</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP234</cbc:ID>
+         <cbc:Name languageID="LAV">Diazepamum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0235</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP235</cbc:ID>
+         <cbc:Name languageID="LAV">Diazepamum (iepakojumā tika pa N10 ampulām)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0236</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP236</cbc:ID>
+         <cbc:Name languageID="LAV">Bromazepamum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0237</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP237</cbc:ID>
+         <cbc:Name languageID="LAV">Quetiapinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0238</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP238</cbc:ID>
+         <cbc:Name languageID="LAV">Midazolamum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0239</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP239</cbc:ID>
+         <cbc:Name languageID="LAV">Midazolamum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0240</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP240</cbc:ID>
+         <cbc:Name languageID="LAV">Chlorprotixenum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0241</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP241</cbc:ID>
+         <cbc:Name languageID="LAV">Amitriptylinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0242</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP242</cbc:ID>
+         <cbc:Name languageID="LAV">Piracetamum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0243</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP243</cbc:ID>
+         <cbc:Name languageID="LAV">Ipidacrinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0244</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP244</cbc:ID>
+         <cbc:Name languageID="LAV">Neostigmini methylsulfas </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0245</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP245</cbc:ID>
+         <cbc:Name languageID="LAV">Metronidazolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0246</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP246</cbc:ID>
+         <cbc:Name languageID="LAV">Permethrinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0247</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP247</cbc:ID>
+         <cbc:Name languageID="LAV">Benzylii benzoas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0248</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP248</cbc:ID>
+         <cbc:Name languageID="LAV">Xylomethazolinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0249</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP249</cbc:ID>
+         <cbc:Name languageID="LAV">Xylomethazolinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0250</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP250</cbc:ID>
+         <cbc:Name languageID="LAV">Salbutamoli sulfas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0251</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP251</cbc:ID>
+         <cbc:Name languageID="LAV">Salbutamolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0252</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP252</cbc:ID>
+         <cbc:Name languageID="LAV">Salbutamolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0253</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP253</cbc:ID>
+         <cbc:Name languageID="LAV">Ipratropii bromidum, Fenoteroli hydrobromidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0254</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP254</cbc:ID>
+         <cbc:Name languageID="LAV">Ephedrini hydrohloridum </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0255</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP255</cbc:ID>
+         <cbc:Name languageID="LAV">Aminophyllinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0256</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP256</cbc:ID>
+         <cbc:Name languageID="LAV">Clemastinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0257</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP257</cbc:ID>
+         <cbc:Name languageID="LAV">Chloropyraminum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0258</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP258</cbc:ID>
+         <cbc:Name languageID="LAV">Chloropyraminum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0259</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP259</cbc:ID>
+         <cbc:Name languageID="LAV">Quifenadini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0260</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP260</cbc:ID>
+         <cbc:Name languageID="LAV">Solutio Ammoniae concentrata</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0261</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP261</cbc:ID>
+         <cbc:Name languageID="LAV">Tobramycinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0262</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP262</cbc:ID>
+         <cbc:Name languageID="LAV">Tobramycinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0263</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP263</cbc:ID>
+         <cbc:Name languageID="LAV">Acetazolamidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0264</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP264</cbc:ID>
+         <cbc:Name languageID="LAV">Moxifloxacinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0265</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP265</cbc:ID>
+         <cbc:Name languageID="LAV">Diclofenacum Natrium</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0266</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP266</cbc:ID>
+         <cbc:Name languageID="LAV">Tobramycinum, Dexamethasonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0267</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP267</cbc:ID>
+         <cbc:Name languageID="LAV">Tobramycinum, Dexamethasonum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0268</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP268</cbc:ID>
+         <cbc:Name languageID="LAV">Dexamethasonum, Chloramphenicolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0269</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP269</cbc:ID>
+         <cbc:Name languageID="LAV">Dexamethasonum, Chloramphenicolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0270</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP270</cbc:ID>
+         <cbc:Name languageID="LAV">Pilocarpinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0271</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP271</cbc:ID>
+         <cbc:Name languageID="LAV">Timololum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0272</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP272</cbc:ID>
+         <cbc:Name languageID="LAV">Timololum, Dorzolamidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0273</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP273</cbc:ID>
+         <cbc:Name languageID="LAV">Cyclopentolati hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0274</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP274</cbc:ID>
+         <cbc:Name languageID="LAV">Tropicamidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0275</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP275</cbc:ID>
+         <cbc:Name languageID="LAV">Phenylephrinum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0276</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP276</cbc:ID>
+         <cbc:Name languageID="LAV">Proxymetacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0277</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP277</cbc:ID>
+         <cbc:Name languageID="LAV">Dexpanthenolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0278</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP278</cbc:ID>
+         <cbc:Name languageID="LAV">Carbomerum </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0279</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP279</cbc:ID>
+         <cbc:Name languageID="LAV">Carbachol intaocular solution</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0280</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP280</cbc:ID>
+         <cbc:Name languageID="LAV">Carbacholin</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0281</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP281</cbc:ID>
+         <cbc:Name languageID="LAV">Naloxoni hydrochloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0282</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP282</cbc:ID>
+         <cbc:Name languageID="LAV">Protamini sulfas </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0283</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP283</cbc:ID>
+         <cbc:Name languageID="LAV">Protamini hydrohloridum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0284</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP284</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii thiosulfas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0285</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP285</cbc:ID>
+         <cbc:Name languageID="LAV">Bleu patente</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0286</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP286</cbc:ID>
+         <cbc:Name languageID="LAV">Haemoderivatum deproteinatum sanguinis bovi</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0287</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP287</cbc:ID>
+         <cbc:Name languageID="LAV">Aqua destillata </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0288</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP288</cbc:ID>
+         <cbc:Name languageID="LAV">Aqua destillata </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0289</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP289</cbc:ID>
+         <cbc:Name languageID="LAV">Aqua destillata </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0290</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP290</cbc:ID>
+         <cbc:Name languageID="LAV">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0291</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP291</cbc:ID>
+         <cbc:Name languageID="LAV">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0292</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP292</cbc:ID>
+         <cbc:Name languageID="LAV">Iohexolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0293</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP293</cbc:ID>
+         <cbc:Name languageID="LAV">Iohexolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0294</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP294</cbc:ID>
+         <cbc:Name languageID="LAV">Iohexolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0295</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP295</cbc:ID>
+         <cbc:Name languageID="LAV">Iopamidolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0296</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP296</cbc:ID>
+         <cbc:Name languageID="LAV">Gadobutrolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0297</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP297</cbc:ID>
+         <cbc:Name languageID="LAV">Gadobutrolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0298</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP298</cbc:ID>
+         <cbc:Name languageID="LAV">Gadobutrolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0299</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP299</cbc:ID>
+         <cbc:Name languageID="LAV">Iopromidum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0300</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP300</cbc:ID>
+         <cbc:Name languageID="LAV"> Dinatrii gadoxetas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0301</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP301</cbc:ID>
+         <cbc:Name languageID="LAV">Granulēts aktivēts sorbents (sorbex)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0302</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP302</cbc:ID>
+         <cbc:Name languageID="LAV">Aether (iepakojums 250-1000 ml)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0303</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP303</cbc:ID>
+         <cbc:Name languageID="LAV">Spiritus aethylicus 960</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0304</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP304</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum boricum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0305</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP305</cbc:ID>
+         <cbc:Name languageID="LAV">Barium sulfas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0306</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP306</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum aceticum conc.maks. iepakojums līdz 200 ml</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0307</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena </cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP307</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum hydrochloric. conc.maks. iepak.līdz 100 ml</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0308</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP308</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum nitotinicum maks. iepak.līdz 20g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0309</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP309</cbc:ID>
+         <cbc:Name languageID="LAV">Acidum salicylicum maks. iepak.līdz 1 kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0310</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP310</cbc:ID>
+         <cbc:Name languageID="LAV">Argenti nitras (maks. iepakojumā 10g-20g)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0311</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP311</cbc:ID>
+         <cbc:Name languageID="LAV">Anaesthesinum maks. iepak. līdz 50g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0312</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP312</cbc:ID>
+         <cbc:Name languageID="LAV">Calcii chloridum maks. iepak. līdz 50g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0313</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP313</cbc:ID>
+         <cbc:Name languageID="LAV">Chlorhexidini digluconas maks. iepak. līdz 1L pudelēs</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0314</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP314</cbc:ID>
+         <cbc:Name languageID="LAV">Dermatolum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0315</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP315</cbc:ID>
+         <cbc:Name languageID="LAV">Dicainum (Tetracainum) (maks. iepakojumā 10g-20g)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0316</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP316</cbc:ID>
+         <cbc:Name languageID="LAV">Extractum Thermopsidis maks. iepak. līdz 100g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0317</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP317</cbc:ID>
+         <cbc:Name languageID="LAV">Euphyllinum maks. iepak. līdz 20g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0318</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP318</cbc:ID>
+         <cbc:Name languageID="LAV">Furacillinum maks. iepak. līdz 20g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0319</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP319</cbc:ID>
+         <cbc:Name languageID="LAV">Formaldehydi (maks. iepakojumā līdz 1,5L pudelēs)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0320</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP320</cbc:ID>
+         <cbc:Name languageID="LAV">Glycerinum (maks. iepakojumā līz 1.5 L pudelēs)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0321</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena </cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP321</cbc:ID>
+         <cbc:Name languageID="LAV">Hydrogeni peroxyidi conc.maks. iepak. 1-5 L pudelēs</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0322</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP322</cbc:ID>
+         <cbc:Name languageID="LAV">Ichthyolum maks. iepak. līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0323</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP323</cbc:ID>
+         <cbc:Name languageID="LAV">Iodoformium maks. iepak. līdz 50g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0324</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP324</cbc:ID>
+         <cbc:Name languageID="LAV">Kalii iodidi maks. iepak. līdz 50g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0325</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP325</cbc:ID>
+         <cbc:Name languageID="LAV">Lanolinum maks. iepak. līdz 5 kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0326</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP326</cbc:ID>
+         <cbc:Name languageID="LAV">Laevomycetinum maks. iepak. līdz 20g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0327</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP327</cbc:ID>
+         <cbc:Name languageID="LAV">Methylviolet 1% 50 ml</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0328</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP328</cbc:ID>
+         <cbc:Name languageID="LAV">Methylviolet 1% 100 ml</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0329</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP329</cbc:ID>
+         <cbc:Name languageID="LAV">Methylviolet 2% 50 ml</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0330</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP330</cbc:ID>
+         <cbc:Name languageID="LAV">Methylviolet 2% 100 ml</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0331</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP331</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii acetas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0332</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP332</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii benzoas maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0333</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP333</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii bromidi maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0334</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP334</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii chloridum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0335</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP335</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii hydrocarbonas maks. iepak. līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0336</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP336</cbc:ID>
+         <cbc:Name languageID="LAV">Natrii salicylas</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0337</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP337</cbc:ID>
+         <cbc:Name languageID="LAV">Norsulfasolum</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0338</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP338</cbc:ID>
+         <cbc:Name languageID="LAV">Novocaini hydrochloridum maks. iepak.līdz 50g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0339</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP339</cbc:ID>
+         <cbc:Name languageID="LAV">Oleum Helianthis maks. iepak.līdz 5kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0340</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP340</cbc:ID>
+         <cbc:Name languageID="LAV">Oleum Ricini maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0341</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP341</cbc:ID>
+         <cbc:Name languageID="LAV">Oleum Vaselini maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0342</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP342</cbc:ID>
+         <cbc:Name languageID="LAV">Oleum Olivarum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0343</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP343</cbc:ID>
+         <cbc:Name languageID="LAV">Oleum Caryophylli (maks. iepakojumā 10g-30g)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0344</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP344</cbc:ID>
+         <cbc:Name languageID="LAV">Pix liquda Betulae </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0345</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP345</cbc:ID>
+         <cbc:Name languageID="LAV">Streptocidum maks. iepak.līdz 100g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0346</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP346</cbc:ID>
+         <cbc:Name languageID="LAV">Sulfur praecipitatum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0347</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP347</cbc:ID>
+         <cbc:Name languageID="LAV">Sēra darvas ziede (pix qiquida 50g,sulfuris 50 g,vaselinum 900 g)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0348</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP348</cbc:ID>
+         <cbc:Name languageID="LAV">Talcum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0349</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP349</cbc:ID>
+         <cbc:Name languageID="LAV">Tinctura Leonuri </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0350</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP350</cbc:ID>
+         <cbc:Name languageID="LAV">Tinctura Valerianae</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0351</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP351</cbc:ID>
+         <cbc:Name languageID="LAV">Trilonum B maks. iepak.līdz 100g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0352</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP352</cbc:ID>
+         <cbc:Name languageID="LAV">Vaselinum maks. iepak.līdz 5kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0353</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP353</cbc:ID>
+         <cbc:Name languageID="LAV">Xeroformum maks. iepak.līdz 100g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0354</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP354</cbc:ID>
+         <cbc:Name languageID="LAV">Zinci oxydum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0355</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP355</cbc:ID>
+         <cbc:Name languageID="LAV">Zinci sulfas maks. iepak.līdz 50g</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0356</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP356</cbc:ID>
+         <cbc:Name languageID="LAV">Pretaizsvīšanas, pretaprasojuma līdzeklis visu veidu optikas izstrādājumiem, (Ultrastop)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0357</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP357</cbc:ID>
+         <cbc:Name languageID="LAV">Prontosan -Sastāvā 0,1% undecilēnamidopropilbetaīns, 0,1% poliamīnopropilbiguanīds (poliheksanīds).Nekairinošs, nesausinošs, piemērots atkārtotai un ilgstošai lietošanai. </cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0358</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP358</cbc:ID>
+         <cbc:Name languageID="LAV">Kastellani liq.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0359</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP359</cbc:ID>
+         <cbc:Name languageID="LAV">Kastellani liq.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0360</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP360</cbc:ID>
+         <cbc:Name languageID="LAV">Kastellani liq.sine fuxini</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0361</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP361</cbc:ID>
+         <cbc:Name languageID="LAV">Kastellani liq.sine fuxini</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0362</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP362</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai (penicilīna ar gumijas un metāla korķišiem)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0363</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP363</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0364</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP364</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0365</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP365</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0366</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP366</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0367</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP367</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0368</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP368</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0369</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP369</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0370</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP370</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0371</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP371</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0372</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP372</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0373</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP373</cbc:ID>
+         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu.</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0374</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP374</cbc:ID>
+         <cbc:Name languageID="LAV">Pudeles -stikls flakoni ( ar gumijas un alumīnija vāciņu valcēšanai)</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0375</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP375</cbc:ID>
+         <cbc:Name languageID="LAV">Alumīnija vāciņš (valcēšanai) infūzijas pudelēm</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0376</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP376</cbc:ID>
+         <cbc:Name languageID="LAV">Gumijas aizbāznis infūzijas pudelēm</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0377</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP377</cbc:ID>
+         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0378</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP378</cbc:ID>
+         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0379</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP379</cbc:ID>
+         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0380</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP380</cbc:ID>
+         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0381</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP381</cbc:ID>
+         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0382</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP382</cbc:ID>
+         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0383</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP383</cbc:ID>
+         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:ProcurementProjectLot>
+      <cbc:ID schemeName="Lot">LOT-0384</cbc:ID>
+      <cac:TenderingTerms>
+         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
+         <cac:AwardingTerms>
+            <cac:AwardingCriterion>
+               <cac:SubordinateAwardingCriterion>
+                  <ext:UBLExtensions>
+                     <ext:UBLExtension>
+                        <ext:ExtensionContent>
+                           <efext:EformsExtension>
+                              <efac:AwardCriterionParameter>
+                                 <efbc:ParameterCode listName="number-weight">poi-exa</efbc:ParameterCode>
+                                 <efbc:ParameterNumeric>100</efbc:ParameterNumeric>
+                              </efac:AwardCriterionParameter>
+                           </efext:EformsExtension>
+                        </ext:ExtensionContent>
+                     </ext:UBLExtension>
+                  </ext:UBLExtensions>
+                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
+                  <cbc:Name languageID="LAV">Cena</cbc:Name>
+                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+               </cac:SubordinateAwardingCriterion>
+            </cac:AwardingCriterion>
+         </cac:AwardingTerms>
+         <cac:AdditionalInformationParty>
+            <cac:PartyIdentification>
+               <cbc:ID>ORG-0001</cbc:ID>
+            </cac:PartyIdentification>
+         </cac:AdditionalInformationParty>
+         <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+            </cac:PresentationPeriod>
+            <cac:AppealReceiverParty>
+               <cac:PartyIdentification>
+                  <cbc:ID>ORG-0002</cbc:ID>
+               </cac:PartyIdentification>
+            </cac:AppealReceiverParty>
+         </cac:AppealTerms>
+      </cac:TenderingTerms>
+      <cac:TenderingProcess>
+         <cbc:GovernmentAgreementConstraintIndicator>false</cbc:GovernmentAgreementConstraintIndicator>
+         <cac:AuctionTerms>
+            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
+         </cac:AuctionTerms>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-wo-rc</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+         <cac:ContractingSystem>
+            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
+         </cac:ContractingSystem>
+      </cac:TenderingProcess>
+      <cac:ProcurementProject>
+         <cbc:ID>R1S 2023/17-IEP384</cbc:ID>
+         <cbc:Name languageID="LAV">Enterālās barošanas līdzekļi	</cbc:Name>
+         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:ProcurementAdditionalType>
+            <cbc:ProcurementTypeCode listName="accessibility">n-inc</cbc:ProcurementTypeCode>
+         </cac:ProcurementAdditionalType>
+         <cac:MainCommodityClassification>
+            <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
+         </cac:MainCommodityClassification>
+         <cac:RealizedLocation>
+            <cac:Address>
+               <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+               <cbc:CityName>Rīga</cbc:CityName>
+               <cbc:PostalZone>LV-1001</cbc:PostalZone>
+               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cac:Country>
+                  <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+               </cac:Country>
+            </cac:Address>
+         </cac:RealizedLocation>
+      </cac:ProcurementProject>
+   </cac:ProcurementProjectLot>
+   <cac:TenderResult>
+      <cbc:AwardDate>2000-01-01Z</cbc:AwardDate>
+   </cac:TenderResult>
+</ContractAwardNotice>

From 755a7d5ce222feeff8fc93e3b6b00957ea614cf4 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Thu, 5 Sep 2024 13:53:09 +0200
Subject: [PATCH 11/22] XmlSchemaValidator: Handle element not found in the
 schema (TEDEFO-3707)

Add a validation error instead of failing with a NullPointerException.
---
 .../validator/XmlSchemaValidator.java         | 80 +++++++++++++++----
 1 file changed, 64 insertions(+), 16 deletions(-)

diff --git a/src/main/java/eu/europa/ted/eforms/sdk/analysis/validator/XmlSchemaValidator.java b/src/main/java/eu/europa/ted/eforms/sdk/analysis/validator/XmlSchemaValidator.java
index f852756..38247a5 100644
--- a/src/main/java/eu/europa/ted/eforms/sdk/analysis/validator/XmlSchemaValidator.java
+++ b/src/main/java/eu/europa/ted/eforms/sdk/analysis/validator/XmlSchemaValidator.java
@@ -104,19 +104,43 @@ private void checkFieldRepeatability(Field field) {
     // If the field's relative XPath has several steps, it's the first that must be repeatable
     final QName fieldQName = buildQName(getFirstElementName(field.getXpathRelative()));
 
+    XmlSchemaElement fieldElement = schemaCollection.getElementByQName(fieldQName);
+    if (fieldElement == null) {
+      results.add(new ValidationResult(new FieldFact(field),
+          "XML element corresponding to the field is not present in the schema", ValidationStatusEnum.ERROR));
+      // We can't check repeatability
+      return;
+    }
+
     if (field.getParentNodeId().equals(ROOT_NODE_ID)) {
       // We don't know in which document root(s) the field can appear, so we look at all roots,
       // and if the element corresponding to the field can appear, it must be repeatable
       documentTypes.stream().forEach(dt -> {
         final QName root = new QName(dt.getNamespace(), dt.getRootElement());
-        if (isDefinedUnder(fieldQName, root) && !canElementBeRepeatedUnder(fieldQName, root)) {
+
+        XmlSchemaElement rootElement = schemaCollection.getElementByQName(root);
+        if (rootElement == null) {
+          results.add(new ValidationResult(new FieldFact(field),
+              "XML element corresponding to the root is not present in the schema", ValidationStatusEnum.ERROR));
+          return;
+        }
+    
+        if (isDefinedUnder(fieldQName, root) && !canElementBeRepeatedUnder(fieldElement, rootElement)) {
           results.add(new ValidationResult(new FieldFact(field),
               "Field is repeatable but this is not allowed by the schema", ValidationStatusEnum.ERROR));
         }
       });
     } else {
-      final QName parent = buildQName(getLastElementName(field.getParentNode().getXpathRelative()));
-      if (!canElementBeRepeatedUnder(fieldQName, parent)) {
+      final QName parentQName = buildQName(getLastElementName(field.getParentNode().getXpathRelative()));
+
+      XmlSchemaElement parentElement = schemaCollection.getElementByQName(parentQName);
+      if (parentElement == null) {
+        results.add(new ValidationResult(new FieldFact(field),
+            "XML element corresponding to the parent is not present in the schema", ValidationStatusEnum.ERROR));
+        return;
+      }
+
+      if (!canElementBeRepeatedUnder(fieldElement, parentElement)) {
         results.add(new ValidationResult(new FieldFact(field),
             "Field is repeatable but this is not allowed by the schema", ValidationStatusEnum.ERROR));
       }
@@ -138,19 +162,43 @@ private void checkNodeRepeatability(XmlStructureNode node) {
     // If the node's relative XPath has several steps, it's the first that must be repeatable
     final QName nodeQName = buildQName(getFirstElementName(node.getXpathRelative()));
 
+    XmlSchemaElement nodeElement = schemaCollection.getElementByQName(nodeQName);
+    if (nodeElement == null) {
+      results.add(new ValidationResult(new NodeFact(node),
+          "XML element corresponding to the node is not present in the schema", ValidationStatusEnum.ERROR));
+      // We can't check repeatability
+      return;
+    }
+
     XmlStructureNode parentNode = node.getParent();
 
     if (parentNode.getId().equals(ROOT_NODE_ID)) {
       documentTypes.stream().forEach(dt -> {
         final QName root = new QName(dt.getNamespace(), dt.getRootElement());
-        if (isDefinedUnder(nodeQName, root) && !canElementBeRepeatedUnder(nodeQName, root)) {
+
+        XmlSchemaElement rootElement = schemaCollection.getElementByQName(root);
+        if (rootElement == null) {
           results.add(new ValidationResult(new NodeFact(node),
-              "Field is repeatable but this is not allowed by the schema", ValidationStatusEnum.ERROR));
+              "XML element corresponding to the root is not present in the schema", ValidationStatusEnum.ERROR));
+          return;
+        }
+
+        if (isDefinedUnder(nodeQName, root) && !canElementBeRepeatedUnder(nodeElement, rootElement)) {
+          results.add(new ValidationResult(new NodeFact(node),
+              "Node is repeatable but this is not allowed by the schema", ValidationStatusEnum.ERROR));
         }
       });
     } else {
       final QName parentQName = buildQName(getLastElementName(parentNode.getXpathRelative()));
-      if (!canElementBeRepeatedUnder(nodeQName, parentQName)) {
+      
+      XmlSchemaElement parentElement = schemaCollection.getElementByQName(parentQName);
+      if (parentElement == null) {
+        results.add(new ValidationResult(new NodeFact(node),
+            "XML element corresponding to the parent is not present in the schema", ValidationStatusEnum.ERROR));
+        return;
+      }
+
+      if (!canElementBeRepeatedUnder(nodeElement, parentElement)) {
         results.add(new ValidationResult(new NodeFact(node),
             "Node is repeatable but this is not allowed by the schema", ValidationStatusEnum.ERROR));
       }
@@ -226,23 +274,23 @@ private boolean isDefinedUnder(final QName childQName, final QName parentQName)
     return found;
   }
 
-  /*
-   * Returns true if the elementQName is referenced in the schema somewhere under the type of
-   * parentQName, and this reference has maxOccurs > 1.
+  /**
+   * Returns true if "element" is referenced in the schema somewhere under the type of "parent",
+   * and this reference has maxOccurs > 1.
    * As an element can be at multiple locations in the descendants of a given element, this
-   * will just look at the closest occurence of elementQName.
+   * will just look at the closest occurence of "element".
+   * 
+   * @param element The element to search for.
+   * @param parent  The element under which to search
+   * @return        True if the schema allows "element" to be repeated under "parent"
    */
-  private boolean canElementBeRepeatedUnder(final QName elementQName, final QName parentQName) {
+  private boolean canElementBeRepeatedUnder(final XmlSchemaElement element, final XmlSchemaElement parent) {
     visited = new HashSet<>();
 
-    XmlSchemaElement parent = schemaCollection.getElementByQName(parentQName);
-
-    XmlSchemaElement element = schemaCollection.getElementByQName(elementQName);
-  
     long maxOccurs = findElementMaxOccursUnder(element, parent);
 
     if (maxOccurs < 0) {
-      throw new RuntimeException("Element not found: " + elementQName);
+      throw new RuntimeException("Element not found: " + element.getName());
     }
 
     return (maxOccurs > 1);

From bef1262ab09c9164460d33649b8f0e5a8ee36382 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 6 Sep 2024 16:53:40 +0200
Subject: [PATCH 12/22] pom: Fix property name to be consistent with all
 "version.*" properties

---
 pom.xml | 6 +++---
 1 file changed, 3 insertions(+), 3 deletions(-)

diff --git a/pom.xml b/pom.xml
index 9eae88c..92dc331 100644
--- a/pom.xml
+++ b/pom.xml
@@ -49,7 +49,7 @@
     <version.jackson>2.14.1</version.jackson>
     <version.jaxb-bind-api>4.0.0</version.jaxb-bind-api>
     <version.jaxb-impl>4.0.4</version.jaxb-impl>
-    <jmh.version>1.37</jmh.version>
+    <version.jmh>1.37</version.jmh>
     <version.junit>5.9.2</version.junit>
     <version.logback>1.4.14</version.logback>
     <version.maven-model>3.9.1</version.maven-model>
@@ -168,12 +168,12 @@
       <dependency>
         <groupId>org.openjdk.jmh</groupId>
         <artifactId>jmh-core</artifactId>
-        <version>${jmh.version}</version>
+        <version>${version.jmh}</version>
       </dependency>
       <dependency>
         <groupId>org.openjdk.jmh</groupId>
         <artifactId>jmh-generator-annprocess</artifactId>
-        <version>${jmh.version}</version>
+        <version>${version.jmh}</version>
         <scope>provided</scope>
       </dependency>
       <dependency>

From 30b28eb5d03c55f860505ec2c2a1483b81ee0f9d Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 6 Sep 2024 17:57:57 +0200
Subject: [PATCH 13/22] pom: Remove all optional tags from dependencies

These dependencies are not optional, they are used by all features.
They are included in the full/shaded JAR with all other dependencies
anyways.
---
 pom.xml | 10 ----------
 1 file changed, 10 deletions(-)

diff --git a/pom.xml b/pom.xml
index 92dc331..dbe64a6 100644
--- a/pom.xml
+++ b/pom.xml
@@ -229,7 +229,6 @@
     <dependency>
       <groupId>eu.europa.ted.eforms</groupId>
       <artifactId>eforms-core-java</artifactId>
-      <optional>true</optional>
     </dependency>
     <dependency>
       <groupId>eu.europa.ted.eforms</groupId>
@@ -240,12 +239,10 @@
     <dependency>
       <groupId>org.apache.commons</groupId>
       <artifactId>commons-collections4</artifactId>
-      <optional>true</optional>
     </dependency>
     <dependency>
       <groupId>org.apache.commons</groupId>
       <artifactId>commons-lang3</artifactId>
-      <optional>true</optional>
     </dependency>
 
     <!-- Cucumber -->
@@ -264,29 +261,24 @@
     <dependency>
       <groupId>org.drools</groupId>
       <artifactId>drools-ruleunits-engine</artifactId>
-      <optional>true</optional>
     </dependency>
     <dependency>
       <groupId>org.drools</groupId>
       <artifactId>drools-model-compiler</artifactId>
-      <optional>true</optional>
     </dependency>
 
     <!-- Jackson -->
     <dependency>
       <groupId>com.fasterxml.jackson.core</groupId>
       <artifactId>jackson-annotations</artifactId>
-      <optional>true</optional>
     </dependency>
     <dependency>
       <groupId>com.fasterxml.jackson.core</groupId>
       <artifactId>jackson-core</artifactId>
-      <optional>true</optional>
     </dependency>
     <dependency>
       <groupId>com.fasterxml.jackson.core</groupId>
       <artifactId>jackson-databind</artifactId>
-      <optional>true</optional>
     </dependency>
     <dependency>
       <groupId>com.fasterxml.jackson.datatype</groupId>
@@ -330,7 +322,6 @@
     <dependency>
       <groupId>org.slf4j</groupId>
       <artifactId>slf4j-api</artifactId>
-      <optional>true</optional>
     </dependency>
 
     <!-- Other -->
@@ -355,7 +346,6 @@
     <dependency>
       <groupId>info.picocli</groupId>
       <artifactId>picocli</artifactId>
-      <optional>true</optional>
     </dependency>
     <dependency>
       <groupId>com.helger.schematron</groupId>

From f304ac458e5ad0675c6fe7e246a418926b817bd5 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 6 Sep 2024 18:05:31 +0200
Subject: [PATCH 14/22] pom: Remove dependency on drools-model-compiler

It's a dependency of drools-ruleunits-engine, and we don't use anything
from it directly, so we don't need to have it in our pom.
---
 pom.xml | 4 ----
 1 file changed, 4 deletions(-)

diff --git a/pom.xml b/pom.xml
index dbe64a6..0217fc1 100644
--- a/pom.xml
+++ b/pom.xml
@@ -262,10 +262,6 @@
       <groupId>org.drools</groupId>
       <artifactId>drools-ruleunits-engine</artifactId>
     </dependency>
-    <dependency>
-      <groupId>org.drools</groupId>
-      <artifactId>drools-model-compiler</artifactId>
-    </dependency>
 
     <!-- Jackson -->
     <dependency>

From 38c7d3dc9047cc9de7cf9a422e3c8ebaa8259627 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 6 Sep 2024 18:15:16 +0200
Subject: [PATCH 15/22] pom: Build the full JAR as
 eforms-sdk-analyzer-*-all.jar

Don't replace the original JAR with the full/shaded JAR, but create
the full JAR with the "-all" suffix.
---
 pom.xml | 3 ++-
 1 file changed, 2 insertions(+), 1 deletion(-)

diff --git a/pom.xml b/pom.xml
index 0217fc1..c6dfddf 100644
--- a/pom.xml
+++ b/pom.xml
@@ -442,7 +442,8 @@
             </goals>
             <configuration>
               <createDependencyReducedPom>false</createDependencyReducedPom>
-              <shadedArtifactAttached>false</shadedArtifactAttached>
+              <shadedArtifactAttached>true</shadedArtifactAttached>
+              <shadedClassifierName>all</shadedClassifierName>
               <transformers>
                 <transformer implementation="org.apache.maven.plugins.shade.resource.ApacheLicenseResourceTransformer" />
                 <transformer implementation="org.apache.maven.plugins.shade.resource.ApacheNoticeResourceTransformer" />

From c42b3253ab8d957b6f108e06af43f876b86819c4 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 6 Sep 2024 18:21:55 +0200
Subject: [PATCH 16/22] pom: Remove indication of finalName element

It's is set to the default value, so we actually don't need to specify
it.
---
 pom.xml | 4 ----
 1 file changed, 4 deletions(-)

diff --git a/pom.xml b/pom.xml
index c6dfddf..e34661f 100644
--- a/pom.xml
+++ b/pom.xml
@@ -26,8 +26,6 @@
   </distributionManagement>
 
   <properties>
-    <finalName>${project.artifactId}-${project.version}</finalName>
-
     <project.build.sourceEncoding>UTF-8</project.build.sourceEncoding>
     <project.build.outputTimestamp>2024-07-16T09:10:14Z</project.build.outputTimestamp>
 
@@ -384,8 +382,6 @@
   </repositories>
 
   <build>
-    <finalName>${finalName}</finalName>
-
     <pluginManagement>
       <plugins>
         <plugin>

From 58e77244634cf9152e04cb1150d02cbd32d01b6c Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Mon, 9 Sep 2024 10:44:29 +0200
Subject: [PATCH 17/22] pom: Add metadata required to publish on Maven Central

---
 pom.xml | 26 ++++++++++++++++++++++++--
 1 file changed, 24 insertions(+), 2 deletions(-)

diff --git a/pom.xml b/pom.xml
index e34661f..cb3af82 100644
--- a/pom.xml
+++ b/pom.xml
@@ -7,10 +7,32 @@
   <version>1.13.0-SNAPSHOT</version>
   <packaging>kjar</packaging>
 
-  <name>eforms-sdk-analyzer</name>
+  <name>eForms SDK Analyzer</name>
+  <description>
+    The eForms SDK Analyzer is a command-line application for the static analysis of the content of the eForms SDK.
+    It loads the files from the eForms SDK, and applies various checks and verifications, to try to ensure that their content is correct and consistent.
+  </description>
+  <url>https://docs.ted.europa.eu/eforms/latest/</url>
+
+  <licenses>
+    <license>
+      <name>European Union Public Licence, Version 1.2</name>
+      <url>https://joinup.ec.europa.eu/sites/default/files/custom-page/attachment/2020-03/EUPL-1.2%20EN.txt</url>
+      <distribution>repo</distribution>
+    </license>
+  </licenses>
+
+  <developers>
+    <developer>
+      <name>TED and EU Public Procurement Unit</name>
+      <email>OP-TED-DEVOPS@publications.europa.eu</email>
+      <organization>Publications Office of the European Union</organization>
+      <organizationUrl>https://op.europa.eu/</organizationUrl>
+    </developer>
+  </developers>
 
   <scm>
-    <connection>scm:git:https://github.com/OP-TED/eforms-sdk-analyzer.git</connection>
+    <connection>scm:git:git://github.com/OP-TED/eforms-sdk-analyzer.git</connection>
     <url>https://github.com/OP-TED/eforms-sdk-analyzer</url>
   </scm>
 

From 6b32217d069308f78ac131f04424d1c612a7ed35 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Mon, 9 Sep 2024 15:49:45 +0200
Subject: [PATCH 18/22] pom: Update to publish to Maven Central

---
 pom.xml | 116 +++++++++++++++++++++++++++++++++++++++++++++++++++++---
 1 file changed, 110 insertions(+), 6 deletions(-)

diff --git a/pom.xml b/pom.xml
index cb3af82..6f5af56 100644
--- a/pom.xml
+++ b/pom.xml
@@ -37,13 +37,13 @@
   </scm>
 
   <distributionManagement>
+    <snapshotRepository>
+      <id>ossrh</id>
+      <url>https://${sonatype.server.url}/content/repositories/snapshots</url>
+    </snapshotRepository>
     <repository>
-      <id>github</id>
-      <name>GitHub Packages</name>
-      <url>https://maven.pkg.github.com/OP-TED/eforms-sdk-analyzer</url>
-      <snapshots>
-        <enabled>true</enabled>
-      </snapshots>
+      <id>ossrh</id>
+      <url>https://${sonatype.server.url}/service/local/staging/deploy/maven2/</url>
     </repository>
   </distributionManagement>
 
@@ -51,6 +51,8 @@
     <project.build.sourceEncoding>UTF-8</project.build.sourceEncoding>
     <project.build.outputTimestamp>2024-07-16T09:10:14Z</project.build.outputTimestamp>
 
+    <sonatype.server.url>s01.oss.sonatype.org</sonatype.server.url>
+
     <java.version>11</java.version>
 
     <maven.compiler.release>${java.version}</maven.compiler.release>
@@ -82,6 +84,11 @@
     <!-- Versions - Plugins -->
     <version.compiler.plugin>3.13.0</version.compiler.plugin>
     <version.shade.plugin>3.6.0</version.shade.plugin>
+    <version.gpg.plugin>3.2.5</version.gpg.plugin>
+    <version.javadoc.plugin>3.10.0</version.javadoc.plugin>
+    <version.source.plugin>3.3.1</version.source.plugin>
+    <version.surefire.plugin>3.2.5</version.surefire.plugin>
+    <version.nexus-staging.plugin>1.6.14</version.nexus-staging.plugin>
   </properties>
 
   <dependencyManagement>
@@ -411,16 +418,44 @@
           <artifactId>maven-compiler-plugin</artifactId>
           <version>${version.compiler.plugin}</version>
         </plugin>
+        <plugin>
+          <artifactId>maven-surefire-plugin</artifactId>
+          <version>${version.surefire.plugin}</version>
+        </plugin>
+        <plugin>
+          <artifactId>maven-install-plugin</artifactId>
+          <version>${version.install.plugin}</version>
+        </plugin>
         <plugin>
           <groupId>org.apache.maven.plugins</groupId>
           <artifactId>maven-shade-plugin</artifactId>
           <version>${version.shade.plugin}</version>
         </plugin>
+        <plugin>
+          <groupId>org.apache.maven.plugins</groupId>
+          <artifactId>maven-source-plugin</artifactId>
+          <version>${version.source.plugin}</version>
+        </plugin>
+        <plugin>
+          <groupId>org.apache.maven.plugins</groupId>
+          <artifactId>maven-javadoc-plugin</artifactId>
+          <version>${version.javadoc.plugin}</version>
+        </plugin>
+        <plugin>
+          <groupId>org.apache.maven.plugins</groupId>
+          <artifactId>maven-gpg-plugin</artifactId>
+          <version>${version.gpg.plugin}</version>
+        </plugin>
         <plugin>
           <groupId>org.kie</groupId>
           <artifactId>kie-maven-plugin</artifactId>
           <version>${version.drools}</version>
         </plugin>
+        <plugin>
+          <groupId>org.sonatype.plugins</groupId>
+          <artifactId>nexus-staging-maven-plugin</artifactId>
+          <version>${version.nexus-staging.plugin}</version>
+        </plugin>
       </plugins>
     </pluginManagement>
 
@@ -430,6 +465,7 @@
         <artifactId>kie-maven-plugin</artifactId>
         <extensions>true</extensions>
       </plugin>
+
       <plugin>
         <groupId>org.apache.maven.plugins</groupId>
         <artifactId>maven-compiler-plugin</artifactId>
@@ -448,6 +484,7 @@
           </annotationProcessorPaths>
         </configuration>
       </plugin>
+
       <plugin>
         <groupId>org.apache.maven.plugins</groupId>
         <artifactId>maven-shade-plugin</artifactId>
@@ -502,4 +539,71 @@
       </plugin>
     </plugins>
   </build>
+
+
+  <profiles>
+    <profile>
+      <!-- Profile "release" caters to the requirements for releasing to Maven Central -->
+      <id>release</id>
+
+      <build>
+        <plugins>
+          <plugin>
+            <groupId>org.apache.maven.plugins</groupId>
+            <artifactId>maven-source-plugin</artifactId>
+            <executions>
+              <execution>
+                <id>attach-sources</id>
+                <goals>
+                  <goal>jar-no-fork</goal>
+                </goals>
+              </execution>
+            </executions>
+          </plugin>
+          <plugin>
+            <groupId>org.apache.maven.plugins</groupId>
+            <artifactId>maven-javadoc-plugin</artifactId>
+            <executions>
+              <execution>
+                <id>attach-javadocs</id>
+                <goals>
+                  <goal>jar</goal>
+                </goals>
+              </execution>
+            </executions>
+          </plugin>
+          <plugin>
+            <groupId>org.apache.maven.plugins</groupId>
+            <artifactId>maven-gpg-plugin</artifactId>
+            <executions>
+              <execution>
+                <id>sign-artifacts</id>
+                <phase>verify</phase>
+                <goals>
+                  <goal>sign</goal>
+                </goals>
+              </execution>
+            </executions>
+            <configuration>
+              <!-- Prevent gpg from using pinentry programs -->
+              <gpgArguments>
+                <arg>--pinentry-mode</arg>
+                <arg>loopback</arg>
+              </gpgArguments>
+            </configuration>
+          </plugin>
+           <plugin>
+              <groupId>org.sonatype.plugins</groupId>
+              <artifactId>nexus-staging-maven-plugin</artifactId>
+              <extensions>true</extensions>
+              <configuration>
+                <serverId>ossrh</serverId>
+                <nexusUrl>https://${sonatype.server.url}/</nexusUrl>
+                <autoReleaseAfterClose>true</autoReleaseAfterClose>
+              </configuration>
+           </plugin>
+        </plugins>
+      </build>
+    </profile>
+  </profiles>
 </project>

From f34da6e03cddcd445ef9ba9845ad0a834a26d74a Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Mon, 9 Sep 2024 15:50:59 +0200
Subject: [PATCH 19/22] workflows: Update publish workflow to publish on Maven
 Central

---
 .github/workflows/publish.yml | 24 ++++++++++++++++++------
 1 file changed, 18 insertions(+), 6 deletions(-)

diff --git a/.github/workflows/publish.yml b/.github/workflows/publish.yml
index b6d711b..d964a08 100644
--- a/.github/workflows/publish.yml
+++ b/.github/workflows/publish.yml
@@ -1,4 +1,5 @@
-name: Publish package to GitHub Packages
+name: Publish package to the Maven Central Repository
+
 on:
   push:
     branches:
@@ -15,14 +16,25 @@ jobs:
     runs-on: ubuntu-latest
     permissions:
       contents: read
-      packages: write
     steps:
       - uses: actions/checkout@v4
-      - uses: actions/setup-java@v4
+      - name: Import GPG Key
+        uses: crazy-max/ghaction-import-gpg@v6
+        with:
+          gpg_private_key: ${{ secrets.GPG_PRIVATE_KEY }}
+          passphrase: ${{ secrets.GPG_PASSPHRASE }}
+      - name: Set up Java for publishing to Maven Central Repository
+        uses: actions/setup-java@v4
         with:
           java-version: '11'
           distribution: 'adopt'
-      - name: Publish package
-        run: mvn --batch-mode deploy
+          server-id: ossrh
+          server-username: MAVEN_USERNAME
+          server-password: MAVEN_PASSWORD
+      - name: Publish to the Maven Central Repository
+        run: mvn --batch-mode deploy -Prelease
         env:
-          GITHUB_TOKEN: ${{ secrets.GITHUB_TOKEN }}
+          MAVEN_GPG_PASSPHRASE: ${{ secrets.GPG_PASSPHRASE }}
+          MAVEN_USERNAME: ${{ secrets.OSSRH_USERNAME }}
+          MAVEN_PASSWORD: ${{ secrets.OSSRH_TOKEN }}
+

From 4203d364b1c99e723881141aef52a95cd9dac049 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Mon, 9 Sep 2024 16:18:10 +0200
Subject: [PATCH 20/22] pom: Add missing install plugin version

---
 pom.xml | 1 +
 1 file changed, 1 insertion(+)

diff --git a/pom.xml b/pom.xml
index 6f5af56..e8fddf3 100644
--- a/pom.xml
+++ b/pom.xml
@@ -85,6 +85,7 @@
     <version.compiler.plugin>3.13.0</version.compiler.plugin>
     <version.shade.plugin>3.6.0</version.shade.plugin>
     <version.gpg.plugin>3.2.5</version.gpg.plugin>
+    <version.install.plugin>3.1.3</version.install.plugin>
     <version.javadoc.plugin>3.10.0</version.javadoc.plugin>
     <version.source.plugin>3.3.1</version.source.plugin>
     <version.surefire.plugin>3.2.5</version.surefire.plugin>

From 792f929308ae19117c591f187df3ae85c70649d9 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Fri, 4 Oct 2024 17:01:33 +0200
Subject: [PATCH 21/22] benchmark: Update notices used in the benchmark

Use a notice with more lots for subtype 16, so that any slowdown is more
noticeable.

Update both notices to SDK 1.13.0, and fix most validation failures.
---
 src/main/resources/benchmark/notices/16.xml | 76814 +++++++++++++++++-
 src/main/resources/benchmark/notices/29.xml |  7972 +-
 2 files changed, 79583 insertions(+), 5203 deletions(-)

diff --git a/src/main/resources/benchmark/notices/16.xml b/src/main/resources/benchmark/notices/16.xml
index bfec3f0..a9f1bcf 100644
--- a/src/main/resources/benchmark/notices/16.xml
+++ b/src/main/resources/benchmark/notices/16.xml
@@ -70,8 +70,8 @@
       </ext:UBLExtension>
    </ext:UBLExtensions>
    <cbc:UBLVersionID>2.3</cbc:UBLVersionID>
-   <cbc:CustomizationID>eforms-sdk-1.10</cbc:CustomizationID>
-   <cbc:ID schemeName="notice-id">0491ebbe-4e45-4c38-8a4e-722a5159d809</cbc:ID>
+   <cbc:CustomizationID>eforms-sdk-1.13</cbc:CustomizationID>
+   <cbc:ID schemeName="notice-id">0491ebbe-4e85-4c38-8a4e-722a5158d809</cbc:ID>
    <cbc:ContractFolderID>b47fd31a-a9e4-4680-a50d-0e577ffcbdf3</cbc:ContractFolderID>
    <cbc:IssueDate>2023-12-14Z</cbc:IssueDate>
    <cbc:IssueTime>07:37:54Z</cbc:IssueTime>
@@ -94,18 +94,24 @@
       </cac:Party>
    </cac:ContractingParty>
    <cac:TenderingTerms>
-      <cac:TendererQualificationRequest>
-         <cac:SpecificTendererRequirement>
-            <cbc:TendererRequirementTypeCode listName="exclusion-ground">corruption</cbc:TendererRequirementTypeCode>
-            <cbc:Description languageID="ENG">If any of the participants are corrupted then they are excluded from the tendering process</cbc:Description>
-         </cac:SpecificTendererRequirement>
-      </cac:TendererQualificationRequest>
+	<cac:TendererQualificationRequest>
+		<cac:SpecificTendererRequirement>
+			<cbc:TendererRequirementTypeCode listName="exclusion-grounds-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+		</cac:SpecificTendererRequirement>
+	</cac:TendererQualificationRequest>
+	<cac:LotDistribution>
+		<cbc:MaximumLotsAwardedNumeric>2</cbc:MaximumLotsAwardedNumeric>
+		<cbc:MaximumLotsSubmittedNumeric>2</cbc:MaximumLotsSubmittedNumeric>
+	</cac:LotDistribution>
    </cac:TenderingTerms>
    <cac:TenderingProcess>
       <cbc:ProcedureCode listName="procurement-procedure-type">open</cbc:ProcedureCode>
+	  <cac:ProcessJustification>
+		<cbc:ProcessReasonCode listName="accelerated-procedure">false</cbc:ProcessReasonCode>
+	  </cac:ProcessJustification>
    </cac:TenderingProcess>
    <cac:ProcurementProject>
-      <cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+      <cbc:Name languageID="ENG">Poor Things</cbc:Name>
       <cbc:Description languageID="ENG">Poor Things is a 2023 surrealist[3] steampunk[4][5] black comedy film directed by Yorgos Lanthimos from a screenplay by Tony McNamara.[6] It is based on the 1992 novel of the same name by Alasdair Gray, and stars Emma Stone alongside Mark Ruffalo, Willem Dafoe, Ramy Youssef, Christopher Abbott, and Jerrod Carmichael. The plot follows a young Victorian woman who, after being crudely resurrected by a scientist following her suicide, runs off with a debauched lawyer to embark on an odyssey of self-discovery and sexual liberation.
 Development on the film began as early as 2009, when Lanthimos visited Gray in his Scotland home to acquire the rights to the novel. Following a period in development hell, the director revisited Poor Things while filming The Favourite (2018), which starred Stone, and approached her with the lead role. The remaining cast joined the project in 2021, with principal photography occurring in Hungary from August to December of that year.
 Poor Things premiered at the 80th Venice International Film Festival on September 1, 2023, where it won the Golden Lion. The film is scheduled to be theatrically released by Searchlight Pictures in the United States on December 8, 2023, and in the United Kingdom on January 12, 2024.</cbc:Description>
@@ -113,6 +119,14 @@ Poor Things premiered at the 80th Venice International Film Festival on Septembe
       <cac:MainCommodityClassification>
          <cbc:ItemClassificationCode listName="cpv">50000000</cbc:ItemClassificationCode>
       </cac:MainCommodityClassification>
+	  <cac:RealizedLocation>
+		<cac:Address>
+			<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+			<cac:Country>
+				<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+			</cac:Country>
+		</cac:Address>
+	 </cac:RealizedLocation>
    </cac:ProcurementProject>
     <cac:ProcurementProjectLot>
       <cbc:ID schemeName="Lot">LOT-0001</cbc:ID>
@@ -143,6 +157,11 @@ Poor Things premiered at the 80th Venice International Film Festival on Septembe
                <cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
             </cac:SpecificTendererRequirement>
          </cac:TendererQualificationRequest>
+		 <cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+		 </cac:TendererQualificationRequest>
          <cac:ContractExecutionRequirement>
             <cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
          </cac:ContractExecutionRequirement>
@@ -152,7 +171,19 @@ Poor Things premiered at the 80th Venice International Film Festival on Septembe
          <cac:ContractExecutionRequirement>
             <cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
          </cac:ContractExecutionRequirement>
-         <cac:AppealTerms>
+         <cac:TenderRecipientParty>
+			<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+			<cac:PartyIdentification>
+				<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+			</cac:PartyIdentification>
+		 </cac:TenderRecipientParty>
+		 <cac:TenderValidityPeriod>
+			<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+		 </cac:TenderValidityPeriod>
+		 <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+            </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
                   <cbc:ID>TPO-0001</cbc:ID>
@@ -168,7 +199,7 @@ Poor Things premiered at the 80th Venice International Film Festival on Septembe
          </cac:PostAwardProcess>
       </cac:TenderingTerms>
       <cac:TenderingProcess>
-         <cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+         <cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
          <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
          <cac:TenderSubmissionDeadlinePeriod>
             <cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -177,6 +208,9 @@ Poor Things premiered at the 80th Venice International Film Festival on Septembe
          <cac:AuctionTerms>
             <cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
          </cac:AuctionTerms>
+		 <cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+		 </cac:FrameworkAgreement>
          <cac:ContractingSystem>
             <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
          </cac:ContractingSystem>
@@ -186,7 +220,7 @@ Poor Things premiered at the 80th Venice International Film Festival on Septembe
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>ABE LOT-0001</cbc:ID>
-         <cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+         <cbc:Name languageID="ENG">Poor Things</cbc:Name>
          <cbc:Description languageID="ENG">Premise
 A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
 Development
@@ -198,6 +232,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
          <cac:MainCommodityClassification>
             <cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
          </cac:MainCommodityClassification>
+		 <cac:RealizedLocation>
+			<cac:Address>
+				<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+				<cac:Country>
+					<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+				</cac:Country>
+			</cac:Address>
+		 </cac:RealizedLocation>
          <cac:PlannedPeriod>
             <cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
          </cac:PlannedPeriod>
@@ -232,6 +274,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
                <cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
             </cac:SpecificTendererRequirement>
          </cac:TendererQualificationRequest>
+		 <cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+		 </cac:TendererQualificationRequest>
          <cac:ContractExecutionRequirement>
             <cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
          </cac:ContractExecutionRequirement>
@@ -241,7 +288,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
          <cac:ContractExecutionRequirement>
             <cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
          </cac:ContractExecutionRequirement>
-         <cac:AppealTerms>
+         <cac:TenderRecipientParty>
+			<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+			<cac:PartyIdentification>
+				<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+			</cac:PartyIdentification>
+		 </cac:TenderRecipientParty>
+		 <cac:TenderValidityPeriod>
+			<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+		 </cac:TenderValidityPeriod>
+		 <cac:AppealTerms>
+            <cac:PresentationPeriod>
+               <cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+            </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
                   <cbc:ID>TPO-0001</cbc:ID>
@@ -257,7 +316,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
          </cac:PostAwardProcess>
       </cac:TenderingTerms>
       <cac:TenderingProcess>
-         <cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+         <cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
          <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
          <cac:TenderSubmissionDeadlinePeriod>
             <cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -266,6 +325,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
          <cac:AuctionTerms>
             <cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
          </cac:AuctionTerms>
+		 <cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+		 </cac:FrameworkAgreement>
          <cac:ContractingSystem>
             <cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
          </cac:ContractingSystem>
@@ -275,7 +337,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>ABE LOT-0002</cbc:ID>
-         <cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+         <cbc:Name languageID="ENG">Poor Things</cbc:Name>
          <cbc:Description languageID="ENG">Premise
 A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
 Development
@@ -287,6 +349,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
          <cac:MainCommodityClassification>
             <cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
          </cac:MainCommodityClassification>
+		 <cac:RealizedLocation>
+			<cac:Address>
+				<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+				<cac:Country>
+					<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+				</cac:Country>
+			</cac:Address>
+		 </cac:RealizedLocation>
          <cac:PlannedPeriod>
             <cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
          </cac:PlannedPeriod>
@@ -321,6 +391,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -330,7 +405,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -346,7 +433,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -355,6 +442,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -364,7 +454,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0003</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -378,6 +468,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -412,6 +510,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -421,7 +524,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -437,7 +552,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -446,6 +561,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -455,7 +573,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0004</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -469,6 +587,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -503,6 +629,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -512,7 +643,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -528,7 +671,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -537,6 +680,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -546,7 +692,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0005</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -560,6 +706,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -594,6 +748,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -603,7 +762,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -619,7 +790,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -628,6 +799,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -637,7 +811,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0006</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -651,6 +825,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -685,6 +867,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -694,7 +881,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -710,7 +909,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -719,6 +918,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -728,7 +930,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0007</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -742,6 +944,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -776,6 +986,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -785,7 +1000,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -801,7 +1028,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -810,6 +1037,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -819,7 +1049,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0008</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -833,6 +1063,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -867,6 +1105,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -876,7 +1119,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -892,7 +1147,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -901,6 +1156,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -910,7 +1168,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0009</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -924,6 +1182,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -958,6 +1224,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -967,7 +1238,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -983,7 +1266,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -992,6 +1275,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1001,7 +1287,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0010</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1015,6 +1301,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1049,6 +1343,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1058,7 +1357,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1074,7 +1385,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1083,6 +1394,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1092,7 +1406,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0011</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1106,6 +1420,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1140,6 +1462,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1149,7 +1476,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1165,7 +1504,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1174,6 +1513,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1183,7 +1525,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0012</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1197,6 +1539,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1231,6 +1581,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1240,7 +1595,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1256,7 +1623,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1265,6 +1632,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1274,7 +1644,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0013</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1288,6 +1658,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1322,6 +1700,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1331,7 +1714,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1347,7 +1742,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1356,6 +1751,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1365,7 +1763,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0014</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1379,6 +1777,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1413,6 +1819,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1422,7 +1833,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1438,7 +1861,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1447,6 +1870,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1456,7 +1882,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0015</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1470,6 +1896,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1504,6 +1938,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1513,7 +1952,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1529,7 +1980,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1538,6 +1989,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1547,7 +2001,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0016</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1561,6 +2015,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1595,6 +2057,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1604,7 +2071,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1620,7 +2099,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1629,6 +2108,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1638,7 +2120,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0017</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1652,6 +2134,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1686,6 +2176,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1695,7 +2190,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1711,7 +2218,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1720,6 +2227,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1729,7 +2239,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0018</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1743,6 +2253,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1777,6 +2295,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1786,7 +2309,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1802,7 +2337,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1811,6 +2346,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1820,7 +2358,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0019</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1834,6 +2372,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1868,6 +2414,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1877,7 +2428,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1893,7 +2456,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1902,6 +2465,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -1911,7 +2477,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0020</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -1925,6 +2491,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -1959,6 +2533,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -1968,7 +2547,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -1984,7 +2575,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -1993,6 +2584,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2002,7 +2596,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0021</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2016,6 +2610,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2050,6 +2652,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2059,7 +2666,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2075,7 +2694,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2084,6 +2703,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2093,7 +2715,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0022</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2107,6 +2729,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2141,6 +2771,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2150,7 +2785,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2166,7 +2813,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2175,6 +2822,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2184,7 +2834,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0023</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2198,6 +2848,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2232,6 +2890,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2241,7 +2904,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2257,7 +2932,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2266,6 +2941,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2275,7 +2953,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0024</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2289,6 +2967,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2323,6 +3009,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2332,7 +3023,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2348,7 +3051,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2357,6 +3060,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2366,7 +3072,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0025</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2380,6 +3086,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2414,6 +3128,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2423,7 +3142,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2439,7 +3170,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2448,6 +3179,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2457,7 +3191,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0026</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2471,6 +3205,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2505,6 +3247,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2514,7 +3261,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2530,7 +3289,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2539,6 +3298,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2548,7 +3310,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0027</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2562,6 +3324,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2596,6 +3366,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2605,7 +3380,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2621,7 +3408,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2630,6 +3417,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2639,7 +3429,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0028</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2653,6 +3443,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2687,6 +3485,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2696,7 +3499,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2712,7 +3527,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2721,6 +3536,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2730,7 +3548,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0029</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2744,6 +3562,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2778,6 +3604,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2787,7 +3618,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2803,7 +3646,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2812,6 +3655,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2821,7 +3667,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0030</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2835,6 +3681,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2869,6 +3723,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2878,7 +3737,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2894,7 +3765,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2903,6 +3774,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -2912,7 +3786,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0031</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -2926,6 +3800,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -2960,6 +3842,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -2969,7 +3856,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -2985,7 +3884,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -2994,6 +3893,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3003,7 +3905,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0032</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3017,6 +3919,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3051,6 +3961,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3060,7 +3975,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3076,7 +4003,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3085,6 +4012,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3094,7 +4024,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0033</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3108,6 +4038,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3142,6 +4080,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3151,7 +4094,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3167,7 +4122,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3176,6 +4131,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3185,7 +4143,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0034</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3199,6 +4157,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3233,6 +4199,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3242,7 +4213,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3258,7 +4241,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3267,6 +4250,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3276,7 +4262,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0035</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3290,6 +4276,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3324,6 +4318,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3333,7 +4332,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3349,7 +4360,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3358,6 +4369,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3367,7 +4381,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0036</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3381,6 +4395,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3415,6 +4437,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3424,7 +4451,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3440,7 +4479,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3449,6 +4488,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3458,7 +4500,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0037</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3472,6 +4514,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3506,6 +4556,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3515,7 +4570,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3531,7 +4598,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3540,6 +4607,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3549,7 +4619,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0038</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3563,6 +4633,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3597,6 +4675,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3606,7 +4689,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3622,7 +4717,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3631,6 +4726,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3640,7 +4738,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0039</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3654,6 +4752,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3688,6 +4794,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3697,7 +4808,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3713,7 +4836,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3722,6 +4845,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3731,7 +4857,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0040</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3745,6 +4871,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3779,6 +4913,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3788,7 +4927,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3804,7 +4955,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3813,6 +4964,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3822,7 +4976,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0041</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3836,6 +4990,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3870,6 +5032,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3879,7 +5046,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3895,7 +5074,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3904,6 +5083,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -3913,7 +5095,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0042</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -3927,6 +5109,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -3961,6 +5151,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -3970,7 +5165,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -3986,7 +5193,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -3995,6 +5202,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4004,7 +5214,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0043</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4018,6 +5228,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4052,6 +5270,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -4061,7 +5284,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4077,7 +5312,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4086,6 +5321,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4095,7 +5333,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0044</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4109,6 +5347,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4143,95 +5389,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:AppealTerms>
-				<cac:AppealReceiverParty>
-					<cac:PartyIdentification>
-						<cbc:ID>TPO-0001</cbc:ID>
-					</cac:PartyIdentification>
-				</cac:AppealReceiverParty>
-			</cac:AppealTerms>
-			<cac:Language>
-				<cbc:ID>ELL</cbc:ID>
-			</cac:Language>
-			<cac:PostAwardProcess>
-				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
-				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
-			</cac:PostAwardProcess>
-		</cac:TenderingTerms>
-		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
-			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
-			<cac:TenderSubmissionDeadlinePeriod>
-				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
-				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
-			</cac:TenderSubmissionDeadlinePeriod>
-			<cac:AuctionTerms>
-				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
-			</cac:AuctionTerms>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-		</cac:TenderingProcess>
-		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0045</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
-			<cbc:Description languageID="ENG">
-				Premise
-				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
-				Development
-				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
-				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
-				Pre-production
-				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
-			</cbc:Description>
-			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
-			<cac:MainCommodityClassification>
-				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
-			</cac:MainCommodityClassification>
-			<cac:PlannedPeriod>
-				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
-			</cac:PlannedPeriod>
-		</cac:ProcurementProject>
-	</cac:ProcurementProjectLot>
-	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0046</cbc:ID>
-		<cac:TenderingTerms>
-			<ext:UBLExtensions>
-				<ext:UBLExtension>
-					<ext:ExtensionContent>
-						<efext:EformsExtension>
-							<efac:SelectionCriteria>
-								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
-							</efac:SelectionCriteria>
-						</efext:EformsExtension>
-					</ext:ExtensionContent>
-				</ext:UBLExtension>
-			</ext:UBLExtensions>
-			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
-			<cac:CallForTendersDocumentReference>
-				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
-				<cbc:DocumentType>restricted-document</cbc:DocumentType>
-				<cac:Attachment>
-					<cac:ExternalReference>
-						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
-					</cac:ExternalReference>
-				</cac:Attachment>
-			</cac:CallForTendersDocumentReference>
 			<cac:TendererQualificationRequest>
 				<cac:SpecificTendererRequirement>
-					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
@@ -4243,7 +5403,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4259,7 +5431,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4268,6 +5440,128 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0045</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0046</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4277,7 +5571,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0046</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4291,6 +5585,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4325,6 +5627,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -4334,7 +5641,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4350,7 +5669,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4359,6 +5678,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4368,7 +5690,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0047</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4382,6 +5704,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4416,6 +5746,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -4425,7 +5760,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4441,7 +5788,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4450,6 +5797,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4459,7 +5809,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0048</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4473,6 +5823,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4507,6 +5865,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -4516,7 +5879,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4532,7 +5907,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4541,6 +5916,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4550,7 +5928,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0049</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4564,6 +5942,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4598,6 +5984,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -4607,7 +5998,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4623,7 +6026,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4632,6 +6035,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4641,7 +6047,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0050</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4655,6 +6061,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4689,6 +6103,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -4698,7 +6117,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4714,7 +6145,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4723,6 +6154,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4732,7 +6166,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0051</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4746,6 +6180,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4780,6 +6222,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -4789,7 +6236,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4805,7 +6264,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4814,6 +6273,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4823,7 +6285,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0052</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4837,6 +6299,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4871,6 +6341,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -4880,7 +6355,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4896,7 +6383,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4905,6 +6392,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -4914,7 +6404,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0053</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -4928,6 +6418,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -4962,6 +6460,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -4971,7 +6474,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -4987,7 +6502,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -4996,6 +6511,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5005,7 +6523,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0054</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5019,6 +6537,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5053,6 +6579,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5062,7 +6593,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5078,7 +6621,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5087,6 +6630,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5096,7 +6642,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0055</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5110,6 +6656,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5144,6 +6698,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5153,7 +6712,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5169,7 +6740,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5178,6 +6749,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5187,7 +6761,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0056</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5201,6 +6775,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5235,6 +6817,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5244,7 +6831,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5260,7 +6859,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5269,6 +6868,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5278,7 +6880,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0057</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5292,6 +6894,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5326,6 +6936,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5335,7 +6950,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5351,7 +6978,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5360,6 +6987,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5369,7 +6999,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0058</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5383,6 +7013,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5417,6 +7055,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5426,7 +7069,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5442,7 +7097,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5451,6 +7106,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5460,7 +7118,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0059</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5474,6 +7132,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5508,6 +7174,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5517,7 +7188,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5533,7 +7216,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5542,6 +7225,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5551,7 +7237,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0060</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5565,6 +7251,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5599,6 +7293,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5608,7 +7307,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5624,7 +7335,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5633,6 +7344,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5642,7 +7356,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0061</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5656,6 +7370,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5690,6 +7412,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5699,7 +7426,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5715,7 +7454,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5724,6 +7463,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5733,7 +7475,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0062</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5747,6 +7489,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5781,6 +7531,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5790,7 +7545,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5806,7 +7573,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5815,6 +7582,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5824,7 +7594,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0063</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5838,6 +7608,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5872,6 +7650,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5881,7 +7664,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5897,7 +7692,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5906,6 +7701,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -5915,7 +7713,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0064</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -5929,6 +7727,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -5963,6 +7769,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -5972,7 +7783,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -5988,7 +7811,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -5997,6 +7820,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6006,7 +7832,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0065</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6020,6 +7846,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6054,6 +7888,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6063,7 +7902,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6079,7 +7930,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6088,6 +7939,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6097,7 +7951,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0066</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6111,6 +7965,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6145,6 +8007,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6154,7 +8021,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6170,7 +8049,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6179,6 +8058,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6188,7 +8070,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0067</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6202,6 +8084,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6236,6 +8126,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6245,7 +8140,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6261,7 +8168,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6270,6 +8177,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6279,7 +8189,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0068</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6293,6 +8203,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6327,6 +8245,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6336,7 +8259,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6352,7 +8287,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6361,6 +8296,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6370,7 +8308,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0069</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6384,6 +8322,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6418,6 +8364,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6427,7 +8378,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6443,7 +8406,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6452,6 +8415,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6461,7 +8427,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0070</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6475,6 +8441,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6509,6 +8483,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6518,7 +8497,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6534,7 +8525,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6543,6 +8534,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6552,7 +8546,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0071</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6566,6 +8560,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6600,6 +8602,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6609,7 +8616,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6625,7 +8644,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6634,6 +8653,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6643,7 +8665,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0072</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6657,6 +8679,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6691,6 +8721,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6700,7 +8735,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6716,7 +8763,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6725,6 +8772,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6734,7 +8784,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0073</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6748,6 +8798,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6782,6 +8840,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6791,7 +8854,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6807,7 +8882,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6816,6 +8891,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6825,7 +8903,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0074</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6839,6 +8917,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6873,6 +8959,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6882,7 +8973,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6898,7 +9001,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6907,6 +9010,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -6916,7 +9022,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0075</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -6930,6 +9036,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -6964,6 +9078,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -6973,7 +9092,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -6989,7 +9120,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -6998,6 +9129,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7007,7 +9141,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0076</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7021,6 +9155,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7055,6 +9197,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7064,7 +9211,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7080,7 +9239,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7089,6 +9248,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7098,7 +9260,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0077</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7112,6 +9274,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7146,6 +9316,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7155,7 +9330,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7171,7 +9358,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7180,6 +9367,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7189,7 +9379,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0078</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7203,6 +9393,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7237,6 +9435,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7246,7 +9449,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7262,7 +9477,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7271,6 +9486,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7280,7 +9498,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0079</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7294,6 +9512,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7328,6 +9554,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7337,7 +9568,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7353,7 +9596,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7362,6 +9605,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7371,7 +9617,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0080</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7385,6 +9631,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7419,6 +9673,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7428,7 +9687,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7444,7 +9715,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7453,6 +9724,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7462,7 +9736,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0081</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7476,6 +9750,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7510,6 +9792,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7519,7 +9806,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7535,7 +9834,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7544,6 +9843,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7553,7 +9855,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0082</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7567,6 +9869,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7601,6 +9911,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7610,7 +9925,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7626,7 +9953,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7635,6 +9962,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7644,7 +9974,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0083</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7658,6 +9988,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7692,6 +10030,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7701,7 +10044,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7717,7 +10072,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7726,6 +10081,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7735,7 +10093,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0084</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7749,6 +10107,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7783,6 +10149,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7792,7 +10163,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7808,7 +10191,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7817,6 +10200,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7826,7 +10212,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0085</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7840,6 +10226,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7874,6 +10268,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7883,7 +10282,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7899,7 +10310,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7908,6 +10319,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -7917,7 +10331,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0086</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -7931,6 +10345,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -7965,6 +10387,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -7974,7 +10401,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -7990,7 +10429,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -7999,6 +10438,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8008,7 +10450,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0087</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8022,6 +10464,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8056,6 +10506,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8065,7 +10520,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8081,7 +10548,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8090,6 +10557,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8099,7 +10569,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0088</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8113,6 +10583,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8147,6 +10625,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8156,7 +10639,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8172,7 +10667,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8181,6 +10676,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8190,7 +10688,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0089</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8204,6 +10702,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8238,6 +10744,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8247,7 +10758,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8263,7 +10786,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8272,6 +10795,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8281,7 +10807,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0090</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8295,6 +10821,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8329,6 +10863,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8338,7 +10877,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8354,7 +10905,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8363,6 +10914,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8372,7 +10926,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0091</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8386,6 +10940,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8420,6 +10982,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8429,7 +10996,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8445,7 +11024,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8454,6 +11033,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8463,7 +11045,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0092</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8477,6 +11059,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8511,6 +11101,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8520,7 +11115,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8536,7 +11143,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8545,6 +11152,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8554,7 +11164,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0093</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8568,6 +11178,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8602,6 +11220,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8611,7 +11234,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8627,7 +11262,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8636,6 +11271,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8645,7 +11283,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0094</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8659,6 +11297,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8693,6 +11339,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8702,7 +11353,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8718,7 +11381,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8727,6 +11390,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8736,7 +11402,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0095</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8750,6 +11416,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8784,6 +11458,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8793,7 +11472,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8809,7 +11500,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8818,6 +11509,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8827,7 +11521,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0096</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8841,6 +11535,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8875,6 +11577,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8884,7 +11591,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8900,7 +11619,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -8909,6 +11628,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -8918,7 +11640,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0097</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -8932,6 +11654,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -8966,6 +11696,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -8975,7 +11710,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -8991,7 +11738,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9000,6 +11747,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9009,7 +11759,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0098</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9023,6 +11773,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9057,6 +11815,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9066,7 +11829,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9082,7 +11857,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9091,6 +11866,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9100,7 +11878,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0099</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9114,6 +11892,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9148,6 +11934,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9157,7 +11948,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9173,7 +11976,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9182,6 +11985,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9191,7 +11997,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0100</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9205,6 +12011,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9239,6 +12053,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9248,7 +12067,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9264,7 +12095,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9273,6 +12104,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9282,7 +12116,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0101</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9296,6 +12130,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9330,6 +12172,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9339,7 +12186,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9355,7 +12214,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9364,6 +12223,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9373,7 +12235,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0102</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9387,6 +12249,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9421,6 +12291,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9430,7 +12305,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9446,7 +12333,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9455,6 +12342,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9464,7 +12354,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0103</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9478,6 +12368,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9512,6 +12410,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9521,7 +12424,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9537,7 +12452,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9546,6 +12461,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9555,7 +12473,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0104</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9569,6 +12487,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9603,6 +12529,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9612,7 +12543,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9628,7 +12571,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9637,6 +12580,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9646,7 +12592,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0105</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9660,6 +12606,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9694,6 +12648,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9703,7 +12662,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9719,7 +12690,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9728,6 +12699,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9737,7 +12711,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0106</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9751,6 +12725,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9785,6 +12767,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9794,7 +12781,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9810,7 +12809,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9819,6 +12818,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9828,7 +12830,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0107</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9842,6 +12844,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9876,6 +12886,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9885,7 +12900,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9901,7 +12928,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -9910,6 +12937,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -9919,7 +12949,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0108</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -9933,6 +12963,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -9967,6 +13005,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -9976,7 +13019,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -9992,7 +13047,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10001,6 +13056,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10010,7 +13068,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0109</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10024,6 +13082,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10058,6 +13124,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10067,7 +13138,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10083,7 +13166,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10092,6 +13175,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10101,7 +13187,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0110</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10115,6 +13201,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10149,6 +13243,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10158,7 +13257,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10174,7 +13285,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10183,6 +13294,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10192,7 +13306,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0111</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10206,6 +13320,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10240,6 +13362,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10249,7 +13376,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10265,7 +13404,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10274,6 +13413,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10283,7 +13425,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0112</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10297,6 +13439,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10331,6 +13481,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10340,7 +13495,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10356,7 +13523,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10365,6 +13532,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10374,7 +13544,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0113</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10388,6 +13558,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10422,6 +13600,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10431,7 +13614,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10447,7 +13642,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10456,6 +13651,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10465,7 +13663,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0114</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10479,6 +13677,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10513,6 +13719,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10522,7 +13733,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10538,7 +13761,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10547,6 +13770,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10556,7 +13782,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0115</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10570,6 +13796,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10604,6 +13838,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10613,7 +13852,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10629,7 +13880,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10638,6 +13889,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10647,7 +13901,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0116</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10661,6 +13915,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10695,6 +13957,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10704,7 +13971,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10720,7 +13999,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10729,6 +14008,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10738,7 +14020,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0117</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10752,6 +14034,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10786,6 +14076,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10795,7 +14090,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10811,7 +14118,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10820,6 +14127,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10829,7 +14139,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0118</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10843,6 +14153,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10877,6 +14195,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10886,7 +14209,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10902,7 +14237,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -10911,6 +14246,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -10920,7 +14258,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0119</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -10934,6 +14272,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -10968,6 +14314,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -10977,7 +14328,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -10993,7 +14356,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11002,6 +14365,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11011,7 +14377,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0120</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11025,6 +14391,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11059,6 +14433,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11068,7 +14447,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11084,7 +14475,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11093,6 +14484,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11102,7 +14496,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0121</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11116,6 +14510,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11150,6 +14552,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11159,7 +14566,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11175,7 +14594,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11184,6 +14603,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11193,7 +14615,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0122</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11207,6 +14629,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11241,6 +14671,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11250,7 +14685,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11266,7 +14713,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11275,6 +14722,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11284,7 +14734,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0123</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11298,6 +14748,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11332,6 +14790,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11341,7 +14804,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11357,7 +14832,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11366,6 +14841,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11375,7 +14853,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0124</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11389,6 +14867,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11423,6 +14909,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11432,7 +14923,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11448,7 +14951,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11457,6 +14960,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11466,7 +14972,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0125</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11480,6 +14986,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11514,6 +15028,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11523,7 +15042,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11539,7 +15070,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11548,6 +15079,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11557,7 +15091,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0126</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11571,6 +15105,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11605,6 +15147,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11614,7 +15161,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11630,7 +15189,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11639,6 +15198,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11648,7 +15210,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0127</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11662,6 +15224,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11696,6 +15266,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11705,7 +15280,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11721,7 +15308,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11730,6 +15317,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11739,7 +15329,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0128</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11753,6 +15343,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11787,6 +15385,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11796,7 +15399,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11812,7 +15427,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11821,6 +15436,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11830,7 +15448,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0129</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11844,6 +15462,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11878,6 +15504,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -11887,7 +15518,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -11903,7 +15546,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -11912,6 +15555,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -11921,7 +15567,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0130</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -11935,6 +15581,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -11969,95 +15623,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:AppealTerms>
-				<cac:AppealReceiverParty>
-					<cac:PartyIdentification>
-						<cbc:ID>TPO-0001</cbc:ID>
-					</cac:PartyIdentification>
-				</cac:AppealReceiverParty>
-			</cac:AppealTerms>
-			<cac:Language>
-				<cbc:ID>ELL</cbc:ID>
-			</cac:Language>
-			<cac:PostAwardProcess>
-				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
-				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
-			</cac:PostAwardProcess>
-		</cac:TenderingTerms>
-		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
-			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
-			<cac:TenderSubmissionDeadlinePeriod>
-				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
-				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
-			</cac:TenderSubmissionDeadlinePeriod>
-			<cac:AuctionTerms>
-				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
-			</cac:AuctionTerms>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-		</cac:TenderingProcess>
-		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0131</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
-			<cbc:Description languageID="ENG">
-				Premise
-				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
-				Development
-				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
-				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
-				Pre-production
-				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
-			</cbc:Description>
-			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
-			<cac:MainCommodityClassification>
-				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
-			</cac:MainCommodityClassification>
-			<cac:PlannedPeriod>
-				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
-			</cac:PlannedPeriod>
-		</cac:ProcurementProject>
-	</cac:ProcurementProjectLot>
-	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0132</cbc:ID>
-		<cac:TenderingTerms>
-			<ext:UBLExtensions>
-				<ext:UBLExtension>
-					<ext:ExtensionContent>
-						<efext:EformsExtension>
-							<efac:SelectionCriteria>
-								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
-							</efac:SelectionCriteria>
-						</efext:EformsExtension>
-					</ext:ExtensionContent>
-				</ext:UBLExtension>
-			</ext:UBLExtensions>
-			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
-			<cac:CallForTendersDocumentReference>
-				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
-				<cbc:DocumentType>restricted-document</cbc:DocumentType>
-				<cac:Attachment>
-					<cac:ExternalReference>
-						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
-					</cac:ExternalReference>
-				</cac:Attachment>
-			</cac:CallForTendersDocumentReference>
 			<cac:TendererQualificationRequest>
 				<cac:SpecificTendererRequirement>
-					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
@@ -12069,7 +15637,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12085,7 +15665,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12094,6 +15674,128 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0131</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0132</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12103,7 +15805,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0132</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12117,6 +15819,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12151,6 +15861,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12160,7 +15875,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12176,7 +15903,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12185,6 +15912,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12194,7 +15924,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0133</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12208,6 +15938,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12242,6 +15980,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12251,7 +15994,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12267,7 +16022,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12276,6 +16031,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12285,7 +16043,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0134</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12299,6 +16057,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12333,6 +16099,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12342,7 +16113,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12358,7 +16141,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12367,6 +16150,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12376,7 +16162,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0135</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12390,6 +16176,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12424,6 +16218,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12433,7 +16232,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12449,7 +16260,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12458,6 +16269,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12467,7 +16281,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0136</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12481,6 +16295,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12515,6 +16337,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12524,7 +16351,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12540,7 +16379,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12549,6 +16388,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12558,7 +16400,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0137</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12572,6 +16414,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12606,6 +16456,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12615,7 +16470,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12631,7 +16498,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12640,6 +16507,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12649,7 +16519,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0138</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12663,6 +16533,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12697,6 +16575,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12706,7 +16589,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12722,7 +16617,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12731,6 +16626,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12740,7 +16638,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0139</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12754,6 +16652,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12788,6 +16694,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12797,7 +16708,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12813,7 +16736,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12822,6 +16745,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12831,7 +16757,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0140</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12845,6 +16771,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12879,6 +16813,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12888,7 +16827,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12904,7 +16855,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -12913,6 +16864,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -12922,7 +16876,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0141</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -12936,6 +16890,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -12970,6 +16932,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -12979,7 +16946,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -12995,7 +16974,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13004,6 +16983,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13013,7 +16995,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0142</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13027,6 +17009,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13061,6 +17051,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13070,7 +17065,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13086,7 +17093,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13095,6 +17102,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13104,7 +17114,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0143</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13118,6 +17128,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13152,6 +17170,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13161,7 +17184,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13177,7 +17212,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13186,6 +17221,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13195,7 +17233,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0144</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13209,6 +17247,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13243,6 +17289,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13252,7 +17303,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13268,7 +17331,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13277,6 +17340,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13286,7 +17352,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0145</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13300,6 +17366,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13334,6 +17408,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13343,7 +17422,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13359,7 +17450,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13368,6 +17459,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13377,7 +17471,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0146</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13391,6 +17485,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13425,6 +17527,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13434,7 +17541,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13450,7 +17569,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13459,6 +17578,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13468,7 +17590,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0147</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13482,6 +17604,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13516,6 +17646,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13525,7 +17660,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13541,7 +17688,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13550,6 +17697,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13559,7 +17709,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0148</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13573,6 +17723,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13607,6 +17765,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13616,7 +17779,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13632,7 +17807,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13641,6 +17816,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13650,7 +17828,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0149</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13664,6 +17842,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13698,6 +17884,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13707,7 +17898,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13723,7 +17926,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13732,6 +17935,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13741,7 +17947,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0150</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13755,6 +17961,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13789,6 +18003,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13798,7 +18017,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13814,7 +18045,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13823,6 +18054,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13832,7 +18066,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0151</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13846,6 +18080,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13880,6 +18122,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13889,7 +18136,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13905,7 +18164,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -13914,6 +18173,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -13923,7 +18185,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0152</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -13937,6 +18199,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -13971,6 +18241,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -13980,7 +18255,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -13996,7 +18283,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14005,6 +18292,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14014,7 +18304,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0153</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14028,6 +18318,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14062,6 +18360,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14071,7 +18374,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14087,7 +18402,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14096,6 +18411,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14105,7 +18423,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0154</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14119,6 +18437,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14153,6 +18479,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14162,7 +18493,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14178,7 +18521,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14187,6 +18530,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14196,7 +18542,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0155</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14210,6 +18556,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14244,6 +18598,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14253,7 +18612,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14269,7 +18640,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14278,6 +18649,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14287,7 +18661,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0156</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14301,6 +18675,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14335,6 +18717,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14344,7 +18731,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14360,7 +18759,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14369,6 +18768,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14378,7 +18780,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0157</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14392,6 +18794,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14426,6 +18836,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14435,7 +18850,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14451,7 +18878,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14460,6 +18887,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14469,7 +18899,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0158</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14483,6 +18913,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14517,6 +18955,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14526,7 +18969,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14542,7 +18997,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14551,6 +19006,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14560,7 +19018,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0159</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14574,6 +19032,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14608,6 +19074,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14617,7 +19088,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14633,7 +19116,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14642,6 +19125,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14651,7 +19137,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0160</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14665,6 +19151,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14699,6 +19193,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14708,7 +19207,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14724,7 +19235,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14733,6 +19244,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14742,7 +19256,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0161</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14756,6 +19270,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14790,6 +19312,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14799,7 +19326,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14815,7 +19354,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14824,6 +19363,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14833,7 +19375,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0162</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14847,6 +19389,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14881,6 +19431,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14890,7 +19445,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14906,7 +19473,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -14915,6 +19482,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -14924,7 +19494,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0163</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -14938,6 +19508,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -14972,6 +19550,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -14981,7 +19564,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -14997,7 +19592,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15006,6 +19601,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15015,7 +19613,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0164</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15029,6 +19627,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15063,6 +19669,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15072,7 +19683,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15088,7 +19711,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15097,6 +19720,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15106,7 +19732,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0165</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15120,6 +19746,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15154,6 +19788,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15163,7 +19802,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15179,7 +19830,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15188,6 +19839,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15197,7 +19851,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0166</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15211,6 +19865,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15245,6 +19907,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15254,7 +19921,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15270,7 +19949,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15279,6 +19958,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15288,7 +19970,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0167</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15302,6 +19984,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15336,6 +20026,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15345,7 +20040,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15361,7 +20068,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15370,6 +20077,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15379,7 +20089,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0168</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15393,6 +20103,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15427,6 +20145,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15436,7 +20159,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15452,7 +20187,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15461,6 +20196,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15470,7 +20208,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0169</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15484,6 +20222,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15518,6 +20264,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15527,7 +20278,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15543,7 +20306,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15552,6 +20315,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15561,7 +20327,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0170</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15575,6 +20341,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15609,6 +20383,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15618,7 +20397,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15634,7 +20425,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15643,6 +20434,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15652,7 +20446,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0171</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15666,6 +20460,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15700,6 +20502,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15709,7 +20516,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15725,7 +20544,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15734,6 +20553,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15743,7 +20565,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0172</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15757,6 +20579,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15791,6 +20621,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15800,7 +20635,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15816,7 +20663,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15825,6 +20672,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15834,7 +20684,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0173</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15848,6 +20698,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15882,6 +20740,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15891,7 +20754,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15907,7 +20782,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -15916,6 +20791,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -15925,7 +20803,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0174</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -15939,6 +20817,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -15973,6 +20859,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -15982,7 +20873,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -15998,7 +20901,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16007,6 +20910,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16016,7 +20922,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0175</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16030,6 +20936,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16064,6 +20978,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16073,7 +20992,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16089,7 +21020,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16098,6 +21029,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16107,7 +21041,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0176</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16121,6 +21055,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16155,6 +21097,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16164,7 +21111,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16180,7 +21139,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16189,6 +21148,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16198,7 +21160,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0177</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16212,6 +21174,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16246,6 +21216,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16255,7 +21230,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16271,7 +21258,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16280,6 +21267,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16289,7 +21279,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0178</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16303,6 +21293,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16337,6 +21335,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16346,7 +21349,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16362,7 +21377,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16371,6 +21386,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16380,7 +21398,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0179</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16394,6 +21412,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16428,6 +21454,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16437,7 +21468,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16453,7 +21496,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16462,6 +21505,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16471,7 +21517,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0180</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16485,6 +21531,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16519,6 +21573,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16528,7 +21587,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16544,7 +21615,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16553,6 +21624,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16562,7 +21636,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0181</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16576,6 +21650,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16610,6 +21692,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16619,7 +21706,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16635,7 +21734,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16644,6 +21743,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16653,7 +21755,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0182</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16667,6 +21769,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16701,6 +21811,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16710,7 +21825,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16726,7 +21853,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16735,6 +21862,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16744,7 +21874,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0183</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16758,6 +21888,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16792,6 +21930,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16801,7 +21944,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16817,7 +21972,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16826,6 +21981,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16835,7 +21993,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0184</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16849,6 +22007,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16883,6 +22049,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16892,7 +22063,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16908,7 +22091,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -16917,6 +22100,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -16926,7 +22112,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0185</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -16940,6 +22126,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -16974,6 +22168,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -16983,7 +22182,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -16999,7 +22210,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17008,6 +22219,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17017,7 +22231,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0186</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17031,6 +22245,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17065,6 +22287,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17074,7 +22301,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17090,7 +22329,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17099,6 +22338,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17108,7 +22350,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0187</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17122,6 +22364,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17156,6 +22406,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17165,7 +22420,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17181,7 +22448,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17190,6 +22457,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17199,7 +22469,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0188</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17213,6 +22483,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17247,6 +22525,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17256,7 +22539,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17272,7 +22567,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17281,6 +22576,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17290,7 +22588,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0189</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17304,6 +22602,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17338,6 +22644,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17347,7 +22658,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17363,7 +22686,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17372,6 +22695,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17381,7 +22707,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0190</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17395,6 +22721,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17429,6 +22763,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17438,7 +22777,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17454,7 +22805,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17463,6 +22814,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17472,7 +22826,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0191</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17486,6 +22840,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17520,6 +22882,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17529,7 +22896,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17545,7 +22924,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17554,6 +22933,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17563,7 +22945,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0192</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17577,6 +22959,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17611,6 +23001,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17620,7 +23015,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17636,7 +23043,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17645,6 +23052,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17654,7 +23064,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0193</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17668,6 +23078,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17702,6 +23120,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17711,7 +23134,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17727,7 +23162,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17736,6 +23171,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17745,7 +23183,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0194</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17759,6 +23197,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17793,6 +23239,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17802,7 +23253,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17818,7 +23281,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17827,6 +23290,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17836,7 +23302,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0195</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17850,6 +23316,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17884,6 +23358,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17893,7 +23372,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -17909,7 +23400,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -17918,6 +23409,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -17927,7 +23421,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0196</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -17941,6 +23435,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -17975,6 +23477,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -17984,7 +23491,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18000,7 +23519,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18009,6 +23528,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18018,7 +23540,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0197</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18032,6 +23554,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18066,6 +23596,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18075,7 +23610,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18091,7 +23638,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18100,6 +23647,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18109,7 +23659,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0198</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18123,6 +23673,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18157,6 +23715,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18166,7 +23729,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18182,7 +23757,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18191,6 +23766,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18200,7 +23778,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0199</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18214,6 +23792,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18248,6 +23834,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18257,7 +23848,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18273,7 +23876,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18282,6 +23885,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18291,7 +23897,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0200</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18305,6 +23911,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18339,6 +23953,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18348,7 +23967,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18364,7 +23995,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18373,6 +24004,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18382,7 +24016,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0201</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18396,6 +24030,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18430,6 +24072,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18439,7 +24086,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18455,7 +24114,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18464,6 +24123,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18473,7 +24135,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0202</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18487,6 +24149,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18521,6 +24191,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18530,7 +24205,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18546,7 +24233,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18555,6 +24242,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18564,7 +24254,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0203</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18578,6 +24268,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18612,6 +24310,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18621,7 +24324,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18637,7 +24352,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18646,6 +24361,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18655,7 +24373,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0204</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18669,6 +24387,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18703,6 +24429,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18712,7 +24443,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18728,7 +24471,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18737,6 +24480,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18746,7 +24492,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0205</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18760,6 +24506,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18794,6 +24548,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18803,7 +24562,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18819,7 +24590,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18828,6 +24599,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18837,7 +24611,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0206</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18851,6 +24625,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18885,6 +24667,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18894,7 +24681,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -18910,7 +24709,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -18919,6 +24718,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -18928,7 +24730,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0207</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -18942,6 +24744,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -18976,6 +24786,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -18985,7 +24800,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19001,7 +24828,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19010,6 +24837,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19019,7 +24849,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0208</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19033,6 +24863,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19067,6 +24905,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -19076,7 +24919,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19092,7 +24947,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19101,6 +24956,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19110,7 +24968,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0209</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19124,6 +24982,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19158,6 +25024,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -19167,7 +25038,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19183,7 +25066,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19192,6 +25075,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19201,7 +25087,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0210</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19215,6 +25101,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19249,6 +25143,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -19258,7 +25157,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19274,7 +25185,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19283,6 +25194,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19292,7 +25206,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0211</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19306,6 +25220,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19340,6 +25262,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -19349,7 +25276,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19365,7 +25304,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19374,6 +25313,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19383,7 +25325,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0212</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19397,6 +25339,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19431,6 +25381,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -19440,7 +25395,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19456,7 +25423,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19465,6 +25432,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19474,7 +25444,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0213</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19488,6 +25458,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19522,6 +25500,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -19531,7 +25514,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19547,7 +25542,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19556,6 +25551,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19565,7 +25563,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0214</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19579,6 +25577,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19613,6 +25619,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -19622,7 +25633,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19638,7 +25661,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19647,6 +25670,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19656,7 +25682,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0215</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19670,6 +25696,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19704,6 +25738,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -19713,7 +25752,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19729,7 +25780,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19738,6 +25789,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19747,7 +25801,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0216</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19761,6 +25815,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19795,95 +25857,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:AppealTerms>
-				<cac:AppealReceiverParty>
-					<cac:PartyIdentification>
-						<cbc:ID>TPO-0001</cbc:ID>
-					</cac:PartyIdentification>
-				</cac:AppealReceiverParty>
-			</cac:AppealTerms>
-			<cac:Language>
-				<cbc:ID>ELL</cbc:ID>
-			</cac:Language>
-			<cac:PostAwardProcess>
-				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
-				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
-			</cac:PostAwardProcess>
-		</cac:TenderingTerms>
-		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
-			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
-			<cac:TenderSubmissionDeadlinePeriod>
-				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
-				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
-			</cac:TenderSubmissionDeadlinePeriod>
-			<cac:AuctionTerms>
-				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
-			</cac:AuctionTerms>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-		</cac:TenderingProcess>
-		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0217</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
-			<cbc:Description languageID="ENG">
-				Premise
-				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
-				Development
-				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
-				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
-				Pre-production
-				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
-			</cbc:Description>
-			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
-			<cac:MainCommodityClassification>
-				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
-			</cac:MainCommodityClassification>
-			<cac:PlannedPeriod>
-				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
-			</cac:PlannedPeriod>
-		</cac:ProcurementProject>
-	</cac:ProcurementProjectLot>
-	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0218</cbc:ID>
-		<cac:TenderingTerms>
-			<ext:UBLExtensions>
-				<ext:UBLExtension>
-					<ext:ExtensionContent>
-						<efext:EformsExtension>
-							<efac:SelectionCriteria>
-								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
-							</efac:SelectionCriteria>
-						</efext:EformsExtension>
-					</ext:ExtensionContent>
-				</ext:UBLExtension>
-			</ext:UBLExtensions>
-			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
-			<cac:CallForTendersDocumentReference>
-				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
-				<cbc:DocumentType>restricted-document</cbc:DocumentType>
-				<cac:Attachment>
-					<cac:ExternalReference>
-						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
-					</cac:ExternalReference>
-				</cac:Attachment>
-			</cac:CallForTendersDocumentReference>
 			<cac:TendererQualificationRequest>
 				<cac:SpecificTendererRequirement>
-					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
@@ -19895,7 +25871,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -19911,7 +25899,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -19920,6 +25908,128 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0217</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0218</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -19929,7 +26039,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0218</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -19943,6 +26053,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -19977,6 +26095,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -19986,7 +26109,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20002,7 +26137,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20011,6 +26146,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20020,7 +26158,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0219</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20034,6 +26172,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20068,6 +26214,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20077,7 +26228,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20093,7 +26256,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20102,6 +26265,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20111,7 +26277,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0220</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20125,6 +26291,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20159,6 +26333,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20168,7 +26347,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20184,7 +26375,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20193,6 +26384,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20202,7 +26396,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0221</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20216,6 +26410,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20250,6 +26452,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20259,7 +26466,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20275,7 +26494,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20284,6 +26503,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20293,7 +26515,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0222</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20307,6 +26529,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20341,6 +26571,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20350,7 +26585,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20366,7 +26613,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20375,6 +26622,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20384,7 +26634,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0223</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20398,6 +26648,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20432,6 +26690,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20441,7 +26704,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20457,7 +26732,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20466,6 +26741,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20475,7 +26753,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0224</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20489,6 +26767,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20523,6 +26809,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20532,7 +26823,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20548,7 +26851,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20557,6 +26860,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20566,7 +26872,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0225</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20580,6 +26886,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20614,6 +26928,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20623,7 +26942,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20639,7 +26970,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20648,6 +26979,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20657,7 +26991,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0226</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20671,6 +27005,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20705,6 +27047,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20714,7 +27061,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20730,7 +27089,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20739,6 +27098,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20748,7 +27110,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0227</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20762,6 +27124,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20796,6 +27166,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20805,7 +27180,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20821,7 +27208,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20830,6 +27217,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20839,7 +27229,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0228</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20853,6 +27243,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20887,6 +27285,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20896,7 +27299,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -20912,7 +27327,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -20921,6 +27336,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -20930,7 +27348,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0229</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -20944,6 +27362,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -20978,6 +27404,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -20987,7 +27418,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21003,7 +27446,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21012,6 +27455,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21021,7 +27467,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0230</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21035,6 +27481,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21069,6 +27523,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21078,7 +27537,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21094,7 +27565,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21103,6 +27574,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21112,7 +27586,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0231</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21126,6 +27600,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21160,6 +27642,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21169,7 +27656,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21185,7 +27684,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21194,6 +27693,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21203,7 +27705,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0232</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21217,6 +27719,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21251,6 +27761,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21260,7 +27775,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21276,7 +27803,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21285,6 +27812,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21294,7 +27824,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0233</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21308,6 +27838,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21342,6 +27880,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21351,7 +27894,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21367,7 +27922,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21376,6 +27931,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21385,7 +27943,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0234</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21399,6 +27957,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21433,6 +27999,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21442,7 +28013,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21458,7 +28041,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21467,6 +28050,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21476,7 +28062,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0235</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21490,6 +28076,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21524,6 +28118,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21533,7 +28132,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21549,7 +28160,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21558,6 +28169,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21567,7 +28181,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0236</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21581,6 +28195,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21615,6 +28237,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21624,7 +28251,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21640,7 +28279,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21649,6 +28288,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21658,7 +28300,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0237</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21672,6 +28314,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21706,6 +28356,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21715,7 +28370,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21731,7 +28398,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21740,6 +28407,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21749,7 +28419,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0238</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21763,6 +28433,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21797,6 +28475,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21806,7 +28489,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21822,7 +28517,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21831,6 +28526,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21840,7 +28538,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0239</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21854,6 +28552,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21888,6 +28594,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21897,7 +28608,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -21913,7 +28636,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -21922,6 +28645,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -21931,7 +28657,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0240</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -21945,6 +28671,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -21979,6 +28713,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -21988,7 +28727,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22004,7 +28755,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22013,6 +28764,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22022,7 +28776,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0241</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22036,6 +28790,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22070,6 +28832,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22079,7 +28846,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22095,7 +28874,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22104,6 +28883,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22113,7 +28895,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0242</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22127,6 +28909,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22161,6 +28951,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22170,7 +28965,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22186,7 +28993,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22195,6 +29002,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22204,7 +29014,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0243</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22218,6 +29028,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22252,6 +29070,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22261,7 +29084,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22277,7 +29112,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22286,6 +29121,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22295,7 +29133,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0244</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22309,6 +29147,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22343,6 +29189,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22352,7 +29203,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22368,7 +29231,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22377,6 +29240,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22386,7 +29252,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0245</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22400,6 +29266,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22434,6 +29308,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22443,7 +29322,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22459,7 +29350,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22468,6 +29359,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22477,7 +29371,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0246</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22491,6 +29385,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22525,6 +29427,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22534,7 +29441,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22550,7 +29469,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22559,6 +29478,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22568,7 +29490,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0247</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22582,6 +29504,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22616,6 +29546,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22625,7 +29560,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22641,7 +29588,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22650,6 +29597,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22659,7 +29609,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0248</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22673,6 +29623,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22707,6 +29665,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22716,7 +29679,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22732,7 +29707,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22741,6 +29716,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22750,7 +29728,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0249</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22764,6 +29742,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22798,6 +29784,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22807,7 +29798,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22823,7 +29826,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22832,6 +29835,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22841,7 +29847,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0250</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22855,6 +29861,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22889,6 +29903,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22898,7 +29917,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -22914,7 +29945,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -22923,6 +29954,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -22932,7 +29966,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0251</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -22946,6 +29980,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -22980,6 +30022,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -22989,7 +30036,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23005,7 +30064,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23014,6 +30073,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23023,7 +30085,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0252</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23037,6 +30099,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23071,6 +30141,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23080,7 +30155,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23096,7 +30183,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23105,6 +30192,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23114,7 +30204,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0253</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23128,6 +30218,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23162,6 +30260,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23171,7 +30274,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23187,7 +30302,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23196,6 +30311,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23205,7 +30323,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0254</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23219,6 +30337,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23253,6 +30379,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23262,7 +30393,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23278,7 +30421,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23287,6 +30430,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23296,7 +30442,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0255</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23310,6 +30456,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23344,6 +30498,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23353,7 +30512,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23369,7 +30540,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23378,6 +30549,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23387,7 +30561,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0256</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23401,6 +30575,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23435,6 +30617,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23444,7 +30631,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23460,7 +30659,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23469,6 +30668,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23478,7 +30680,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0257</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23492,6 +30694,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23526,6 +30736,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23535,7 +30750,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23551,7 +30778,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23560,6 +30787,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23569,7 +30799,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0258</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23583,6 +30813,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23617,6 +30855,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23626,7 +30869,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23642,7 +30897,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23651,6 +30906,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23660,7 +30918,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0259</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23674,6 +30932,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23708,6 +30974,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23717,7 +30988,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23733,7 +31016,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23742,6 +31025,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23751,7 +31037,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0260</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23765,6 +31051,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23799,6 +31093,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23808,7 +31107,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23824,7 +31135,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23833,6 +31144,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23842,7 +31156,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0261</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23856,6 +31170,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23890,6 +31212,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23899,7 +31226,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -23915,7 +31254,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -23924,6 +31263,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -23933,7 +31275,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0262</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -23947,6 +31289,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -23981,6 +31331,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -23990,7 +31345,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24006,7 +31373,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24015,6 +31382,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24024,7 +31394,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0263</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24038,6 +31408,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24072,6 +31450,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24081,7 +31464,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24097,7 +31492,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24106,6 +31501,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24115,7 +31513,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0264</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24129,6 +31527,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24163,6 +31569,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24172,7 +31583,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24188,7 +31611,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24197,6 +31620,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24206,7 +31632,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0265</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24220,6 +31646,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24254,6 +31688,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24263,7 +31702,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24279,7 +31730,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24288,6 +31739,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24297,7 +31751,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0266</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24311,6 +31765,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24345,6 +31807,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24354,7 +31821,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24370,7 +31849,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24379,6 +31858,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24388,7 +31870,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0267</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24402,6 +31884,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24436,6 +31926,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24445,7 +31940,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24461,7 +31968,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24470,6 +31977,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24479,7 +31989,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0268</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24493,6 +32003,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24527,6 +32045,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24536,7 +32059,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24552,7 +32087,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24561,6 +32096,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24570,7 +32108,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0269</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24584,6 +32122,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24618,6 +32164,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24627,7 +32178,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24643,7 +32206,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24652,6 +32215,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24661,7 +32227,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0270</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24675,6 +32241,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24709,6 +32283,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24718,7 +32297,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24734,7 +32325,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24743,6 +32334,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24752,7 +32346,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0271</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24766,6 +32360,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24800,6 +32402,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24809,7 +32416,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24825,7 +32444,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24834,6 +32453,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24843,7 +32465,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0272</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24857,6 +32479,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24891,6 +32521,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24900,7 +32535,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -24916,7 +32563,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -24925,6 +32572,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -24934,7 +32584,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0273</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -24948,6 +32598,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -24982,6 +32640,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -24991,7 +32654,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25007,7 +32682,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25016,6 +32691,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25025,7 +32703,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0274</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25039,6 +32717,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25073,6 +32759,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25082,7 +32773,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25098,7 +32801,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25107,6 +32810,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25116,7 +32822,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0275</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25130,6 +32836,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25164,6 +32878,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25173,7 +32892,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25189,7 +32920,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25198,6 +32929,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25207,7 +32941,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0276</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25221,6 +32955,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25255,6 +32997,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25264,7 +33011,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25280,7 +33039,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25289,6 +33048,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25298,7 +33060,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0277</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25312,6 +33074,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25346,6 +33116,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25355,7 +33130,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25371,7 +33158,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25380,6 +33167,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25389,7 +33179,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0278</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25403,6 +33193,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25437,6 +33235,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25446,7 +33249,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25462,7 +33277,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25471,6 +33286,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25480,7 +33298,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0279</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25494,6 +33312,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25528,6 +33354,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25537,7 +33368,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25553,7 +33396,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25562,6 +33405,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25571,7 +33417,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0280</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25585,6 +33431,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25619,6 +33473,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25628,7 +33487,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25644,7 +33515,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25653,6 +33524,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25662,7 +33536,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0281</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25676,6 +33550,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25710,6 +33592,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25719,7 +33606,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25735,7 +33634,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25744,6 +33643,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25753,7 +33655,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0282</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25767,6 +33669,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25801,6 +33711,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25810,7 +33725,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25826,7 +33753,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25835,6 +33762,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25844,7 +33774,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0283</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25858,6 +33788,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25892,6 +33830,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25901,7 +33844,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -25917,7 +33872,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -25926,6 +33881,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -25935,7 +33893,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0284</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -25949,6 +33907,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -25983,6 +33949,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -25992,7 +33963,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26008,7 +33991,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26017,6 +34000,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26026,7 +34012,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0285</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26040,6 +34026,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26074,6 +34068,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26083,7 +34082,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26099,7 +34110,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26108,6 +34119,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26117,7 +34131,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0286</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26131,6 +34145,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26165,6 +34187,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26174,7 +34201,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26190,7 +34229,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26199,6 +34238,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26208,7 +34250,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0287</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26222,6 +34264,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26256,6 +34306,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26265,7 +34320,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26281,7 +34348,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26290,6 +34357,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26299,7 +34369,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0288</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26313,6 +34383,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26347,6 +34425,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26356,7 +34439,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26372,7 +34467,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26381,6 +34476,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26390,7 +34488,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0289</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26404,6 +34502,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26438,6 +34544,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26447,7 +34558,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26463,7 +34586,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26472,6 +34595,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26481,7 +34607,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0290</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26495,6 +34621,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26529,6 +34663,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26538,7 +34677,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26554,7 +34705,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26563,6 +34714,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26572,7 +34726,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0291</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26586,6 +34740,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26620,6 +34782,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26629,7 +34796,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26645,7 +34824,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26654,6 +34833,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26663,7 +34845,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0292</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26677,6 +34859,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26711,6 +34901,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26720,7 +34915,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26736,7 +34943,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26745,6 +34952,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26754,7 +34964,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0293</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26768,6 +34978,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26802,6 +35020,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26811,7 +35034,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26827,7 +35062,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26836,6 +35071,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26845,7 +35083,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0294</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26859,6 +35097,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26893,6 +35139,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26902,7 +35153,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -26918,7 +35181,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -26927,6 +35190,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -26936,7 +35202,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0295</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -26950,6 +35216,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -26984,6 +35258,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -26993,7 +35272,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27009,7 +35300,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27018,6 +35309,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27027,7 +35321,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0296</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27041,6 +35335,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27075,6 +35377,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -27084,7 +35391,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27100,7 +35419,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27109,6 +35428,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27118,7 +35440,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0297</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27132,6 +35454,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27166,6 +35496,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -27175,7 +35510,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27191,7 +35538,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27200,6 +35547,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27209,7 +35559,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0298</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27223,6 +35573,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27257,6 +35615,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -27266,7 +35629,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27282,7 +35657,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27291,6 +35666,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27300,7 +35678,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0299</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27314,6 +35692,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27348,6 +35734,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -27357,7 +35748,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27373,7 +35776,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27382,6 +35785,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27391,7 +35797,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0300</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27405,6 +35811,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27439,6 +35853,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -27448,7 +35867,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27464,7 +35895,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27473,6 +35904,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27482,7 +35916,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0301</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27496,6 +35930,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27530,6 +35972,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -27539,7 +35986,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27555,7 +36014,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27564,6 +36023,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27573,7 +36035,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0302</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27587,6 +36049,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27621,95 +36091,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:AppealTerms>
-				<cac:AppealReceiverParty>
-					<cac:PartyIdentification>
-						<cbc:ID>TPO-0001</cbc:ID>
-					</cac:PartyIdentification>
-				</cac:AppealReceiverParty>
-			</cac:AppealTerms>
-			<cac:Language>
-				<cbc:ID>ELL</cbc:ID>
-			</cac:Language>
-			<cac:PostAwardProcess>
-				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
-				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
-			</cac:PostAwardProcess>
-		</cac:TenderingTerms>
-		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
-			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
-			<cac:TenderSubmissionDeadlinePeriod>
-				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
-				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
-			</cac:TenderSubmissionDeadlinePeriod>
-			<cac:AuctionTerms>
-				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
-			</cac:AuctionTerms>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-		</cac:TenderingProcess>
-		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0303</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
-			<cbc:Description languageID="ENG">
-				Premise
-				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
-				Development
-				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
-				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
-				Pre-production
-				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
-			</cbc:Description>
-			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
-			<cac:MainCommodityClassification>
-				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
-			</cac:MainCommodityClassification>
-			<cac:PlannedPeriod>
-				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
-			</cac:PlannedPeriod>
-		</cac:ProcurementProject>
-	</cac:ProcurementProjectLot>
-	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0304</cbc:ID>
-		<cac:TenderingTerms>
-			<ext:UBLExtensions>
-				<ext:UBLExtension>
-					<ext:ExtensionContent>
-						<efext:EformsExtension>
-							<efac:SelectionCriteria>
-								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
-							</efac:SelectionCriteria>
-						</efext:EformsExtension>
-					</ext:ExtensionContent>
-				</ext:UBLExtension>
-			</ext:UBLExtensions>
-			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
-			<cac:CallForTendersDocumentReference>
-				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
-				<cbc:DocumentType>restricted-document</cbc:DocumentType>
-				<cac:Attachment>
-					<cac:ExternalReference>
-						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
-					</cac:ExternalReference>
-				</cac:Attachment>
-			</cac:CallForTendersDocumentReference>
 			<cac:TendererQualificationRequest>
 				<cac:SpecificTendererRequirement>
-					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
@@ -27721,7 +36105,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27737,7 +36133,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27746,6 +36142,128 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0303</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0304</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27755,7 +36273,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0304</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27769,6 +36287,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27803,6 +36329,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -27812,7 +36343,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27828,7 +36371,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27837,6 +36380,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27846,7 +36392,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0305</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27860,6 +36406,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27894,6 +36448,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -27903,7 +36462,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -27919,7 +36490,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -27928,6 +36499,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -27937,7 +36511,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0306</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -27951,6 +36525,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -27985,6 +36567,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -27994,7 +36581,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28010,7 +36609,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28019,6 +36618,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28028,7 +36630,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0307</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28042,6 +36644,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28076,6 +36686,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28085,7 +36700,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28101,7 +36728,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28110,6 +36737,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28119,7 +36749,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0308</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28133,6 +36763,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28167,6 +36805,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28176,7 +36819,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28192,7 +36847,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28201,6 +36856,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28210,7 +36868,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0309</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28224,6 +36882,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28258,6 +36924,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28267,7 +36938,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28283,7 +36966,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28292,6 +36975,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28301,7 +36987,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0310</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28315,6 +37001,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28349,6 +37043,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28358,7 +37057,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28374,7 +37085,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28383,6 +37094,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28392,7 +37106,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0311</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28406,6 +37120,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28440,6 +37162,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28449,7 +37176,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28465,7 +37204,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28474,6 +37213,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28483,7 +37225,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0312</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28497,6 +37239,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28531,6 +37281,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28540,7 +37295,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28556,7 +37323,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28565,6 +37332,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28574,7 +37344,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0313</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28588,6 +37358,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28622,6 +37400,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28631,7 +37414,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28647,7 +37442,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28656,6 +37451,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28665,7 +37463,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0314</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28679,6 +37477,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28713,6 +37519,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28722,7 +37533,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28738,7 +37561,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28747,6 +37570,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28756,7 +37582,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0315</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28770,6 +37596,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28804,6 +37638,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28813,7 +37652,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28829,7 +37680,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28838,6 +37689,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28847,7 +37701,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0316</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28861,6 +37715,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28895,6 +37757,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28904,7 +37771,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -28920,7 +37799,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -28929,6 +37808,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -28938,7 +37820,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0317</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -28952,6 +37834,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -28986,6 +37876,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -28995,7 +37890,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29011,7 +37918,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29020,6 +37927,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29029,7 +37939,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0318</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29043,6 +37953,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29077,6 +37995,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29086,7 +38009,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29102,7 +38037,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29111,6 +38046,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29120,7 +38058,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0319</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29134,6 +38072,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29168,6 +38114,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29177,7 +38128,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29193,7 +38156,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29202,6 +38165,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29211,7 +38177,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0320</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29225,6 +38191,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29259,6 +38233,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29268,7 +38247,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29284,7 +38275,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29293,6 +38284,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29302,7 +38296,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0321</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29316,6 +38310,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29350,6 +38352,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29359,7 +38366,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29375,7 +38394,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29384,6 +38403,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29393,7 +38415,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0322</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29407,6 +38429,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29441,6 +38471,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29450,7 +38485,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29466,7 +38513,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29475,6 +38522,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29484,7 +38534,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0323</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29498,6 +38548,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29532,6 +38590,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29541,7 +38604,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29557,7 +38632,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29566,6 +38641,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29575,7 +38653,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0324</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29589,6 +38667,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29623,6 +38709,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29632,7 +38723,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29648,7 +38751,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29657,6 +38760,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29666,7 +38772,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0325</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29680,6 +38786,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29714,6 +38828,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29723,7 +38842,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29739,7 +38870,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29748,6 +38879,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29757,7 +38891,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0326</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29771,6 +38905,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29805,6 +38947,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29814,7 +38961,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29830,7 +38989,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29839,6 +38998,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29848,7 +39010,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0327</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29862,6 +39024,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29896,6 +39066,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29905,7 +39080,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -29921,7 +39108,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -29930,6 +39117,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -29939,7 +39129,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0328</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -29953,6 +39143,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -29987,6 +39185,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -29996,7 +39199,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30012,7 +39227,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30021,6 +39236,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30030,7 +39248,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0329</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30044,6 +39262,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30078,6 +39304,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30087,7 +39318,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30103,7 +39346,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30112,6 +39355,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30121,7 +39367,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0330</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30135,6 +39381,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30169,6 +39423,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30178,7 +39437,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30194,7 +39465,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30203,6 +39474,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30212,7 +39486,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0331</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30226,6 +39500,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30260,6 +39542,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30269,7 +39556,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30285,7 +39584,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30294,6 +39593,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30303,7 +39605,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0332</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30317,6 +39619,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30351,6 +39661,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30360,7 +39675,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30376,7 +39703,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30385,6 +39712,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30394,7 +39724,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0333</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30408,6 +39738,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30442,6 +39780,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30451,7 +39794,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30467,7 +39822,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30476,6 +39831,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30485,7 +39843,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0334</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30499,6 +39857,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30533,6 +39899,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30542,7 +39913,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30558,7 +39941,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30567,6 +39950,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30576,7 +39962,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0335</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30590,6 +39976,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30624,6 +40018,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30633,7 +40032,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30649,7 +40060,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30658,6 +40069,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30667,7 +40081,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0336</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30681,6 +40095,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30715,6 +40137,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30724,7 +40151,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30740,7 +40179,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30749,6 +40188,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30758,7 +40200,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0337</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30772,6 +40214,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30806,6 +40256,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30815,7 +40270,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30831,7 +40298,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30840,6 +40307,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30849,7 +40319,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0338</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30863,6 +40333,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30897,6 +40375,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30906,7 +40389,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -30922,7 +40417,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -30931,6 +40426,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -30940,7 +40438,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0339</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -30954,6 +40452,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -30988,6 +40494,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -30997,7 +40508,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31013,7 +40536,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31022,6 +40545,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31031,7 +40557,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0340</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31045,6 +40571,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31079,6 +40613,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31088,7 +40627,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31104,7 +40655,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31113,6 +40664,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31122,7 +40676,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0341</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31136,6 +40690,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31170,6 +40732,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31179,7 +40746,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31195,7 +40774,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31204,6 +40783,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31213,7 +40795,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0342</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31227,6 +40809,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31261,6 +40851,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31270,7 +40865,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31286,7 +40893,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31295,6 +40902,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31304,7 +40914,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0343</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31318,6 +40928,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31352,6 +40970,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31361,7 +40984,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31377,7 +41012,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31386,6 +41021,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31395,7 +41033,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0344</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31409,6 +41047,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31443,6 +41089,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31452,7 +41103,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31468,7 +41131,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31477,6 +41140,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31486,7 +41152,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0345</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31500,6 +41166,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31534,6 +41208,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31543,7 +41222,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31559,7 +41250,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31568,6 +41259,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31577,7 +41271,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0346</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31591,6 +41285,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31625,6 +41327,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31634,7 +41341,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31650,7 +41369,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31659,6 +41378,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31668,7 +41390,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0347</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31682,6 +41404,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31716,6 +41446,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31725,7 +41460,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31741,7 +41488,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31750,6 +41497,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31759,7 +41509,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0348</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31773,6 +41523,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31807,6 +41565,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31816,7 +41579,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31832,7 +41607,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31841,6 +41616,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31850,7 +41628,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0349</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31864,6 +41642,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31898,6 +41684,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31907,7 +41698,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -31923,7 +41726,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -31932,6 +41735,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -31941,7 +41747,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0350</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -31955,6 +41761,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -31989,6 +41803,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -31998,7 +41817,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32014,7 +41845,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32023,6 +41854,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32032,7 +41866,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0351</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32046,6 +41880,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32080,6 +41922,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32089,7 +41936,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32105,7 +41964,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32114,6 +41973,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32123,7 +41985,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0352</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32137,6 +41999,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32171,6 +42041,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32180,7 +42055,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32196,7 +42083,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32205,6 +42092,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32214,7 +42104,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0353</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32228,6 +42118,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32262,6 +42160,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32271,7 +42174,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32287,7 +42202,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32296,6 +42211,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32305,7 +42223,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0354</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32319,6 +42237,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32353,6 +42279,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32362,7 +42293,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32378,7 +42321,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32387,6 +42330,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32396,7 +42342,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0355</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32410,6 +42356,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32444,6 +42398,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32453,7 +42412,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32469,7 +42440,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32478,6 +42449,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32487,7 +42461,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0356</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32501,6 +42475,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32535,6 +42517,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32544,7 +42531,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32560,7 +42559,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32569,6 +42568,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32578,7 +42580,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0357</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32592,6 +42594,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32626,6 +42636,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32635,7 +42650,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32651,7 +42678,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32660,6 +42687,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32669,7 +42699,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0358</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32683,6 +42713,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32717,6 +42755,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32726,7 +42769,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32742,7 +42797,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32751,6 +42806,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32760,7 +42818,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0359</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32774,6 +42832,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32808,6 +42874,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32817,7 +42888,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32833,7 +42916,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32842,6 +42925,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32851,7 +42937,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0360</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32865,6 +42951,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32899,6 +42993,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32908,7 +43007,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -32924,7 +43035,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -32933,6 +43044,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -32942,7 +43056,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0361</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -32956,6 +43070,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -32990,6 +43112,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -32999,7 +43126,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33015,7 +43154,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33024,6 +43163,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33033,7 +43175,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0362</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33047,6 +43189,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33081,6 +43231,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33090,7 +43245,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33106,7 +43273,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33115,6 +43282,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33124,7 +43294,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0363</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33138,6 +43308,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33172,6 +43350,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33181,7 +43364,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33197,7 +43392,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33206,6 +43401,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33215,7 +43413,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0364</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33229,6 +43427,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33263,6 +43469,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33272,7 +43483,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33288,7 +43511,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33297,6 +43520,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33306,7 +43532,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0365</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33320,6 +43546,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33354,6 +43588,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33363,7 +43602,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33379,7 +43630,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33388,6 +43639,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33397,7 +43651,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0366</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33411,6 +43665,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33445,6 +43707,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33454,7 +43721,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33470,7 +43749,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33479,6 +43758,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33488,7 +43770,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0367</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33502,6 +43784,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33536,6 +43826,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33545,7 +43840,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33561,7 +43868,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33570,6 +43877,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33579,7 +43889,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0368</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33593,6 +43903,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33627,6 +43945,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33636,7 +43959,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33652,7 +43987,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33661,6 +43996,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33670,7 +44008,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0369</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33684,6 +44022,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33718,6 +44064,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33727,7 +44078,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33743,7 +44106,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33752,6 +44115,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33761,7 +44127,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0370</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33775,6 +44141,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33809,6 +44183,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33818,7 +44197,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33834,7 +44225,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33843,6 +44234,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33852,7 +44246,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0371</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33866,6 +44260,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33900,6 +44302,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -33909,7 +44316,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -33925,7 +44344,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -33934,6 +44353,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -33943,7 +44365,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0372</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -33957,6 +44379,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -33991,6 +44421,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34000,7 +44435,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34016,7 +44463,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34025,6 +44472,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34034,7 +44484,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0373</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34048,6 +44498,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34082,6 +44540,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34091,7 +44554,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34107,7 +44582,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34116,6 +44591,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34125,7 +44603,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0374</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34139,6 +44617,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34173,6 +44659,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34182,7 +44673,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34198,7 +44701,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34207,6 +44710,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34216,7 +44722,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0375</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34230,6 +44736,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34264,6 +44778,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34273,7 +44792,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34289,7 +44820,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34298,6 +44829,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34307,7 +44841,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0376</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34321,6 +44855,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34355,6 +44897,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34364,7 +44911,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34380,7 +44939,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34389,6 +44948,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34398,7 +44960,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0377</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34412,6 +44974,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34446,6 +45016,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34455,7 +45030,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34471,7 +45058,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34480,6 +45067,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34489,7 +45079,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0378</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34503,6 +45093,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34537,6 +45135,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34546,7 +45149,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34562,7 +45177,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34571,6 +45186,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34580,7 +45198,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0379</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34594,6 +45212,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34628,6 +45254,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34637,7 +45268,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34653,7 +45296,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34662,6 +45305,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34671,7 +45317,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0380</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34685,6 +45331,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34719,6 +45373,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34728,7 +45387,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34744,7 +45415,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34753,6 +45424,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34762,7 +45436,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0381</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34776,6 +45450,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34810,6 +45492,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34819,7 +45506,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34835,7 +45534,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34844,6 +45543,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34853,7 +45555,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0382</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34867,6 +45569,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34901,6 +45611,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -34910,7 +45625,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -34926,7 +45653,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -34935,6 +45662,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -34944,7 +45674,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0383</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -34958,6 +45688,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -34992,6 +45730,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -35001,7 +45744,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35017,7 +45772,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35026,6 +45781,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35035,7 +45793,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0384</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35049,6 +45807,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35083,6 +45849,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -35092,7 +45863,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35108,7 +45891,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35117,6 +45900,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35126,7 +45912,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0385</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35140,6 +45926,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35174,6 +45968,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -35183,7 +45982,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35199,7 +46010,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35208,6 +46019,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35217,7 +46031,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0386</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35231,6 +46045,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35265,6 +46087,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -35274,7 +46101,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35290,7 +46129,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35299,6 +46138,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35308,7 +46150,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0387</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35322,6 +46164,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35356,6 +46206,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -35365,7 +46220,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35381,7 +46248,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35390,6 +46257,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35399,7 +46269,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0388</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35413,6 +46283,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35447,95 +46325,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:AppealTerms>
-				<cac:AppealReceiverParty>
-					<cac:PartyIdentification>
-						<cbc:ID>TPO-0001</cbc:ID>
-					</cac:PartyIdentification>
-				</cac:AppealReceiverParty>
-			</cac:AppealTerms>
-			<cac:Language>
-				<cbc:ID>ELL</cbc:ID>
-			</cac:Language>
-			<cac:PostAwardProcess>
-				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
-				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
-			</cac:PostAwardProcess>
-		</cac:TenderingTerms>
-		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
-			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
-			<cac:TenderSubmissionDeadlinePeriod>
-				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
-				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
-			</cac:TenderSubmissionDeadlinePeriod>
-			<cac:AuctionTerms>
-				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
-			</cac:AuctionTerms>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-		</cac:TenderingProcess>
-		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0389</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
-			<cbc:Description languageID="ENG">
-				Premise
-				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
-				Development
-				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
-				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
-				Pre-production
-				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
-			</cbc:Description>
-			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
-			<cac:MainCommodityClassification>
-				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
-			</cac:MainCommodityClassification>
-			<cac:PlannedPeriod>
-				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
-			</cac:PlannedPeriod>
-		</cac:ProcurementProject>
-	</cac:ProcurementProjectLot>
-	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0390</cbc:ID>
-		<cac:TenderingTerms>
-			<ext:UBLExtensions>
-				<ext:UBLExtension>
-					<ext:ExtensionContent>
-						<efext:EformsExtension>
-							<efac:SelectionCriteria>
-								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
-							</efac:SelectionCriteria>
-						</efext:EformsExtension>
-					</ext:ExtensionContent>
-				</ext:UBLExtension>
-			</ext:UBLExtensions>
-			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
-			<cac:CallForTendersDocumentReference>
-				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
-				<cbc:DocumentType>restricted-document</cbc:DocumentType>
-				<cac:Attachment>
-					<cac:ExternalReference>
-						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
-					</cac:ExternalReference>
-				</cac:Attachment>
-			</cac:CallForTendersDocumentReference>
 			<cac:TendererQualificationRequest>
 				<cac:SpecificTendererRequirement>
-					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
@@ -35547,7 +46339,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35563,7 +46367,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35572,6 +46376,128 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0389</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0390</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35581,7 +46507,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0390</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35595,6 +46521,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35629,6 +46563,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -35638,7 +46577,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35654,7 +46605,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35663,6 +46614,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35672,7 +46626,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0391</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35686,6 +46640,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35720,6 +46682,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -35729,7 +46696,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35745,7 +46724,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35754,6 +46733,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35763,7 +46745,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0392</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35777,6 +46759,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35811,6 +46801,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -35820,7 +46815,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35836,7 +46843,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35845,6 +46852,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35854,7 +46864,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0393</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35868,6 +46878,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35902,6 +46920,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -35911,7 +46934,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -35927,7 +46962,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -35936,6 +46971,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -35945,7 +46983,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0394</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -35959,6 +46997,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -35993,6 +47039,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36002,7 +47053,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36018,7 +47081,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36027,6 +47090,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36036,7 +47102,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0395</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36050,6 +47116,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36084,6 +47158,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36093,7 +47172,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36109,7 +47200,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36118,6 +47209,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36127,7 +47221,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0396</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36141,6 +47235,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36175,6 +47277,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36184,7 +47291,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36200,7 +47319,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36209,6 +47328,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36218,7 +47340,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0397</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36232,6 +47354,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36266,6 +47396,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36275,7 +47410,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36291,7 +47438,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36300,6 +47447,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36309,7 +47459,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0398</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36323,6 +47473,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36357,6 +47515,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36366,7 +47529,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36382,7 +47557,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36391,6 +47566,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36400,7 +47578,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0399</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36414,6 +47592,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36448,6 +47634,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36457,7 +47648,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36473,7 +47676,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36482,6 +47685,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36491,7 +47697,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0400</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36505,6 +47711,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36539,6 +47753,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36548,7 +47767,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36564,7 +47795,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36573,6 +47804,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36582,7 +47816,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0401</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36596,6 +47830,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36630,6 +47872,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36639,7 +47886,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36655,7 +47914,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36664,6 +47923,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36673,7 +47935,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0402</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36687,6 +47949,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36721,6 +47991,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36730,7 +48005,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36746,7 +48033,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36755,6 +48042,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36764,7 +48054,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0403</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36778,6 +48068,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36812,6 +48110,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36821,7 +48124,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36837,7 +48152,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36846,6 +48161,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36855,7 +48173,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0404</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36869,6 +48187,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36903,6 +48229,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -36912,7 +48243,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -36928,7 +48271,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -36937,6 +48280,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -36946,7 +48292,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0405</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -36960,6 +48306,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -36994,6 +48348,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37003,7 +48362,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37019,7 +48390,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37028,6 +48399,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37037,7 +48411,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0406</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37051,6 +48425,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37085,6 +48467,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37094,7 +48481,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37110,7 +48509,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37119,6 +48518,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37128,7 +48530,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0407</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37142,6 +48544,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37176,6 +48586,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37185,7 +48600,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37201,7 +48628,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37210,6 +48637,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37219,7 +48649,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0408</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37233,6 +48663,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37267,6 +48705,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37276,7 +48719,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37292,7 +48747,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37301,6 +48756,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37310,7 +48768,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0409</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37324,6 +48782,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37358,6 +48824,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37367,7 +48838,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37383,7 +48866,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37392,6 +48875,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37401,7 +48887,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0410</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37415,6 +48901,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37449,6 +48943,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37458,7 +48957,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37474,7 +48985,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37483,6 +48994,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37492,7 +49006,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0411</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37506,6 +49020,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37540,6 +49062,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37549,7 +49076,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37565,7 +49104,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37574,6 +49113,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37583,7 +49125,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0412</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37597,6 +49139,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37631,6 +49181,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37640,7 +49195,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37656,7 +49223,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37665,6 +49232,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37674,7 +49244,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0413</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37688,6 +49258,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37722,6 +49300,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37731,7 +49314,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37747,7 +49342,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37756,6 +49351,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37765,7 +49363,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0414</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37779,6 +49377,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37813,6 +49419,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37822,7 +49433,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37838,7 +49461,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37847,6 +49470,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37856,7 +49482,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0415</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37870,6 +49496,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37904,6 +49538,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -37913,7 +49552,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -37929,7 +49580,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -37938,6 +49589,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -37947,7 +49601,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0416</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -37961,6 +49615,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -37995,6 +49657,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38004,7 +49671,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38020,7 +49699,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38029,6 +49708,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38038,7 +49720,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0417</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38052,6 +49734,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38086,6 +49776,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38095,7 +49790,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38111,7 +49818,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38120,6 +49827,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38129,7 +49839,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0418</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38143,6 +49853,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38177,6 +49895,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38186,7 +49909,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38202,7 +49937,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38211,6 +49946,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38220,7 +49958,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0419</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38234,6 +49972,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38268,6 +50014,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38277,7 +50028,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38293,7 +50056,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38302,6 +50065,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38311,7 +50077,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0420</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38325,6 +50091,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38359,6 +50133,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38368,7 +50147,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38384,7 +50175,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38393,6 +50184,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38402,7 +50196,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0421</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38416,6 +50210,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38450,6 +50252,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38459,7 +50266,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38475,7 +50294,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38484,6 +50303,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38493,7 +50315,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0422</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38507,6 +50329,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38541,6 +50371,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38550,7 +50385,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38566,7 +50413,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38575,6 +50422,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38584,7 +50434,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0423</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38598,6 +50448,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38632,6 +50490,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38641,7 +50504,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38657,7 +50532,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38666,6 +50541,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38675,7 +50553,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0424</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38689,6 +50567,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38723,6 +50609,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38732,7 +50623,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38748,7 +50651,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38757,6 +50660,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38766,7 +50672,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0425</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38780,6 +50686,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38814,6 +50728,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38823,7 +50742,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38839,7 +50770,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38848,6 +50779,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38857,7 +50791,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0426</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38871,6 +50805,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38905,6 +50847,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -38914,7 +50861,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -38930,7 +50889,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -38939,6 +50898,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -38948,7 +50910,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0427</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -38962,6 +50924,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -38996,6 +50966,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39005,7 +50980,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39021,7 +51008,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39030,6 +51017,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39039,7 +51029,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0428</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39053,6 +51043,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39087,6 +51085,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39096,7 +51099,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39112,7 +51127,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39121,6 +51136,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39130,7 +51148,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0429</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39144,6 +51162,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39178,6 +51204,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39187,7 +51218,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39203,7 +51246,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39212,6 +51255,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39221,7 +51267,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0430</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39235,6 +51281,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39269,6 +51323,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39278,7 +51337,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39294,7 +51365,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39303,6 +51374,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39312,7 +51386,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0431</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39326,6 +51400,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39360,6 +51442,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39369,7 +51456,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39385,7 +51484,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39394,6 +51493,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39403,7 +51505,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0432</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39417,6 +51519,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39451,6 +51561,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39460,7 +51575,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39476,7 +51603,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39485,6 +51612,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39494,7 +51624,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0433</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39508,6 +51638,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39542,6 +51680,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39551,7 +51694,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39567,7 +51722,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39576,6 +51731,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39585,7 +51743,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0434</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39599,6 +51757,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39633,6 +51799,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39642,7 +51813,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39658,7 +51841,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39667,6 +51850,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39676,7 +51862,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0435</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39690,6 +51876,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39724,6 +51918,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39733,7 +51932,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39749,7 +51960,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39758,6 +51969,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39767,7 +51981,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0436</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39781,6 +51995,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39815,6 +52037,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39824,7 +52051,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39840,7 +52079,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39849,6 +52088,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39858,7 +52100,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0437</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39872,6 +52114,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39906,6 +52156,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -39915,7 +52170,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -39931,7 +52198,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -39940,6 +52207,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -39949,7 +52219,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0438</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -39963,6 +52233,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -39997,6 +52275,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40006,7 +52289,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40022,7 +52317,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40031,6 +52326,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40040,7 +52338,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0439</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40054,6 +52352,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40088,6 +52394,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40097,7 +52408,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40113,7 +52436,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40122,6 +52445,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40131,7 +52457,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0440</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40145,6 +52471,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40179,6 +52513,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40188,7 +52527,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40204,7 +52555,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40213,6 +52564,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40222,7 +52576,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0441</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40236,6 +52590,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40270,6 +52632,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40279,7 +52646,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40295,7 +52674,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40304,6 +52683,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40313,7 +52695,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0442</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40327,6 +52709,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40361,6 +52751,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40370,7 +52765,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40386,7 +52793,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40395,6 +52802,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40404,7 +52814,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0443</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40418,6 +52828,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40452,6 +52870,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40461,7 +52884,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40477,7 +52912,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40486,6 +52921,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40495,7 +52933,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0444</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40509,6 +52947,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40543,6 +52989,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40552,7 +53003,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40568,7 +53031,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40577,6 +53040,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40586,7 +53052,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0445</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40600,6 +53066,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40634,6 +53108,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40643,7 +53122,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40659,7 +53150,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40668,6 +53159,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40677,7 +53171,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0446</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40691,6 +53185,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40725,6 +53227,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40734,7 +53241,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40750,7 +53269,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40759,6 +53278,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40768,7 +53290,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0447</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40782,6 +53304,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40816,6 +53346,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40825,7 +53360,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40841,7 +53388,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40850,6 +53397,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40859,7 +53409,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0448</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40873,6 +53423,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40907,6 +53465,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -40916,7 +53479,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -40932,7 +53507,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -40941,6 +53516,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -40950,7 +53528,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0449</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -40964,6 +53542,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -40998,6 +53584,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41007,7 +53598,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41023,7 +53626,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41032,6 +53635,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41041,7 +53647,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0450</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41055,6 +53661,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41089,6 +53703,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41098,7 +53717,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41114,7 +53745,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41123,6 +53754,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41132,7 +53766,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0451</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41146,6 +53780,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41180,6 +53822,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41189,7 +53836,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41205,7 +53864,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41214,6 +53873,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41223,7 +53885,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0452</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41237,6 +53899,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41271,6 +53941,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41280,7 +53955,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41296,7 +53983,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41305,6 +53992,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41314,7 +54004,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0453</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41328,6 +54018,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41362,6 +54060,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41371,7 +54074,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41387,7 +54102,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41396,6 +54111,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41405,7 +54123,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0454</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41419,6 +54137,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41453,6 +54179,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41462,7 +54193,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41478,7 +54221,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41487,6 +54230,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41496,7 +54242,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0455</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41510,6 +54256,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41544,6 +54298,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41553,7 +54312,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41569,7 +54340,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41578,6 +54349,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41587,7 +54361,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0456</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41601,6 +54375,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41635,6 +54417,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41644,7 +54431,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41660,7 +54459,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41669,6 +54468,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41678,7 +54480,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0457</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41692,6 +54494,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41726,6 +54536,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41735,7 +54550,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41751,7 +54578,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41760,6 +54587,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41769,7 +54599,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0458</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41783,6 +54613,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41817,6 +54655,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41826,7 +54669,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41842,7 +54697,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41851,6 +54706,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41860,7 +54718,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0459</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41874,6 +54732,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41908,6 +54774,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -41917,7 +54788,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -41933,7 +54816,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -41942,6 +54825,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -41951,7 +54837,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0460</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -41965,6 +54851,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -41999,6 +54893,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42008,7 +54907,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42024,7 +54935,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42033,6 +54944,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42042,7 +54956,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0461</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42056,6 +54970,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42090,6 +55012,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42099,7 +55026,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42115,7 +55054,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42124,6 +55063,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42133,7 +55075,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0462</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42147,6 +55089,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42181,6 +55131,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42190,7 +55145,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42206,7 +55173,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42215,6 +55182,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42224,7 +55194,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0463</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42238,6 +55208,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42272,6 +55250,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42281,7 +55264,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42297,7 +55292,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42306,6 +55301,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42315,7 +55313,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0464</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42329,6 +55327,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42363,6 +55369,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42372,7 +55383,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42388,7 +55411,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42397,6 +55420,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42406,7 +55432,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0465</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42420,6 +55446,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42454,6 +55488,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42463,7 +55502,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42479,7 +55530,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42488,6 +55539,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42497,7 +55551,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0466</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42511,6 +55565,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42545,6 +55607,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42554,7 +55621,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42570,7 +55649,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42579,6 +55658,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42588,7 +55670,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0467</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42602,6 +55684,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42636,6 +55726,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42645,7 +55740,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42661,7 +55768,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42670,6 +55777,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42679,7 +55789,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0468</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42693,6 +55803,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42727,6 +55845,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42736,7 +55859,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42752,7 +55887,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42761,6 +55896,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42770,7 +55908,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0469</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42784,6 +55922,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42818,6 +55964,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42827,7 +55978,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42843,7 +56006,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42852,6 +56015,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42861,7 +56027,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0470</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42875,6 +56041,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -42909,6 +56083,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -42918,7 +56097,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -42934,7 +56125,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -42943,6 +56134,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -42952,7 +56146,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0471</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -42966,6 +56160,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -43000,6 +56202,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -43009,7 +56216,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -43025,7 +56244,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -43034,6 +56253,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -43043,7 +56265,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0472</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -43057,6 +56279,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -43091,6 +56321,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -43100,7 +56335,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -43116,7 +56363,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -43125,6 +56372,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -43134,7 +56384,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0473</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -43148,6 +56398,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -43182,6 +56440,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -43191,7 +56454,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -43207,7 +56482,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -43216,6 +56491,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -43225,7 +56503,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0474</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -43239,6 +56517,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -43273,95 +56559,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:AppealTerms>
-				<cac:AppealReceiverParty>
-					<cac:PartyIdentification>
-						<cbc:ID>TPO-0001</cbc:ID>
-					</cac:PartyIdentification>
-				</cac:AppealReceiverParty>
-			</cac:AppealTerms>
-			<cac:Language>
-				<cbc:ID>ELL</cbc:ID>
-			</cac:Language>
-			<cac:PostAwardProcess>
-				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
-				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
-			</cac:PostAwardProcess>
-		</cac:TenderingTerms>
-		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
-			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
-			<cac:TenderSubmissionDeadlinePeriod>
-				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
-				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
-			</cac:TenderSubmissionDeadlinePeriod>
-			<cac:AuctionTerms>
-				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
-			</cac:AuctionTerms>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-		</cac:TenderingProcess>
-		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0475</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
-			<cbc:Description languageID="ENG">
-				Premise
-				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
-				Development
-				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
-				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
-				Pre-production
-				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
-			</cbc:Description>
-			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
-			<cac:MainCommodityClassification>
-				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
-			</cac:MainCommodityClassification>
-			<cac:PlannedPeriod>
-				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
-			</cac:PlannedPeriod>
-		</cac:ProcurementProject>
-	</cac:ProcurementProjectLot>
-	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0476</cbc:ID>
-		<cac:TenderingTerms>
-			<ext:UBLExtensions>
-				<ext:UBLExtension>
-					<ext:ExtensionContent>
-						<efext:EformsExtension>
-							<efac:SelectionCriteria>
-								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
-							</efac:SelectionCriteria>
-						</efext:EformsExtension>
-					</ext:ExtensionContent>
-				</ext:UBLExtension>
-			</ext:UBLExtensions>
-			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
-			<cac:CallForTendersDocumentReference>
-				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
-				<cbc:DocumentType>restricted-document</cbc:DocumentType>
-				<cac:Attachment>
-					<cac:ExternalReference>
-						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
-					</cac:ExternalReference>
-				</cac:Attachment>
-			</cac:CallForTendersDocumentReference>
 			<cac:TendererQualificationRequest>
 				<cac:SpecificTendererRequirement>
-					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
@@ -43373,7 +56573,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -43389,7 +56601,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -43398,6 +56610,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -43406,8 +56621,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0476</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0475</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -43421,13 +56636,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0477</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0476</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -43455,95 +56678,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:ContractExecutionRequirement>
-				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
-			</cac:ContractExecutionRequirement>
-			<cac:AppealTerms>
-				<cac:AppealReceiverParty>
-					<cac:PartyIdentification>
-						<cbc:ID>TPO-0001</cbc:ID>
-					</cac:PartyIdentification>
-				</cac:AppealReceiverParty>
-			</cac:AppealTerms>
-			<cac:Language>
-				<cbc:ID>ELL</cbc:ID>
-			</cac:Language>
-			<cac:PostAwardProcess>
-				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
-				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
-			</cac:PostAwardProcess>
-		</cac:TenderingTerms>
-		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
-			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
-			<cac:TenderSubmissionDeadlinePeriod>
-				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
-				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
-			</cac:TenderSubmissionDeadlinePeriod>
-			<cac:AuctionTerms>
-				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
-			</cac:AuctionTerms>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-			<cac:ContractingSystem>
-				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
-			</cac:ContractingSystem>
-		</cac:TenderingProcess>
-		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0477</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
-			<cbc:Description languageID="ENG">
-				Premise
-				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
-				Development
-				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
-				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
-				Pre-production
-				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
-			</cbc:Description>
-			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
-			<cac:MainCommodityClassification>
-				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
-			</cac:MainCommodityClassification>
-			<cac:PlannedPeriod>
-				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
-			</cac:PlannedPeriod>
-		</cac:ProcurementProject>
-	</cac:ProcurementProjectLot>
-	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0478</cbc:ID>
-		<cac:TenderingTerms>
-			<ext:UBLExtensions>
-				<ext:UBLExtension>
-					<ext:ExtensionContent>
-						<efext:EformsExtension>
-							<efac:SelectionCriteria>
-								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
-							</efac:SelectionCriteria>
-						</efext:EformsExtension>
-					</ext:ExtensionContent>
-				</ext:UBLExtension>
-			</ext:UBLExtensions>
-			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
-			<cac:CallForTendersDocumentReference>
-				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
-				<cbc:DocumentType>restricted-document</cbc:DocumentType>
-				<cac:Attachment>
-					<cac:ExternalReference>
-						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
-					</cac:ExternalReference>
-				</cac:Attachment>
-			</cac:CallForTendersDocumentReference>
 			<cac:TendererQualificationRequest>
 				<cac:SpecificTendererRequirement>
-					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
@@ -43555,7 +56692,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -43571,7 +56720,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -43580,6 +56729,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -43588,8 +56740,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0478</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0476</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -43603,13 +56755,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0479</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0477</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -43637,6 +56797,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -43646,7 +56811,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -43662,7 +56839,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -43671,6 +56848,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -43679,8 +56859,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0479</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0477</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -43694,13 +56874,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0480</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0478</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -43728,6 +56916,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -43737,7 +56930,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -43753,7 +56958,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -43762,6 +56967,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -43770,8 +56978,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0480</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0478</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -43785,13 +56993,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0481</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0479</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -43819,6 +57035,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -43828,7 +57049,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -43844,7 +57077,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -43853,6 +57086,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -43861,8 +57097,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0481</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0479</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -43876,13 +57112,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0482</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0480</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -43910,6 +57154,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -43919,7 +57168,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -43935,7 +57196,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -43944,6 +57205,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -43952,8 +57216,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0482</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0480</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -43967,13 +57231,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0483</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0481</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44001,6 +57273,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44010,7 +57287,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44026,7 +57315,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44035,6 +57324,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44043,8 +57335,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0483</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0481</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44058,13 +57350,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0484</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0482</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44092,6 +57392,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44101,7 +57406,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44117,7 +57434,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44126,6 +57443,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44134,8 +57454,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0484</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0482</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44149,13 +57469,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0485</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0483</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44183,6 +57511,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44192,7 +57525,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44208,7 +57553,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44217,6 +57562,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44225,8 +57573,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0485</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0483</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44240,13 +57588,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0486</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0484</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44274,6 +57630,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44283,7 +57644,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44299,7 +57672,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44308,6 +57681,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44316,8 +57692,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0486</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0484</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44331,13 +57707,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0487</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0485</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44365,6 +57749,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44374,7 +57763,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44390,7 +57791,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44399,6 +57800,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44407,8 +57811,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0487</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0485</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44422,13 +57826,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0488</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0486</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44456,6 +57868,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44465,7 +57882,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44481,7 +57910,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44490,6 +57919,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44498,8 +57930,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0488</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0486</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44513,13 +57945,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0489</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0487</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44547,6 +57987,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44556,7 +58001,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44572,7 +58029,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44581,6 +58038,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44589,8 +58049,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0489</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0487</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44604,13 +58064,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0490</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0488</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44638,6 +58106,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44647,7 +58120,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44663,7 +58148,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44672,6 +58157,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44680,8 +58168,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0490</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0488</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44695,13 +58183,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0491</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0489</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44729,6 +58225,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44738,7 +58239,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44754,7 +58267,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44763,6 +58276,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44771,8 +58287,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0491</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0489</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44786,13 +58302,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0492</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0490</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44820,6 +58344,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44829,7 +58358,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44845,7 +58386,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44854,6 +58395,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44862,8 +58406,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0492</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0490</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44877,13 +58421,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0493</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0491</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -44911,6 +58463,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -44920,7 +58477,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -44936,7 +58505,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -44945,6 +58514,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -44953,8 +58525,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0493</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0491</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -44968,13 +58540,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0494</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0492</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -45002,6 +58582,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -45011,7 +58596,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -45027,7 +58624,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -45036,6 +58633,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -45044,8 +58644,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0494</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0492</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -45059,13 +58659,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0495</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0493</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -45093,6 +58701,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -45102,7 +58715,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -45118,7 +58743,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -45127,6 +58752,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -45135,8 +58763,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0495</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0493</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -45150,13 +58778,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0496</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0494</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -45184,6 +58820,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -45193,7 +58834,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -45209,7 +58862,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -45218,6 +58871,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -45226,8 +58882,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0496</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0494</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -45241,13 +58897,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0497</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0495</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -45275,6 +58939,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -45284,7 +58953,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -45300,7 +58981,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -45309,6 +58990,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -45317,8 +59001,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0497</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0495</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -45332,13 +59016,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0498</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0496</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -45366,6 +59058,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -45375,7 +59072,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -45391,7 +59100,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -45400,6 +59109,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -45408,8 +59120,8 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:ContractingSystem>
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
-			<cbc:ID>ABE LOT-0498</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:ID>ABE LOT-0496</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -45423,13 +59135,21 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
 		</cac:ProcurementProject>
 	</cac:ProcurementProjectLot>
 	<cac:ProcurementProjectLot>
-		<cbc:ID schemeName="Lot">LOT-0499</cbc:ID>
+		<cbc:ID schemeName="Lot">LOT-0497</cbc:ID>
 		<cac:TenderingTerms>
 			<ext:UBLExtensions>
 				<ext:UBLExtension>
@@ -45457,6 +59177,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -45466,7 +59191,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -45482,7 +59219,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -45491,6 +59228,247 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0497</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0498</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0498</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0499</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -45500,7 +59478,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0499</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -45514,6 +59492,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
@@ -45548,6 +59534,11 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
 				</cac:SpecificTendererRequirement>
 			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
@@ -45557,7 +59548,19 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:ContractExecutionRequirement>
 				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
 			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
 			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
 				<cac:AppealReceiverParty>
 					<cac:PartyIdentification>
 						<cbc:ID>TPO-0001</cbc:ID>
@@ -45573,7 +59576,7 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			</cac:PostAwardProcess>
 		</cac:TenderingTerms>
 		<cac:TenderingProcess>
-			<cbc:SubmissionMethodCode listName="esubmission">not-allowed</cbc:SubmissionMethodCode>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
 			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
 			<cac:TenderSubmissionDeadlinePeriod>
 				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
@@ -45582,6 +59585,9 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:AuctionTerms>
 				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
 			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
 			<cac:ContractingSystem>
 				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
 			</cac:ContractingSystem>
@@ -45591,7 +59597,59507 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 		</cac:TenderingProcess>
 		<cac:ProcurementProject>
 			<cbc:ID>ABE LOT-0500</cbc:ID>
-			<cbc:Name languageID="ENG">Poor Things SDK 1.10 </cbc:Name>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0501</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0501</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0502</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0502</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0503</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0503</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0504</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0504</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0505</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0505</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0506</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0506</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0507</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0507</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0508</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0508</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0509</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0509</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0510</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0510</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0511</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0511</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0512</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0512</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0513</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0513</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0514</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0514</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0515</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0515</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0516</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0516</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0517</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0517</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0518</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0518</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0519</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0519</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0520</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0520</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0521</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0521</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0522</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0522</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0523</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0523</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0524</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0524</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0525</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0525</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0526</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0526</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0527</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0527</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0528</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0528</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0529</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0529</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0530</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0530</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0531</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0531</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0532</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0532</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0533</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0533</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0534</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0534</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0535</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0535</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0536</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0536</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0537</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0537</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0538</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0538</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0539</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0539</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0540</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0540</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0541</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0541</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0542</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0542</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0543</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0543</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0544</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0544</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0545</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0545</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0546</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0546</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0547</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0547</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0548</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0548</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0549</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0549</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0550</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0550</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0551</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0551</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0552</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0552</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0553</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0553</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0554</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0554</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0555</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0555</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0556</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0556</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0557</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0557</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0558</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0558</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0559</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0559</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0560</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0560</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0561</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0561</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0562</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0562</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0563</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0563</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0564</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0564</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0565</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0565</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0566</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0566</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0567</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0567</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0568</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0568</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0569</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0569</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0570</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0570</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0571</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0571</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0572</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0572</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0573</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0573</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0574</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0574</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0575</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0575</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0576</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0576</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0577</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0577</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0578</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0578</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0579</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0579</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0580</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0580</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0581</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0581</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0582</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0582</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0583</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0583</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0584</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0584</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0585</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0585</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0586</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0586</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0587</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0587</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0588</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0588</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0589</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0589</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0590</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0590</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0591</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0591</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0592</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0592</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0593</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0593</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0594</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0594</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0595</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0595</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0596</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0596</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0597</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0597</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0598</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0598</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0599</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0599</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0600</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0600</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0601</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0601</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0602</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0602</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0603</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0603</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0604</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0604</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0605</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0605</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0606</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0606</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0607</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0607</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0608</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0608</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0609</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0609</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0610</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0610</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0611</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0611</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0612</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0612</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0613</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0613</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0614</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0614</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0615</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0615</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0616</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0616</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0617</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0617</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0618</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0618</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0619</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0619</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0620</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0620</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0621</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0621</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0622</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0622</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0623</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0623</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0624</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0624</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0625</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0625</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0626</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0626</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0627</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0627</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0628</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0628</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0629</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0629</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0630</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0630</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0631</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0631</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0632</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0632</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0633</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0633</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0634</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0634</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0635</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0635</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0636</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0636</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0637</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0637</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0638</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0638</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0639</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0639</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0640</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0640</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0641</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0641</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0642</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0642</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0643</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0643</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0644</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0644</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0645</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0645</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0646</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0646</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0647</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0647</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0648</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0648</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0649</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0649</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0650</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0650</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0651</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0651</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0652</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0652</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0653</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0653</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0654</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0654</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0655</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0655</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0656</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0656</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0657</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0657</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0658</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0658</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0659</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0659</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0660</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0660</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0661</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0661</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0662</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0662</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0663</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0663</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0664</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0664</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0665</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0665</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0666</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0666</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0667</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0667</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0668</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0668</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0669</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0669</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0670</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0670</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0671</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0671</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0672</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0672</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0673</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0673</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0674</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0674</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0675</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0675</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0676</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0676</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0677</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0677</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0678</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0678</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0679</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0679</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0680</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0680</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0681</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0681</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0682</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0682</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0683</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0683</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0684</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0684</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0685</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0685</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0686</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0686</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0687</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0687</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0688</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0688</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0689</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0689</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0690</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0690</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0691</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0691</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0692</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0692</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0693</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0693</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0694</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0694</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0695</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0695</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0696</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0696</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0697</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0697</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0698</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0698</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0699</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0699</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0700</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0700</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0701</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0701</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0702</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0702</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0703</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0703</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0704</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0704</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0705</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0705</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0706</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0706</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0707</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0707</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0708</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0708</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0709</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0709</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0710</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0710</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0711</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0711</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0712</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0712</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0713</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0713</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0714</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0714</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0715</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0715</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0716</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0716</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0717</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0717</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0718</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0718</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0719</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0719</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0720</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0720</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0721</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0721</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0722</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0722</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0723</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0723</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0724</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0724</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0725</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0725</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0726</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0726</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0727</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0727</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0728</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0728</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0729</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0729</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0730</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0730</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0731</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0731</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0732</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0732</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0733</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0733</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0734</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0734</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0735</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0735</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0736</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0736</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0737</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0737</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0738</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0738</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0739</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0739</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0740</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0740</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0741</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0741</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0742</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0742</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0743</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0743</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0744</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0744</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0745</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0745</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0746</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0746</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0747</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0747</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0748</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0748</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0749</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0749</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0750</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0750</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0751</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0751</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0752</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0752</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0753</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0753</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0754</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0754</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0755</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0755</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0756</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0756</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0757</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0757</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0758</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0758</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0759</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0759</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0760</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0760</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0761</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0761</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0762</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0762</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0763</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0763</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0764</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0764</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0765</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0765</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0766</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0766</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0767</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0767</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0768</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0768</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0769</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0769</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0770</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0770</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0771</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0771</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0772</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0772</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0773</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0773</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0774</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0774</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0775</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0775</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0776</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0776</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0777</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0777</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0778</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0778</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0779</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0779</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0780</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0780</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0781</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0781</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0782</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0782</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0783</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0783</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0784</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0784</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0785</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0785</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0786</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0786</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0787</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0787</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0788</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0788</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0789</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0789</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0790</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0790</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0791</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0791</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0792</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0792</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0793</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0793</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0794</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0794</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0795</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0795</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0796</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0796</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0797</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0797</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0798</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0798</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0799</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0799</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0800</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0800</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0801</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0801</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0802</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0802</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0803</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0803</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0804</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0804</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0805</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0805</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0806</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0806</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0807</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0807</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0808</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0808</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0809</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0809</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0810</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0810</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0811</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0811</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0812</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0812</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0813</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0813</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0814</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0814</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0815</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0815</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0816</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0816</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0817</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0817</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0818</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0818</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0819</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0819</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0820</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0820</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0821</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0821</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0822</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0822</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0823</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0823</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0824</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0824</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0825</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0825</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0826</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0826</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0827</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0827</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0828</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0828</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0829</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0829</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0830</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0830</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0831</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0831</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0832</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0832</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0833</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0833</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0834</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0834</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0835</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0835</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0836</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0836</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0837</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0837</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0838</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0838</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0839</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0839</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0840</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0840</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0841</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0841</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0842</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0842</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0843</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0843</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0844</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0844</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0845</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0845</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0846</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0846</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0847</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0847</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0848</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0848</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0849</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0849</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0850</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0850</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0851</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0851</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0852</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0852</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0853</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0853</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0854</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0854</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0855</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0855</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0856</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0856</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0857</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0857</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0858</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0858</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0859</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0859</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0860</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0860</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0861</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0861</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0862</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0862</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0863</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0863</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0864</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0864</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0865</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0865</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0866</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0866</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0867</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0867</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0868</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0868</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0869</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0869</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0870</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0870</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0871</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0871</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0872</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0872</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0873</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0873</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0874</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0874</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0875</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0875</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0876</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0876</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0877</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0877</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0878</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0878</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0879</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0879</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0880</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0880</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0881</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0881</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0882</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0882</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0883</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0883</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0884</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0884</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0885</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0885</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0886</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0886</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0887</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0887</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0888</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0888</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0889</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0889</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0890</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0890</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0891</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0891</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0892</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0892</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0893</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0893</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0894</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0894</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0895</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0895</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0896</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0896</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0897</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0897</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0898</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0898</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0899</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0899</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0900</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0900</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0901</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0901</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0902</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0902</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0903</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0903</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0904</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0904</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0905</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0905</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0906</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0906</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0907</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0907</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0908</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0908</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0909</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0909</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0910</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0910</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0911</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0911</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0912</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0912</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0913</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0913</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0914</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0914</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0915</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0915</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0916</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0916</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0917</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0917</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0918</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0918</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0919</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0919</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0920</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0920</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0921</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0921</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0922</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0922</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0923</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0923</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0924</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0924</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0925</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0925</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0926</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0926</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0927</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0927</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0928</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0928</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0929</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0929</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0930</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0930</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0931</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0931</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0932</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0932</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0933</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0933</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0934</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0934</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0935</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0935</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0936</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0936</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0937</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0937</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0938</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0938</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0939</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0939</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0940</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0940</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0941</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0941</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0942</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0942</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0943</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0943</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0944</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0944</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0945</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0945</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0946</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0946</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0947</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0947</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0948</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0948</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0949</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0949</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0950</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0950</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0951</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0951</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0952</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0952</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0953</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0953</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0954</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0954</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0955</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0955</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0956</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0956</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0957</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0957</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0958</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0958</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0959</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0959</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0960</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0960</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0961</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0961</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0962</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0962</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0963</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0963</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0964</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0964</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0965</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0965</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0966</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0966</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0967</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0967</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0968</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0968</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0969</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0969</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0970</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0970</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0971</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0971</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0972</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0972</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0973</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0973</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0974</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0974</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0975</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0975</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0976</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0976</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0977</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0977</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0978</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0978</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0979</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0979</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0980</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0980</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0981</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0981</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0982</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0982</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0983</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0983</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0984</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0984</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0985</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0985</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0986</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0986</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0987</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0987</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0988</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0988</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0989</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0989</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0990</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0990</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0991</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0991</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0992</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0992</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0993</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0993</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0994</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0994</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0995</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0995</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0996</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0996</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0997</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0997</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0998</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0998</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-0999</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-0999</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
+			<cbc:Description languageID="ENG">
+				Premise
+				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
+				Development
+				Lanthimos read Poor Things years prior to developing the film and met with the author, Alasdair Gray, in Scotland to acquire the rights. "He was a very lovely man," Lanthimos shared, "Unfortunately, he died just a couple of years before we actually made the film, but he was very special and energetic; he was 80-something [when we met], and as soon as I got there, he had seen Dogtooth and said, 'I had my friend put on the DVD, because I don’t know how to operate these things, but I think you're very talented, young man.'" Lanthimos shared that Gray took him on a personal tour of Glasgow, where Gray showed Lanthimos several places that he had incorporated into the story.[citation needed]
+				While filming The Favourite (2018), Lanthimos revisited the project, which he discussed with Emma Stone, who also starred in the film. Lanthimos began developing Poor Things more actively following the success of The Favourite: “After the relative success of The Favourite, where I actually made a slightly more expensive film that was successful, people were more inclined to allow me to do whatever it is that I wanted, so I just went back to Gray’s book and said, ‘This is what I want to do.’ It was a long process, but the book was always on my mind.” While developing the film, Lanthimos and Stone collaborated with each other on the short film Bleat (2022).[8]
+				Pre-production
+				Poor Things was officially announced in February 2021.[9] Lanthimos felt that working with Stone again gave him an advantage to the production, as they developed a mutual trust towards one another. Stone also discussed how the process of making Poor Things was different in comparison to The Favourite, due to also acting as a producer: “It was so interesting to be involved in how the film was being pieced together, from cast to department heads to what have you. Ultimately, Yorgos was the one making those decisions, but I was very involved in the process, which started during the pandemic; we were reaching out to people and casting and everything during that time, because we couldn’t go anywhere.”[10]
+			</cbc:Description>
+			<cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
+			<cac:MainCommodityClassification>
+				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
+			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
+			<cac:PlannedPeriod>
+				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
+			</cac:PlannedPeriod>
+		</cac:ProcurementProject>
+	</cac:ProcurementProjectLot>
+	<cac:ProcurementProjectLot>
+		<cbc:ID schemeName="Lot">LOT-1000</cbc:ID>
+		<cac:TenderingTerms>
+			<ext:UBLExtensions>
+				<ext:UBLExtension>
+					<ext:ExtensionContent>
+						<efext:EformsExtension>
+							<efac:SelectionCriteria>
+								<cbc:CriterionTypeCode listName="selection-criterion">tp-abil</cbc:CriterionTypeCode>
+							</efac:SelectionCriteria>
+						</efext:EformsExtension>
+					</ext:ExtensionContent>
+				</ext:UBLExtension>
+			</ext:UBLExtensions>
+			<cbc:FundingProgramCode listName="eu-funded">eu-funds</cbc:FundingProgramCode>
+			<cac:CallForTendersDocumentReference>
+				<cbc:ID>_DEFAULT_VALUE_CHANGE_ME_</cbc:ID>
+				<cbc:DocumentType>restricted-document</cbc:DocumentType>
+				<cac:Attachment>
+					<cac:ExternalReference>
+						<cbc:URI>https://enotices2.acceptance.ted.europa.eu/home</cbc:URI>
+					</cac:ExternalReference>
+				</cac:Attachment>
+			</cac:CallForTendersDocumentReference>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="reserved-procurement">res-pub-ser</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:TendererQualificationRequest>
+				<cac:SpecificTendererRequirement>
+					<cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
+				</cac:SpecificTendererRequirement>
+			</cac:TendererQualificationRequest>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="einvoicing">not-allowed</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:ContractExecutionRequirement>
+				<cbc:ExecutionRequirementCode listName="ecatalog-submission">required</cbc:ExecutionRequirementCode>
+			</cac:ContractExecutionRequirement>
+			<cac:TenderRecipientParty>
+				<cbc:EndpointID>https://endpoint.example.com</cbc:EndpointID>
+				<cac:PartyIdentification>
+					<cbc:ID schemeName="organization">ORG-0001</cbc:ID>
+				</cac:PartyIdentification>
+			</cac:TenderRecipientParty>
+			<cac:TenderValidityPeriod>
+				<cbc:DurationMeasure unitCode="MONTH">6</cbc:DurationMeasure>
+			</cac:TenderValidityPeriod>
+			<cac:AppealTerms>
+				<cac:PresentationPeriod>
+					<cbc:Description languageID="ENG">Within 2 months of the notification to the plaintiff</cbc:Description>
+				</cac:PresentationPeriod>
+				<cac:AppealReceiverParty>
+					<cac:PartyIdentification>
+						<cbc:ID>TPO-0001</cbc:ID>
+					</cac:PartyIdentification>
+				</cac:AppealReceiverParty>
+			</cac:AppealTerms>
+			<cac:Language>
+				<cbc:ID>ELL</cbc:ID>
+			</cac:Language>
+			<cac:PostAwardProcess>
+				<cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
+				<cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
+			</cac:PostAwardProcess>
+		</cac:TenderingTerms>
+		<cac:TenderingProcess>
+			<cbc:SubmissionMethodCode listName="esubmission">allowed</cbc:SubmissionMethodCode>
+			<cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
+			<cac:TenderSubmissionDeadlinePeriod>
+				<cbc:EndDate>2023-12-30+02:00</cbc:EndDate>
+				<cbc:EndTime>15:16:17+02:00</cbc:EndTime>
+			</cac:TenderSubmissionDeadlinePeriod>
+			<cac:AuctionTerms>
+				<cbc:AuctionConstraintIndicator>true</cbc:AuctionConstraintIndicator>
+			</cac:AuctionTerms>
+			<cac:FrameworkAgreement>
+				<cbc:MaximumOperatorQuantity>3</cbc:MaximumOperatorQuantity>
+			</cac:FrameworkAgreement>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="framework-agreement">fa-mix</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+			<cac:ContractingSystem>
+				<cbc:ContractingSystemTypeCode listName="dps-usage">dps-nlist</cbc:ContractingSystemTypeCode>
+			</cac:ContractingSystem>
+		</cac:TenderingProcess>
+		<cac:ProcurementProject>
+			<cbc:ID>ABE LOT-1000</cbc:ID>
+			<cbc:Name languageID="ENG">Poor Things</cbc:Name>
 			<cbc:Description languageID="ENG">
 				Premise
 				A young woman, Bella, is brought back to life by her guardian, the scientist Dr. Godwin Baxter. Initially naïve, Bella is eager to learn about the world around her, albeit under Baxter's protection. Wanting to see more, she runs off with Duncan Wedderburn, a slick and debauched lawyer, and travels across continents. Free from the prejudices of her times, Bella demands equality and liberation.[7]
@@ -45605,6 +119111,14 @@ Poor Things was officially announced in February 2021.[9] Lanthimos felt that wo
 			<cac:MainCommodityClassification>
 				<cbc:ItemClassificationCode listName="cpv">75121000</cbc:ItemClassificationCode>
 			</cac:MainCommodityClassification>
+			<cac:RealizedLocation>
+				<cac:Address>
+					<cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
+					<cac:Country>
+						<cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
+					</cac:Country>
+				</cac:Address>
+			</cac:RealizedLocation>
 			<cac:PlannedPeriod>
 				<cbc:DurationMeasure unitCode="DAY">10</cbc:DurationMeasure>
 			</cac:PlannedPeriod>
diff --git a/src/main/resources/benchmark/notices/29.xml b/src/main/resources/benchmark/notices/29.xml
index ec8dddf..5df9794 100644
--- a/src/main/resources/benchmark/notices/29.xml
+++ b/src/main/resources/benchmark/notices/29.xml
@@ -13,7 +13,7 @@
                      <cbc:ID schemeName="result">RES-0001</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -66,7 +66,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0002</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0001</cbc:ID>
                      </efac:LotTender>
@@ -128,7 +127,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0003</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0002</cbc:ID>
                      </efac:LotTender>
@@ -190,7 +188,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0004</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0003</cbc:ID>
                      </efac:LotTender>
@@ -252,7 +249,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0005</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0004</cbc:ID>
                      </efac:LotTender>
@@ -314,7 +310,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0006</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0005</cbc:ID>
                      </efac:LotTender>
@@ -376,7 +371,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0007</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0006</cbc:ID>
                      </efac:LotTender>
@@ -438,7 +432,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0008</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0007</cbc:ID>
                      </efac:LotTender>
@@ -500,7 +493,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0009</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0008</cbc:ID>
                      </efac:LotTender>
@@ -562,7 +554,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0010</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0009</cbc:ID>
                      </efac:LotTender>
@@ -624,7 +615,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0011</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0010</cbc:ID>
                      </efac:LotTender>
@@ -686,7 +676,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0012</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0011</cbc:ID>
                      </efac:LotTender>
@@ -748,7 +737,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0013</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0012</cbc:ID>
                      </efac:LotTender>
@@ -810,7 +798,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0014</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0013</cbc:ID>
                      </efac:LotTender>
@@ -872,7 +859,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0015</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0014</cbc:ID>
                      </efac:LotTender>
@@ -934,7 +920,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0016</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0015</cbc:ID>
                      </efac:LotTender>
@@ -996,7 +981,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0017</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0016</cbc:ID>
                      </efac:LotTender>
@@ -1058,7 +1042,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0018</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0017</cbc:ID>
                      </efac:LotTender>
@@ -1120,7 +1103,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0019</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0018</cbc:ID>
                      </efac:LotTender>
@@ -1182,7 +1164,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0020</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0019</cbc:ID>
                      </efac:LotTender>
@@ -1244,7 +1225,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0021</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0020</cbc:ID>
                      </efac:LotTender>
@@ -1306,7 +1286,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0022</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0021</cbc:ID>
                      </efac:LotTender>
@@ -1368,7 +1347,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0023</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0022</cbc:ID>
                      </efac:LotTender>
@@ -1430,7 +1408,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0024</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0023</cbc:ID>
                      </efac:LotTender>
@@ -1492,7 +1469,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0025</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0024</cbc:ID>
                      </efac:LotTender>
@@ -1554,7 +1530,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0026</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0025</cbc:ID>
                      </efac:LotTender>
@@ -1616,7 +1591,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0027</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0026</cbc:ID>
                      </efac:LotTender>
@@ -1678,7 +1652,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0028</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0027</cbc:ID>
                      </efac:LotTender>
@@ -1740,7 +1713,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0029</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0028</cbc:ID>
                      </efac:LotTender>
@@ -1802,7 +1774,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0030</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0029</cbc:ID>
                      </efac:LotTender>
@@ -1864,7 +1835,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0031</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0030</cbc:ID>
                      </efac:LotTender>
@@ -1926,7 +1896,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0032</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0031</cbc:ID>
                      </efac:LotTender>
@@ -1989,7 +1958,7 @@
                      <cbc:ID schemeName="result">RES-0033</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">all-rej</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -2042,7 +2011,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0034</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0032</cbc:ID>
                      </efac:LotTender>
@@ -2104,7 +2072,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0035</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0033</cbc:ID>
                      </efac:LotTender>
@@ -2166,7 +2133,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0036</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0034</cbc:ID>
                      </efac:LotTender>
@@ -2228,7 +2194,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0037</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0035</cbc:ID>
                      </efac:LotTender>
@@ -2290,7 +2255,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0038</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0036</cbc:ID>
                      </efac:LotTender>
@@ -2352,7 +2316,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0039</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0037</cbc:ID>
                      </efac:LotTender>
@@ -2414,7 +2377,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0040</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0038</cbc:ID>
                      </efac:LotTender>
@@ -2476,7 +2438,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0041</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0039</cbc:ID>
                      </efac:LotTender>
@@ -2538,7 +2499,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0042</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0040</cbc:ID>
                      </efac:LotTender>
@@ -2600,7 +2560,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0043</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0041</cbc:ID>
                      </efac:LotTender>
@@ -2662,7 +2621,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0044</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0042</cbc:ID>
                      </efac:LotTender>
@@ -2724,7 +2682,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0045</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0043</cbc:ID>
                      </efac:LotTender>
@@ -2786,7 +2743,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0046</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0044</cbc:ID>
                      </efac:LotTender>
@@ -2848,7 +2804,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0047</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0045</cbc:ID>
                      </efac:LotTender>
@@ -2910,7 +2865,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0048</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0046</cbc:ID>
                      </efac:LotTender>
@@ -2972,7 +2926,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0049</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0047</cbc:ID>
                      </efac:LotTender>
@@ -3034,7 +2987,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0050</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0048</cbc:ID>
                      </efac:LotTender>
@@ -3096,7 +3048,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0051</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0049</cbc:ID>
                      </efac:LotTender>
@@ -3158,7 +3109,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0052</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0050</cbc:ID>
                      </efac:LotTender>
@@ -3220,7 +3170,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0053</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0051</cbc:ID>
                      </efac:LotTender>
@@ -3282,7 +3231,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0054</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0052</cbc:ID>
                      </efac:LotTender>
@@ -3344,7 +3292,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0055</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0053</cbc:ID>
                      </efac:LotTender>
@@ -3406,7 +3353,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0056</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0054</cbc:ID>
                      </efac:LotTender>
@@ -3468,7 +3414,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0057</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0055</cbc:ID>
                      </efac:LotTender>
@@ -3530,7 +3475,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0058</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0056</cbc:ID>
                      </efac:LotTender>
@@ -3592,7 +3536,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0059</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0057</cbc:ID>
                      </efac:LotTender>
@@ -3654,7 +3597,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0060</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0058</cbc:ID>
                      </efac:LotTender>
@@ -3716,7 +3658,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0061</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0059</cbc:ID>
                      </efac:LotTender>
@@ -3778,7 +3719,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0062</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0060</cbc:ID>
                      </efac:LotTender>
@@ -3840,7 +3780,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0063</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0061</cbc:ID>
                      </efac:LotTender>
@@ -3902,7 +3841,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0064</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0062</cbc:ID>
                      </efac:LotTender>
@@ -3964,7 +3902,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0065</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0063</cbc:ID>
                      </efac:LotTender>
@@ -4026,7 +3963,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0066</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0064</cbc:ID>
                      </efac:LotTender>
@@ -4088,7 +4024,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0067</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0065</cbc:ID>
                      </efac:LotTender>
@@ -4150,7 +4085,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0068</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0066</cbc:ID>
                      </efac:LotTender>
@@ -4212,7 +4146,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0069</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0067</cbc:ID>
                      </efac:LotTender>
@@ -4274,7 +4207,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0070</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0068</cbc:ID>
                      </efac:LotTender>
@@ -4336,7 +4268,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0071</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0069</cbc:ID>
                      </efac:LotTender>
@@ -4398,7 +4329,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0072</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0070</cbc:ID>
                      </efac:LotTender>
@@ -4460,7 +4390,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0073</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0071</cbc:ID>
                      </efac:LotTender>
@@ -4522,7 +4451,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0074</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0072</cbc:ID>
                      </efac:LotTender>
@@ -4584,7 +4512,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0075</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0073</cbc:ID>
                      </efac:LotTender>
@@ -4646,7 +4573,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0076</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0074</cbc:ID>
                      </efac:LotTender>
@@ -4708,7 +4634,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0077</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0075</cbc:ID>
                      </efac:LotTender>
@@ -4770,7 +4695,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0078</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0076</cbc:ID>
                      </efac:LotTender>
@@ -4832,7 +4756,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0079</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0077</cbc:ID>
                      </efac:LotTender>
@@ -4894,7 +4817,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0080</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0078</cbc:ID>
                      </efac:LotTender>
@@ -4957,7 +4879,7 @@
                      <cbc:ID schemeName="result">RES-0081</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -5010,7 +4932,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0082</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0079</cbc:ID>
                      </efac:LotTender>
@@ -5072,7 +4993,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0083</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0080</cbc:ID>
                      </efac:LotTender>
@@ -5134,7 +5054,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0084</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0081</cbc:ID>
                      </efac:LotTender>
@@ -5196,7 +5115,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0085</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0082</cbc:ID>
                      </efac:LotTender>
@@ -5258,7 +5176,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0086</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0083</cbc:ID>
                      </efac:LotTender>
@@ -5320,7 +5237,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0087</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0084</cbc:ID>
                      </efac:LotTender>
@@ -5382,7 +5298,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0088</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0085</cbc:ID>
                      </efac:LotTender>
@@ -5444,7 +5359,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0089</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0086</cbc:ID>
                      </efac:LotTender>
@@ -5506,7 +5420,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0090</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0087</cbc:ID>
                      </efac:LotTender>
@@ -5568,7 +5481,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0091</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0088</cbc:ID>
                      </efac:LotTender>
@@ -5630,7 +5542,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0092</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0089</cbc:ID>
                      </efac:LotTender>
@@ -5692,7 +5603,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0093</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0090</cbc:ID>
                      </efac:LotTender>
@@ -5754,7 +5664,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0094</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0091</cbc:ID>
                      </efac:LotTender>
@@ -5816,7 +5725,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0095</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0092</cbc:ID>
                      </efac:LotTender>
@@ -5878,7 +5786,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0096</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0093</cbc:ID>
                      </efac:LotTender>
@@ -5940,7 +5847,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0097</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0094</cbc:ID>
                      </efac:LotTender>
@@ -6002,7 +5908,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0098</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0095</cbc:ID>
                      </efac:LotTender>
@@ -6064,7 +5969,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0099</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0096</cbc:ID>
                      </efac:LotTender>
@@ -6126,7 +6030,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0100</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0097</cbc:ID>
                      </efac:LotTender>
@@ -6188,7 +6091,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0101</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0098</cbc:ID>
                      </efac:LotTender>
@@ -6250,7 +6152,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0102</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0099</cbc:ID>
                      </efac:LotTender>
@@ -6312,7 +6213,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0103</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0100</cbc:ID>
                      </efac:LotTender>
@@ -6374,7 +6274,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0104</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0101</cbc:ID>
                      </efac:LotTender>
@@ -6436,7 +6335,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0105</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0102</cbc:ID>
                      </efac:LotTender>
@@ -6498,7 +6396,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0106</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0103</cbc:ID>
                      </efac:LotTender>
@@ -6560,7 +6457,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0107</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0104</cbc:ID>
                      </efac:LotTender>
@@ -6622,7 +6518,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0108</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0105</cbc:ID>
                      </efac:LotTender>
@@ -6684,7 +6579,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0109</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0106</cbc:ID>
                      </efac:LotTender>
@@ -6746,7 +6640,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0110</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0107</cbc:ID>
                      </efac:LotTender>
@@ -6809,7 +6702,7 @@
                      <cbc:ID schemeName="result">RES-0111</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -6862,7 +6755,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0112</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0108</cbc:ID>
                      </efac:LotTender>
@@ -6924,7 +6816,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0113</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0109</cbc:ID>
                      </efac:LotTender>
@@ -6986,7 +6877,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0114</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0110</cbc:ID>
                      </efac:LotTender>
@@ -7048,7 +6938,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0115</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0111</cbc:ID>
                      </efac:LotTender>
@@ -7110,7 +6999,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0116</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0112</cbc:ID>
                      </efac:LotTender>
@@ -7172,7 +7060,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0117</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0113</cbc:ID>
                      </efac:LotTender>
@@ -7234,7 +7121,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0118</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0114</cbc:ID>
                      </efac:LotTender>
@@ -7296,7 +7182,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0119</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0115</cbc:ID>
                      </efac:LotTender>
@@ -7358,7 +7243,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0120</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0116</cbc:ID>
                      </efac:LotTender>
@@ -7420,7 +7304,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0121</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0117</cbc:ID>
                      </efac:LotTender>
@@ -7482,7 +7365,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0122</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0118</cbc:ID>
                      </efac:LotTender>
@@ -7544,7 +7426,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0123</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0119</cbc:ID>
                      </efac:LotTender>
@@ -7606,7 +7487,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0124</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0120</cbc:ID>
                      </efac:LotTender>
@@ -7668,7 +7548,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0125</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0121</cbc:ID>
                      </efac:LotTender>
@@ -7730,7 +7609,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0126</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0122</cbc:ID>
                      </efac:LotTender>
@@ -7792,7 +7670,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0127</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0123</cbc:ID>
                      </efac:LotTender>
@@ -7854,7 +7731,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0128</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0124</cbc:ID>
                      </efac:LotTender>
@@ -7916,7 +7792,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0129</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0125</cbc:ID>
                      </efac:LotTender>
@@ -7978,7 +7853,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0130</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0126</cbc:ID>
                      </efac:LotTender>
@@ -8040,7 +7914,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0131</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0127</cbc:ID>
                      </efac:LotTender>
@@ -8102,7 +7975,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0132</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0128</cbc:ID>
                      </efac:LotTender>
@@ -8164,7 +8036,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0133</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0129</cbc:ID>
                      </efac:LotTender>
@@ -8227,7 +8098,7 @@
                      <cbc:ID schemeName="result">RES-0134</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -8280,7 +8151,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0135</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0130</cbc:ID>
                      </efac:LotTender>
@@ -8342,7 +8212,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0136</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0131</cbc:ID>
                      </efac:LotTender>
@@ -8404,7 +8273,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0137</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0132</cbc:ID>
                      </efac:LotTender>
@@ -8466,7 +8334,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0138</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0133</cbc:ID>
                      </efac:LotTender>
@@ -8528,7 +8395,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0139</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0134</cbc:ID>
                      </efac:LotTender>
@@ -8590,7 +8456,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0140</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0135</cbc:ID>
                      </efac:LotTender>
@@ -8652,7 +8517,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0141</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0136</cbc:ID>
                      </efac:LotTender>
@@ -8714,7 +8578,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0142</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0137</cbc:ID>
                      </efac:LotTender>
@@ -8776,7 +8639,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0143</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0138</cbc:ID>
                      </efac:LotTender>
@@ -8838,7 +8700,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0144</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0139</cbc:ID>
                      </efac:LotTender>
@@ -8900,7 +8761,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0145</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0140</cbc:ID>
                      </efac:LotTender>
@@ -8962,7 +8822,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0146</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0141</cbc:ID>
                      </efac:LotTender>
@@ -9024,7 +8883,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0147</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0142</cbc:ID>
                      </efac:LotTender>
@@ -9086,7 +8944,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0148</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0143</cbc:ID>
                      </efac:LotTender>
@@ -9149,7 +9006,7 @@
                      <cbc:ID schemeName="result">RES-0149</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -9202,7 +9059,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0150</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0144</cbc:ID>
                      </efac:LotTender>
@@ -9264,7 +9120,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0151</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0145</cbc:ID>
                      </efac:LotTender>
@@ -9326,7 +9181,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0152</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0146</cbc:ID>
                      </efac:LotTender>
@@ -9388,7 +9242,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0153</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0147</cbc:ID>
                      </efac:LotTender>
@@ -9450,7 +9303,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0154</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0148</cbc:ID>
                      </efac:LotTender>
@@ -9512,7 +9364,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0155</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0149</cbc:ID>
                      </efac:LotTender>
@@ -9574,7 +9425,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0156</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0150</cbc:ID>
                      </efac:LotTender>
@@ -9636,7 +9486,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0157</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0151</cbc:ID>
                      </efac:LotTender>
@@ -9699,7 +9548,7 @@
                      <cbc:ID schemeName="result">RES-0158</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -9752,7 +9601,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0159</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0152</cbc:ID>
                      </efac:LotTender>
@@ -9814,7 +9662,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0160</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0153</cbc:ID>
                      </efac:LotTender>
@@ -9876,7 +9723,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0161</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0154</cbc:ID>
                      </efac:LotTender>
@@ -9938,7 +9784,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0162</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0155</cbc:ID>
                      </efac:LotTender>
@@ -10000,7 +9845,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0163</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0156</cbc:ID>
                      </efac:LotTender>
@@ -10062,7 +9906,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0164</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0157</cbc:ID>
                      </efac:LotTender>
@@ -10124,7 +9967,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0165</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0158</cbc:ID>
                      </efac:LotTender>
@@ -10186,7 +10028,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0166</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0159</cbc:ID>
                      </efac:LotTender>
@@ -10248,7 +10089,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0167</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0160</cbc:ID>
                      </efac:LotTender>
@@ -10310,7 +10150,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0168</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0161</cbc:ID>
                      </efac:LotTender>
@@ -10372,7 +10211,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0169</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0162</cbc:ID>
                      </efac:LotTender>
@@ -10434,7 +10272,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0170</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0163</cbc:ID>
                      </efac:LotTender>
@@ -10496,7 +10333,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0171</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0164</cbc:ID>
                      </efac:LotTender>
@@ -10558,7 +10394,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0172</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0165</cbc:ID>
                      </efac:LotTender>
@@ -10621,7 +10456,7 @@
                      <cbc:ID schemeName="result">RES-0173</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -10674,7 +10509,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0174</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0166</cbc:ID>
                      </efac:LotTender>
@@ -10737,7 +10571,7 @@
                      <cbc:ID schemeName="result">RES-0175</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -10790,7 +10624,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0176</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0167</cbc:ID>
                      </efac:LotTender>
@@ -10852,7 +10685,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0177</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0168</cbc:ID>
                      </efac:LotTender>
@@ -10914,7 +10746,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0178</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0169</cbc:ID>
                      </efac:LotTender>
@@ -10976,7 +10807,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0179</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0170</cbc:ID>
                      </efac:LotTender>
@@ -11038,7 +10868,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0180</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0171</cbc:ID>
                      </efac:LotTender>
@@ -11101,7 +10930,7 @@
                      <cbc:ID schemeName="result">RES-0181</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -11154,7 +10983,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0182</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0172</cbc:ID>
                      </efac:LotTender>
@@ -11216,7 +11044,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0183</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0173</cbc:ID>
                      </efac:LotTender>
@@ -11278,7 +11105,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0184</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0174</cbc:ID>
                      </efac:LotTender>
@@ -11340,7 +11166,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0185</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0175</cbc:ID>
                      </efac:LotTender>
@@ -11402,7 +11227,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0186</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0176</cbc:ID>
                      </efac:LotTender>
@@ -11464,7 +11288,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0187</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0177</cbc:ID>
                      </efac:LotTender>
@@ -11526,7 +11349,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0188</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0178</cbc:ID>
                      </efac:LotTender>
@@ -11588,7 +11410,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0189</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0179</cbc:ID>
                      </efac:LotTender>
@@ -11650,7 +11471,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0190</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0180</cbc:ID>
                      </efac:LotTender>
@@ -11712,7 +11532,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0191</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0181</cbc:ID>
                      </efac:LotTender>
@@ -11774,7 +11593,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0192</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0182</cbc:ID>
                      </efac:LotTender>
@@ -11836,7 +11654,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0193</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0183</cbc:ID>
                      </efac:LotTender>
@@ -11898,7 +11715,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0194</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0184</cbc:ID>
                      </efac:LotTender>
@@ -11960,7 +11776,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0195</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0185</cbc:ID>
                      </efac:LotTender>
@@ -12022,7 +11837,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0196</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0186</cbc:ID>
                      </efac:LotTender>
@@ -12084,7 +11898,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0197</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0187</cbc:ID>
                      </efac:LotTender>
@@ -12147,7 +11960,7 @@
                      <cbc:ID schemeName="result">RES-0198</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -12201,7 +12014,7 @@
                      <cbc:ID schemeName="result">RES-0199</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -12254,7 +12067,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0200</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0188</cbc:ID>
                      </efac:LotTender>
@@ -12316,7 +12128,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0201</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0189</cbc:ID>
                      </efac:LotTender>
@@ -12378,7 +12189,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0202</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0190</cbc:ID>
                      </efac:LotTender>
@@ -12440,7 +12250,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0203</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0191</cbc:ID>
                      </efac:LotTender>
@@ -12502,7 +12311,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0204</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0192</cbc:ID>
                      </efac:LotTender>
@@ -12564,7 +12372,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0205</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0193</cbc:ID>
                      </efac:LotTender>
@@ -12626,7 +12433,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0206</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0194</cbc:ID>
                      </efac:LotTender>
@@ -12688,7 +12494,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0207</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0195</cbc:ID>
                      </efac:LotTender>
@@ -12750,7 +12555,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0208</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0196</cbc:ID>
                      </efac:LotTender>
@@ -12812,7 +12616,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0209</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0197</cbc:ID>
                      </efac:LotTender>
@@ -12874,7 +12677,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0210</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0198</cbc:ID>
                      </efac:LotTender>
@@ -12936,7 +12738,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0211</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0199</cbc:ID>
                      </efac:LotTender>
@@ -12998,7 +12799,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0212</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0200</cbc:ID>
                      </efac:LotTender>
@@ -13060,7 +12860,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0213</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0201</cbc:ID>
                      </efac:LotTender>
@@ -13122,7 +12921,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0214</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0202</cbc:ID>
                      </efac:LotTender>
@@ -13184,7 +12982,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0215</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0203</cbc:ID>
                      </efac:LotTender>
@@ -13246,7 +13043,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0216</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0204</cbc:ID>
                      </efac:LotTender>
@@ -13308,7 +13104,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0217</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0205</cbc:ID>
                      </efac:LotTender>
@@ -13370,7 +13165,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0218</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0206</cbc:ID>
                      </efac:LotTender>
@@ -13432,7 +13226,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0219</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0207</cbc:ID>
                      </efac:LotTender>
@@ -13494,7 +13287,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0220</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0208</cbc:ID>
                      </efac:LotTender>
@@ -13556,7 +13348,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0221</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0209</cbc:ID>
                      </efac:LotTender>
@@ -13618,7 +13409,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0222</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0210</cbc:ID>
                      </efac:LotTender>
@@ -13680,7 +13470,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0223</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0211</cbc:ID>
                      </efac:LotTender>
@@ -13742,7 +13531,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0224</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0212</cbc:ID>
                      </efac:LotTender>
@@ -13804,7 +13592,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0225</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0213</cbc:ID>
                      </efac:LotTender>
@@ -13866,7 +13653,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0226</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0214</cbc:ID>
                      </efac:LotTender>
@@ -13928,7 +13714,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0227</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0215</cbc:ID>
                      </efac:LotTender>
@@ -13990,7 +13775,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0228</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0216</cbc:ID>
                      </efac:LotTender>
@@ -14052,7 +13836,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0229</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0217</cbc:ID>
                      </efac:LotTender>
@@ -14114,7 +13897,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0230</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0218</cbc:ID>
                      </efac:LotTender>
@@ -14176,7 +13958,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0231</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0219</cbc:ID>
                      </efac:LotTender>
@@ -14238,7 +14019,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0232</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0220</cbc:ID>
                      </efac:LotTender>
@@ -14301,7 +14081,7 @@
                      <cbc:ID schemeName="result">RES-0233</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">all-rej</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -14354,7 +14134,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0234</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0221</cbc:ID>
                      </efac:LotTender>
@@ -14416,7 +14195,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0235</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0222</cbc:ID>
                      </efac:LotTender>
@@ -14478,7 +14256,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0236</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0223</cbc:ID>
                      </efac:LotTender>
@@ -14540,7 +14317,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0237</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0224</cbc:ID>
                      </efac:LotTender>
@@ -14602,7 +14378,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0238</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0225</cbc:ID>
                      </efac:LotTender>
@@ -14664,7 +14439,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0239</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0226</cbc:ID>
                      </efac:LotTender>
@@ -14726,7 +14500,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0240</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0227</cbc:ID>
                      </efac:LotTender>
@@ -14788,7 +14561,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0241</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0228</cbc:ID>
                      </efac:LotTender>
@@ -14850,7 +14622,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0242</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0229</cbc:ID>
                      </efac:LotTender>
@@ -14912,7 +14683,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0243</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0230</cbc:ID>
                      </efac:LotTender>
@@ -14974,7 +14744,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0244</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0231</cbc:ID>
                      </efac:LotTender>
@@ -15036,7 +14805,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0245</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0232</cbc:ID>
                      </efac:LotTender>
@@ -15098,7 +14866,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0246</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0233</cbc:ID>
                      </efac:LotTender>
@@ -15160,7 +14927,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0247</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0234</cbc:ID>
                      </efac:LotTender>
@@ -15222,7 +14988,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0248</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0235</cbc:ID>
                      </efac:LotTender>
@@ -15284,7 +15049,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0249</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0236</cbc:ID>
                      </efac:LotTender>
@@ -15346,7 +15110,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0250</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0237</cbc:ID>
                      </efac:LotTender>
@@ -15409,7 +15172,7 @@
                      <cbc:ID schemeName="result">RES-0251</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -15462,7 +15225,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0252</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0238</cbc:ID>
                      </efac:LotTender>
@@ -15524,7 +15286,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0253</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0239</cbc:ID>
                      </efac:LotTender>
@@ -15587,7 +15348,7 @@
                      <cbc:ID schemeName="result">RES-0254</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -15640,7 +15401,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0255</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0240</cbc:ID>
                      </efac:LotTender>
@@ -15702,7 +15462,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0256</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0241</cbc:ID>
                      </efac:LotTender>
@@ -15764,7 +15523,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0257</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0242</cbc:ID>
                      </efac:LotTender>
@@ -15826,7 +15584,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0258</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0243</cbc:ID>
                      </efac:LotTender>
@@ -15888,7 +15645,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0259</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0244</cbc:ID>
                      </efac:LotTender>
@@ -15950,7 +15706,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0260</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0245</cbc:ID>
                      </efac:LotTender>
@@ -16012,7 +15767,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0261</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0246</cbc:ID>
                      </efac:LotTender>
@@ -16074,7 +15828,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0262</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0247</cbc:ID>
                      </efac:LotTender>
@@ -16136,7 +15889,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0263</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0248</cbc:ID>
                      </efac:LotTender>
@@ -16198,7 +15950,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0264</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0249</cbc:ID>
                      </efac:LotTender>
@@ -16260,7 +16011,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0265</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0250</cbc:ID>
                      </efac:LotTender>
@@ -16322,7 +16072,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0266</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0251</cbc:ID>
                      </efac:LotTender>
@@ -16384,7 +16133,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0267</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0252</cbc:ID>
                      </efac:LotTender>
@@ -16446,7 +16194,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0268</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0253</cbc:ID>
                      </efac:LotTender>
@@ -16508,7 +16255,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0269</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0254</cbc:ID>
                      </efac:LotTender>
@@ -16571,7 +16317,7 @@
                      <cbc:ID schemeName="result">RES-0270</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -16624,7 +16370,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0271</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0255</cbc:ID>
                      </efac:LotTender>
@@ -16686,7 +16431,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0272</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0256</cbc:ID>
                      </efac:LotTender>
@@ -16748,7 +16492,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0273</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0257</cbc:ID>
                      </efac:LotTender>
@@ -16810,7 +16553,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0274</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0258</cbc:ID>
                      </efac:LotTender>
@@ -16872,7 +16614,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0275</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0259</cbc:ID>
                      </efac:LotTender>
@@ -16934,7 +16675,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0276</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0260</cbc:ID>
                      </efac:LotTender>
@@ -16996,7 +16736,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0277</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0261</cbc:ID>
                      </efac:LotTender>
@@ -17058,7 +16797,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0278</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0262</cbc:ID>
                      </efac:LotTender>
@@ -17121,7 +16859,7 @@
                      <cbc:ID schemeName="result">RES-0279</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -17175,7 +16913,7 @@
                      <cbc:ID schemeName="result">RES-0280</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -17228,7 +16966,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0281</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0263</cbc:ID>
                      </efac:LotTender>
@@ -17290,7 +17027,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0282</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0264</cbc:ID>
                      </efac:LotTender>
@@ -17353,7 +17089,7 @@
                      <cbc:ID schemeName="result">RES-0283</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -17406,7 +17142,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0284</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0265</cbc:ID>
                      </efac:LotTender>
@@ -17468,7 +17203,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0285</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0266</cbc:ID>
                      </efac:LotTender>
@@ -17530,7 +17264,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0286</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0267</cbc:ID>
                      </efac:LotTender>
@@ -17592,7 +17325,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0287</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0268</cbc:ID>
                      </efac:LotTender>
@@ -17654,7 +17386,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0288</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0269</cbc:ID>
                      </efac:LotTender>
@@ -17716,7 +17447,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0289</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0270</cbc:ID>
                      </efac:LotTender>
@@ -17778,7 +17508,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0290</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0271</cbc:ID>
                      </efac:LotTender>
@@ -17840,7 +17569,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0291</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0272</cbc:ID>
                      </efac:LotTender>
@@ -17903,7 +17631,7 @@
                      <cbc:ID schemeName="result">RES-0292</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">all-rej</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -17957,7 +17685,7 @@
                      <cbc:ID schemeName="result">RES-0293</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">all-rej</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18011,7 +17739,7 @@
                      <cbc:ID schemeName="result">RES-0294</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>all-rej</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">all-rej</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18064,7 +17792,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0295</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0273</cbc:ID>
                      </efac:LotTender>
@@ -18126,7 +17853,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0296</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0274</cbc:ID>
                      </efac:LotTender>
@@ -18188,7 +17914,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0297</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0275</cbc:ID>
                      </efac:LotTender>
@@ -18250,7 +17975,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0298</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0276</cbc:ID>
                      </efac:LotTender>
@@ -18312,7 +18036,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0299</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0277</cbc:ID>
                      </efac:LotTender>
@@ -18374,7 +18097,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0300</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0278</cbc:ID>
                      </efac:LotTender>
@@ -18436,7 +18158,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0301</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0279</cbc:ID>
                      </efac:LotTender>
@@ -18499,7 +18220,7 @@
                      <cbc:ID schemeName="result">RES-0302</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18552,7 +18273,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0303</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0280</cbc:ID>
                      </efac:LotTender>
@@ -18615,7 +18335,7 @@
                      <cbc:ID schemeName="result">RES-0304</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18669,7 +18389,7 @@
                      <cbc:ID schemeName="result">RES-0305</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18723,7 +18443,7 @@
                      <cbc:ID schemeName="result">RES-0306</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18777,7 +18497,7 @@
                      <cbc:ID schemeName="result">RES-0307</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18831,7 +18551,7 @@
                      <cbc:ID schemeName="result">RES-0308</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18885,7 +18605,7 @@
                      <cbc:ID schemeName="result">RES-0309</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18939,7 +18659,7 @@
                      <cbc:ID schemeName="result">RES-0310</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -18993,7 +18713,7 @@
                      <cbc:ID schemeName="result">RES-0311</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19047,7 +18767,7 @@
                      <cbc:ID schemeName="result">RES-0312</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19101,7 +18821,7 @@
                      <cbc:ID schemeName="result">RES-0313</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19155,7 +18875,7 @@
                      <cbc:ID schemeName="result">RES-0314</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19209,7 +18929,7 @@
                      <cbc:ID schemeName="result">RES-0315</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19263,7 +18983,7 @@
                      <cbc:ID schemeName="result">RES-0316</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19317,7 +19037,7 @@
                      <cbc:ID schemeName="result">RES-0317</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19371,7 +19091,7 @@
                      <cbc:ID schemeName="result">RES-0318</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19425,7 +19145,7 @@
                      <cbc:ID schemeName="result">RES-0319</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19479,7 +19199,7 @@
                      <cbc:ID schemeName="result">RES-0320</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19533,7 +19253,7 @@
                      <cbc:ID schemeName="result">RES-0321</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19587,7 +19307,7 @@
                      <cbc:ID schemeName="result">RES-0322</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19641,7 +19361,7 @@
                      <cbc:ID schemeName="result">RES-0323</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19695,7 +19415,7 @@
                      <cbc:ID schemeName="result">RES-0324</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19749,7 +19469,7 @@
                      <cbc:ID schemeName="result">RES-0325</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19803,7 +19523,7 @@
                      <cbc:ID schemeName="result">RES-0326</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19857,7 +19577,7 @@
                      <cbc:ID schemeName="result">RES-0327</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19911,7 +19631,7 @@
                      <cbc:ID schemeName="result">RES-0328</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -19965,7 +19685,7 @@
                      <cbc:ID schemeName="result">RES-0329</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20019,7 +19739,7 @@
                      <cbc:ID schemeName="result">RES-0330</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20073,7 +19793,7 @@
                      <cbc:ID schemeName="result">RES-0331</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20127,7 +19847,7 @@
                      <cbc:ID schemeName="result">RES-0332</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20181,7 +19901,7 @@
                      <cbc:ID schemeName="result">RES-0333</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20235,7 +19955,7 @@
                      <cbc:ID schemeName="result">RES-0334</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20289,7 +20009,7 @@
                      <cbc:ID schemeName="result">RES-0335</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20343,7 +20063,7 @@
                      <cbc:ID schemeName="result">RES-0336</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20397,7 +20117,7 @@
                      <cbc:ID schemeName="result">RES-0337</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20451,7 +20171,7 @@
                      <cbc:ID schemeName="result">RES-0338</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20505,7 +20225,7 @@
                      <cbc:ID schemeName="result">RES-0339</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20559,7 +20279,7 @@
                      <cbc:ID schemeName="result">RES-0340</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20613,7 +20333,7 @@
                      <cbc:ID schemeName="result">RES-0341</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20667,7 +20387,7 @@
                      <cbc:ID schemeName="result">RES-0342</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20721,7 +20441,7 @@
                      <cbc:ID schemeName="result">RES-0343</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20775,7 +20495,7 @@
                      <cbc:ID schemeName="result">RES-0344</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20829,7 +20549,7 @@
                      <cbc:ID schemeName="result">RES-0345</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20883,7 +20603,7 @@
                      <cbc:ID schemeName="result">RES-0346</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20937,7 +20657,7 @@
                      <cbc:ID schemeName="result">RES-0347</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -20991,7 +20711,7 @@
                      <cbc:ID schemeName="result">RES-0348</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21044,7 +20764,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0349</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0281</cbc:ID>
                      </efac:LotTender>
@@ -21106,7 +20825,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0350</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0282</cbc:ID>
                      </efac:LotTender>
@@ -21169,7 +20887,7 @@
                      <cbc:ID schemeName="result">RES-0351</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21223,7 +20941,7 @@
                      <cbc:ID schemeName="result">RES-0352</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21277,7 +20995,7 @@
                      <cbc:ID schemeName="result">RES-0353</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21331,7 +21049,7 @@
                      <cbc:ID schemeName="result">RES-0354</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21385,7 +21103,7 @@
                      <cbc:ID schemeName="result">RES-0355</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21438,7 +21156,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0356</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0283</cbc:ID>
                      </efac:LotTender>
@@ -21500,7 +21217,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0357</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0284</cbc:ID>
                      </efac:LotTender>
@@ -21563,7 +21279,7 @@
                      <cbc:ID schemeName="result">RES-0358</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21617,7 +21333,7 @@
                      <cbc:ID schemeName="result">RES-0359</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21671,7 +21387,7 @@
                      <cbc:ID schemeName="result">RES-0360</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21725,7 +21441,7 @@
                      <cbc:ID schemeName="result">RES-0361</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21779,7 +21495,7 @@
                      <cbc:ID schemeName="result">RES-0362</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21833,7 +21549,7 @@
                      <cbc:ID schemeName="result">RES-0363</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21887,7 +21603,7 @@
                      <cbc:ID schemeName="result">RES-0364</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21941,7 +21657,7 @@
                      <cbc:ID schemeName="result">RES-0365</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -21995,7 +21711,7 @@
                      <cbc:ID schemeName="result">RES-0366</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22049,7 +21765,7 @@
                      <cbc:ID schemeName="result">RES-0367</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22103,7 +21819,7 @@
                      <cbc:ID schemeName="result">RES-0368</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22157,7 +21873,7 @@
                      <cbc:ID schemeName="result">RES-0369</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22211,7 +21927,7 @@
                      <cbc:ID schemeName="result">RES-0370</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22265,7 +21981,7 @@
                      <cbc:ID schemeName="result">RES-0371</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22319,7 +22035,7 @@
                      <cbc:ID schemeName="result">RES-0372</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22373,7 +22089,7 @@
                      <cbc:ID schemeName="result">RES-0373</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22427,7 +22143,7 @@
                      <cbc:ID schemeName="result">RES-0374</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22481,7 +22197,7 @@
                      <cbc:ID schemeName="result">RES-0375</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22535,7 +22251,7 @@
                      <cbc:ID schemeName="result">RES-0376</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22589,7 +22305,7 @@
                      <cbc:ID schemeName="result">RES-0377</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22643,7 +22359,7 @@
                      <cbc:ID schemeName="result">RES-0378</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22697,7 +22413,7 @@
                      <cbc:ID schemeName="result">RES-0379</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22751,7 +22467,7 @@
                      <cbc:ID schemeName="result">RES-0380</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22805,7 +22521,7 @@
                      <cbc:ID schemeName="result">RES-0381</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22859,7 +22575,7 @@
                      <cbc:ID schemeName="result">RES-0382</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22913,7 +22629,7 @@
                      <cbc:ID schemeName="result">RES-0383</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">clos-nw</cbc:TenderResultCode>
                      <efac:DecisionReason>
-                        <efbc:DecisionReasonCode>no-rece</efbc:DecisionReasonCode>
+                        <efbc:DecisionReasonCode listName="non-award-justification">no-rece</efbc:DecisionReasonCode>
                      </efac:DecisionReason>
                      <efac:ReceivedSubmissionsStatistics>
                         <efbc:StatisticsCode listName="received-submission-type">tenders</efbc:StatisticsCode>
@@ -22966,7 +22682,6 @@
                   <efac:LotResult>
                      <cbc:ID schemeName="result">RES-0384</cbc:ID>
                      <cbc:TenderResultCode listName="winner-selection-status">selec-w</cbc:TenderResultCode>
-                     <efbc:DPSTerminationIndicator>false</efbc:DPSTerminationIndicator>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0285</cbc:ID>
                      </efac:LotTender>
@@ -27305,8 +27020,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0001</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Triamcinolone acetonide ,demeclocycline hydrochloride (Ledermix)</cbc:Title>
+                     <cbc:Title languageID="ENG">Triamcinolone acetonide ,demeclocycline hydrochloride (Ledermix)</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-1</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0001</cbc:ID>
                      </efac:LotTender>
@@ -27314,8 +27032,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0002</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Lidocaini hydrochloridum, Matricariae extractum fluidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Lidocaini hydrochloridum, Matricariae extractum fluidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-2</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0002</cbc:ID>
                      </efac:LotTender>
@@ -27323,8 +27044,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0003</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Omeprazolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Omeprazolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-3</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0003</cbc:ID>
                      </efac:LotTender>
@@ -27332,8 +27056,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0004</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Pantoprazolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Pantoprazolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-4</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0004</cbc:ID>
                      </efac:LotTender>
@@ -27341,8 +27068,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0005</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Drotaverini hydrochlorium</cbc:Title>
+                     <cbc:Title languageID="ENG">Drotaverini hydrochlorium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-5</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0005</cbc:ID>
                      </efac:LotTender>
@@ -27350,8 +27080,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0006</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Atropini sulfas </cbc:Title>
+                     <cbc:Title languageID="ENG">Atropini sulfas </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-6</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0006</cbc:ID>
                      </efac:LotTender>
@@ -27359,8 +27092,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0007</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Butylscopolamini bromidum </cbc:Title>
+                     <cbc:Title languageID="ENG">Butylscopolamini bromidum </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-7</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0007</cbc:ID>
                      </efac:LotTender>
@@ -27368,8 +27104,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0008</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Metoclopramidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Metoclopramidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-8</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0008</cbc:ID>
                      </efac:LotTender>
@@ -27377,8 +27116,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0009</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ondansetronum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ondansetronum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-9</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0009</cbc:ID>
                      </efac:LotTender>
@@ -27386,8 +27128,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0010</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Bisacodilum</cbc:Title>
+                     <cbc:Title languageID="ENG">Bisacodilum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-10</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0010</cbc:ID>
                      </efac:LotTender>
@@ -27395,8 +27140,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0011</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Lactulosum</cbc:Title>
+                     <cbc:Title languageID="ENG">Lactulosum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-11</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0011</cbc:ID>
                      </efac:LotTender>
@@ -27404,8 +27152,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0012</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Sorbitolum, Natrii citras, Natrii laurilsulfoacetas</cbc:Title>
+                     <cbc:Title languageID="ENG">Sorbitolum, Natrii citras, Natrii laurilsulfoacetas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-12</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0012</cbc:ID>
                      </efac:LotTender>
@@ -27413,8 +27164,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0013</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Loperamidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Loperamidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-13</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0013</cbc:ID>
                      </efac:LotTender>
@@ -27422,8 +27176,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0014</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Insulinum lispro - ātras darbības insulīni, to analogi</cbc:Title>
+                     <cbc:Title languageID="ENG">Insulinum lispro - ātras darbības insulīni, to analogi</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-14</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0014</cbc:ID>
                      </efac:LotTender>
@@ -27431,8 +27188,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0015</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Insulinum aspartum - ātras darbības insulīni, to analogi</cbc:Title>
+                     <cbc:Title languageID="ENG">Insulinum aspartum - ātras darbības insulīni, to analogi</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-15</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0015</cbc:ID>
                      </efac:LotTender>
@@ -27440,8 +27200,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0016</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Insulinum glarginum - garas darbības insulīni, to analogi</cbc:Title>
+                     <cbc:Title languageID="ENG">Insulinum glarginum - garas darbības insulīni, to analogi</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-16</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0016</cbc:ID>
                      </efac:LotTender>
@@ -27449,8 +27212,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0017</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Metformini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Metformini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-17</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0017</cbc:ID>
                      </efac:LotTender>
@@ -27458,8 +27224,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0018</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Metformini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Metformini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-18</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0018</cbc:ID>
                      </efac:LotTender>
@@ -27467,8 +27236,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0019</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Thiamini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Thiamini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-19</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0019</cbc:ID>
                      </efac:LotTender>
@@ -27476,8 +27248,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0020</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Pyridoxini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Pyridoxini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-20</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0020</cbc:ID>
                      </efac:LotTender>
@@ -27485,8 +27260,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0021</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Calcii gluconas </cbc:Title>
+                     <cbc:Title languageID="ENG">Calcii gluconas </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-21</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0021</cbc:ID>
                      </efac:LotTender>
@@ -27494,8 +27272,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0022</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Heparinum natricum</cbc:Title>
+                     <cbc:Title languageID="ENG">Heparinum natricum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-22</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0022</cbc:ID>
                      </efac:LotTender>
@@ -27503,8 +27284,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0023</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Heparinum natricum</cbc:Title>
+                     <cbc:Title languageID="ENG">Heparinum natricum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-23</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0023</cbc:ID>
                      </efac:LotTender>
@@ -27512,8 +27296,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0024</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Bemiparinum natrium</cbc:Title>
+                     <cbc:Title languageID="ENG">Bemiparinum natrium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-24</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0024</cbc:ID>
                      </efac:LotTender>
@@ -27521,8 +27308,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0025</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Bemiparinum natrium</cbc:Title>
+                     <cbc:Title languageID="ENG">Bemiparinum natrium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-25</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0025</cbc:ID>
                      </efac:LotTender>
@@ -27530,8 +27320,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0026</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Nadroparinum calcicum</cbc:Title>
+                     <cbc:Title languageID="ENG">Nadroparinum calcicum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-26</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0026</cbc:ID>
                      </efac:LotTender>
@@ -27539,8 +27332,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0027</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Nadroparinum calcicum</cbc:Title>
+                     <cbc:Title languageID="ENG">Nadroparinum calcicum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-27</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0027</cbc:ID>
                      </efac:LotTender>
@@ -27548,8 +27344,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0028</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Acidum acetylsalicylicum</cbc:Title>
+                     <cbc:Title languageID="ENG">Acidum acetylsalicylicum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-28</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0028</cbc:ID>
                      </efac:LotTender>
@@ -27557,8 +27356,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0029</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Rivaroxabanum</cbc:Title>
+                     <cbc:Title languageID="ENG">Rivaroxabanum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-29</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0029</cbc:ID>
                      </efac:LotTender>
@@ -27566,8 +27368,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0030</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Etamsylatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Etamsylatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-30</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0030</cbc:ID>
                      </efac:LotTender>
@@ -27575,8 +27380,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0031</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Acidum tranexamicum</cbc:Title>
+                     <cbc:Title languageID="ENG">Acidum tranexamicum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-31</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0031</cbc:ID>
                      </efac:LotTender>
@@ -27584,8 +27392,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0032</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Phytomenadionum</cbc:Title>
+                     <cbc:Title languageID="ENG">Phytomenadionum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-32</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0032</cbc:ID>
                      </efac:LotTender>
@@ -27593,8 +27404,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0033</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Phytomenadionum</cbc:Title>
+                     <cbc:Title languageID="ENG">Phytomenadionum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-33</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0033</cbc:ID>
                      </efac:LotTender>
@@ -27602,8 +27416,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0034</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Cyanocobolaminum</cbc:Title>
+                     <cbc:Title languageID="ENG">Cyanocobolaminum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-34</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0034</cbc:ID>
                      </efac:LotTender>
@@ -27611,8 +27428,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0035</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Elektrolītu šķīdums (Ringera) </cbc:Title>
+                     <cbc:Title languageID="ENG">*Elektrolītu šķīdums (Ringera) </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-35</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0035</cbc:ID>
                      </efac:LotTender>
@@ -27620,8 +27440,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0036</cbc:ID>
                      <cbc:IssueDate>2023-11-06+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">**Elektrolītu šķīdums (Ringera) </cbc:Title>
+                     <cbc:Title languageID="ENG">**Elektrolītu šķīdums (Ringera) </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-36</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0036</cbc:ID>
                      </efac:LotTender>
@@ -27629,8 +27452,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0037</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Elektrolītu šķīdums (Ringera) </cbc:Title>
+                     <cbc:Title languageID="ENG">*Elektrolītu šķīdums (Ringera) </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-37</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0037</cbc:ID>
                      </efac:LotTender>
@@ -27638,8 +27464,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0038</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">**Elektrolītu šķīdums (Ringera) </cbc:Title>
+                     <cbc:Title languageID="ENG">**Elektrolītu šķīdums (Ringera) </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-38</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0038</cbc:ID>
                      </efac:LotTender>
@@ -27647,8 +27476,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0039</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Title>
+                     <cbc:Title languageID="ENG">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-39</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0039</cbc:ID>
                      </efac:LotTender>
@@ -27656,8 +27488,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0040</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Title>
+                     <cbc:Title languageID="ENG">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-40</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0040</cbc:ID>
                      </efac:LotTender>
@@ -27665,8 +27500,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0041</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Glucosum</cbc:Title>
+                     <cbc:Title languageID="ENG">*Glucosum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-41</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0041</cbc:ID>
                      </efac:LotTender>
@@ -27674,8 +27512,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0042</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">**Glucosum</cbc:Title>
+                     <cbc:Title languageID="ENG">**Glucosum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-42</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0042</cbc:ID>
                      </efac:LotTender>
@@ -27683,8 +27524,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0043</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Glucosum</cbc:Title>
+                     <cbc:Title languageID="ENG">*Glucosum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-43</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0043</cbc:ID>
                      </efac:LotTender>
@@ -27692,8 +27536,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0044</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">**Glucosum</cbc:Title>
+                     <cbc:Title languageID="ENG">**Glucosum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-44</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0044</cbc:ID>
                      </efac:LotTender>
@@ -27701,8 +27548,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0045</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Glucosum</cbc:Title>
+                     <cbc:Title languageID="ENG">*Glucosum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-45</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0045</cbc:ID>
                      </efac:LotTender>
@@ -27710,8 +27560,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0046</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Glucosum</cbc:Title>
+                     <cbc:Title languageID="ENG">Glucosum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-46</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0046</cbc:ID>
                      </efac:LotTender>
@@ -27719,8 +27572,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0047</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Glucosum</cbc:Title>
+                     <cbc:Title languageID="ENG">Glucosum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-47</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0047</cbc:ID>
                      </efac:LotTender>
@@ -27728,8 +27584,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0048</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Gelatinum succinas, Natrii chloridum, Natrii hydroxidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Gelatinum succinas, Natrii chloridum, Natrii hydroxidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-48</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0048</cbc:ID>
                      </efac:LotTender>
@@ -27737,8 +27596,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0049</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Central emulsija infūzijāmTrīskambaru maisu sistēma ar kopējo tilpumu 493 ml, kas sastāv no glikozes 42% šķīduma, aminoskābes šķīduma ar elektrolītiem un tauku emulsijas, kas bagātināta ar omega 3 taukskābēm, parenterālai barošanai centrālā vēnā. Osmolaritāte 1500 mosmol/l, kopējais enerģijas daudzums 550 kcal.</cbc:Title>
+                     <cbc:Title languageID="ENG">Central emulsija infūzijāmTrīskambaru maisu sistēma ar kopējo tilpumu 493 ml, kas sastāv no glikozes 42% šķīduma, aminoskābes šķīduma ar elektrolītiem un tauku emulsijas, kas bagātināta ar omega 3 taukskābēm, parenterālai barošanai centrālā vēnā. Osmolaritāte 1500 mosmol/l, kopējais enerģijas daudzums 550 kcal.</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-49</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0049</cbc:ID>
                      </efac:LotTender>
@@ -27746,8 +27608,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0050</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Peripheral emulsija infūzijām,Trīskambaru maisu sistēma ar kopējo tilpumu 1904 ml, kas sastāv no glikozes 13% šķīduma, aminoskābes šķīduma ar elektrolītiem un tauku emulsijas, kas bagātināta ar omega 3 taukskābēm, parenterālai barošanai perifērā vēnā. Osmolaritāte 850 mosmol/l, kopējais enerģijas daudzums 1300 kcal.</cbc:Title>
+                     <cbc:Title languageID="ENG">Peripheral emulsija infūzijām,Trīskambaru maisu sistēma ar kopējo tilpumu 1904 ml, kas sastāv no glikozes 13% šķīduma, aminoskābes šķīduma ar elektrolītiem un tauku emulsijas, kas bagātināta ar omega 3 taukskābēm, parenterālai barošanai perifērā vēnā. Osmolaritāte 850 mosmol/l, kopējais enerģijas daudzums 1300 kcal.</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-50</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0050</cbc:ID>
                      </efac:LotTender>
@@ -27755,8 +27620,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0051</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Mannitolum</cbc:Title>
+                     <cbc:Title languageID="ENG">*Mannitolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-51</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0051</cbc:ID>
                      </efac:LotTender>
@@ -27764,8 +27632,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0052</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Kalii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Kalii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-52</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0052</cbc:ID>
                      </efac:LotTender>
@@ -27773,8 +27644,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0053</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Kalii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Kalii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-53</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0053</cbc:ID>
                      </efac:LotTender>
@@ -27782,8 +27656,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0054</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-54</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0054</cbc:ID>
                      </efac:LotTender>
@@ -27791,8 +27668,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0055</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-55</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0055</cbc:ID>
                      </efac:LotTender>
@@ -27800,8 +27680,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0056</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">*Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-56</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0056</cbc:ID>
                      </efac:LotTender>
@@ -27809,8 +27692,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0057</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">**Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-57</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0057</cbc:ID>
                      </efac:LotTender>
@@ -27818,8 +27704,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0058</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">*Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-58</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0058</cbc:ID>
                      </efac:LotTender>
@@ -27827,8 +27716,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0059</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">**Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-59</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0059</cbc:ID>
                      </efac:LotTender>
@@ -27836,8 +27728,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0060</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">*Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-60</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0060</cbc:ID>
                      </efac:LotTender>
@@ -27845,8 +27740,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0061</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">**Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-61</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0061</cbc:ID>
                      </efac:LotTender>
@@ -27854,8 +27752,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0062</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-62</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0062</cbc:ID>
                      </efac:LotTender>
@@ -27863,8 +27764,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0063</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-63</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0063</cbc:ID>
                      </efac:LotTender>
@@ -27872,8 +27776,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0064</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">*Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">*Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-64</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0064</cbc:ID>
                      </efac:LotTender>
@@ -27881,8 +27788,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0065</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">**Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-65</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0065</cbc:ID>
                      </efac:LotTender>
@@ -27890,8 +27800,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0066</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">**Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">**Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-66</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0066</cbc:ID>
                      </efac:LotTender>
@@ -27899,8 +27812,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0067</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-67</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0067</cbc:ID>
                      </efac:LotTender>
@@ -27908,8 +27824,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0068</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Natrii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Natrii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-68</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0068</cbc:ID>
                      </efac:LotTender>
@@ -27917,8 +27836,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0069</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Natrii hydrocarbonas</cbc:Title>
+                     <cbc:Title languageID="ENG">Natrii hydrocarbonas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-69</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0069</cbc:ID>
                      </efac:LotTender>
@@ -27926,8 +27848,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0070</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Natrii hydrocarbonas</cbc:Title>
+                     <cbc:Title languageID="ENG">Natrii hydrocarbonas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-70</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0070</cbc:ID>
                      </efac:LotTender>
@@ -27935,8 +27860,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0071</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Magnesii sulfas</cbc:Title>
+                     <cbc:Title languageID="ENG">Magnesii sulfas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-71</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0071</cbc:ID>
                      </efac:LotTender>
@@ -27944,8 +27872,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0072</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Digoxinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Digoxinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-72</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0072</cbc:ID>
                      </efac:LotTender>
@@ -27953,8 +27884,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0073</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Amiodaronum</cbc:Title>
+                     <cbc:Title languageID="ENG">Amiodaronum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-73</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0073</cbc:ID>
                      </efac:LotTender>
@@ -27962,8 +27896,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0074</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Norepinephrinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Norepinephrinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-74</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0074</cbc:ID>
                      </efac:LotTender>
@@ -27971,8 +27908,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0075</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ephedrini hydrohloridum </cbc:Title>
+                     <cbc:Title languageID="ENG">Ephedrini hydrohloridum </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-75</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0075</cbc:ID>
                      </efac:LotTender>
@@ -27980,8 +27920,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0076</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dopamini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dopamini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-76</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0076</cbc:ID>
                      </efac:LotTender>
@@ -27989,8 +27932,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0077</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dobutaminum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dobutaminum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-77</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0077</cbc:ID>
                      </efac:LotTender>
@@ -27998,8 +27944,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0078</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Epinephrinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Epinephrinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-78</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0078</cbc:ID>
                      </efac:LotTender>
@@ -28007,8 +27956,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0079</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Glyceroli trinitras</cbc:Title>
+                     <cbc:Title languageID="ENG">Glyceroli trinitras</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-79</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0079</cbc:ID>
                      </efac:LotTender>
@@ -28016,8 +27968,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0080</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Meldonium</cbc:Title>
+                     <cbc:Title languageID="ENG">Meldonium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-80</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0080</cbc:ID>
                      </efac:LotTender>
@@ -28025,8 +27980,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0081</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Adenosinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Adenosinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-81</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0081</cbc:ID>
                      </efac:LotTender>
@@ -28034,8 +27992,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0082</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ivabradinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ivabradinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-82</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0082</cbc:ID>
                      </efac:LotTender>
@@ -28043,8 +28004,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0083</cbc:ID>
                      <cbc:IssueDate>2023-10-26+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Clonidinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Clonidinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-83</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0083</cbc:ID>
                      </efac:LotTender>
@@ -28052,8 +28016,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0084</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Clonidinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Clonidinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-84</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0084</cbc:ID>
                      </efac:LotTender>
@@ -28061,8 +28028,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0085</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Furosemidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Furosemidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-85</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0085</cbc:ID>
                      </efac:LotTender>
@@ -28070,8 +28040,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0086</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Furosemidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Furosemidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-86</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0086</cbc:ID>
                      </efac:LotTender>
@@ -28079,8 +28052,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0087</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Torasemidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Torasemidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-87</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0087</cbc:ID>
                      </efac:LotTender>
@@ -28088,8 +28064,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0088</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Spironolactonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Spironolactonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-88</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0088</cbc:ID>
                      </efac:LotTender>
@@ -28097,8 +28076,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0089</cbc:ID>
                      <cbc:IssueDate>2023-10-11+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Pentoxifyllinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Pentoxifyllinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-89</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0089</cbc:ID>
                      </efac:LotTender>
@@ -28106,8 +28088,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0090</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Xylocain</cbc:Title>
+                     <cbc:Title languageID="ENG">Xylocain</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-90</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0090</cbc:ID>
                      </efac:LotTender>
@@ -28115,8 +28100,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0091</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Xylocain</cbc:Title>
+                     <cbc:Title languageID="ENG">Xylocain</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-91</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0091</cbc:ID>
                      </efac:LotTender>
@@ -28124,8 +28112,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0092</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Troxerutinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Troxerutinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-92</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0092</cbc:ID>
                      </efac:LotTender>
@@ -28133,8 +28124,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0093</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Polidocanolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Polidocanolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-93</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0093</cbc:ID>
                      </efac:LotTender>
@@ -28142,8 +28136,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0094</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Propranololum</cbc:Title>
+                     <cbc:Title languageID="ENG">Propranololum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-94</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0094</cbc:ID>
                      </efac:LotTender>
@@ -28151,8 +28148,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0095</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Metoprololi tartras</cbc:Title>
+                     <cbc:Title languageID="ENG">Metoprololi tartras</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-95</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0095</cbc:ID>
                      </efac:LotTender>
@@ -28160,8 +28160,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0096</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Bisoprololi fumaras</cbc:Title>
+                     <cbc:Title languageID="ENG">Bisoprololi fumaras</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-96</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0096</cbc:ID>
                      </efac:LotTender>
@@ -28169,8 +28172,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0097</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Nebivololum</cbc:Title>
+                     <cbc:Title languageID="ENG">Nebivololum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-97</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0097</cbc:ID>
                      </efac:LotTender>
@@ -28178,8 +28184,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0098</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Labetalolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Labetalolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-98</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0098</cbc:ID>
                      </efac:LotTender>
@@ -28187,8 +28196,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0099</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Amlodipinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Amlodipinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-99</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0099</cbc:ID>
                      </efac:LotTender>
@@ -28196,8 +28208,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0100</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Nitrendipinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Nitrendipinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-100</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0100</cbc:ID>
                      </efac:LotTender>
@@ -28205,8 +28220,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0101</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Verapamili hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Verapamili hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-101</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0101</cbc:ID>
                      </efac:LotTender>
@@ -28214,8 +28232,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0102</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Captoprilum</cbc:Title>
+                     <cbc:Title languageID="ENG">Captoprilum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-102</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0102</cbc:ID>
                      </efac:LotTender>
@@ -28223,8 +28244,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0103</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Enalaprilum</cbc:Title>
+                     <cbc:Title languageID="ENG">Enalaprilum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-103</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0103</cbc:ID>
                      </efac:LotTender>
@@ -28232,8 +28256,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0104</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Enalaprilatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Enalaprilatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-104</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0104</cbc:ID>
                      </efac:LotTender>
@@ -28241,8 +28268,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0105</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Perindoprili argininum</cbc:Title>
+                     <cbc:Title languageID="ENG">Perindoprili argininum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-105</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0105</cbc:ID>
                      </efac:LotTender>
@@ -28250,8 +28280,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0106</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Isoconazoli nitras, Diflucortoloni valeras</cbc:Title>
+                     <cbc:Title languageID="ENG">Isoconazoli nitras, Diflucortoloni valeras</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-106</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0106</cbc:ID>
                      </efac:LotTender>
@@ -28259,8 +28292,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0107</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Zinci oxydum</cbc:Title>
+                     <cbc:Title languageID="ENG">Zinci oxydum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-107</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0107</cbc:ID>
                      </efac:LotTender>
@@ -28268,8 +28304,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0108</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dexpanthenolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dexpanthenolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-108</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0108</cbc:ID>
                      </efac:LotTender>
@@ -28277,8 +28316,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0109</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dexpanthenolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dexpanthenolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-109</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0109</cbc:ID>
                      </efac:LotTender>
@@ -28286,8 +28328,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0110</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Acidum fusidicum</cbc:Title>
+                     <cbc:Title languageID="ENG">Acidum fusidicum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-110</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0110</cbc:ID>
                      </efac:LotTender>
@@ -28295,8 +28340,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0111</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Acidum fusidicum</cbc:Title>
+                     <cbc:Title languageID="ENG">Acidum fusidicum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-111</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0111</cbc:ID>
                      </efac:LotTender>
@@ -28304,8 +28352,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0112</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Methyluracilum, Lidocainum</cbc:Title>
+                     <cbc:Title languageID="ENG">Methyluracilum, Lidocainum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-112</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0112</cbc:ID>
                      </efac:LotTender>
@@ -28313,8 +28364,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0113</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Methyluracilum, Chloramphenicolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Methyluracilum, Chloramphenicolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-113</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0113</cbc:ID>
                      </efac:LotTender>
@@ -28322,8 +28376,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0114</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Hydrocortisonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Hydrocortisonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-114</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0114</cbc:ID>
                      </efac:LotTender>
@@ -28331,8 +28388,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0115</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Fluocinoloni acetonidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Fluocinoloni acetonidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-115</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0115</cbc:ID>
                      </efac:LotTender>
@@ -28340,8 +28400,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0116</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Fluocinoloni acetonidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Fluocinoloni acetonidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-116</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0116</cbc:ID>
                      </efac:LotTender>
@@ -28349,8 +28412,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0117</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Acidum boricum</cbc:Title>
+                     <cbc:Title languageID="ENG">Acidum boricum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-117</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0117</cbc:ID>
                      </efac:LotTender>
@@ -28358,8 +28424,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0118</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Povidonum iodinatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Povidonum iodinatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-118</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0118</cbc:ID>
                      </efac:LotTender>
@@ -28367,8 +28436,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0119</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Povidonum iodinatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Povidonum iodinatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-119</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0119</cbc:ID>
                      </efac:LotTender>
@@ -28376,8 +28448,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0120</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Iodum</cbc:Title>
+                     <cbc:Title languageID="ENG">Iodum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-120</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0120</cbc:ID>
                      </efac:LotTender>
@@ -28385,8 +28460,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0121</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Viride nitens, sp.aethylicus</cbc:Title>
+                     <cbc:Title languageID="ENG">Viride nitens, sp.aethylicus</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-121</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0121</cbc:ID>
                      </efac:LotTender>
@@ -28394,8 +28472,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0122</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Hydrogenii peroxidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Hydrogenii peroxidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-122</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0122</cbc:ID>
                      </efac:LotTender>
@@ -28403,8 +28484,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0123</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">E vitamīna acetāts, bišu vasks</cbc:Title>
+                     <cbc:Title languageID="ENG">E vitamīna acetāts, bišu vasks</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-123</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0123</cbc:ID>
                      </efac:LotTender>
@@ -28412,8 +28496,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0124</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Desmopressinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Desmopressinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-124</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0124</cbc:ID>
                      </efac:LotTender>
@@ -28421,8 +28508,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0125</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Oxytocinumum</cbc:Title>
+                     <cbc:Title languageID="ENG">Oxytocinumum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-125</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0125</cbc:ID>
                      </efac:LotTender>
@@ -28430,8 +28520,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0126</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Octreotidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Octreotidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-126</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0126</cbc:ID>
                      </efac:LotTender>
@@ -28439,8 +28532,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0127</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dexamethasonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dexamethasonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-127</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0127</cbc:ID>
                      </efac:LotTender>
@@ -28448,8 +28544,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0128</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dexamethasonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dexamethasonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-128</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0128</cbc:ID>
                      </efac:LotTender>
@@ -28457,8 +28556,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0129</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Methylprednisoloni acetas</cbc:Title>
+                     <cbc:Title languageID="ENG">Methylprednisoloni acetas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-129</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0129</cbc:ID>
                      </efac:LotTender>
@@ -28466,8 +28568,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0130</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Methylprednisolonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Methylprednisolonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-130</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0130</cbc:ID>
                      </efac:LotTender>
@@ -28475,8 +28580,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0131</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Prednisolonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Prednisolonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-131</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0131</cbc:ID>
                      </efac:LotTender>
@@ -28484,8 +28592,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0132</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Hydrocortisonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Hydrocortisonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-132</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0132</cbc:ID>
                      </efac:LotTender>
@@ -28493,8 +28604,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0133</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Triamcinoloni acetonidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Triamcinoloni acetonidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-133</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0133</cbc:ID>
                      </efac:LotTender>
@@ -28502,8 +28616,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0134</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Thiamazolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Thiamazolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-134</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0134</cbc:ID>
                      </efac:LotTender>
@@ -28511,8 +28628,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0135</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Doxycyclinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Doxycyclinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-135</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0135</cbc:ID>
                      </efac:LotTender>
@@ -28520,8 +28640,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0136</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Amoxicillinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Amoxicillinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-136</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0136</cbc:ID>
                      </efac:LotTender>
@@ -28529,8 +28652,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0137</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Benzylpencillinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Benzylpencillinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-137</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0137</cbc:ID>
                      </efac:LotTender>
@@ -28538,8 +28664,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0138</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Amoxicillinum / Acidum clavulanicum</cbc:Title>
+                     <cbc:Title languageID="ENG">Amoxicillinum / Acidum clavulanicum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-138</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0138</cbc:ID>
                      </efac:LotTender>
@@ -28547,8 +28676,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0139</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Piperacillinum / Tazobactamum</cbc:Title>
+                     <cbc:Title languageID="ENG">Piperacillinum / Tazobactamum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-139</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0139</cbc:ID>
                      </efac:LotTender>
@@ -28556,8 +28688,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0140</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Cefazolinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Cefazolinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-140</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0140</cbc:ID>
                      </efac:LotTender>
@@ -28565,8 +28700,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0141</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ceftriaxonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ceftriaxonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-141</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0141</cbc:ID>
                      </efac:LotTender>
@@ -28574,17 +28712,23 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0142</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Imipenemum / Cilastatinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Imipenemum / Cilastatinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-142</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0142</cbc:ID>
                      </efac:LotTender>
                   </efac:SettledContract>
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0143</cbc:ID>
-                     <cbc:AwardDate>2023-10-11+02:00</cbc:AwardDate>
-                     <cbc:Title languageID="LAV">Sulfamethoxazolum, Trimethoprimum</cbc:Title>
+                     <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
+                     <cbc:Title languageID="ENG">Sulfamethoxazolum, Trimethoprimum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-143</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0143</cbc:ID>
                      </efac:LotTender>
@@ -28592,8 +28736,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0144</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Erythromycinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Erythromycinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-144</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0144</cbc:ID>
                      </efac:LotTender>
@@ -28601,8 +28748,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0145</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Erythromycinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Erythromycinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-145</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0145</cbc:ID>
                      </efac:LotTender>
@@ -28610,8 +28760,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0146</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Erythromycinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Erythromycinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-146</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0146</cbc:ID>
                      </efac:LotTender>
@@ -28619,8 +28772,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0147</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Gentamicinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Gentamicinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-147</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0147</cbc:ID>
                      </efac:LotTender>
@@ -28628,8 +28784,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0148</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ciprofloxacinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ciprofloxacinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-148</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0148</cbc:ID>
                      </efac:LotTender>
@@ -28637,8 +28796,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0149</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ciprofloxacinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ciprofloxacinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-149</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0149</cbc:ID>
                      </efac:LotTender>
@@ -28646,8 +28808,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0150</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ciprofloxacinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ciprofloxacinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-150</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0150</cbc:ID>
                      </efac:LotTender>
@@ -28655,8 +28820,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0151</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Metronidazolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Metronidazolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-151</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0151</cbc:ID>
                      </efac:LotTender>
@@ -28664,8 +28832,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0152</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Fluconazolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Fluconazolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-152</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0152</cbc:ID>
                      </efac:LotTender>
@@ -28673,8 +28844,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0153</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-153</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0153</cbc:ID>
                      </efac:LotTender>
@@ -28682,8 +28856,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0154</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-154</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0154</cbc:ID>
                      </efac:LotTender>
@@ -28691,8 +28868,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0155</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-155</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0155</cbc:ID>
                      </efac:LotTender>
@@ -28700,8 +28880,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0156</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Viri hepatitidis A inactivatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Viri hepatitidis A inactivatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-156</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0156</cbc:ID>
                      </efac:LotTender>
@@ -28709,8 +28892,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0157</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum hepatitidis A inactivatum adsorbatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum hepatitidis A inactivatum adsorbatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-157</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0157</cbc:ID>
                      </efac:LotTender>
@@ -28718,8 +28904,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0158</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum hepatitidis B (ADNr)</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum hepatitidis B (ADNr)</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-158</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0158</cbc:ID>
                      </efac:LotTender>
@@ -28727,8 +28916,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0159</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum papillomaviri humani 9-valent, (recombinantum, adsorbatum)</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum papillomaviri humani 9-valent, (recombinantum, adsorbatum)</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-159</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0159</cbc:ID>
                      </efac:LotTender>
@@ -28736,8 +28928,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0160</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum et poliomyelitidis inactivatum adsorbatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum et poliomyelitidis inactivatum adsorbatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-160</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0160</cbc:ID>
                      </efac:LotTender>
@@ -28745,8 +28940,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0161</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum pneumococcale polysaccharidicum coniugatum adsorbatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum pneumococcale polysaccharidicum coniugatum adsorbatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-161</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0161</cbc:ID>
                      </efac:LotTender>
@@ -28754,8 +28952,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0162</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum hepatitidis A inactivatum et hepatitidis B (ADNr) adsorbatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum hepatitidis A inactivatum et hepatitidis B (ADNr) adsorbatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-162</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0162</cbc:ID>
                      </efac:LotTender>
@@ -28763,8 +28964,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0163</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Viri rabiei inactivatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Viri rabiei inactivatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-163</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0163</cbc:ID>
                      </efac:LotTender>
@@ -28772,8 +28976,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0164</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum diphtheriae et tetani adsorbatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum diphtheriae et tetani adsorbatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-164</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0164</cbc:ID>
                      </efac:LotTender>
@@ -28781,8 +28988,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0165</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum morbillorum, parotitidis et rubellae vivum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum morbillorum, parotitidis et rubellae vivum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-165</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0165</cbc:ID>
                      </efac:LotTender>
@@ -28790,8 +29000,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0166</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum, antigeni-o(-is) minutum, adsorbatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum, antigeni-o(-is) minutum, adsorbatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-166</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0166</cbc:ID>
                      </efac:LotTender>
@@ -28799,8 +29012,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0167</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Methotrexatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Methotrexatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-167</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0167</cbc:ID>
                      </efac:LotTender>
@@ -28808,8 +29024,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0168</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Mitomycinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Mitomycinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-168</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0168</cbc:ID>
                      </efac:LotTender>
@@ -28817,8 +29036,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0169</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Doxorubicinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Doxorubicinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-169</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0169</cbc:ID>
                      </efac:LotTender>
@@ -28826,8 +29048,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0170</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Diclofenacum natrium</cbc:Title>
+                     <cbc:Title languageID="ENG">Diclofenacum natrium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-170</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0170</cbc:ID>
                      </efac:LotTender>
@@ -28835,8 +29060,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0171</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Diclofenacum natrium</cbc:Title>
+                     <cbc:Title languageID="ENG">Diclofenacum natrium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-171</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0171</cbc:ID>
                      </efac:LotTender>
@@ -28844,8 +29072,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0172</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Diclofenacum natrium</cbc:Title>
+                     <cbc:Title languageID="ENG">Diclofenacum natrium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-172</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0172</cbc:ID>
                      </efac:LotTender>
@@ -28853,8 +29084,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0173</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ketorolaci trometamolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ketorolaci trometamolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-173</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0173</cbc:ID>
                      </efac:LotTender>
@@ -28862,8 +29096,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0174</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ibuprofenum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ibuprofenum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-174</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0174</cbc:ID>
                      </efac:LotTender>
@@ -28871,8 +29108,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0175</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dexketoprofenum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dexketoprofenum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-175</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0175</cbc:ID>
                      </efac:LotTender>
@@ -28880,8 +29120,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0176</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dexketoprofenum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dexketoprofenum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-176</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0176</cbc:ID>
                      </efac:LotTender>
@@ -28889,8 +29132,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0177</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Etoricoxibum</cbc:Title>
+                     <cbc:Title languageID="ENG">Etoricoxibum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-177</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0177</cbc:ID>
                      </efac:LotTender>
@@ -28898,8 +29144,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0178</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Suxamethonii chloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Suxamethonii chloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-178</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0178</cbc:ID>
                      </efac:LotTender>
@@ -28907,8 +29156,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0179</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Atracurii besilas</cbc:Title>
+                     <cbc:Title languageID="ENG">Atracurii besilas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-179</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0179</cbc:ID>
                      </efac:LotTender>
@@ -28916,8 +29168,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0180</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Atracurii besilas</cbc:Title>
+                     <cbc:Title languageID="ENG">Atracurii besilas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-180</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0180</cbc:ID>
                      </efac:LotTender>
@@ -28925,8 +29180,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0181</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Mivacurium</cbc:Title>
+                     <cbc:Title languageID="ENG">Mivacurium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-181</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0181</cbc:ID>
                      </efac:LotTender>
@@ -28934,8 +29192,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0182</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Cisatracurium</cbc:Title>
+                     <cbc:Title languageID="ENG">Cisatracurium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-182</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0182</cbc:ID>
                      </efac:LotTender>
@@ -28943,8 +29204,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0183</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Toxinum A Clostridii botulini haemagglutininum multiplex</cbc:Title>
+                     <cbc:Title languageID="ENG">Toxinum A Clostridii botulini haemagglutininum multiplex</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-183</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0183</cbc:ID>
                      </efac:LotTender>
@@ -28952,8 +29216,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0184</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tizanidinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tizanidinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-184</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0184</cbc:ID>
                      </efac:LotTender>
@@ -28961,8 +29228,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0185</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tolperisonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tolperisonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-185</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0185</cbc:ID>
                      </efac:LotTender>
@@ -28970,8 +29240,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0186</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Sevofluranum</cbc:Title>
+                     <cbc:Title languageID="ENG">Sevofluranum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-186</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0186</cbc:ID>
                      </efac:LotTender>
@@ -28979,8 +29252,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0187</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Thiopentalum natricum</cbc:Title>
+                     <cbc:Title languageID="ENG">Thiopentalum natricum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-187</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0187</cbc:ID>
                      </efac:LotTender>
@@ -28988,8 +29264,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0188</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Etomidatum</cbc:Title>
+                     <cbc:Title languageID="ENG">Etomidatum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-188</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0188</cbc:ID>
                      </efac:LotTender>
@@ -28997,8 +29276,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0189</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Propofolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Propofolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-189</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0189</cbc:ID>
                      </efac:LotTender>
@@ -29006,8 +29288,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0190</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Propofolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Propofolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-190</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0190</cbc:ID>
                      </efac:LotTender>
@@ -29015,8 +29300,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0191</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Bupivacaini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Bupivacaini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-191</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0191</cbc:ID>
                      </efac:LotTender>
@@ -29024,8 +29312,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0192</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Bupivacaini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Bupivacaini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-192</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0192</cbc:ID>
                      </efac:LotTender>
@@ -29033,8 +29324,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0193</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Bupivacaini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Bupivacaini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-193</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0193</cbc:ID>
                      </efac:LotTender>
@@ -29042,8 +29336,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0194</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ropivacaini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ropivacaini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-194</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0194</cbc:ID>
                      </efac:LotTender>
@@ -29051,8 +29348,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0195</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Lidocaini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Lidocaini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-195</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0195</cbc:ID>
                      </efac:LotTender>
@@ -29060,8 +29360,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0196</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Lidocaini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Lidocaini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-196</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0196</cbc:ID>
                      </efac:LotTender>
@@ -29069,8 +29372,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0197</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Lidocaini hydrochloridum, Chlorhexidinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Lidocaini hydrochloridum, Chlorhexidinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-197</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0197</cbc:ID>
                      </efac:LotTender>
@@ -29078,8 +29384,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0198</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Prilocainum, Lidocainum</cbc:Title>
+                     <cbc:Title languageID="ENG">Prilocainum, Lidocainum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-198</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0198</cbc:ID>
                      </efac:LotTender>
@@ -29087,8 +29396,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0199</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Morphini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Morphini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-199</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0199</cbc:ID>
                      </efac:LotTender>
@@ -29096,8 +29408,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0200</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Fentanylum</cbc:Title>
+                     <cbc:Title languageID="ENG">Fentanylum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-200</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0200</cbc:ID>
                      </efac:LotTender>
@@ -29105,8 +29420,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0201</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Trimeperidini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Trimeperidini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-201</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0201</cbc:ID>
                      </efac:LotTender>
@@ -29114,8 +29432,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0202</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tramadoli hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tramadoli hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-202</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0202</cbc:ID>
                      </efac:LotTender>
@@ -29123,8 +29444,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0203</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tramadoli hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tramadoli hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-203</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0203</cbc:ID>
                      </efac:LotTender>
@@ -29132,8 +29456,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0204</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tramadoli hydrochloridum, Dexketoprofenum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tramadoli hydrochloridum, Dexketoprofenum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-204</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0204</cbc:ID>
                      </efac:LotTender>
@@ -29141,8 +29468,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0205</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Paracetamolum, Codeini phosphas hemihydricus</cbc:Title>
+                     <cbc:Title languageID="ENG">Paracetamolum, Codeini phosphas hemihydricus</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-205</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0205</cbc:ID>
                      </efac:LotTender>
@@ -29150,8 +29480,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0206</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Sumatriptanum</cbc:Title>
+                     <cbc:Title languageID="ENG">Sumatriptanum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-206</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0206</cbc:ID>
                      </efac:LotTender>
@@ -29159,8 +29492,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0207</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Metamizolum natricum</cbc:Title>
+                     <cbc:Title languageID="ENG">Metamizolum natricum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-207</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0207</cbc:ID>
                      </efac:LotTender>
@@ -29168,8 +29504,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0208</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Metamizolum natricum</cbc:Title>
+                     <cbc:Title languageID="ENG">Metamizolum natricum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-208</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0208</cbc:ID>
                      </efac:LotTender>
@@ -29177,8 +29516,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0209</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Acidum acetylsalicylicum</cbc:Title>
+                     <cbc:Title languageID="ENG">Acidum acetylsalicylicum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-209</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0209</cbc:ID>
                      </efac:LotTender>
@@ -29186,8 +29528,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0210</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Paracetamolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Paracetamolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-210</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0210</cbc:ID>
                      </efac:LotTender>
@@ -29195,8 +29540,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0211</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Paracetamolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Paracetamolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-211</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0211</cbc:ID>
                      </efac:LotTender>
@@ -29204,8 +29552,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0212</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Clonazepamum</cbc:Title>
+                     <cbc:Title languageID="ENG">Clonazepamum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-212</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0212</cbc:ID>
                      </efac:LotTender>
@@ -29213,8 +29564,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0213</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Gabapentinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Gabapentinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-213</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0213</cbc:ID>
                      </efac:LotTender>
@@ -29222,8 +29576,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0214</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Pregabalinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Pregabalinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-214</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0214</cbc:ID>
                      </efac:LotTender>
@@ -29231,8 +29588,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0215</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Carbamazepinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Carbamazepinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-215</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0215</cbc:ID>
                      </efac:LotTender>
@@ -29240,8 +29600,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0216</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Trihexyphenidylum</cbc:Title>
+                     <cbc:Title languageID="ENG">Trihexyphenidylum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-216</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0216</cbc:ID>
                      </efac:LotTender>
@@ -29249,8 +29612,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0217</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Levodopum, Benserazidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Levodopum, Benserazidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-217</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0217</cbc:ID>
                      </efac:LotTender>
@@ -29258,8 +29624,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0218</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Haloperidolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Haloperidolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-218</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0218</cbc:ID>
                      </efac:LotTender>
@@ -29267,8 +29636,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0219</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Haloperidolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Haloperidolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-219</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0219</cbc:ID>
                      </efac:LotTender>
@@ -29276,8 +29648,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0220</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Melperonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Melperonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-220</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0220</cbc:ID>
                      </efac:LotTender>
@@ -29285,8 +29660,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0221</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Diazepamum</cbc:Title>
+                     <cbc:Title languageID="ENG">Diazepamum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-221</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0221</cbc:ID>
                      </efac:LotTender>
@@ -29294,8 +29672,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0222</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Diazepamum (iepakojumā tika pa N10 ampulām)</cbc:Title>
+                     <cbc:Title languageID="ENG">Diazepamum (iepakojumā tika pa N10 ampulām)</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-222</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0222</cbc:ID>
                      </efac:LotTender>
@@ -29303,8 +29684,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0223</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Bromazepamum</cbc:Title>
+                     <cbc:Title languageID="ENG">Bromazepamum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-223</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0223</cbc:ID>
                      </efac:LotTender>
@@ -29312,8 +29696,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0224</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Quetiapinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Quetiapinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-224</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0224</cbc:ID>
                      </efac:LotTender>
@@ -29321,8 +29708,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0225</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Midazolamum</cbc:Title>
+                     <cbc:Title languageID="ENG">Midazolamum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-225</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0225</cbc:ID>
                      </efac:LotTender>
@@ -29330,8 +29720,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0226</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Midazolamum</cbc:Title>
+                     <cbc:Title languageID="ENG">Midazolamum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-226</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0226</cbc:ID>
                      </efac:LotTender>
@@ -29339,8 +29732,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0227</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Chlorprotixenum</cbc:Title>
+                     <cbc:Title languageID="ENG">Chlorprotixenum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-227</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0227</cbc:ID>
                      </efac:LotTender>
@@ -29348,8 +29744,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0228</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Amitriptylinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Amitriptylinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-228</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0228</cbc:ID>
                      </efac:LotTender>
@@ -29357,8 +29756,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0229</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Piracetamum</cbc:Title>
+                     <cbc:Title languageID="ENG">Piracetamum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-229</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0229</cbc:ID>
                      </efac:LotTender>
@@ -29366,8 +29768,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0230</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ipidacrinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ipidacrinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-230</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0230</cbc:ID>
                      </efac:LotTender>
@@ -29375,8 +29780,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0231</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Neostigmini methylsulfas</cbc:Title>
+                     <cbc:Title languageID="ENG">Neostigmini methylsulfas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-231</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0231</cbc:ID>
                      </efac:LotTender>
@@ -29384,8 +29792,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0232</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Metronidazolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Metronidazolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-232</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0232</cbc:ID>
                      </efac:LotTender>
@@ -29393,8 +29804,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0233</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Permethrinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Permethrinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-233</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0233</cbc:ID>
                      </efac:LotTender>
@@ -29402,8 +29816,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0234</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Benzylii benzoas</cbc:Title>
+                     <cbc:Title languageID="ENG">Benzylii benzoas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-234</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0234</cbc:ID>
                      </efac:LotTender>
@@ -29411,8 +29828,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0235</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Xylomethazolinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Xylomethazolinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-235</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0235</cbc:ID>
                      </efac:LotTender>
@@ -29420,8 +29840,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0236</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Xylomethazolinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Xylomethazolinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-236</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0236</cbc:ID>
                      </efac:LotTender>
@@ -29429,8 +29852,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0237</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Salbutamoli sulfas</cbc:Title>
+                     <cbc:Title languageID="ENG">Salbutamoli sulfas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-237</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0237</cbc:ID>
                      </efac:LotTender>
@@ -29438,8 +29864,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0238</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Salbutamolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Salbutamolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-238</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0238</cbc:ID>
                      </efac:LotTender>
@@ -29447,8 +29876,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0239</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Ipratropii bromidum, Fenoteroli hydrobromidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Ipratropii bromidum, Fenoteroli hydrobromidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-239</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0239</cbc:ID>
                      </efac:LotTender>
@@ -29456,8 +29888,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0240</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Aminophyllinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Aminophyllinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-240</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0240</cbc:ID>
                      </efac:LotTender>
@@ -29465,8 +29900,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0241</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Clemastinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Clemastinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-241</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0241</cbc:ID>
                      </efac:LotTender>
@@ -29474,8 +29912,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0242</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Chloropyraminum</cbc:Title>
+                     <cbc:Title languageID="ENG">Chloropyraminum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-242</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0242</cbc:ID>
                      </efac:LotTender>
@@ -29483,8 +29924,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0243</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Chloropyraminum</cbc:Title>
+                     <cbc:Title languageID="ENG">Chloropyraminum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-243</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0243</cbc:ID>
                      </efac:LotTender>
@@ -29492,8 +29936,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0244</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Quifenadini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Quifenadini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-244</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0244</cbc:ID>
                      </efac:LotTender>
@@ -29501,8 +29948,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0245</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Solutio Ammoniae concentrata</cbc:Title>
+                     <cbc:Title languageID="ENG">Solutio Ammoniae concentrata</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-245</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0245</cbc:ID>
                      </efac:LotTender>
@@ -29510,8 +29960,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0246</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tobramycinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tobramycinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-246</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0246</cbc:ID>
                      </efac:LotTender>
@@ -29519,8 +29972,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0247</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tobramycinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tobramycinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-247</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0247</cbc:ID>
                      </efac:LotTender>
@@ -29528,8 +29984,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0248</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Acetazolamidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Acetazolamidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-248</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0248</cbc:ID>
                      </efac:LotTender>
@@ -29537,8 +29996,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0249</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Moxifloxacinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Moxifloxacinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-249</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0249</cbc:ID>
                      </efac:LotTender>
@@ -29546,8 +30008,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0250</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Diclofenacum Natrium</cbc:Title>
+                     <cbc:Title languageID="ENG">Diclofenacum Natrium</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-250</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0250</cbc:ID>
                      </efac:LotTender>
@@ -29555,8 +30020,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0251</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tobramycinum, Dexamethasonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tobramycinum, Dexamethasonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-251</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0251</cbc:ID>
                      </efac:LotTender>
@@ -29564,8 +30032,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0252</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tobramycinum, Dexamethasonum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tobramycinum, Dexamethasonum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-252</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0252</cbc:ID>
                      </efac:LotTender>
@@ -29573,8 +30044,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0253</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dexamethasonum, Chloramphenicolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dexamethasonum, Chloramphenicolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-253</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0253</cbc:ID>
                      </efac:LotTender>
@@ -29582,8 +30056,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0254</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dexamethasonum, Chloramphenicolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dexamethasonum, Chloramphenicolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-254</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0254</cbc:ID>
                      </efac:LotTender>
@@ -29591,8 +30068,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0255</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Timololum</cbc:Title>
+                     <cbc:Title languageID="ENG">Timololum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-255</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0255</cbc:ID>
                      </efac:LotTender>
@@ -29600,8 +30080,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0256</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Timololum, Dorzolamidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Timololum, Dorzolamidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-256</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0256</cbc:ID>
                      </efac:LotTender>
@@ -29609,8 +30092,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0257</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Cyclopentolati hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Cyclopentolati hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-257</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0257</cbc:ID>
                      </efac:LotTender>
@@ -29618,8 +30104,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0258</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tropicamidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Tropicamidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-258</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0258</cbc:ID>
                      </efac:LotTender>
@@ -29627,8 +30116,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0259</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Phenylephrinum</cbc:Title>
+                     <cbc:Title languageID="ENG">Phenylephrinum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-259</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0259</cbc:ID>
                      </efac:LotTender>
@@ -29636,8 +30128,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0260</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Proxymetacaini hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Proxymetacaini hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-260</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0260</cbc:ID>
                      </efac:LotTender>
@@ -29645,8 +30140,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0261</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Dexpanthenolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Dexpanthenolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-261</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0261</cbc:ID>
                      </efac:LotTender>
@@ -29654,8 +30152,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0262</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Carbomerum</cbc:Title>
+                     <cbc:Title languageID="ENG">Carbomerum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-262</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0262</cbc:ID>
                      </efac:LotTender>
@@ -29663,8 +30164,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0263</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Naloxoni hydrochloridum</cbc:Title>
+                     <cbc:Title languageID="ENG">Naloxoni hydrochloridum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-263</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0263</cbc:ID>
                      </efac:LotTender>
@@ -29672,8 +30176,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0264</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Protamini sulfas </cbc:Title>
+                     <cbc:Title languageID="ENG">Protamini sulfas </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-264</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0264</cbc:ID>
                      </efac:LotTender>
@@ -29681,8 +30188,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0265</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Natrii thiosulfas</cbc:Title>
+                     <cbc:Title languageID="ENG">Natrii thiosulfas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-265</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0265</cbc:ID>
                      </efac:LotTender>
@@ -29690,8 +30200,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0266</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Bleu patente</cbc:Title>
+                     <cbc:Title languageID="ENG">Bleu patente</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-266</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0266</cbc:ID>
                      </efac:LotTender>
@@ -29699,8 +30212,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0267</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Haemoderivatum deproteinatum sanguinis bovi</cbc:Title>
+                     <cbc:Title languageID="ENG">Haemoderivatum deproteinatum sanguinis bovi</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-267</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0267</cbc:ID>
                      </efac:LotTender>
@@ -29708,8 +30224,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0268</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Aqua destillata </cbc:Title>
+                     <cbc:Title languageID="ENG">Aqua destillata </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-268</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0268</cbc:ID>
                      </efac:LotTender>
@@ -29717,8 +30236,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0269</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Aqua destillata </cbc:Title>
+                     <cbc:Title languageID="ENG">Aqua destillata </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-269</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0269</cbc:ID>
                      </efac:LotTender>
@@ -29726,8 +30248,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0270</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Aqua destillata </cbc:Title>
+                     <cbc:Title languageID="ENG">Aqua destillata </cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-270</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0270</cbc:ID>
                      </efac:LotTender>
@@ -29735,8 +30260,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0271</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Title>
+                     <cbc:Title languageID="ENG">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-271</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0271</cbc:ID>
                      </efac:LotTender>
@@ -29744,8 +30272,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0272</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Title>
+                     <cbc:Title languageID="ENG">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-272</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0272</cbc:ID>
                      </efac:LotTender>
@@ -29753,8 +30284,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0273</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Iopamidolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Iopamidolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-273</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0273</cbc:ID>
                      </efac:LotTender>
@@ -29762,8 +30296,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0274</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Gadobutrolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Gadobutrolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-274</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0274</cbc:ID>
                      </efac:LotTender>
@@ -29771,8 +30308,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0275</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Gadobutrolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Gadobutrolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-275</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0275</cbc:ID>
                      </efac:LotTender>
@@ -29780,8 +30320,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0276</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Gadobutrolum</cbc:Title>
+                     <cbc:Title languageID="ENG">Gadobutrolum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-276</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0276</cbc:ID>
                      </efac:LotTender>
@@ -29789,8 +30332,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0277</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Iopromidum</cbc:Title>
+                     <cbc:Title languageID="ENG">Iopromidum</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-277</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0277</cbc:ID>
                      </efac:LotTender>
@@ -29798,8 +30344,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0278</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV"> Dinatrii gadoxetas</cbc:Title>
+                     <cbc:Title languageID="ENG"> Dinatrii gadoxetas</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-278</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0278</cbc:ID>
                      </efac:LotTender>
@@ -29807,8 +30356,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0279</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Granulēts aktivēts sorbents (sorbex)</cbc:Title>
+                     <cbc:Title languageID="ENG">Granulēts aktivēts sorbents (sorbex)</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-279</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0279</cbc:ID>
                      </efac:LotTender>
@@ -29816,8 +30368,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0280</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Spiritus aethylicus 960</cbc:Title>
+                     <cbc:Title languageID="ENG">Spiritus aethylicus 960</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-280</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0280</cbc:ID>
                      </efac:LotTender>
@@ -29825,8 +30380,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0281</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Tinctura Leonuri</cbc:Title>
+                     <cbc:Title languageID="ENG">Tinctura Leonuri</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-281</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0281</cbc:ID>
                      </efac:LotTender>
@@ -29834,8 +30392,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0282</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">TincturaValerianae</cbc:Title>
+                     <cbc:Title languageID="ENG">TincturaValerianae</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-282</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0282</cbc:ID>
                      </efac:LotTender>
@@ -29843,8 +30404,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0283</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Pretaizsvīšanas, pretaprasojuma līdzeklis visu veidu optikas izstrādājumiem, (Ultrastop)</cbc:Title>
+                     <cbc:Title languageID="ENG">Pretaizsvīšanas, pretaprasojuma līdzeklis visu veidu optikas izstrādājumiem, (Ultrastop)</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-283</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0283</cbc:ID>
                      </efac:LotTender>
@@ -29852,8 +30416,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0284</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Prontosan -Sastāvā 0,1% undecilēnamidopropilbetaīns, 0,1% poliamīnopropilbiguanīds (poliheksanīds).Nekairinošs, nesausinošs, piemērots atkārtotai un ilgstošai lietošanai. Flakonu iespējams izmantot astoņas nedēļas pēc tā atvēršanas.</cbc:Title>
+                     <cbc:Title languageID="ENG">Prontosan -Sastāvā 0,1% undecilēnamidopropilbetaīns, 0,1% poliamīnopropilbiguanīds (poliheksanīds).Nekairinošs, nesausinošs, piemērots atkārtotai un ilgstošai lietošanai. Flakonu iespējams izmantot astoņas nedēļas pēc tā atvēršanas.</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-284</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0284</cbc:ID>
                      </efac:LotTender>
@@ -29861,8 +30428,11 @@
                   <efac:SettledContract>
                      <cbc:ID schemeName="contract">CON-0285</cbc:ID>
                      <cbc:IssueDate>2023-07-24+02:00</cbc:IssueDate>
-                     <cbc:Title languageID="LAV">Enterālās barošanas līdzekļi</cbc:Title>
+                     <cbc:Title languageID="ENG">Enterālās barošanas līdzekļi</cbc:Title>
                      <cbc:URI>https://www.eis.gov.lv/EKEIS/Supplier/Procurement/96354</cbc:URI>
+                     <efac:ContractReference>
+                        <cbc:ID>CON-REF-285</cbc:ID>
+                     </efac:ContractReference>
                      <efac:LotTender>
                         <cbc:ID schemeName="tender">TEN-0285</cbc:ID>
                      </efac:LotTender>
@@ -31579,7 +32149,7 @@
                   </efac:TenderingParty>
                </efac:NoticeResult>
                <efac:NoticeSubType>
-                  <cbc:SubTypeCode>29</cbc:SubTypeCode>
+                  <cbc:SubTypeCode listName="notice-subtype">29</cbc:SubTypeCode>
                </efac:NoticeSubType>
                <efac:Organizations>
                   <efac:Organization>
@@ -31589,13 +32159,13 @@
                            <cbc:ID>ORG-0001</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Rīgas 1.slimnīca”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Rīgas 1.slimnīca”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1001</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31613,17 +32183,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0003</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31640,17 +32211,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0004</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA "Oribalt Rīga"</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA "Oribalt Rīga"</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31667,17 +32239,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0005</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31694,17 +32267,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0006</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31721,17 +32295,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0007</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31748,17 +32323,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0008</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31775,17 +32351,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0009</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31802,17 +32379,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0010</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31829,17 +32407,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0011</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31856,17 +32435,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0012</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Aniss”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Aniss”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 19A</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31883,17 +32463,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0013</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Elpis”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1005</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31910,17 +32491,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0014</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31937,17 +32519,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0015</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31964,17 +32547,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0016</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -31991,17 +32575,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0017</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32018,17 +32603,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0018</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32045,17 +32631,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0019</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32072,17 +32659,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0020</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32099,17 +32687,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0021</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32126,17 +32715,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0022</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32153,17 +32743,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0023</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32180,17 +32771,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0024</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA „Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32207,17 +32799,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0025</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA „Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32234,17 +32827,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0026</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32261,17 +32855,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0027</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32288,17 +32883,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0028</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32315,17 +32911,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0029</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32342,17 +32939,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0030</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32369,17 +32967,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0031</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32396,17 +32995,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0032</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32423,17 +33023,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0033</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA „Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32450,17 +33051,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0034</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA „Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32477,17 +33079,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0035</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA „Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA „Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32504,17 +33107,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0036</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32531,17 +33135,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0037</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32558,17 +33163,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0038</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32585,17 +33191,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0039</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32612,17 +33219,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0040</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32639,17 +33247,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0041</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32666,17 +33275,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0042</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32693,17 +33303,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0043</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32720,17 +33331,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0044</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32747,17 +33359,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0045</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32774,17 +33387,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0046</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32801,17 +33415,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0047</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32828,17 +33443,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0048</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32855,17 +33471,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0049</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32882,17 +33499,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0050</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32909,17 +33527,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0051</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32936,17 +33555,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0052</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32963,17 +33583,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0053</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -32990,17 +33611,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0054</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33017,17 +33639,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0055</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33044,17 +33667,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0056</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33071,17 +33695,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0057</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33098,17 +33723,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0058</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33125,17 +33751,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0059</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33152,17 +33779,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0060</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33179,17 +33807,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0061</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33206,17 +33835,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0062</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33233,17 +33863,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0063</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33260,17 +33891,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0064</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33287,17 +33919,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0065</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33314,17 +33947,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0066</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33341,17 +33975,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0067</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33368,17 +34003,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0068</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33395,17 +34031,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0069</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33422,17 +34059,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0070</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33449,17 +34087,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0071</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33476,17 +34115,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0072</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33503,17 +34143,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0073</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33530,17 +34171,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0074</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33557,17 +34199,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0075</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33584,17 +34227,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0076</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unikmed Baltija”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unikmed Baltija”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ģertrūdes iela 33/35 – 2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1011</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33611,17 +34255,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0077</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unikmed Baltija”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unikmed Baltija”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ģertrūdes iela 33/35 – 2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1011</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33638,17 +34283,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0078</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33665,17 +34311,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0079</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33692,17 +34339,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0080</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33719,17 +34367,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0081</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33746,17 +34395,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0082</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Olainfarm”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
                            <cbc:CityName>Olaine</cbc:CityName>
                            <cbc:PostalZone>LV-2114</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33773,17 +34423,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0083</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33800,17 +34451,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0084</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33827,17 +34479,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0085</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Elpis”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1005</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33854,17 +34507,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0086</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33881,17 +34535,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0087</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33908,17 +34563,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0088</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Olainfarm”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
                            <cbc:CityName>Olaine</cbc:CityName>
                            <cbc:PostalZone>LV-2114</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33935,17 +34591,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0089</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33962,17 +34619,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0090</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -33989,17 +34647,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0091</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34016,17 +34675,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0092</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Signamed”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1039</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34043,17 +34703,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0093</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Signamed”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1039</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34070,17 +34731,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0094</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34097,17 +34759,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0095</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34124,17 +34787,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0096</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Olainfarm”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
                            <cbc:CityName>Olaine</cbc:CityName>
                            <cbc:PostalZone>LV-2114</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34151,17 +34815,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0097</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34178,17 +34843,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0098</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34205,17 +34871,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0099</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34232,17 +34899,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0100</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34259,17 +34927,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0101</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34286,17 +34955,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0102</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34313,17 +34983,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0103</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Elpis”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1005</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34340,17 +35011,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0104</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34367,17 +35039,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0105</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34394,17 +35067,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0106</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34421,17 +35095,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0107</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34448,17 +35123,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0108</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34475,17 +35151,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0109</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34502,17 +35179,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0110</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34529,17 +35207,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0111</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34556,17 +35235,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0112</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Elpis”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1005</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34583,17 +35263,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0113</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34610,17 +35291,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0114</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34637,17 +35319,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0115</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Aniss”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Aniss”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 19A</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34664,17 +35347,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0116</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34691,17 +35375,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0117</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34718,17 +35403,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0118</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34745,17 +35431,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0119</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34772,17 +35459,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0120</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34799,17 +35487,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0121</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34826,17 +35515,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0122</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34853,17 +35543,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0123</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34880,17 +35571,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0124</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34907,17 +35599,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0125</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34934,17 +35627,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0126</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34961,17 +35655,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0127</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -34988,17 +35683,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0128</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Elpis”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1005</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35015,17 +35711,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0129</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35042,17 +35739,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0130</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35069,17 +35767,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0131</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35096,17 +35795,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0132</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35123,17 +35823,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0133</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35150,17 +35851,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0134</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35177,17 +35879,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0135</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35204,17 +35907,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0136</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35231,17 +35935,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0137</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35258,17 +35963,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0138</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35285,17 +35991,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0139</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35312,17 +36019,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0140</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35339,17 +36047,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0141</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35366,17 +36075,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0142</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35393,17 +36103,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0143</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35420,17 +36131,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0144</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35447,17 +36159,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0145</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35474,17 +36187,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0146</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35501,17 +36215,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0147</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Signamed”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1039</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35528,17 +36243,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0148</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35555,17 +36271,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0149</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35582,17 +36299,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0150</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35609,17 +36327,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0151</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35636,17 +36355,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0152</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35663,17 +36383,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0153</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35690,17 +36411,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0154</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35717,17 +36439,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0155</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35744,17 +36467,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0156</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35771,17 +36495,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0157</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Vakcīna”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1006</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35798,17 +36523,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0158</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Vakcīna”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1006</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35825,17 +36551,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0159</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Vakcīna”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1006</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35852,17 +36579,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0160</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Vakcīna”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1006</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35879,17 +36607,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0161</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35906,17 +36635,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0162</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Vakcīna”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1006</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35933,17 +36663,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0163</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35960,17 +36691,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0164</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Vakcīna”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1006</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -35987,17 +36719,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0165</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36014,17 +36747,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0166</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36041,17 +36775,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0167</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Vakcīna”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1006</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36068,17 +36803,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0168</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Vakcīna”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Vakcīna”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Lielvārdes iela 68</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1006</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36095,17 +36831,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0169</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36122,17 +36859,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0170</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Signamed”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1039</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36149,17 +36887,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0171</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36176,17 +36915,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0172</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36203,17 +36943,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0173</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36230,17 +36971,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0174</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36257,17 +36999,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0175</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36284,17 +37027,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0176</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36311,17 +37055,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0177</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36338,17 +37083,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0178</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36365,17 +37111,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0179</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36392,17 +37139,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0180</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36419,17 +37167,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0181</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Elpis”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1005</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36446,17 +37195,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0182</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36473,17 +37223,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0183</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36500,17 +37251,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0184</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36527,17 +37279,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0185</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36554,17 +37307,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0186</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36581,17 +37335,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0187</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36608,17 +37363,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0188</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName> Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36635,17 +37391,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0189</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36662,17 +37419,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0190</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36689,17 +37447,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0191</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma"</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma"</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone> LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36716,17 +37475,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0192</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36743,17 +37503,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0193</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36770,17 +37531,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0194</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B, Rīga, LV-1004</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>Rīga</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36797,17 +37559,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0195</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36824,17 +37587,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0196</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36851,17 +37615,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0197</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36878,17 +37643,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0198</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “A.Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “A.Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>arkaļu iela 13a</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1067</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36905,17 +37671,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0199</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Elvim”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Elvim”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Kurzemes prospekts 3G</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1067</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36932,17 +37699,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0200</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Elpis”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1005</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36959,17 +37727,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0201</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -36986,17 +37755,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0202</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37013,17 +37783,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0203</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37040,17 +37811,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0204</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37067,17 +37839,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0205</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37094,17 +37867,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0206</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37121,17 +37895,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0207</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37148,17 +37923,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0208</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37175,17 +37951,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0209</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37202,17 +37979,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0210</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37229,17 +38007,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0211</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37256,17 +38035,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0212</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37283,17 +38063,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0213</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName> Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37310,17 +38091,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0214</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37337,17 +38119,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0215</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37364,17 +38147,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0216</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37391,17 +38175,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0217</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>ūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37418,17 +38203,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0218</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37445,17 +38231,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0219</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37472,17 +38259,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0220</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37499,17 +38287,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0221</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Elpis”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Elpis”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rāmuļu iela 15</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1005</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37526,17 +38315,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0222</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37553,17 +38343,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0223</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37580,17 +38371,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0224</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Unifarma”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Unifarma”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Vangažu iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1024</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37607,17 +38399,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0225</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37634,17 +38427,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0226</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37661,17 +38455,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0227</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “A.Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “A.Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Varkaļu iela 13a</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1067</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37688,17 +38483,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0228</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37715,17 +38511,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0229</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37742,17 +38539,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0230</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37769,17 +38567,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0231</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37796,17 +38595,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0232</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Olainfarm”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
                            <cbc:CityName>Olaine</cbc:CityName>
                            <cbc:PostalZone>LV-2114</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37823,17 +38623,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0233</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37850,17 +38651,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0234</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37877,17 +38679,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0235</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37904,17 +38707,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0236</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37931,17 +38735,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0237</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37958,17 +38763,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0238</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -37985,17 +38791,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0239</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38012,17 +38819,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0240</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38039,17 +38847,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0241</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38066,17 +38875,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0242</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38093,17 +38903,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0243</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Signamed”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1039</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38120,17 +38931,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0244</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38147,17 +38959,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0245</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38174,17 +38987,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0246</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Olainfarm”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Olainfarm”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Rūpnīcu iela 5</cbc:StreetName>
                            <cbc:CityName>Olaine</cbc:CityName>
                            <cbc:PostalZone>LV-2114</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38201,17 +39015,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0247</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38228,17 +39043,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0248</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV003</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38255,17 +39071,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0249</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38282,17 +39099,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0250</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38309,17 +39127,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0251</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38336,17 +39155,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0252</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38363,17 +39183,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0253</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38390,17 +39211,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0254</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38417,17 +39239,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0255</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38444,17 +39267,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0256</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38471,17 +39295,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0257</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38498,17 +39323,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0258</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38525,17 +39351,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0259</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38552,17 +39379,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0260</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38579,17 +39407,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0261</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Signamed”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1039</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38606,17 +39435,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0262</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38633,17 +39463,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0263</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38660,17 +39491,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0264</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38687,17 +39519,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0265</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38714,17 +39547,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0266</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Signamed”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1039</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38741,17 +39575,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0267</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Aniss”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Aniss”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 19A</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38768,17 +39603,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0268</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Signamed”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Signamed”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Brīvības gatve 226 k-2</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1039</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38795,17 +39631,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0269</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38822,17 +39659,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0270</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38849,17 +39687,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0271</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38876,17 +39715,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0272</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38903,17 +39743,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0273</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38930,17 +39771,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0274</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38957,17 +39799,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0275</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “A.Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “A.Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Varkaļu iela 13a</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1067</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -38984,17 +39827,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0276</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39011,17 +39855,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0277</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39038,17 +39883,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0278</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39065,17 +39911,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0279</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39092,17 +39939,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0280</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39119,17 +39967,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0281</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39146,17 +39995,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0282</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39173,17 +40023,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0283</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39200,17 +40051,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0284</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">AS “Recipe Plus”</cbc:Name>
+                           <cbc:Name languageID="ENG">AS “Recipe Plus”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Mūkusalas iela 41B</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1004</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39227,17 +40079,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0285</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Magnum Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Magnum Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ulbrokas iela 23</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1021</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39254,17 +40107,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0286</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “B.Braun Medical”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “B.Braun Medical”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Ūdeļu iela 16</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1064</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39281,17 +40135,18 @@
                   <efac:Organization>
                      <efbc:NaturalPersonIndicator>false</efbc:NaturalPersonIndicator>
                      <efac:Company>
+                        <efbc:CompanySizeCode listName="economic-operator-size">micro</efbc:CompanySizeCode>
                         <cac:PartyIdentification>
                            <cbc:ID>ORG-0287</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">SIA “Oribalt Rīga”</cbc:Name>
+                           <cbc:Name languageID="ENG">SIA “Oribalt Rīga”</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Dzirnieku iela 26</cbc:StreetName>
                            <cbc:CityName>Mārupe</cbc:CityName>
                            <cbc:PostalZone>LV-2167</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39313,13 +40168,13 @@
                            <cbc:ID>ORG-0002</cbc:ID>
                         </cac:PartyIdentification>
                         <cac:PartyName>
-                           <cbc:Name languageID="LAV">Iepirkumu uzraudzības birojs</cbc:Name>
+                           <cbc:Name languageID="ENG">Iepirkumu uzraudzības birojs</cbc:Name>
                         </cac:PartyName>
                         <cac:PostalAddress>
                            <cbc:StreetName>Smilšu iela 1</cbc:StreetName>
                            <cbc:CityName>Rīga</cbc:CityName>
                            <cbc:PostalZone>LV-1919</cbc:PostalZone>
-                           <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+                           <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                            <cac:Country>
                               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                            </cac:Country>
@@ -39345,7 +40200,7 @@
       </ext:UBLExtension>
    </ext:UBLExtensions>
    <cbc:UBLVersionID>2.3</cbc:UBLVersionID>
-   <cbc:CustomizationID>eforms-sdk-1.10</cbc:CustomizationID>
+   <cbc:CustomizationID>eforms-sdk-1.13</cbc:CustomizationID>
    <cbc:ID schemeName="notice-id">e1e0a80a-6a9e-42f4-ae18-e2b8bd91bbde</cbc:ID>
    <cbc:ContractFolderID>e7902ce8-a88b-4470-9d0e-f4ae0729370c</cbc:ContractFolderID>
    <cbc:IssueDate>2024-03-22Z</cbc:IssueDate>
@@ -39353,7 +40208,7 @@
    <cbc:VersionID>01</cbc:VersionID>
    <cbc:RegulatoryDomain>32014L0024</cbc:RegulatoryDomain>
    <cbc:NoticeTypeCode listName="result">can-standard</cbc:NoticeTypeCode>
-   <cbc:NoticeLanguageCode>LAV</cbc:NoticeLanguageCode>
+   <cbc:NoticeLanguageCode listName="language">ENG</cbc:NoticeLanguageCode>
    <cac:ContractingParty>
       <cac:ContractingPartyType>
          <cbc:PartyTypeCode listName="buyer-legal-type">pub-undert-la</cbc:PartyTypeCode>
@@ -39380,12 +40235,23 @@
    </cac:TenderingProcess>
    <cac:ProcurementProject>
       <cbc:ID schemeName="InternalID">R1S 2023/17-IEP</cbc:ID>
-      <cbc:Name languageID="LAV">Medikamentu iegāde</cbc:Name>
-      <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+      <cbc:Name languageID="ENG">Medikamentu iegāde</cbc:Name>
+      <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
       <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
       <cac:MainCommodityClassification>
          <cbc:ItemClassificationCode listName="cpv">33000000</cbc:ItemClassificationCode>
       </cac:MainCommodityClassification>
+      <cac:RealizedLocation>
+         <cac:Address>
+            <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
+            <cbc:CityName>Rīga</cbc:CityName>
+            <cbc:PostalZone>LV-1001</cbc:PostalZone>
+            <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
+            <cac:Country>
+               <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
+            </cac:Country>
+         </cac:Address>
+      </cac:RealizedLocation>
    </cac:ProcurementProject>
    <cac:ProcurementProjectLot>
       <cbc:ID schemeName="Lot">LOT-0001</cbc:ID>
@@ -39407,8 +40273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -39419,7 +40285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -39442,8 +40308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP1</cbc:ID>
-         <cbc:Name languageID="LAV">Polidocanolum, Dialysatum deproteinatum sanguinis vituli</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Polidocanolum, Dialysatum deproteinatum sanguinis vituli</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -39459,7 +40325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -39487,8 +40353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -39499,7 +40365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -39522,8 +40388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP2</cbc:ID>
-         <cbc:Name languageID="LAV">Triamcinolone acetonide ,demeclocycline hydrochloride (Ledermix)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Triamcinolone acetonide ,demeclocycline hydrochloride (Ledermix)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -39539,7 +40405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -39567,8 +40433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -39579,7 +40445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -39602,8 +40468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP3</cbc:ID>
-         <cbc:Name languageID="LAV">Lidocaini hydrochloridum, Matricariae extractum fluidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Lidocaini hydrochloridum, Matricariae extractum fluidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -39619,7 +40485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -39647,8 +40513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -39659,7 +40525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -39682,8 +40548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP4</cbc:ID>
-         <cbc:Name languageID="LAV">Omeprazolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Omeprazolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -39699,7 +40565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -39727,8 +40593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -39739,7 +40605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -39762,8 +40628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP5</cbc:ID>
-         <cbc:Name languageID="LAV">Pantoprazolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Pantoprazolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -39779,7 +40645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -39807,8 +40673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -39819,7 +40685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -39842,8 +40708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP6</cbc:ID>
-         <cbc:Name languageID="LAV">Drotaverini hydrochlorium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Drotaverini hydrochlorium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -39859,7 +40725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -39887,8 +40753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -39899,7 +40765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -39922,8 +40788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP7</cbc:ID>
-         <cbc:Name languageID="LAV">Atropini sulfas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Atropini sulfas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -39939,7 +40805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -39967,8 +40833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -39979,7 +40845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40002,8 +40868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP8</cbc:ID>
-         <cbc:Name languageID="LAV">Butylscopolamini bromidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Butylscopolamini bromidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40019,7 +40885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40047,8 +40913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40059,7 +40925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40082,8 +40948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP9</cbc:ID>
-         <cbc:Name languageID="LAV">Metoclopramidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Metoclopramidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40099,7 +40965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40127,8 +40993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40139,7 +41005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40162,8 +41028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP10</cbc:ID>
-         <cbc:Name languageID="LAV">Ondansetronum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ondansetronum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40179,7 +41045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40207,8 +41073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40219,7 +41085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40242,8 +41108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP11</cbc:ID>
-         <cbc:Name languageID="LAV">Bisacodilum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bisacodilum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40259,7 +41125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40287,8 +41153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40299,7 +41165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40322,8 +41188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP12</cbc:ID>
-         <cbc:Name languageID="LAV">Lactulosum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Lactulosum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40339,7 +41205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40367,8 +41233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40379,7 +41245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40402,8 +41268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP13</cbc:ID>
-         <cbc:Name languageID="LAV">Sorbitolum, Natrii citras, Natrii laurilsulfoacetas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Sorbitolum, Natrii citras, Natrii laurilsulfoacetas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40419,7 +41285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40447,8 +41313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40459,7 +41325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40482,8 +41348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP14</cbc:ID>
-         <cbc:Name languageID="LAV">Loperamidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Loperamidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40499,7 +41365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40527,8 +41393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40539,7 +41405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40562,8 +41428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP15</cbc:ID>
-         <cbc:Name languageID="LAV">Insulinum lispro - ātras darbības insulīni, to analogi</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Insulinum lispro - ātras darbības insulīni, to analogi</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40579,7 +41445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40607,8 +41473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40619,7 +41485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40642,8 +41508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP16</cbc:ID>
-         <cbc:Name languageID="LAV">Insulinum aspartum - ātras darbības insulīni, to analogi</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Insulinum aspartum - ātras darbības insulīni, to analogi</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40659,7 +41525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40687,8 +41553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40699,7 +41565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40722,8 +41588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP17</cbc:ID>
-         <cbc:Name languageID="LAV">Insulinum glarginum - garas darbības insulīni, to analogi</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Insulinum glarginum - garas darbības insulīni, to analogi</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40739,7 +41605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40767,8 +41633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40779,7 +41645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40802,8 +41668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP18</cbc:ID>
-         <cbc:Name languageID="LAV">Metformini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Metformini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40819,7 +41685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40847,8 +41713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40859,7 +41725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40882,8 +41748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP19</cbc:ID>
-         <cbc:Name languageID="LAV">Metformini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Metformini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40899,7 +41765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -40927,8 +41793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -40939,7 +41805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -40962,8 +41828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP20</cbc:ID>
-         <cbc:Name languageID="LAV">Thiamini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Thiamini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -40979,7 +41845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41007,8 +41873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41019,7 +41885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41042,8 +41908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP21</cbc:ID>
-         <cbc:Name languageID="LAV">Pyridoxini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Pyridoxini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41059,7 +41925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41087,8 +41953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41099,7 +41965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41122,8 +41988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP22</cbc:ID>
-         <cbc:Name languageID="LAV">Calcii gluconas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Calcii gluconas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41139,7 +42005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41167,8 +42033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41179,7 +42045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41202,8 +42068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP23</cbc:ID>
-         <cbc:Name languageID="LAV">Heparinum natricum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Heparinum natricum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41219,7 +42085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41247,8 +42113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41259,7 +42125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41282,8 +42148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP24</cbc:ID>
-         <cbc:Name languageID="LAV">Heparinum natricum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Heparinum natricum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41299,7 +42165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41327,8 +42193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41339,7 +42205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41362,8 +42228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP25</cbc:ID>
-         <cbc:Name languageID="LAV">Bemiparinum natrium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bemiparinum natrium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41379,7 +42245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41407,8 +42273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41419,7 +42285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41442,8 +42308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP26</cbc:ID>
-         <cbc:Name languageID="LAV">Bemiparinum natrium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bemiparinum natrium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41459,7 +42325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41487,8 +42353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41499,7 +42365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41522,8 +42388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP27</cbc:ID>
-         <cbc:Name languageID="LAV">Nadroparinum calcicum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Nadroparinum calcicum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41539,7 +42405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41567,8 +42433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41579,7 +42445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41602,8 +42468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP28</cbc:ID>
-         <cbc:Name languageID="LAV">Nadroparinum calcicum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Nadroparinum calcicum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41619,7 +42485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41647,8 +42513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41659,7 +42525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41682,8 +42548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP29</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum acetylsalicylicum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum acetylsalicylicum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41699,7 +42565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41727,8 +42593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41739,7 +42605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41762,8 +42628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP30</cbc:ID>
-         <cbc:Name languageID="LAV">Rivaroxabanum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Rivaroxabanum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41779,7 +42645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41807,8 +42673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41819,7 +42685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41842,8 +42708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP31</cbc:ID>
-         <cbc:Name languageID="LAV">Etamsylatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Etamsylatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41859,7 +42725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41887,8 +42753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41899,7 +42765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -41922,8 +42788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP32</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum tranexamicum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum tranexamicum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -41939,7 +42805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -41967,8 +42833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -41979,7 +42845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42002,8 +42868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP33</cbc:ID>
-         <cbc:Name languageID="LAV">Fibrinogenum humanum, Thrombinum humanum, 4,8cm*4,8cm *0,5cm</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Fibrinogenum humanum, Thrombinum humanum, 4,8cm*4,8cm *0,5cm</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42019,7 +42885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42047,8 +42913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42059,7 +42925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42082,8 +42948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP34</cbc:ID>
-         <cbc:Name languageID="LAV">Phytomenadionum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Phytomenadionum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42099,7 +42965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42127,8 +42993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42139,7 +43005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42162,8 +43028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP35</cbc:ID>
-         <cbc:Name languageID="LAV">Phytomenadionum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Phytomenadionum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42179,7 +43045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42207,8 +43073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42219,7 +43085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42242,8 +43108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP36</cbc:ID>
-         <cbc:Name languageID="LAV">Cyanocobolaminum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Cyanocobolaminum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42259,7 +43125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42287,8 +43153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42299,7 +43165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42322,8 +43188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP37</cbc:ID>
-         <cbc:Name languageID="LAV">*Elektrolītu šķīdums (Ringera) </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Elektrolītu šķīdums (Ringera) </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42339,7 +43205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42367,8 +43233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42379,7 +43245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42402,8 +43268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP38</cbc:ID>
-         <cbc:Name languageID="LAV">**Elektrolītu šķīdums (Ringera) </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">**Elektrolītu šķīdums (Ringera) </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42419,7 +43285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42447,8 +43313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42459,7 +43325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42482,8 +43348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP39</cbc:ID>
-         <cbc:Name languageID="LAV">*Elektrolītu šķīdums (Ringera) </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Elektrolītu šķīdums (Ringera) </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42499,7 +43365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42527,8 +43393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42539,7 +43405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42562,8 +43428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP40</cbc:ID>
-         <cbc:Name languageID="LAV">**Elektrolītu šķīdums (Ringera) </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">**Elektrolītu šķīdums (Ringera) </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42579,7 +43445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42607,8 +43473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42619,7 +43485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42642,8 +43508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP41</cbc:ID>
-         <cbc:Name languageID="LAV">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42659,7 +43525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42687,8 +43553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42699,7 +43565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42722,8 +43588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP42</cbc:ID>
-         <cbc:Name languageID="LAV">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Elektolīti un ogļhidrāti (Sterofundin BG-5) </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42739,7 +43605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42767,8 +43633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42779,7 +43645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42802,8 +43668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP43</cbc:ID>
-         <cbc:Name languageID="LAV">*Glucosum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Glucosum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42819,7 +43685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42847,8 +43713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42859,7 +43725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42882,8 +43748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP44</cbc:ID>
-         <cbc:Name languageID="LAV">**Glucosum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">**Glucosum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42899,7 +43765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -42927,8 +43793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -42939,7 +43805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -42962,8 +43828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP45</cbc:ID>
-         <cbc:Name languageID="LAV">*Glucosum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Glucosum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -42979,7 +43845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43007,8 +43873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43019,7 +43885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43042,8 +43908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP46</cbc:ID>
-         <cbc:Name languageID="LAV">**Glucosum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">**Glucosum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43059,7 +43925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43087,8 +43953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43099,7 +43965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43122,8 +43988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP47</cbc:ID>
-         <cbc:Name languageID="LAV">*Glucosum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Glucosum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43139,7 +44005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43167,8 +44033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43179,7 +44045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43202,8 +44068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP48</cbc:ID>
-         <cbc:Name languageID="LAV">Glucosum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Glucosum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43219,7 +44085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43247,8 +44113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43259,7 +44125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43282,8 +44148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP49</cbc:ID>
-         <cbc:Name languageID="LAV">Glucosum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Glucosum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43299,7 +44165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43327,8 +44193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43339,7 +44205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43362,8 +44228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP50</cbc:ID>
-         <cbc:Name languageID="LAV">Gelatinum succinas, Natrii chloridum, Natrii hydroxidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Gelatinum succinas, Natrii chloridum, Natrii hydroxidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43379,7 +44245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43407,8 +44273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43419,7 +44285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43442,8 +44308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP51</cbc:ID>
-         <cbc:Name languageID="LAV">Central emulsija infūzijām</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Central emulsija infūzijām</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43459,7 +44325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43487,8 +44353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43499,7 +44365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43522,8 +44388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP52</cbc:ID>
-         <cbc:Name languageID="LAV">Peripheral emulsija infūzijām</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Peripheral emulsija infūzijām</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43539,7 +44405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43567,8 +44433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43579,7 +44445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43602,8 +44468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP53</cbc:ID>
-         <cbc:Name languageID="LAV">*Mannitolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Mannitolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43619,7 +44485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43647,8 +44513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43659,7 +44525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43682,8 +44548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP54</cbc:ID>
-         <cbc:Name languageID="LAV">Kalii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Kalii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43699,7 +44565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43727,8 +44593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43739,7 +44605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43762,8 +44628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP55</cbc:ID>
-         <cbc:Name languageID="LAV">Kalii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Kalii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43779,7 +44645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43807,8 +44673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43819,7 +44685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43842,8 +44708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP56</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43859,7 +44725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43887,8 +44753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43899,7 +44765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -43922,8 +44788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP57</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -43939,7 +44805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -43967,8 +44833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -43979,7 +44845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44002,8 +44868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP58</cbc:ID>
-         <cbc:Name languageID="LAV">*Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44019,7 +44885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44047,8 +44913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44059,7 +44925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44082,8 +44948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP59</cbc:ID>
-         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44099,7 +44965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44127,8 +44993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44139,7 +45005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44162,8 +45028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP60</cbc:ID>
-         <cbc:Name languageID="LAV">*Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44179,7 +45045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44207,8 +45073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44219,7 +45085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44242,8 +45108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP61</cbc:ID>
-         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44259,7 +45125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44287,8 +45153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44299,7 +45165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44322,8 +45188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP62</cbc:ID>
-         <cbc:Name languageID="LAV">*Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44339,7 +45205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44367,8 +45233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44379,7 +45245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44402,8 +45268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP63</cbc:ID>
-         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44419,7 +45285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44447,8 +45313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44459,7 +45325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44482,8 +45348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP64</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44499,7 +45365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44527,8 +45393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44539,7 +45405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44562,8 +45428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP65</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44579,7 +45445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44607,8 +45473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44619,7 +45485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44642,8 +45508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP66</cbc:ID>
-         <cbc:Name languageID="LAV">*Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">*Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44659,7 +45525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44687,8 +45553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44699,7 +45565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44722,8 +45588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP67</cbc:ID>
-         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44739,7 +45605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44767,8 +45633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44779,7 +45645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44802,8 +45668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP68</cbc:ID>
-         <cbc:Name languageID="LAV">**Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">**Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44819,7 +45685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44847,8 +45713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44859,7 +45725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44882,8 +45748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP69</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44899,7 +45765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -44927,8 +45793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -44939,7 +45805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -44962,8 +45828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP70</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -44979,7 +45845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45007,8 +45873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45019,7 +45885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45042,8 +45908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP71</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii hydrocarbonas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii hydrocarbonas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45059,7 +45925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45087,8 +45953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45099,7 +45965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45122,8 +45988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP72</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii hydrocarbonas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii hydrocarbonas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45139,7 +46005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45167,8 +46033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45179,7 +46045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45202,8 +46068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP73</cbc:ID>
-         <cbc:Name languageID="LAV">Magnesii sulfas </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Magnesii sulfas </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45219,7 +46085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45247,8 +46113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45259,7 +46125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45282,8 +46148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP74</cbc:ID>
-         <cbc:Name languageID="LAV">Digoxinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Digoxinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45299,7 +46165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45327,8 +46193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45339,7 +46205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45362,8 +46228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP75</cbc:ID>
-         <cbc:Name languageID="LAV">Amiodaronum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Amiodaronum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45379,7 +46245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45407,8 +46273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45419,7 +46285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45442,8 +46308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP76</cbc:ID>
-         <cbc:Name languageID="LAV">Norepinephrinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Norepinephrinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45459,7 +46325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45487,8 +46353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45499,7 +46365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45522,8 +46388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP77</cbc:ID>
-         <cbc:Name languageID="LAV">Ephedrini hydrohloridum </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ephedrini hydrohloridum </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45539,7 +46405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45567,8 +46433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45579,7 +46445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45602,8 +46468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP78</cbc:ID>
-         <cbc:Name languageID="LAV">Dopamini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dopamini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45619,7 +46485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45647,8 +46513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45659,7 +46525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45682,8 +46548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP79</cbc:ID>
-         <cbc:Name languageID="LAV">Dobutaminum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dobutaminum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45699,7 +46565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45727,8 +46593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45739,7 +46605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45762,8 +46628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP80</cbc:ID>
-         <cbc:Name languageID="LAV">Epinephrinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Epinephrinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45779,7 +46645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45807,8 +46673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45819,7 +46685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45842,8 +46708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP81</cbc:ID>
-         <cbc:Name languageID="LAV">Glyceroli trinitras</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Glyceroli trinitras</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45859,7 +46725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45887,8 +46753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45899,7 +46765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -45922,8 +46788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP82</cbc:ID>
-         <cbc:Name languageID="LAV">Glyceroli trinitras</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Glyceroli trinitras</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -45939,7 +46805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -45967,8 +46833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -45979,7 +46845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46002,8 +46868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP83</cbc:ID>
-         <cbc:Name languageID="LAV">Meldonium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Meldonium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46019,7 +46885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46047,8 +46913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46059,7 +46925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46082,8 +46948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP84</cbc:ID>
-         <cbc:Name languageID="LAV">Adenosinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Adenosinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46099,7 +46965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46127,8 +46993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46139,7 +47005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46162,8 +47028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP85</cbc:ID>
-         <cbc:Name languageID="LAV">Ivabradinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ivabradinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46179,7 +47045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46207,8 +47073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46219,7 +47085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46242,8 +47108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP86</cbc:ID>
-         <cbc:Name languageID="LAV">Clonidinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Clonidinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46259,7 +47125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46287,8 +47153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46299,7 +47165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46322,8 +47188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP87</cbc:ID>
-         <cbc:Name languageID="LAV">Clonidinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Clonidinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46339,7 +47205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46367,8 +47233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46379,7 +47245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46402,8 +47268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP88</cbc:ID>
-         <cbc:Name languageID="LAV">Furosemidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Furosemidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46419,7 +47285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46447,8 +47313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46459,7 +47325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46482,8 +47348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP89</cbc:ID>
-         <cbc:Name languageID="LAV">Furosemidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Furosemidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46499,7 +47365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46527,8 +47393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46539,7 +47405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46562,8 +47428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP90</cbc:ID>
-         <cbc:Name languageID="LAV">Torasemidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Torasemidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46579,7 +47445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46607,8 +47473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46619,7 +47485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46642,8 +47508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP91</cbc:ID>
-         <cbc:Name languageID="LAV">Spironolactonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Spironolactonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46659,7 +47525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46687,8 +47553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46699,7 +47565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46722,8 +47588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP92</cbc:ID>
-         <cbc:Name languageID="LAV">Pentoxifyllinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Pentoxifyllinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46739,7 +47605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46767,8 +47633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46779,7 +47645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46802,8 +47668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP93</cbc:ID>
-         <cbc:Name languageID="LAV">Xylocain</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Xylocain</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46819,7 +47685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46847,8 +47713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46859,7 +47725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46882,8 +47748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP94</cbc:ID>
-         <cbc:Name languageID="LAV">Xylocain</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Xylocain</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46899,7 +47765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -46927,8 +47793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -46939,7 +47805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -46962,8 +47828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP95</cbc:ID>
-         <cbc:Name languageID="LAV">Troxerutinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Troxerutinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -46979,7 +47845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47007,8 +47873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47019,7 +47885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47042,8 +47908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP96</cbc:ID>
-         <cbc:Name languageID="LAV">Polidocanolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Polidocanolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47059,7 +47925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47087,8 +47953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47099,7 +47965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47122,8 +47988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP97</cbc:ID>
-         <cbc:Name languageID="LAV">Propranololum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Propranololum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47139,7 +48005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47167,8 +48033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47179,7 +48045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47202,8 +48068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP98</cbc:ID>
-         <cbc:Name languageID="LAV">Metoprololi tartras</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Metoprololi tartras</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47219,7 +48085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47247,8 +48113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47259,7 +48125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47282,8 +48148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP99</cbc:ID>
-         <cbc:Name languageID="LAV">Bisoprololi fumaras</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bisoprololi fumaras</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47299,7 +48165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47327,8 +48193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47339,7 +48205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47362,8 +48228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP100</cbc:ID>
-         <cbc:Name languageID="LAV">Nebivololum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Nebivololum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47379,7 +48245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47407,8 +48273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47419,7 +48285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47442,8 +48308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP101</cbc:ID>
-         <cbc:Name languageID="LAV">Labetalolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Labetalolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47459,7 +48325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47487,8 +48353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47499,7 +48365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47522,8 +48388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP102</cbc:ID>
-         <cbc:Name languageID="LAV">Amlodipinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Amlodipinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47539,7 +48405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47567,8 +48433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47579,7 +48445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47602,8 +48468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP103</cbc:ID>
-         <cbc:Name languageID="LAV">Nitrendipinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Nitrendipinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47619,7 +48485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47647,8 +48513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47659,7 +48525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47682,8 +48548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP104</cbc:ID>
-         <cbc:Name languageID="LAV">Verapamili hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Verapamili hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47699,7 +48565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47727,8 +48593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47739,7 +48605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47762,8 +48628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP105</cbc:ID>
-         <cbc:Name languageID="LAV">Captoprilum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Captoprilum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47779,7 +48645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47807,8 +48673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47819,7 +48685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47842,8 +48708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP106</cbc:ID>
-         <cbc:Name languageID="LAV">Enalaprilum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Enalaprilum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47859,7 +48725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47887,8 +48753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47899,7 +48765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -47922,8 +48788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP107</cbc:ID>
-         <cbc:Name languageID="LAV">Enalaprilatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Enalaprilatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -47939,7 +48805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -47967,8 +48833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -47979,7 +48845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48002,8 +48868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP108</cbc:ID>
-         <cbc:Name languageID="LAV">Perindoprili argininum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Perindoprili argininum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48019,7 +48885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48047,8 +48913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48059,7 +48925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48082,8 +48948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP109</cbc:ID>
-         <cbc:Name languageID="LAV">Isoconazoli nitras, Diflucortoloni valeras</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Isoconazoli nitras, Diflucortoloni valeras</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48099,7 +48965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48127,8 +48993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48139,7 +49005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48162,8 +49028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP110</cbc:ID>
-         <cbc:Name languageID="LAV">Zinci oxydum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Zinci oxydum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48179,7 +49045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48207,8 +49073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48219,7 +49085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48242,8 +49108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP111</cbc:ID>
-         <cbc:Name languageID="LAV">Sulfathiazolum argentum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Sulfathiazolum argentum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48259,7 +49125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48287,8 +49153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48299,7 +49165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48322,8 +49188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP112</cbc:ID>
-         <cbc:Name languageID="LAV">Dexpanthenolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dexpanthenolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48339,7 +49205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48367,8 +49233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48379,7 +49245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48402,8 +49268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP113</cbc:ID>
-         <cbc:Name languageID="LAV">Dexpanthenolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dexpanthenolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48419,7 +49285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48447,8 +49313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48459,7 +49325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48482,8 +49348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP114</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum fusidicum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum fusidicum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48499,7 +49365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48527,8 +49393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48539,7 +49405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48562,8 +49428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP115</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum fusidicum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum fusidicum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48579,7 +49445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48607,8 +49473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48619,7 +49485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48642,8 +49508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP116</cbc:ID>
-         <cbc:Name languageID="LAV">Methyluracilum, Lidocainum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methyluracilum, Lidocainum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48659,7 +49525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48687,8 +49553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48699,7 +49565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48722,8 +49588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP117</cbc:ID>
-         <cbc:Name languageID="LAV">Methyluracilum, Chloramphenicolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methyluracilum, Chloramphenicolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48739,7 +49605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48767,8 +49633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48779,7 +49645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48802,8 +49668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP118</cbc:ID>
-         <cbc:Name languageID="LAV">Hydrocortisonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Hydrocortisonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48819,7 +49685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48847,8 +49713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48859,7 +49725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48882,8 +49748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP119</cbc:ID>
-         <cbc:Name languageID="LAV">Fluocinoloni acetonidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Fluocinoloni acetonidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48899,7 +49765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -48927,8 +49793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -48939,7 +49805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -48962,8 +49828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP120</cbc:ID>
-         <cbc:Name languageID="LAV">Fluocinoloni acetonidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Fluocinoloni acetonidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -48979,7 +49845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49007,8 +49873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49019,7 +49885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49042,8 +49908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP121</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum boricum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum boricum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49059,7 +49925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49087,8 +49953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49099,7 +49965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49122,8 +49988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP122</cbc:ID>
-         <cbc:Name languageID="LAV">Povidonum iodinatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Povidonum iodinatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49139,7 +50005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49167,8 +50033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49179,7 +50045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49202,8 +50068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP123</cbc:ID>
-         <cbc:Name languageID="LAV">Povidonum iodinatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Povidonum iodinatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49219,7 +50085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49247,8 +50113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49259,7 +50125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49282,8 +50148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP124</cbc:ID>
-         <cbc:Name languageID="LAV">Iodum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Iodum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49299,7 +50165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49327,8 +50193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49339,7 +50205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49362,8 +50228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP125</cbc:ID>
-         <cbc:Name languageID="LAV">Viride nitens, sp.aethylicus</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Viride nitens, sp.aethylicus</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49379,7 +50245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49407,8 +50273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49419,7 +50285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49442,8 +50308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP126</cbc:ID>
-         <cbc:Name languageID="LAV">Hydrogenii peroxidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Hydrogenii peroxidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49459,7 +50325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49487,8 +50353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49499,7 +50365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49522,8 +50388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP127</cbc:ID>
-         <cbc:Name languageID="LAV">E vitamīna acetāts, bišu vasks</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">E vitamīna acetāts, bišu vasks</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49539,7 +50405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49567,8 +50433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49579,7 +50445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49602,8 +50468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP128</cbc:ID>
-         <cbc:Name languageID="LAV">Desmopressinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Desmopressinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49619,7 +50485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49647,8 +50513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49659,7 +50525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49682,8 +50548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP129</cbc:ID>
-         <cbc:Name languageID="LAV">Oxytocinumum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Oxytocinumum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49699,7 +50565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49727,8 +50593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49739,7 +50605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49762,8 +50628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP130</cbc:ID>
-         <cbc:Name languageID="LAV">Octreotidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Octreotidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49779,7 +50645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49807,8 +50673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49819,7 +50685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49842,8 +50708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP131</cbc:ID>
-         <cbc:Name languageID="LAV">Dexamethasonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dexamethasonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49859,7 +50725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49887,8 +50753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49899,7 +50765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -49922,8 +50788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP132</cbc:ID>
-         <cbc:Name languageID="LAV">Dexamethasonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dexamethasonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -49939,7 +50805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -49967,8 +50833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -49979,7 +50845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50002,8 +50868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP133</cbc:ID>
-         <cbc:Name languageID="LAV">Methylprednisoloni acetas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methylprednisoloni acetas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50019,7 +50885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50047,8 +50913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50059,7 +50925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50082,8 +50948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP134</cbc:ID>
-         <cbc:Name languageID="LAV">Methylprednisolonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methylprednisolonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50099,7 +50965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50127,8 +50993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50139,7 +51005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50162,8 +51028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP135</cbc:ID>
-         <cbc:Name languageID="LAV">Methylprednisolonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methylprednisolonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50179,7 +51045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50207,8 +51073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50219,7 +51085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50242,8 +51108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP136</cbc:ID>
-         <cbc:Name languageID="LAV">Prednisolonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Prednisolonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50259,7 +51125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50287,8 +51153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50299,7 +51165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50322,8 +51188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP137</cbc:ID>
-         <cbc:Name languageID="LAV">Hydrocortisonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Hydrocortisonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50339,7 +51205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50367,8 +51233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50379,7 +51245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50402,8 +51268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP138</cbc:ID>
-         <cbc:Name languageID="LAV">Triamcinoloni acetonidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Triamcinoloni acetonidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50419,7 +51285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50447,8 +51313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50459,7 +51325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50482,8 +51348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP139</cbc:ID>
-         <cbc:Name languageID="LAV">Thiamazolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Thiamazolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50499,7 +51365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50527,8 +51393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50539,7 +51405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50562,8 +51428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP140</cbc:ID>
-         <cbc:Name languageID="LAV">Doxycyclinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Doxycyclinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50579,7 +51445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50607,8 +51473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50619,7 +51485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50642,8 +51508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP141</cbc:ID>
-         <cbc:Name languageID="LAV">Amoxicillinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Amoxicillinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50659,7 +51525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50687,8 +51553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50699,7 +51565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50722,8 +51588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP142</cbc:ID>
-         <cbc:Name languageID="LAV">Benzylpencillinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Benzylpencillinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50739,7 +51605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50767,8 +51633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50779,7 +51645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50802,8 +51668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP143</cbc:ID>
-         <cbc:Name languageID="LAV">Amoxicillinum / Acidum clavulanicum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Amoxicillinum / Acidum clavulanicum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50819,7 +51685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50847,8 +51713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50859,7 +51725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50882,8 +51748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP144</cbc:ID>
-         <cbc:Name languageID="LAV">Piperacillinum / Tazobactamum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Piperacillinum / Tazobactamum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50899,7 +51765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -50927,8 +51793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -50939,7 +51805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -50962,8 +51828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP145</cbc:ID>
-         <cbc:Name languageID="LAV">Cefazolinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Cefazolinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -50979,7 +51845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51007,8 +51873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51019,7 +51885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51042,8 +51908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP146</cbc:ID>
-         <cbc:Name languageID="LAV">Ceftriaxonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ceftriaxonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51059,7 +51925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51087,8 +51953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51099,7 +51965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51122,8 +51988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP147</cbc:ID>
-         <cbc:Name languageID="LAV">Imipenemum / Cilastatinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Imipenemum / Cilastatinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51139,7 +52005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51167,8 +52033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51179,7 +52045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51202,8 +52068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP148</cbc:ID>
-         <cbc:Name languageID="LAV">Sulfamethoxazolum, Trimethoprimum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Sulfamethoxazolum, Trimethoprimum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51219,7 +52085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51247,8 +52113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51259,7 +52125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51282,8 +52148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP149</cbc:ID>
-         <cbc:Name languageID="LAV">Sulfamethoxazolum / Trimethoprimum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Sulfamethoxazolum / Trimethoprimum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51299,7 +52165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51327,8 +52193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51339,7 +52205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51362,8 +52228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP150</cbc:ID>
-         <cbc:Name languageID="LAV">Erythromycinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Erythromycinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51379,7 +52245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51407,8 +52273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51419,7 +52285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51442,8 +52308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP151</cbc:ID>
-         <cbc:Name languageID="LAV">Erythromycinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Erythromycinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51459,7 +52325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51487,8 +52353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51499,7 +52365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51522,8 +52388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP152</cbc:ID>
-         <cbc:Name languageID="LAV">Erythromycinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Erythromycinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51539,7 +52405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51567,8 +52433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51579,7 +52445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51602,8 +52468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP153</cbc:ID>
-         <cbc:Name languageID="LAV">Gentamicinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Gentamicinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51619,7 +52485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51647,8 +52513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51659,7 +52525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51682,8 +52548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP154</cbc:ID>
-         <cbc:Name languageID="LAV">Ciprofloxacinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ciprofloxacinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51699,7 +52565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51727,8 +52593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51739,7 +52605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51762,8 +52628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP155</cbc:ID>
-         <cbc:Name languageID="LAV">Ciprofloxacinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ciprofloxacinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51779,7 +52645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51807,8 +52673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51819,7 +52685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51842,8 +52708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP156</cbc:ID>
-         <cbc:Name languageID="LAV">Ciprofloxacinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ciprofloxacinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51859,7 +52725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51887,8 +52753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51899,7 +52765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -51922,8 +52788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP157</cbc:ID>
-         <cbc:Name languageID="LAV">Metronidazolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Metronidazolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -51939,7 +52805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -51967,8 +52833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -51979,7 +52845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52002,8 +52868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP158</cbc:ID>
-         <cbc:Name languageID="LAV">Furaginum solubile</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Furaginum solubile</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52019,7 +52885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52047,8 +52913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52059,7 +52925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52082,8 +52948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP159</cbc:ID>
-         <cbc:Name languageID="LAV">Fluconazolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Fluconazolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52099,7 +52965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52127,8 +52993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52139,7 +53005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52162,8 +53028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP160</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52179,7 +53045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52207,8 +53073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52219,7 +53085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52242,8 +53108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP161</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum encephalitidis ixodibus advectae inactivatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52259,7 +53125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52287,8 +53153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52299,7 +53165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52322,8 +53188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP162</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52339,7 +53205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52367,8 +53233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52379,7 +53245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52402,8 +53268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP163</cbc:ID>
-         <cbc:Name languageID="LAV">Viri hepatitidis A inactivatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Viri hepatitidis A inactivatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52419,7 +53285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52447,8 +53313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52459,7 +53325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52482,8 +53348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP164</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum hepatitidis A inactivatum adsorbatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum hepatitidis A inactivatum adsorbatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52499,7 +53365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52527,8 +53393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52539,7 +53405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52562,8 +53428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP165</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum hepatitidis B (ADNr)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum hepatitidis B (ADNr)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52579,7 +53445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52607,8 +53473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52619,7 +53485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52642,8 +53508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP166</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum papillomaviri humani 9-valent, (recombinantum, adsorbatum)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum papillomaviri humani 9-valent, (recombinantum, adsorbatum)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52659,7 +53525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52687,8 +53553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52699,7 +53565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52722,8 +53588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP167</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum et poliomyelitidis inactivatum adsorbatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum et poliomyelitidis inactivatum adsorbatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52739,7 +53605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52767,8 +53633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52779,7 +53645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52802,8 +53668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP168</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum pneumococcale polysaccharidicum coniugatum adsorbatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum pneumococcale polysaccharidicum coniugatum adsorbatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52819,7 +53685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52847,8 +53713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52859,7 +53725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52882,8 +53748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP169</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum hepatitidis A inactivatum et hepatitidis B (ADNr) adsorbatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum hepatitidis A inactivatum et hepatitidis B (ADNr) adsorbatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52899,7 +53765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -52927,8 +53793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -52939,7 +53805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -52962,8 +53828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP170</cbc:ID>
-         <cbc:Name languageID="LAV">Viri rabiei inactivatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Viri rabiei inactivatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -52979,7 +53845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53007,8 +53873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53019,7 +53885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53042,8 +53908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP171</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum diphtheriae et tetani adsorbatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum diphtheriae et tetani adsorbatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53059,7 +53925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53087,8 +53953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53099,7 +53965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53122,8 +53988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP172</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum morbillorum, parotitidis et rubellae vivum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum morbillorum, parotitidis et rubellae vivum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53139,7 +54005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53167,8 +54033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53179,7 +54045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53202,8 +54068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP173</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum varicellae vivum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum varicellae vivum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53219,7 +54085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53247,8 +54113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53259,7 +54125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53282,8 +54148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP174</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum, antigeni-o(-is) minutum, adsorbatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum, antigeni-o(-is) minutum, adsorbatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53299,7 +54165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53327,8 +54193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53339,7 +54205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53362,8 +54228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP175</cbc:ID>
-         <cbc:Name languageID="LAV">Vaccinum rotaviri vivum perorale</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaccinum rotaviri vivum perorale</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53379,7 +54245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53407,8 +54273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53419,7 +54285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53442,8 +54308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP176</cbc:ID>
-         <cbc:Name languageID="LAV">Methotrexatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methotrexatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53459,7 +54325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53487,8 +54353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53499,7 +54365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53522,8 +54388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP177</cbc:ID>
-         <cbc:Name languageID="LAV">Mitomycinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Mitomycinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53539,7 +54405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53567,8 +54433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53579,7 +54445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53602,8 +54468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP178</cbc:ID>
-         <cbc:Name languageID="LAV">Doxorubicinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Doxorubicinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53619,7 +54485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53647,8 +54513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53659,7 +54525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53682,8 +54548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP179</cbc:ID>
-         <cbc:Name languageID="LAV">Diclofenacum natrium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Diclofenacum natrium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53699,7 +54565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53727,8 +54593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53739,7 +54605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53762,8 +54628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP180</cbc:ID>
-         <cbc:Name languageID="LAV">Diclofenacum natrium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Diclofenacum natrium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53779,7 +54645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53807,8 +54673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53819,7 +54685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53842,8 +54708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP181</cbc:ID>
-         <cbc:Name languageID="LAV">Diclofenacum natrium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Diclofenacum natrium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53859,7 +54725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53887,8 +54753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53899,7 +54765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -53922,8 +54788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP182</cbc:ID>
-         <cbc:Name languageID="LAV">Diclofenacum natrium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Diclofenacum natrium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -53939,7 +54805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -53967,8 +54833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -53979,7 +54845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54002,8 +54868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP183</cbc:ID>
-         <cbc:Name languageID="LAV">Ketorolaci trometamolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ketorolaci trometamolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54019,7 +54885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54047,8 +54913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54059,7 +54925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54082,8 +54948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP184</cbc:ID>
-         <cbc:Name languageID="LAV">Ibuprofenum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ibuprofenum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54099,7 +54965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54127,8 +54993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54139,7 +55005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54162,8 +55028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP185</cbc:ID>
-         <cbc:Name languageID="LAV">Dexketoprofenum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dexketoprofenum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54179,7 +55045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54207,8 +55073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54219,7 +55085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54242,8 +55108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP186</cbc:ID>
-         <cbc:Name languageID="LAV">Dexketoprofenum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dexketoprofenum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54259,7 +55125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54287,8 +55153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54299,7 +55165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54322,8 +55188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP187</cbc:ID>
-         <cbc:Name languageID="LAV">Etoricoxibum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Etoricoxibum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54339,7 +55205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54367,8 +55233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54379,7 +55245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54402,8 +55268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP188</cbc:ID>
-         <cbc:Name languageID="LAV">Suxamethonii chloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Suxamethonii chloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54419,7 +55285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54447,8 +55313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54459,7 +55325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54482,8 +55348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP189</cbc:ID>
-         <cbc:Name languageID="LAV">Atracurii besilas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Atracurii besilas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54499,7 +55365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54527,8 +55393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54539,7 +55405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54562,8 +55428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP190</cbc:ID>
-         <cbc:Name languageID="LAV">Atracurii besilas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Atracurii besilas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54579,7 +55445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54607,8 +55473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54619,7 +55485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54642,8 +55508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP191</cbc:ID>
-         <cbc:Name languageID="LAV">Mivacurium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Mivacurium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54659,7 +55525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54687,8 +55553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54699,7 +55565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54722,8 +55588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP192</cbc:ID>
-         <cbc:Name languageID="LAV">Cisatracurium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Cisatracurium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54739,7 +55605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54767,8 +55633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54779,7 +55645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54802,8 +55668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP193</cbc:ID>
-         <cbc:Name languageID="LAV">Toxinum A Clostridii botulini haemagglutininum multiplex</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Toxinum A Clostridii botulini haemagglutininum multiplex</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54819,7 +55685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54847,8 +55713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54859,7 +55725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54882,8 +55748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP194</cbc:ID>
-         <cbc:Name languageID="LAV">Tizanidinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tizanidinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54899,7 +55765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -54927,8 +55793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -54939,7 +55805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -54962,8 +55828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP195</cbc:ID>
-         <cbc:Name languageID="LAV">Tolperisonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tolperisonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -54979,7 +55845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55007,8 +55873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55019,7 +55885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55042,8 +55908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP196</cbc:ID>
-         <cbc:Name languageID="LAV">Sevofluranum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Sevofluranum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55059,7 +55925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55087,8 +55953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55099,7 +55965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55122,8 +55988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP197</cbc:ID>
-         <cbc:Name languageID="LAV">Thiopentalum natricum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Thiopentalum natricum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55139,7 +56005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55167,8 +56033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55179,7 +56045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55202,8 +56068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP198</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii oxybutyras</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii oxybutyras</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55219,7 +56085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55247,8 +56113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55259,7 +56125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55282,8 +56148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP199</cbc:ID>
-         <cbc:Name languageID="LAV">Ketamini hydrochloridum </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ketamini hydrochloridum </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55299,7 +56165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55327,8 +56193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55339,7 +56205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55362,8 +56228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP200</cbc:ID>
-         <cbc:Name languageID="LAV">Etomidatum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Etomidatum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55379,7 +56245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55407,8 +56273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55419,7 +56285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55442,8 +56308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP201</cbc:ID>
-         <cbc:Name languageID="LAV">Propofolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Propofolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55459,7 +56325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55487,8 +56353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55499,7 +56365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55522,8 +56388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP202</cbc:ID>
-         <cbc:Name languageID="LAV">Propofolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Propofolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55539,7 +56405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55567,8 +56433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55579,7 +56445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55602,8 +56468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP203</cbc:ID>
-         <cbc:Name languageID="LAV">Bupivacaini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bupivacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55619,7 +56485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55647,8 +56513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55659,7 +56525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55682,8 +56548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP204</cbc:ID>
-         <cbc:Name languageID="LAV">Bupivacaini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bupivacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55699,7 +56565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55727,8 +56593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55739,7 +56605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55762,8 +56628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP205</cbc:ID>
-         <cbc:Name languageID="LAV">Bupivacaini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bupivacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55779,7 +56645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55807,8 +56673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55819,7 +56685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55842,8 +56708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP206</cbc:ID>
-         <cbc:Name languageID="LAV">Ropivacaini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ropivacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55859,7 +56725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55887,8 +56753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55899,7 +56765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -55922,8 +56788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP207</cbc:ID>
-         <cbc:Name languageID="LAV">Lidocaini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Lidocaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -55939,7 +56805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -55967,8 +56833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -55979,7 +56845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56002,8 +56868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP208</cbc:ID>
-         <cbc:Name languageID="LAV">Lidocaini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Lidocaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56019,7 +56885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56047,8 +56913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56059,7 +56925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56082,8 +56948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP209</cbc:ID>
-         <cbc:Name languageID="LAV">Lidocaini hydrochloridum, Chlorhexidinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Lidocaini hydrochloridum, Chlorhexidinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56099,7 +56965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56127,8 +56993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56139,7 +57005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56162,8 +57028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP210</cbc:ID>
-         <cbc:Name languageID="LAV">Prilocainum, Lidocainum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Prilocainum, Lidocainum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56179,7 +57045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56207,8 +57073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56219,7 +57085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56242,8 +57108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP211</cbc:ID>
-         <cbc:Name languageID="LAV">Morphini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Morphini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56259,7 +57125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56287,8 +57153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56299,7 +57165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56322,8 +57188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP212</cbc:ID>
-         <cbc:Name languageID="LAV">Fentanylum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Fentanylum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56339,7 +57205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56367,8 +57233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56379,7 +57245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56402,8 +57268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP213</cbc:ID>
-         <cbc:Name languageID="LAV">Trimeperidini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Trimeperidini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56419,7 +57285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56447,8 +57313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56459,7 +57325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56482,8 +57348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP214</cbc:ID>
-         <cbc:Name languageID="LAV">Tramadoli hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tramadoli hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56499,7 +57365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56527,8 +57393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56539,7 +57405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56562,8 +57428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP215</cbc:ID>
-         <cbc:Name languageID="LAV">Tramadoli hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tramadoli hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56579,7 +57445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56607,8 +57473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56619,7 +57485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56642,8 +57508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP216</cbc:ID>
-         <cbc:Name languageID="LAV">Tramadoli hydrochloridum, Dexketoprofenum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tramadoli hydrochloridum, Dexketoprofenum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56659,7 +57525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56687,8 +57553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56699,7 +57565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56722,8 +57588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP217</cbc:ID>
-         <cbc:Name languageID="LAV">Paracetamolum, Codeini phosphas hemihydricus</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Paracetamolum, Codeini phosphas hemihydricus</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56739,7 +57605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56767,8 +57633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56779,7 +57645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56802,8 +57668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP218</cbc:ID>
-         <cbc:Name languageID="LAV">Sumatriptanum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Sumatriptanum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56819,7 +57685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56847,8 +57713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56859,7 +57725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56882,8 +57748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP219</cbc:ID>
-         <cbc:Name languageID="LAV">Metamizolum natricum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Metamizolum natricum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56899,7 +57765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -56927,8 +57793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -56939,7 +57805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -56962,8 +57828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP220</cbc:ID>
-         <cbc:Name languageID="LAV">Metamizolum natricum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Metamizolum natricum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -56979,7 +57845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57007,8 +57873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57019,7 +57885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57042,8 +57908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP221</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum acetylsalicylicum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum acetylsalicylicum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57059,7 +57925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57087,8 +57953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57099,7 +57965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57122,8 +57988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP222</cbc:ID>
-         <cbc:Name languageID="LAV">Paracetamolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Paracetamolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57139,7 +58005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57167,8 +58033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57179,7 +58045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57202,8 +58068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP223</cbc:ID>
-         <cbc:Name languageID="LAV">Paracetamolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Paracetamolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57219,7 +58085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57247,8 +58113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57259,7 +58125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57282,8 +58148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP224</cbc:ID>
-         <cbc:Name languageID="LAV">Clonazepamum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Clonazepamum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57299,7 +58165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57327,8 +58193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57339,7 +58205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57362,8 +58228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP225</cbc:ID>
-         <cbc:Name languageID="LAV">Gabapentinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Gabapentinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57379,7 +58245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57407,8 +58273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57419,7 +58285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57442,8 +58308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP226</cbc:ID>
-         <cbc:Name languageID="LAV">Pregabalinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Pregabalinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57459,7 +58325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57487,8 +58353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57499,7 +58365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57522,8 +58388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP227</cbc:ID>
-         <cbc:Name languageID="LAV">Carbamazepinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Carbamazepinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57539,7 +58405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57567,8 +58433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57579,7 +58445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57602,8 +58468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP228</cbc:ID>
-         <cbc:Name languageID="LAV">Trihexyphenidylum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Trihexyphenidylum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57619,7 +58485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57647,8 +58513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57659,7 +58525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57682,8 +58548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP229</cbc:ID>
-         <cbc:Name languageID="LAV">Levodopum, Benserazidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Levodopum, Benserazidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57699,7 +58565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57727,8 +58593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57739,7 +58605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57762,8 +58628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP230</cbc:ID>
-         <cbc:Name languageID="LAV">Haloperidolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Haloperidolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57779,7 +58645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57807,8 +58673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57819,7 +58685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57842,8 +58708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP231</cbc:ID>
-         <cbc:Name languageID="LAV">Haloperidolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Haloperidolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57859,7 +58725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57887,8 +58753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57899,7 +58765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -57922,8 +58788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP232</cbc:ID>
-         <cbc:Name languageID="LAV">Melperonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Melperonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -57939,7 +58805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -57967,8 +58833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -57979,7 +58845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58002,8 +58868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP233</cbc:ID>
-         <cbc:Name languageID="LAV">Droperidolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Droperidolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58019,7 +58885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58047,8 +58913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58059,7 +58925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58082,8 +58948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP234</cbc:ID>
-         <cbc:Name languageID="LAV">Diazepamum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Diazepamum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58099,7 +58965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58127,8 +58993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58139,7 +59005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58162,8 +59028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP235</cbc:ID>
-         <cbc:Name languageID="LAV">Diazepamum (iepakojumā tika pa N10 ampulām)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Diazepamum (iepakojumā tika pa N10 ampulām)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58179,7 +59045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58207,8 +59073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58219,7 +59085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58242,8 +59108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP236</cbc:ID>
-         <cbc:Name languageID="LAV">Bromazepamum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bromazepamum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58259,7 +59125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58287,8 +59153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58299,7 +59165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58322,8 +59188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP237</cbc:ID>
-         <cbc:Name languageID="LAV">Quetiapinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Quetiapinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58339,7 +59205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58367,8 +59233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58379,7 +59245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58402,8 +59268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP238</cbc:ID>
-         <cbc:Name languageID="LAV">Midazolamum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Midazolamum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58419,7 +59285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58447,8 +59313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58459,7 +59325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58482,8 +59348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP239</cbc:ID>
-         <cbc:Name languageID="LAV">Midazolamum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Midazolamum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58499,7 +59365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58527,8 +59393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58539,7 +59405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58562,8 +59428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP240</cbc:ID>
-         <cbc:Name languageID="LAV">Chlorprotixenum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Chlorprotixenum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58579,7 +59445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58607,8 +59473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58619,7 +59485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58642,8 +59508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP241</cbc:ID>
-         <cbc:Name languageID="LAV">Amitriptylinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Amitriptylinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58659,7 +59525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58687,8 +59553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58699,7 +59565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58722,8 +59588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP242</cbc:ID>
-         <cbc:Name languageID="LAV">Piracetamum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Piracetamum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58739,7 +59605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58767,8 +59633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58779,7 +59645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58802,8 +59668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP243</cbc:ID>
-         <cbc:Name languageID="LAV">Ipidacrinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ipidacrinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58819,7 +59685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58847,8 +59713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58859,7 +59725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58882,8 +59748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP244</cbc:ID>
-         <cbc:Name languageID="LAV">Neostigmini methylsulfas </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Neostigmini methylsulfas </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58899,7 +59765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -58927,8 +59793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -58939,7 +59805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -58962,8 +59828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP245</cbc:ID>
-         <cbc:Name languageID="LAV">Metronidazolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Metronidazolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -58979,7 +59845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59007,8 +59873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59019,7 +59885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59042,8 +59908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP246</cbc:ID>
-         <cbc:Name languageID="LAV">Permethrinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Permethrinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59059,7 +59925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59087,8 +59953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59099,7 +59965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59122,8 +59988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP247</cbc:ID>
-         <cbc:Name languageID="LAV">Benzylii benzoas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Benzylii benzoas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59139,7 +60005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59167,8 +60033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59179,7 +60045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59202,8 +60068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP248</cbc:ID>
-         <cbc:Name languageID="LAV">Xylomethazolinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Xylomethazolinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59219,7 +60085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59247,8 +60113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59259,7 +60125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59282,8 +60148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP249</cbc:ID>
-         <cbc:Name languageID="LAV">Xylomethazolinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Xylomethazolinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59299,7 +60165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59327,8 +60193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59339,7 +60205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59362,8 +60228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP250</cbc:ID>
-         <cbc:Name languageID="LAV">Salbutamoli sulfas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Salbutamoli sulfas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59379,7 +60245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59407,8 +60273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59419,7 +60285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59442,8 +60308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP251</cbc:ID>
-         <cbc:Name languageID="LAV">Salbutamolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Salbutamolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59459,7 +60325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59487,8 +60353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59499,7 +60365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59522,8 +60388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP252</cbc:ID>
-         <cbc:Name languageID="LAV">Salbutamolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Salbutamolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59539,7 +60405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59567,8 +60433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59579,7 +60445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59602,8 +60468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP253</cbc:ID>
-         <cbc:Name languageID="LAV">Ipratropii bromidum, Fenoteroli hydrobromidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ipratropii bromidum, Fenoteroli hydrobromidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59619,7 +60485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59647,8 +60513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59659,7 +60525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59682,8 +60548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP254</cbc:ID>
-         <cbc:Name languageID="LAV">Ephedrini hydrohloridum </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ephedrini hydrohloridum </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59699,7 +60565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59727,8 +60593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59739,7 +60605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59762,8 +60628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP255</cbc:ID>
-         <cbc:Name languageID="LAV">Aminophyllinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Aminophyllinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59779,7 +60645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59807,8 +60673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59819,7 +60685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59842,8 +60708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP256</cbc:ID>
-         <cbc:Name languageID="LAV">Clemastinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Clemastinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59859,7 +60725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59887,8 +60753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59899,7 +60765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -59922,8 +60788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP257</cbc:ID>
-         <cbc:Name languageID="LAV">Chloropyraminum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Chloropyraminum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -59939,7 +60805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -59967,8 +60833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -59979,7 +60845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60002,8 +60868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP258</cbc:ID>
-         <cbc:Name languageID="LAV">Chloropyraminum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Chloropyraminum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60019,7 +60885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60047,8 +60913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60059,7 +60925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60082,8 +60948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP259</cbc:ID>
-         <cbc:Name languageID="LAV">Quifenadini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Quifenadini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60099,7 +60965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60127,8 +60993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60139,7 +61005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60162,8 +61028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP260</cbc:ID>
-         <cbc:Name languageID="LAV">Solutio Ammoniae concentrata</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Solutio Ammoniae concentrata</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60179,7 +61045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60207,8 +61073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60219,7 +61085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60242,8 +61108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP261</cbc:ID>
-         <cbc:Name languageID="LAV">Tobramycinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tobramycinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60259,7 +61125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60287,8 +61153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60299,7 +61165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60322,8 +61188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP262</cbc:ID>
-         <cbc:Name languageID="LAV">Tobramycinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tobramycinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60339,7 +61205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60367,8 +61233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60379,7 +61245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60402,8 +61268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP263</cbc:ID>
-         <cbc:Name languageID="LAV">Acetazolamidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acetazolamidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60419,7 +61285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60447,8 +61313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60459,7 +61325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60482,8 +61348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP264</cbc:ID>
-         <cbc:Name languageID="LAV">Moxifloxacinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Moxifloxacinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60499,7 +61365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60527,8 +61393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60539,7 +61405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60562,8 +61428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP265</cbc:ID>
-         <cbc:Name languageID="LAV">Diclofenacum Natrium</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Diclofenacum Natrium</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60579,7 +61445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60607,8 +61473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60619,7 +61485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60642,8 +61508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP266</cbc:ID>
-         <cbc:Name languageID="LAV">Tobramycinum, Dexamethasonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tobramycinum, Dexamethasonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60659,7 +61525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60687,8 +61553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60699,7 +61565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60722,8 +61588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP267</cbc:ID>
-         <cbc:Name languageID="LAV">Tobramycinum, Dexamethasonum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tobramycinum, Dexamethasonum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60739,7 +61605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60767,8 +61633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60779,7 +61645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60802,8 +61668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP268</cbc:ID>
-         <cbc:Name languageID="LAV">Dexamethasonum, Chloramphenicolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dexamethasonum, Chloramphenicolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60819,7 +61685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60847,8 +61713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60859,7 +61725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60882,8 +61748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP269</cbc:ID>
-         <cbc:Name languageID="LAV">Dexamethasonum, Chloramphenicolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dexamethasonum, Chloramphenicolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60899,7 +61765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -60927,8 +61793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -60939,7 +61805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -60962,8 +61828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP270</cbc:ID>
-         <cbc:Name languageID="LAV">Pilocarpinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Pilocarpinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -60979,7 +61845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61007,8 +61873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61019,7 +61885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61042,8 +61908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP271</cbc:ID>
-         <cbc:Name languageID="LAV">Timololum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Timololum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61059,7 +61925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61087,8 +61953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61099,7 +61965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61122,8 +61988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP272</cbc:ID>
-         <cbc:Name languageID="LAV">Timololum, Dorzolamidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Timololum, Dorzolamidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61139,7 +62005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61167,8 +62033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61179,7 +62045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61202,8 +62068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP273</cbc:ID>
-         <cbc:Name languageID="LAV">Cyclopentolati hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Cyclopentolati hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61219,7 +62085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61247,8 +62113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61259,7 +62125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61282,8 +62148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP274</cbc:ID>
-         <cbc:Name languageID="LAV">Tropicamidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tropicamidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61299,7 +62165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61327,8 +62193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61339,7 +62205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61362,8 +62228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP275</cbc:ID>
-         <cbc:Name languageID="LAV">Phenylephrinum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Phenylephrinum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61379,7 +62245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61407,8 +62273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61419,7 +62285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61442,8 +62308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP276</cbc:ID>
-         <cbc:Name languageID="LAV">Proxymetacaini hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Proxymetacaini hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61459,7 +62325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61487,8 +62353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61499,7 +62365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61522,8 +62388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP277</cbc:ID>
-         <cbc:Name languageID="LAV">Dexpanthenolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dexpanthenolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61539,7 +62405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61567,8 +62433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61579,7 +62445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61602,8 +62468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP278</cbc:ID>
-         <cbc:Name languageID="LAV">Carbomerum </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Carbomerum </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61619,7 +62485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61647,8 +62513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61659,7 +62525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61682,8 +62548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP279</cbc:ID>
-         <cbc:Name languageID="LAV">Carbachol intaocular solution</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Carbachol intaocular solution</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61699,7 +62565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61727,8 +62593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61739,7 +62605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61762,8 +62628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP280</cbc:ID>
-         <cbc:Name languageID="LAV">Carbacholin</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Carbacholin</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61779,7 +62645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61807,8 +62673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61819,7 +62685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61842,8 +62708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP281</cbc:ID>
-         <cbc:Name languageID="LAV">Naloxoni hydrochloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Naloxoni hydrochloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61859,7 +62725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61887,8 +62753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61899,7 +62765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -61922,8 +62788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP282</cbc:ID>
-         <cbc:Name languageID="LAV">Protamini sulfas </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Protamini sulfas </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -61939,7 +62805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -61967,8 +62833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -61979,7 +62845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62002,8 +62868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP283</cbc:ID>
-         <cbc:Name languageID="LAV">Protamini hydrohloridum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Protamini hydrohloridum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62019,7 +62885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62047,8 +62913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62059,7 +62925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62082,8 +62948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP284</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii thiosulfas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii thiosulfas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62099,7 +62965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62127,8 +62993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62139,7 +63005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62162,8 +63028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP285</cbc:ID>
-         <cbc:Name languageID="LAV">Bleu patente</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bleu patente</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62179,7 +63045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62207,8 +63073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62219,7 +63085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62242,8 +63108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP286</cbc:ID>
-         <cbc:Name languageID="LAV">Haemoderivatum deproteinatum sanguinis bovi</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Haemoderivatum deproteinatum sanguinis bovi</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62259,7 +63125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62287,8 +63153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62299,7 +63165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62322,8 +63188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP287</cbc:ID>
-         <cbc:Name languageID="LAV">Aqua destillata </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Aqua destillata </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62339,7 +63205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62367,8 +63233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62379,7 +63245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62402,8 +63268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP288</cbc:ID>
-         <cbc:Name languageID="LAV">Aqua destillata </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Aqua destillata </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62419,7 +63285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62447,8 +63313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62459,7 +63325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62482,8 +63348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP289</cbc:ID>
-         <cbc:Name languageID="LAV">Aqua destillata </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Aqua destillata </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62499,7 +63365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62527,8 +63393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62539,7 +63405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62562,8 +63428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP290</cbc:ID>
-         <cbc:Name languageID="LAV">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62579,7 +63445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62607,8 +63473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62619,7 +63485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62642,8 +63508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP291</cbc:ID>
-         <cbc:Name languageID="LAV">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Irigācijas šķīdums uroloģ./ginekoloģ.operācijām (ecobag)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62659,7 +63525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62687,8 +63553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62699,7 +63565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62722,8 +63588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP292</cbc:ID>
-         <cbc:Name languageID="LAV">Iohexolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Iohexolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62739,7 +63605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62767,8 +63633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62779,7 +63645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62802,8 +63668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP293</cbc:ID>
-         <cbc:Name languageID="LAV">Iohexolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Iohexolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62819,7 +63685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62847,8 +63713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62859,7 +63725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62882,8 +63748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP294</cbc:ID>
-         <cbc:Name languageID="LAV">Iohexolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Iohexolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62899,7 +63765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -62927,8 +63793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -62939,7 +63805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -62962,8 +63828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP295</cbc:ID>
-         <cbc:Name languageID="LAV">Iopamidolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Iopamidolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -62979,7 +63845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63007,8 +63873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63019,7 +63885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63042,8 +63908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP296</cbc:ID>
-         <cbc:Name languageID="LAV">Gadobutrolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Gadobutrolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63059,7 +63925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63087,8 +63953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63099,7 +63965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63122,8 +63988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP297</cbc:ID>
-         <cbc:Name languageID="LAV">Gadobutrolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Gadobutrolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63139,7 +64005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63167,8 +64033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63179,7 +64045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63202,8 +64068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP298</cbc:ID>
-         <cbc:Name languageID="LAV">Gadobutrolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Gadobutrolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63219,7 +64085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63247,8 +64113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63259,7 +64125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63282,8 +64148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP299</cbc:ID>
-         <cbc:Name languageID="LAV">Iopromidum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Iopromidum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63299,7 +64165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63327,8 +64193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63339,7 +64205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63362,8 +64228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP300</cbc:ID>
-         <cbc:Name languageID="LAV"> Dinatrii gadoxetas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG"> Dinatrii gadoxetas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63379,7 +64245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63407,8 +64273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63419,7 +64285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63442,8 +64308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP301</cbc:ID>
-         <cbc:Name languageID="LAV">Granulēts aktivēts sorbents (sorbex)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Granulēts aktivēts sorbents (sorbex)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63459,7 +64325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63487,8 +64353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63499,7 +64365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63522,8 +64388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP302</cbc:ID>
-         <cbc:Name languageID="LAV">Aether (iepakojums 250-1000 ml)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Aether (iepakojums 250-1000 ml)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63539,7 +64405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63567,8 +64433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63579,7 +64445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63602,8 +64468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP303</cbc:ID>
-         <cbc:Name languageID="LAV">Spiritus aethylicus 960</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Spiritus aethylicus 960</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63619,7 +64485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63647,8 +64513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63659,7 +64525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63682,8 +64548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP304</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum boricum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum boricum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63699,7 +64565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63727,8 +64593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63739,7 +64605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63762,8 +64628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP305</cbc:ID>
-         <cbc:Name languageID="LAV">Barium sulfas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Barium sulfas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63779,7 +64645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63807,8 +64673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63819,7 +64685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63842,8 +64708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP306</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum aceticum conc.maks. iepakojums līdz 200 ml</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum aceticum conc.maks. iepakojums līdz 200 ml</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63859,7 +64725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63887,8 +64753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena </cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena </cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63899,7 +64765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -63922,8 +64788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP307</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum hydrochloric. conc.maks. iepak.līdz 100 ml</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum hydrochloric. conc.maks. iepak.līdz 100 ml</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -63939,7 +64805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -63967,8 +64833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -63979,7 +64845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64002,8 +64868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP308</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum nitotinicum maks. iepak.līdz 20g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum nitotinicum maks. iepak.līdz 20g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64019,7 +64885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64047,8 +64913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64059,7 +64925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64082,8 +64948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP309</cbc:ID>
-         <cbc:Name languageID="LAV">Acidum salicylicum maks. iepak.līdz 1 kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Acidum salicylicum maks. iepak.līdz 1 kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64099,7 +64965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64127,8 +64993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64139,7 +65005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64162,8 +65028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP310</cbc:ID>
-         <cbc:Name languageID="LAV">Argenti nitras (maks. iepakojumā 10g-20g)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Argenti nitras (maks. iepakojumā 10g-20g)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64179,7 +65045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64207,8 +65073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64219,7 +65085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64242,8 +65108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP311</cbc:ID>
-         <cbc:Name languageID="LAV">Anaesthesinum maks. iepak. līdz 50g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Anaesthesinum maks. iepak. līdz 50g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64259,7 +65125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64287,8 +65153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64299,7 +65165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64322,8 +65188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP312</cbc:ID>
-         <cbc:Name languageID="LAV">Calcii chloridum maks. iepak. līdz 50g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Calcii chloridum maks. iepak. līdz 50g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64339,7 +65205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64367,8 +65233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64379,7 +65245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64402,8 +65268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP313</cbc:ID>
-         <cbc:Name languageID="LAV">Chlorhexidini digluconas maks. iepak. līdz 1L pudelēs</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Chlorhexidini digluconas maks. iepak. līdz 1L pudelēs</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64419,7 +65285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64447,8 +65313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64459,7 +65325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64482,8 +65348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP314</cbc:ID>
-         <cbc:Name languageID="LAV">Dermatolum maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dermatolum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64499,7 +65365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64527,8 +65393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64539,7 +65405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64562,8 +65428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP315</cbc:ID>
-         <cbc:Name languageID="LAV">Dicainum (Tetracainum) (maks. iepakojumā 10g-20g)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Dicainum (Tetracainum) (maks. iepakojumā 10g-20g)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64579,7 +65445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64607,8 +65473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64619,7 +65485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64642,8 +65508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP316</cbc:ID>
-         <cbc:Name languageID="LAV">Extractum Thermopsidis maks. iepak. līdz 100g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Extractum Thermopsidis maks. iepak. līdz 100g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64659,7 +65525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64687,8 +65553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64699,7 +65565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64722,8 +65588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP317</cbc:ID>
-         <cbc:Name languageID="LAV">Euphyllinum maks. iepak. līdz 20g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Euphyllinum maks. iepak. līdz 20g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64739,7 +65605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64767,8 +65633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64779,7 +65645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64802,8 +65668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP318</cbc:ID>
-         <cbc:Name languageID="LAV">Furacillinum maks. iepak. līdz 20g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Furacillinum maks. iepak. līdz 20g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64819,7 +65685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64847,8 +65713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64859,7 +65725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64882,8 +65748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP319</cbc:ID>
-         <cbc:Name languageID="LAV">Formaldehydi (maks. iepakojumā līdz 1,5L pudelēs)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Formaldehydi (maks. iepakojumā līdz 1,5L pudelēs)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64899,7 +65765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -64927,8 +65793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -64939,7 +65805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -64962,8 +65828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP320</cbc:ID>
-         <cbc:Name languageID="LAV">Glycerinum (maks. iepakojumā līz 1.5 L pudelēs)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Glycerinum (maks. iepakojumā līz 1.5 L pudelēs)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -64979,7 +65845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65007,8 +65873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena </cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena </cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65019,7 +65885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65042,8 +65908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP321</cbc:ID>
-         <cbc:Name languageID="LAV">Hydrogeni peroxyidi conc.maks. iepak. 1-5 L pudelēs</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Hydrogeni peroxyidi conc.maks. iepak. 1-5 L pudelēs</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65059,7 +65925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65087,8 +65953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65099,7 +65965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65122,8 +65988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP322</cbc:ID>
-         <cbc:Name languageID="LAV">Ichthyolum maks. iepak. līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Ichthyolum maks. iepak. līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65139,7 +66005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65167,8 +66033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65179,7 +66045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65202,8 +66068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP323</cbc:ID>
-         <cbc:Name languageID="LAV">Iodoformium maks. iepak. līdz 50g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Iodoformium maks. iepak. līdz 50g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65219,7 +66085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65247,8 +66113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65259,7 +66125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65282,8 +66148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP324</cbc:ID>
-         <cbc:Name languageID="LAV">Kalii iodidi maks. iepak. līdz 50g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Kalii iodidi maks. iepak. līdz 50g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65299,7 +66165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65327,8 +66193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65339,7 +66205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65362,8 +66228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP325</cbc:ID>
-         <cbc:Name languageID="LAV">Lanolinum maks. iepak. līdz 5 kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Lanolinum maks. iepak. līdz 5 kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65379,7 +66245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65407,8 +66273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65419,7 +66285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65442,8 +66308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP326</cbc:ID>
-         <cbc:Name languageID="LAV">Laevomycetinum maks. iepak. līdz 20g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Laevomycetinum maks. iepak. līdz 20g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65459,7 +66325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65487,8 +66353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65499,7 +66365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65522,8 +66388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP327</cbc:ID>
-         <cbc:Name languageID="LAV">Methylviolet 1% 50 ml</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methylviolet 1% 50 ml</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65539,7 +66405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65567,8 +66433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65579,7 +66445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65602,8 +66468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP328</cbc:ID>
-         <cbc:Name languageID="LAV">Methylviolet 1% 100 ml</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methylviolet 1% 100 ml</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65619,7 +66485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65647,8 +66513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65659,7 +66525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65682,8 +66548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP329</cbc:ID>
-         <cbc:Name languageID="LAV">Methylviolet 2% 50 ml</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methylviolet 2% 50 ml</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65699,7 +66565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65727,8 +66593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65739,7 +66605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65762,8 +66628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP330</cbc:ID>
-         <cbc:Name languageID="LAV">Methylviolet 2% 100 ml</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Methylviolet 2% 100 ml</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65779,7 +66645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65807,8 +66673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65819,7 +66685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65842,8 +66708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP331</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii acetas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii acetas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65859,7 +66725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65887,8 +66753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65899,7 +66765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -65922,8 +66788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP332</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii benzoas maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii benzoas maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -65939,7 +66805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -65967,8 +66833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -65979,7 +66845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66002,8 +66868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP333</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii bromidi maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii bromidi maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66019,7 +66885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66047,8 +66913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66059,7 +66925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66082,8 +66948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP334</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii chloridum maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii chloridum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66099,7 +66965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66127,8 +66993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66139,7 +67005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66162,8 +67028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP335</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii hydrocarbonas maks. iepak. līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii hydrocarbonas maks. iepak. līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66179,7 +67045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66207,8 +67073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66219,7 +67085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66242,8 +67108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP336</cbc:ID>
-         <cbc:Name languageID="LAV">Natrii salicylas</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Natrii salicylas</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66259,7 +67125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66287,8 +67153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66299,7 +67165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66322,8 +67188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP337</cbc:ID>
-         <cbc:Name languageID="LAV">Norsulfasolum</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Norsulfasolum</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66339,7 +67205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66367,8 +67233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66379,7 +67245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66402,8 +67268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP338</cbc:ID>
-         <cbc:Name languageID="LAV">Novocaini hydrochloridum maks. iepak.līdz 50g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Novocaini hydrochloridum maks. iepak.līdz 50g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66419,7 +67285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66447,8 +67313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66459,7 +67325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66482,8 +67348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP339</cbc:ID>
-         <cbc:Name languageID="LAV">Oleum Helianthis maks. iepak.līdz 5kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Oleum Helianthis maks. iepak.līdz 5kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66499,7 +67365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66527,8 +67393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66539,7 +67405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66562,8 +67428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP340</cbc:ID>
-         <cbc:Name languageID="LAV">Oleum Ricini maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Oleum Ricini maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66579,7 +67445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66607,8 +67473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66619,7 +67485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66642,8 +67508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP341</cbc:ID>
-         <cbc:Name languageID="LAV">Oleum Vaselini maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Oleum Vaselini maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66659,7 +67525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66687,8 +67553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66699,7 +67565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66722,8 +67588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP342</cbc:ID>
-         <cbc:Name languageID="LAV">Oleum Olivarum maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Oleum Olivarum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66739,7 +67605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66767,8 +67633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66779,7 +67645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66802,8 +67668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP343</cbc:ID>
-         <cbc:Name languageID="LAV">Oleum Caryophylli (maks. iepakojumā 10g-30g)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Oleum Caryophylli (maks. iepakojumā 10g-30g)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66819,7 +67685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66847,8 +67713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66859,7 +67725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66882,8 +67748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP344</cbc:ID>
-         <cbc:Name languageID="LAV">Pix liquda Betulae </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Pix liquda Betulae </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66899,7 +67765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -66927,8 +67793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -66939,7 +67805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -66962,8 +67828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP345</cbc:ID>
-         <cbc:Name languageID="LAV">Streptocidum maks. iepak.līdz 100g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Streptocidum maks. iepak.līdz 100g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -66979,7 +67845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67007,8 +67873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67019,7 +67885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67042,8 +67908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP346</cbc:ID>
-         <cbc:Name languageID="LAV">Sulfur praecipitatum maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Sulfur praecipitatum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67059,7 +67925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67087,8 +67953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67099,7 +67965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67122,8 +67988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP347</cbc:ID>
-         <cbc:Name languageID="LAV">Sēra darvas ziede (pix qiquida 50g,sulfuris 50 g,vaselinum 900 g)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Sēra darvas ziede (pix qiquida 50g,sulfuris 50 g,vaselinum 900 g)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67139,7 +68005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67167,8 +68033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67179,7 +68045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67202,8 +68068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP348</cbc:ID>
-         <cbc:Name languageID="LAV">Talcum maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Talcum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67219,7 +68085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67247,8 +68113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67259,7 +68125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67282,8 +68148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP349</cbc:ID>
-         <cbc:Name languageID="LAV">Tinctura Leonuri </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tinctura Leonuri </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67299,7 +68165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67327,8 +68193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67339,7 +68205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67362,8 +68228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP350</cbc:ID>
-         <cbc:Name languageID="LAV">Tinctura Valerianae</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Tinctura Valerianae</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67379,7 +68245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67407,8 +68273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67419,7 +68285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67442,8 +68308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP351</cbc:ID>
-         <cbc:Name languageID="LAV">Trilonum B maks. iepak.līdz 100g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Trilonum B maks. iepak.līdz 100g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67459,7 +68325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67487,8 +68353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67499,7 +68365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67522,8 +68388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP352</cbc:ID>
-         <cbc:Name languageID="LAV">Vaselinum maks. iepak.līdz 5kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Vaselinum maks. iepak.līdz 5kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67539,7 +68405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67567,8 +68433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67579,7 +68445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67602,8 +68468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP353</cbc:ID>
-         <cbc:Name languageID="LAV">Xeroformum maks. iepak.līdz 100g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Xeroformum maks. iepak.līdz 100g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67619,7 +68485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67647,8 +68513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67659,7 +68525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67682,8 +68548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP354</cbc:ID>
-         <cbc:Name languageID="LAV">Zinci oxydum maks. iepak.līdz 1kg</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Zinci oxydum maks. iepak.līdz 1kg</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67699,7 +68565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67727,8 +68593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67739,7 +68605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67762,8 +68628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP355</cbc:ID>
-         <cbc:Name languageID="LAV">Zinci sulfas maks. iepak.līdz 50g</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Zinci sulfas maks. iepak.līdz 50g</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67779,7 +68645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67807,8 +68673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67819,7 +68685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67842,8 +68708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP356</cbc:ID>
-         <cbc:Name languageID="LAV">Pretaizsvīšanas, pretaprasojuma līdzeklis visu veidu optikas izstrādājumiem, (Ultrastop)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Pretaizsvīšanas, pretaprasojuma līdzeklis visu veidu optikas izstrādājumiem, (Ultrastop)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67859,7 +68725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67887,8 +68753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67899,7 +68765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -67922,8 +68788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP357</cbc:ID>
-         <cbc:Name languageID="LAV">Prontosan -Sastāvā 0,1% undecilēnamidopropilbetaīns, 0,1% poliamīnopropilbiguanīds (poliheksanīds).Nekairinošs, nesausinošs, piemērots atkārtotai un ilgstošai lietošanai. </cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Prontosan -Sastāvā 0,1% undecilēnamidopropilbetaīns, 0,1% poliamīnopropilbiguanīds (poliheksanīds).Nekairinošs, nesausinošs, piemērots atkārtotai un ilgstošai lietošanai. </cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -67939,7 +68805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -67967,8 +68833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -67979,7 +68845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68002,8 +68868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP358</cbc:ID>
-         <cbc:Name languageID="LAV">Kastellani liq.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Kastellani liq.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68019,7 +68885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68047,8 +68913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68059,7 +68925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68082,8 +68948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP359</cbc:ID>
-         <cbc:Name languageID="LAV">Kastellani liq.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Kastellani liq.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68099,7 +68965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68127,8 +68993,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68139,7 +69005,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68162,8 +69028,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP360</cbc:ID>
-         <cbc:Name languageID="LAV">Kastellani liq.sine fuxini</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Kastellani liq.sine fuxini</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68179,7 +69045,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68207,8 +69073,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68219,7 +69085,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68242,8 +69108,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP361</cbc:ID>
-         <cbc:Name languageID="LAV">Kastellani liq.sine fuxini</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Kastellani liq.sine fuxini</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68259,7 +69125,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68287,8 +69153,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68299,7 +69165,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68322,8 +69188,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP362</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai (penicilīna ar gumijas un metāla korķišiem)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai (penicilīna ar gumijas un metāla korķišiem)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68339,7 +69205,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68367,8 +69233,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68379,7 +69245,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68402,8 +69268,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP363</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68419,7 +69285,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68447,8 +69313,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68459,7 +69325,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68482,8 +69348,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP364</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68499,7 +69365,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68527,8 +69393,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68539,7 +69405,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68562,8 +69428,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP365</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68579,7 +69445,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68607,8 +69473,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68619,7 +69485,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68642,8 +69508,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP366</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68659,7 +69525,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68687,8 +69553,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68699,7 +69565,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68722,8 +69588,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP367</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68739,7 +69605,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68767,8 +69633,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68779,7 +69645,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68802,8 +69668,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP368</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68819,7 +69685,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68847,8 +69713,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68859,7 +69725,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68882,8 +69748,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP369</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68899,7 +69765,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -68927,8 +69793,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -68939,7 +69805,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -68962,8 +69828,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP370</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu, paplatinātu kaklu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -68979,7 +69845,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69007,8 +69873,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69019,7 +69885,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69042,8 +69908,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP371</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69059,7 +69925,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69087,8 +69953,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69099,7 +69965,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69122,8 +69988,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP372</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69139,7 +70005,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69167,8 +70033,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69179,7 +70045,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69202,8 +70068,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP373</cbc:ID>
-         <cbc:Name languageID="LAV">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu.</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Flakoni -pudeles zāļu fasēšanai -tumša stikla ar aizskrūvējamu vāciņu.</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69219,7 +70085,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69247,8 +70113,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69259,7 +70125,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69282,8 +70148,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP374</cbc:ID>
-         <cbc:Name languageID="LAV">Pudeles -stikls flakoni ( ar gumijas un alumīnija vāciņu valcēšanai)</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Pudeles -stikls flakoni ( ar gumijas un alumīnija vāciņu valcēšanai)</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69299,7 +70165,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69327,8 +70193,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69339,7 +70205,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69362,8 +70228,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP375</cbc:ID>
-         <cbc:Name languageID="LAV">Alumīnija vāciņš (valcēšanai) infūzijas pudelēm</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Alumīnija vāciņš (valcēšanai) infūzijas pudelēm</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69379,7 +70245,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69407,8 +70273,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69419,7 +70285,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69442,8 +70308,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP376</cbc:ID>
-         <cbc:Name languageID="LAV">Gumijas aizbāznis infūzijas pudelēm</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Gumijas aizbāznis infūzijas pudelēm</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69459,7 +70325,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69487,8 +70353,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69499,7 +70365,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69522,8 +70388,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP377</cbc:ID>
-         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69539,7 +70405,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69567,8 +70433,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69579,7 +70445,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69602,8 +70468,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP378</cbc:ID>
-         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69619,7 +70485,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69647,8 +70513,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69659,7 +70525,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69682,8 +70548,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP379</cbc:ID>
-         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69699,7 +70565,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69727,8 +70593,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69739,7 +70605,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69762,8 +70628,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP380</cbc:ID>
-         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69779,7 +70645,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69807,8 +70673,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69819,7 +70685,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69842,8 +70708,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP381</cbc:ID>
-         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69859,7 +70725,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69887,8 +70753,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69899,7 +70765,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -69922,8 +70788,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP382</cbc:ID>
-         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -69939,7 +70805,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -69967,8 +70833,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -69979,7 +70845,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -70002,8 +70868,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP383</cbc:ID>
-         <cbc:Name languageID="LAV">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Bankas ziežu fasēšanai-plastmasas (platkakla) ar vāciņiem</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -70019,7 +70885,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>
@@ -70047,8 +70913,8 @@
                      </ext:UBLExtension>
                   </ext:UBLExtensions>
                   <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
-                  <cbc:Name languageID="LAV">Cena</cbc:Name>
-                  <cbc:Description languageID="LAV">Cena</cbc:Description>
+                  <cbc:Name languageID="ENG">Cena</cbc:Name>
+                  <cbc:Description languageID="ENG">Cena</cbc:Description>
                </cac:SubordinateAwardingCriterion>
             </cac:AwardingCriterion>
          </cac:AwardingTerms>
@@ -70059,7 +70925,7 @@
          </cac:AdditionalInformationParty>
          <cac:AppealTerms>
             <cac:PresentationPeriod>
-               <cbc:Description languageID="LAV">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
+               <cbc:Description languageID="ENG">Iesniegumu Iepirkumu uzraudzības birojam var iesniegt līdz iepirkuma līguma vai vispārīgās vienošanās noslēgšanas dienai šādos termiņos:1) 10 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai elektroniski, izmantojot drošu elektronisko parakstu vai pievienojot elektroniskajam pastam skenētu dokumentu, vai pa faksu vai nodota personiski;2) 15 dienu laikā pēc dienas, kad Publisko iepirkumu likuma 37. pantā minētā informācija nosūtīta attiecīgajai personai pa pastu</cbc:Description>
             </cac:PresentationPeriod>
             <cac:AppealReceiverParty>
                <cac:PartyIdentification>
@@ -70082,8 +70948,8 @@
       </cac:TenderingProcess>
       <cac:ProcurementProject>
          <cbc:ID>R1S 2023/17-IEP384</cbc:ID>
-         <cbc:Name languageID="LAV">Enterālās barošanas līdzekļi	</cbc:Name>
-         <cbc:Description languageID="LAV">Medikamentu iegāde</cbc:Description>
+         <cbc:Name languageID="ENG">Enterālās barošanas līdzekļi	</cbc:Name>
+         <cbc:Description languageID="ENG">Medikamentu iegāde</cbc:Description>
          <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
          <cac:ProcurementAdditionalType>
             <cbc:ProcurementTypeCode listName="strategic-procurement">none</cbc:ProcurementTypeCode>
@@ -70099,7 +70965,7 @@
                <cbc:StreetName>Bruņinieku iela 5</cbc:StreetName>
                <cbc:CityName>Rīga</cbc:CityName>
                <cbc:PostalZone>LV-1001</cbc:PostalZone>
-               <cbc:CountrySubentityCode listName="nuts">LV006</cbc:CountrySubentityCode>
+               <cbc:CountrySubentityCode listName="nuts">LV00A</cbc:CountrySubentityCode>
                <cac:Country>
                   <cbc:IdentificationCode listName="country">LVA</cbc:IdentificationCode>
                </cac:Country>

From 39dbebc5641a3d260bfc81fbd3f347467ea49697 Mon Sep 17 00:00:00 2001
From: Bertrand Lorentz <bertrand.lorentz@publications.europa.eu>
Date: Mon, 14 Oct 2024 17:54:40 +0200
Subject: [PATCH 22/22] pom: Update version to 1.13.0

---
 pom.xml | 4 ++--
 1 file changed, 2 insertions(+), 2 deletions(-)

diff --git a/pom.xml b/pom.xml
index e8fddf3..5c9641d 100644
--- a/pom.xml
+++ b/pom.xml
@@ -4,7 +4,7 @@
 
   <groupId>eu.europa.ted.eforms</groupId>
   <artifactId>eforms-sdk-analyzer</artifactId>
-  <version>1.13.0-SNAPSHOT</version>
+  <version>1.13.0</version>
   <packaging>kjar</packaging>
 
   <name>eForms SDK Analyzer</name>
@@ -49,7 +49,7 @@
 
   <properties>
     <project.build.sourceEncoding>UTF-8</project.build.sourceEncoding>
-    <project.build.outputTimestamp>2024-07-16T09:10:14Z</project.build.outputTimestamp>
+    <project.build.outputTimestamp>2024-10-14T15:54:01Z</project.build.outputTimestamp>
 
     <sonatype.server.url>s01.oss.sonatype.org</sonatype.server.url>